~~0001411342efc:~~0001411342srt:WeightedAverageMemberefc:CorporateloanMemberus-gaap:~~IncomeApproachValuationTechniqueMemberus-gaap:FairValueInputsLevel3Membersrt:WeightedAverageMemberus-gaap:MeasurementInputDiscountRateMember2019-12-31~~MeasurementInputQuotedPriceMemberus-gaap:MarketApproachValuationTechniqueMemberus-gaap:FairValueInputsLevel3Member2020-12-31

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September 30, 2020~~March 31, 2021


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 001-34569

Ellington Financial Inc.

(Exact Name of Registrant as Specified in Its Charter)


Delaware						26-0489289
(State or Other Jurisdiction of Incorporation or Organization)						(I.R.S. Employer Identification No.)

53 Forest Avenue

Old Greenwich, Connecticut, 06870

(Address of Principal Executive Offices) (Zip Code)

(203) 698-1200

(Registrant's Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol(s)

Name of Each Exchange on Which Registered

Common Stock, $0.001 par value per share

EFC

The New York Stock Exchange

6.750% Series A Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock

EFC PR A

The New York Stock Exchange

~~Securities registered pursuant to Section 12(g) of the Act: None~~

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.


Large Accelerated Filer	☐	Accelerated Filer	☒
Non-Accelerated Filer	☐	Smaller Reporting Company	☐
		Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x

Number of shares of the Registrant's common stock outstanding as of ~~November 6, 2020:~~May 7, 2021: 43,781,684

Table of Contents

ELLINGTON FINANCIAL INC.

INDEX


Part I. Financial Information
	Item 1. Condensed Consolidated Financial Statements (unaudited)	3
	Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	7665
	Item 3. Quantitative and Qualitative Disclosures about Market Risk	~~108~~92
	Item 4. Controls and Procedures	~~111~~95
Part II. Other Information
	Item 1. Legal Proceedings	~~112~~96
	Item 1A. Risk Factors	~~112~~96
	Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	~~112~~96
	Item 6. Exhibits	~~113~~97

Table of Contents

PART I—FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements (Unaudited)

ELLINGTON FINANCIAL INC.

CONDENSED CONSOLIDATED BALANCE SHEET

(UNAUDITED)


		September 30, 2020		December 31, 2019			March 31, 2021		December 31, 2020
(In thousands, except share amounts)	(In thousands, except share amounts)	Expressed in U.S. Dollars				(In thousands, except share amounts)	Expressed in U.S. Dollars
Assets	Assets					Assets
Cash and cash equivalents(1)	Cash and cash equivalents(1)	$	126,783	$	72,302	Cash and cash equivalents(1)	$	149,350	$	111,647
Restricted cash(1)	Restricted cash(1)	175		175		Restricted cash(1)	175		175
Securities, at fair value~~(1)~~(2)	Securities, at fair value~~(1)~~(2)	1,451,420		2,449,941		Securities, at fair value~~(1)~~(2)	1,909,127		1,514,185
Loans, at fair value~~(1)~~(2)	Loans, at fair value~~(1)~~(2)	1,442,612		1,412,426		Loans, at fair value~~(1)~~(2)	1,582,516		1,453,480
Investments in unconsolidated entities, at fair value(1)	Investments in unconsolidated entities, at fair value(1)	95,803		71,850		Investments in unconsolidated entities, at fair value(1)	147,684		141,620
Real estate owned~~(1)~~(2)	Real estate owned~~(1)~~(2)	24,794		30,584		Real estate owned~~(1)~~(2)	35,557		23,598
Financial derivatives—assets, at fair value	Financial derivatives—assets, at fair value	27,864		16,788		Financial derivatives—assets, at fair value	23,082		15,479
Reverse repurchase agreements	Reverse repurchase agreements	47,041		73,639		Reverse repurchase agreements	96,783		38,640
Due from brokers(1)	Due from brokers(1)	63,991		79,829		Due from brokers(1)	91,814		63,147
Investment related receivables(1)	Investment related receivables(1)	67,540		123,120		Investment related receivables(1)	67,338		49,317
Other assets(1)	Other assets(1)	2,850		7,563		Other assets(1)	3,499		2,575
Total Assets	Total Assets	$	3,350,873	$	4,338,217	Total Assets	$	4,106,925	$	3,413,863
Liabilities	Liabilities					Liabilities
Securities sold short, at fair value	Securities sold short, at fair value	$	51,493	$	73,409	Securities sold short, at fair value	$	96,398	$	38,642
Repurchase agreements(1)	Repurchase agreements(1)	1,439,984		2,445,300		Repurchase agreements(1)	1,909,511		1,496,931
Financial derivatives—liabilities, at fair value	Financial derivatives—liabilities, at fair value	34,814		27,621		Financial derivatives—liabilities, at fair value	19,438		24,553
Due to brokers	Due to brokers	7,147		2,197		Due to brokers	5,337		5,059
Investment related payables(1)	Investment related payables(1)	0		66,133		Investment related payables(1)	40,836		4,754
Other secured borrowings(1)	Other secured borrowings(1)	142,674		150,334		Other secured borrowings(1)	64,506		51,062
Other secured borrowings, at fair value(1)	Other secured borrowings, at fair value(1)	695,516		594,396		Other secured borrowings, at fair value(1)	911,256		754,921
Senior notes, net	Senior notes, net	85,495		85,298		Senior notes, net	85,627		85,561
Base management fee payable to affiliate	Base management fee payable to affiliate	2,981		2,663		Base management fee payable to affiliate	3,277		3,178
Incentive fee payable to affiliate		0		116
Dividends payable	Dividends payable	5,299		6,978		Dividends payable	5,740		5,738
Interest payable(1)	Interest payable(1)	2,074		7,320		Interest payable(1)	1,915		3,233
Accrued expenses and other liabilities(1)	Accrued expenses and other liabilities(1)	11,119		7,753		Accrued expenses and other liabilities(1)	19,708		18,659
Total Liabilities	Total Liabilities	2,478,596		3,469,518		Total Liabilities	3,163,549		2,492,291
Commitments and contingencies (Note 21)	Commitments and contingencies (Note 21)					Commitments and contingencies (Note 21)	0
Equity	Equity					Equity
Preferred stock, par value $0.001 per share, 100,000,000 shares authorized; 6.750% Series A Fixed-to-Floating Rate Cumulative Redeemable; 4,600,000 shares issued and outstanding, respectively ($115,000 liquidation preference)	Preferred stock, par value $0.001 per share, 100,000,000 shares authorized; 6.750% Series A Fixed-to-Floating Rate Cumulative Redeemable; 4,600,000 shares issued and outstanding, respectively ($115,000 liquidation preference)	111,034		111,034		Preferred stock, par value $0.001 per share, 100,000,000 shares authorized; 6.750% Series A Fixed-to-Floating Rate Cumulative Redeemable; 4,600,000 shares issued and outstanding, respectively ($115,000 liquidation preference)	111,034		111,034
Common stock, par value $0.001 per share, 100,000,000 shares authorized; 43,781,684 and 38,647,943 shares issued and outstanding, respectively		44		39
Common stock, par value $0.001 per share, 100,000,000 shares authorized; 43,781,684 and 43,781,684 shares issued and outstanding, respectively						Common stock, par value $0.001 per share, 100,000,000 shares authorized; 43,781,684 and 43,781,684 shares issued and outstanding, respectively	44		44
Additional paid-in-capital	Additional paid-in-capital	916,038		821,747		Additional paid-in-capital	915,577		915,658
Retained earnings (accumulated deficit)	Retained earnings (accumulated deficit)	(191,986)		(103,555)		Retained earnings (accumulated deficit)	(116,799)		(141,521)
Total Stockholders' Equity	Total Stockholders' Equity	835,130		829,265		Total Stockholders' Equity	909,856		885,215
Non-controlling interests(1)	Non-controlling interests(1)	37,147		39,434		Non-controlling interests(1)	33,520		36,357
Total Equity	Total Equity	872,277		868,699		Total Equity	943,376		921,572
Total Liabilities and Equity	Total Liabilities and Equity	$	3,350,873	$	4,338,217	Total Liabilities and Equity	$	4,106,925	$	3,413,863

(1)Ellington Financial Inc.'s Condensed Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.

(2)Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.

See Notes to Condensed Consolidated Financial Statements

Table of Contents

ELLINGTON FINANCIAL INC.

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(UNAUDITED)


		Three-Month Period Ended				Nine-Month Period Ended					Three-Month Period Ended
		September 30, 2020		September 30, 2019		September 30, 2020		September 30, 2019			March 31, 2021		March 31, 2020
(In thousands, except per share amounts)	(In thousands, except per share amounts)	Expressed in U.S. Dollars								(In thousands, except per share amounts)
Net Interest Income	Net Interest Income									Net Interest Income
Interest income	Interest income	$	43,075	$	39,985	$	134,463	$	114,548	Interest income	$	40,079	$	52,108
Interest expense	Interest expense	(12,937)		(19,954)		(49,713)		(57,275)		Interest expense	(11,342)		(22,090)
Total net interest income	Total net interest income	30,138		20,031		84,750		57,273		Total net interest income	28,737		30,018
Other Income (Loss)	Other Income (Loss)									Other Income (Loss)
Realized gains (losses) on securities and loans, net	Realized gains (losses) on securities and loans, net	1,446		3,368		(2,335)		(3,460)		Realized gains (losses) on securities and loans, net	4,276		12,260
Realized gains (losses) on financial derivatives, net	Realized gains (losses) on financial derivatives, net	(1,620)		(9,360)		(25,702)		(31,850)		Realized gains (losses) on financial derivatives, net	5,795		(12,406)
Realized gains (losses) on real estate owned, net	Realized gains (losses) on real estate owned, net	(18)		1,165		121		1,205		Realized gains (losses) on real estate owned, net	61		350
Unrealized gains (losses) on securities and loans, net	Unrealized gains (losses) on securities and loans, net	24,208		6,519		(65,418)		51,395		Unrealized gains (losses) on securities and loans, net	(1,781)		(133,738)
Unrealized gains (losses) on financial derivatives, net	Unrealized gains (losses) on financial derivatives, net	(298)		1,473		(2,109)		(9,136)		Unrealized gains (losses) on financial derivatives, net	10,711		(9,984)
Unrealized gains (losses) on real estate owned, net	Unrealized gains (losses) on real estate owned, net	122		(22)		(462)		(535)		Unrealized gains (losses) on real estate owned, net	(792)		(357)
Other, net	Other, net	(2,747)		539		(1,503)		4,349		Other, net	1,960		1,679
Total other income (loss)	Total other income (loss)	21,093		3,682		(97,408)		11,968		Total other income (loss)	20,230		(142,196)
Expenses	Expenses									Expenses
Base management fee to affiliate (Net of fee rebates of $201, $503, $853, and $1,458, respectively)(1)		2,981		1,942		8,330		5,324
Base management fee to affiliate (Net of fee rebates of $194 and $507, respectively)(1)										Base management fee to affiliate (Net of fee rebates of $194 and $507, respectively)(1)	3,277		2,443
Investment related expenses:	Investment related expenses:									Investment related expenses:
Servicing expense	Servicing expense	2,379		1,940		7,402		6,578		Servicing expense	986		2,531
Debt issuance costs related to Other secured borrowings, at fair value	Debt issuance costs related to Other secured borrowings, at fair value	0		0		2,075		1,671		Debt issuance costs related to Other secured borrowings, at fair value	1,665		0
Other	Other	1,199		1,347		3,328		3,668		Other	2,204		1,423
Professional fees	Professional fees	1,209		698		3,819		3,832		Professional fees	1,198		1,277
Compensation expense	Compensation expense	1,085		712		2,813		2,687		Compensation expense	1,420		788
Other expenses	Other expenses	1,625		1,156		4,876		3,194		Other expenses	1,579		1,752
Total expenses	Total expenses	10,478		7,795		32,643		26,954		Total expenses	12,329		10,214
Net Income (Loss) before Income Tax Expense (Benefit) and Earnings (Losses) from Investments in Unconsolidated Entities	Net Income (Loss) before Income Tax Expense (Benefit) and Earnings (Losses) from Investments in Unconsolidated Entities	40,753		15,918		(45,301)		42,287		Net Income (Loss) before Income Tax Expense (Benefit) and Earnings (Losses) from Investments in Unconsolidated Entities	36,638		(122,392)
Income tax expense (benefit)	Income tax expense (benefit)	2,494		2		3,490		378		Income tax expense (benefit)	2,017		(547)
Earnings (losses) from investments in unconsolidated entities	Earnings (losses) from investments in unconsolidated entities	11,443		2,796		10,590		6,947		Earnings (losses) from investments in unconsolidated entities	6,635		(6,497)
Net Income (Loss)	Net Income (Loss)	49,702		18,712		(38,201)		48,856		Net Income (Loss)	41,256		(128,342)
Net income (loss) attributable to non-controlling interests	Net income (loss) attributable to non-controlling interests	1,559		1,419		1,894		3,511		Net income (loss) attributable to non-controlling interests	1,459		(885)
Dividends on preferred stock	Dividends on preferred stock	1,940		0		5,822		0		Dividends on preferred stock	1,941		1,941
Net Income (Loss) Attributable to Common Stockholders	Net Income (Loss) Attributable to Common Stockholders	$	46,203	$	17,293	$	(45,917)	$	45,345	Net Income (Loss) Attributable to Common Stockholders	$	37,856	$	(129,398)
Net Income (Loss) per Share of Common Stock:	Net Income (Loss) per Share of Common Stock:									Net Income (Loss) per Share of Common Stock:
Basic and Diluted	Basic and Diluted	$	1.06	$	0.53	$	(1.06)	$	1.47	Basic and Diluted	$	0.86	$	(3.04)

(1)See Note 13 for further details on management fee rebates.

See Notes to Condensed Consolidated Financial Statements

Table of Contents

ELLINGTON FINANCIAL INC.

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

(UNAUDITED)

Common Stock Additional
Paid-in
Capital Retained
Earnings/(Accumulated Deficit) Total Stockholders' Equity Non-controlling Interest Total Equity
Preferred Stock Shares Par Value
(In thousands, except share amounts) Expressed in U.S. Dollars
BALANCE, December 31, 2019 $ 111,034 38,647,943 $ 39 $ 821,747 $ (103,555) $ 829,265 $ 39,434 $ 868,699
Net income (loss) (127,457) (127,457) (885) (128,342)
Net proceeds from the issuance of common stock(1)
5,290,000 5 95,287 95,292 — 95,292
Shares of common stock issued in connection with incentive fee payment 637 0 12 12 — 12
Contributions from non-controlling interests 3,487 3,487
Common dividends(2)
(19,748) (19,748) (309) (20,057)
Preferred dividends(3)
(1,941) (1,941) 0 (1,941)
Distributions to non-controlling interests (4,798) (4,798)
Conversion of non-controlling interest units to shares of common stock 129,516 — 2,378 2,378 (2,378) —
Adjustment to non-controlling interests (545) (545) 545 —
Repurchase of shares of common stock (288,172) — (3,035) (3,035) (3,035)
Share-based long term incentive plan unit awards — — 162 162 2 164
BALANCE, March 31, 2020 111,034 43,779,924 44 916,006 (252,701) 774,383 35,098 809,481
Net income (loss) 39,219 39,219 1,220 40,439
Contributions from non-controlling interests 2,895 2,895
Common dividends(2)
(10,945) (10,945) (152) (11,097)
Preferred dividends(3)
(1,941) (1,941) 0 (1,941)
Distributions to non-controlling interests (2,280) (2,280)
Share-based long term incentive plan unit awards 180 180 2 182
BALANCE, June 30, 2020 111,034 43,779,924 44 916,186 (226,368) 800,896 36,783 837,679
Net income (loss) 48,143 48,143 1,559 49,702
Contributions from non-controlling interests 1,199 1,199
Common dividends(2)
(11,821) (11,821) (166) (11,987)
Preferred dividends(3)
(1,940) (1,940) 0 (1,940)
Distributions to non-controlling interests (2,541) (2,541)
Conversion of non-controlling interest units to shares of common stock 3,638 — 59 59 (59) —
Adjustment to non-controlling interests (369) (369) 369 —
Repurchase of shares of common stock (1,878) — (21) (21) — (21)
Share-based long term incentive plan unit awards 0 — 183 183 3 186
BALANCE, September 30, 2020 $ 111,034 43,781,684 $ 44 $ 916,038 $ (191,986) $ 835,130 $ 37,147 $ 872,277

~~See Notes to Condensed Consolidated Financial Statements~~

~~Table of Contents~~


ELLINGTON FINANCIAL INC.
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (CONTINUED)
(UNAUDITED)

																								Common Stock						Additional Paid-in Capital						Retained Earnings/(Accumulated Deficit)	Total Stockholders' Equity			Non-controlling Interest		Total Equity
				Common Stock			Additional Paid-in Capital				Retained Earnings/(Accumulated Deficit)			Total Stockholders' Equity			Non-controlling Interest				Total Equity			Preferred Stock					Shares			Additional Paid-in Capital							Total Equity
		Preferred Stock		Shares	Par Value								Total Equity
BALANCE, January 1, 2019		$	0	29,796,601	$	0			$	665,356				$	(101,523)				$	563,833					$	31,337	$	595,170
Share conversion(4)				—	30		(30)						—			—			—				—
(In thousands, except share amounts)																							(In thousands, except share amounts)							Expressed in U.S. Dollars
BALANCE, December 31, 2020																							BALANCE, December 31, 2020	$	111,034				43,781,684	$	44			$	915,658					$	(141,521)	$	885,215	$	36,357	$	921,572
Net income (loss)	Net income (loss)										15,408			15,408			1,080				16,488		Net income (loss)														39,797			39,797		1,459		41,256
Contributions from non-controlling interests	Contributions from non-controlling interests																2,512				2,512		Contributions from non-controlling interests																			1,517		1,517
Common dividends(2)											(16,360)			(16,360)			(404)				(16,764)
Common dividends(1)																							Common dividends(1)														(13,134)			(13,134)		(200)		(13,334)
Preferred dividends(2)																							Preferred dividends(2)														(1,941)			(1,941)				(1,941)
Distributions to non-controlling interests	Distributions to non-controlling interests																(4,306)				(4,306)		Distributions to non-controlling interests																			(5,923)		(5,923)
Adjustment to non-controlling interests																							Adjustment to non-controlling interests									(307)								(307)		307		—
Share-based long term incentive plan unit awards																							Share-based long term incentive plan unit awards									226								226		3		229
BALANCE, March 31, 2021																							BALANCE, March 31, 2021	$	111,034				43,781,684	$	44	$	915,577				$	(116,799)		$	909,856	$	33,520	$	943,376

BALANCE, December 31, 2019																							BALANCE, December 31, 2019	$	111,034				38,647,943	$	39	$	821,747				$	(103,555)		$	829,265	$	39,434	$	868,699
Net income (loss)																							Net income (loss)														(127,457)			(127,457)		(885)		(128,342)
Net proceeds from the issuance of common stock(3)																							Net proceeds from the issuance of common stock(3)						5,290,000	5		95,287								95,292		—		95,292
Shares of common stock issued in connection with incentive fee payment																							Shares of common stock issued in connection with incentive fee payment						637	0		12								12		—		12
Contributions from non-controlling interests																							Contributions from non-controlling interests																			3,487		3,487
Common dividends(1)																							Common dividends(1)														(19,748)			(19,748)		(309)		(20,057)
Preferred dividends(2)																							Preferred dividends(2)														(1,941)			(1,941)				(1,941)
Distributions to non-controlling interests																							Distributions to non-controlling interests																			(4,798)		(4,798)
Conversion of non-controlling interest units to shares of common stock																							Conversion of non-controlling interest units to shares of common stock						129,516	—		2,378								2,378		(2,378)		—
Adjustment to non-controlling interests	Adjustment to non-controlling interests						(4)							(4)			4				—		Adjustment to non-controlling interests						—	—		(545)								(545)		545		—
Repurchase of shares of common stock	Repurchase of shares of common stock			(50,825)	—		(782)							(782)							(782)		Repurchase of shares of common stock						(288,172)	—		(3,035)								(3,035)				(3,035)
Share-based long term incentive plan unit awards	Share-based long term incentive plan unit awards						114							114			2				116		Share-based long term incentive plan unit awards						—	—		162								162		2		164
BALANCE, March 31, 2019		0		29,745,776	30		664,654				(102,475)			562,209			30,225				592,434
Net income (loss)											12,644			12,644			1,012				13,656
Contributions from non-controlling interests																	4,936				4,936
Common dividends(2)											(12,493)			(12,493)			(308)				(12,801)
Distributions to non-controlling interests																	(5,225)				(5,225)
Share-based long term incentive plan unit awards							110							110			4				114
BALANCE, June 30, 2019		0		29,745,776	30		664,764				(102,324)			562,470			30,644				593,114
Net income (loss)											17,293			17,293			1,419				18,712
Net proceeds from the issuance of common stock(1)				4,025,000	4		69,806				—			69,810			—				69,810
Contributions from non-controlling interests																	9,428				9,428
Common dividends(2)											(14,185)			(14,185)			(309)				(14,494)
Distributions to non-controlling interests																	(7,719)				(7,719)
Adjustment to non-controlling interests							(56)							(56)			56				—
Share-based long term incentive plan unit awards				3,610	—		114							114			2				116
BALANCE, September 30, 2019		$	0	33,774,386	$	34	$	734,628			$	(99,216)		$	635,446		$	33,521			$	668,967
BALANCE, March 31, 2020																							BALANCE, March 31, 2020	$	111,034				43,779,924	$	44	$	916,006				$	(252,701)		$	774,383	$	35,098	$	809,481

(1)~~Net of underwriters' discounts and offering costs.~~

~~(2)~~For the three-month periods ended ~~September 30,~~March 31, 2021 and 2020, ~~and 2019,~~ dividends totaling ~~$0.27~~$0.30 and ~~$0.42, respectively, per share of common stock and convertible unit outstanding, were declared. For the nine-month periods ended September 30, 2020 and 2019, dividends totaling $0.97 and $1.39,~~$0.45, respectively, per share of common stock and convertible unit outstanding, were declared.

~~(3)~~(2)For the ~~three- and nine-month periods~~three-month period ended ~~September 30, 2020,~~March 31, 2021 dividends totaling $0.421875 ~~and $0.84375, respectively,~~ per share of preferred stock was declared. No such dividends were declared during the three-month period ended March 31, 2020.

~~(4)~~(3)~~See Note 1 for further details on the share conversion.~~Net of underwriters' discounts and offering costs.

See Notes to Condensed Consolidated Financial Statements

Table of Contents

ELLINGTON FINANCIAL INC.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(UNAUDITED)


		Nine-Month Period Ended					Three-Month Period Ended
		September 30, 2020		September 30, 2019			March 31, 2021		March 31, 2020
(In thousands)	(In thousands)	Expressed in U.S. Dollars				(In thousands)	Expressed in U.S. Dollars
Cash Flows from Operating Activities:	Cash Flows from Operating Activities:					Cash Flows from Operating Activities:

Net cash provided by (used in) operating activities	Net cash provided by (used in) operating activities	$	82,480	$	56,119	Net cash provided by (used in) operating activities	$	9,164	$	28,867

Cash Flows from Investing Activities:	Cash Flows from Investing Activities:					Cash Flows from Investing Activities:
Purchase of securities	Purchase of securities	(1,189,684)		(1,890,456)		Purchase of securities	(761,382)		(827,252)
Purchase of loans	Purchase of loans	(548,104)		(701,569)		Purchase of loans	(302,567)		(273,571)
Capital improvements of real estate owned	Capital improvements of real estate owned	(153)		(240)		Capital improvements of real estate owned	(473)		0
Proceeds from disposition of securities	Proceeds from disposition of securities	1,830,612		1,353,755		Proceeds from disposition of securities	285,767		1,241,449
Proceeds from disposition of loans	Proceeds from disposition of loans	8,006		28,344		Proceeds from disposition of loans	0		38
Contributions to investments in unconsolidated entities	Contributions to investments in unconsolidated entities	(19,711)		(39,369)		Contributions to investments in unconsolidated entities	200		(3,034)
Distributions from investments in unconsolidated entities	Distributions from investments in unconsolidated entities	17,181		43,587		Distributions from investments in unconsolidated entities	12,971		13,824
Proceeds from disposition of real estate owned	Proceeds from disposition of real estate owned	7,801		5,579		Proceeds from disposition of real estate owned	336		6,946
Proceeds from principal payments of securities	Proceeds from principal payments of securities	284,242		175,804		Proceeds from principal payments of securities	108,082		135,093
Proceeds from principal payments of loans	Proceeds from principal payments of loans	337,748		207,413		Proceeds from principal payments of loans	53,586		154,441
Proceeds from securities sold short	Proceeds from securities sold short	264,267		508,074		Proceeds from securities sold short	86,373		201,998
Repurchase of securities sold short	Repurchase of securities sold short	(292,105)		(549,782)		Repurchase of securities sold short	(25,219)		(265,932)
Payments on financial derivatives	Payments on financial derivatives	(99,800)		(79,558)		Payments on financial derivatives	(14,566)		(48,081)
Proceeds from financial derivatives	Proceeds from financial derivatives	68,546		45,368		Proceeds from financial derivatives	18,138		26,877
Payments made on reverse repurchase agreements	Payments made on reverse repurchase agreements	(6,659,967)		(4,171,036)		Payments made on reverse repurchase agreements	(1,866,265)		(5,880,200)
Proceeds from reverse repurchase agreements	Proceeds from reverse repurchase agreements	6,686,565		4,343,602		Proceeds from reverse repurchase agreements	1,806,591		5,940,600
Due from brokers, net	Due from brokers, net	12,376		10,160		Due from brokers, net	6,044		(3,029)
Due to brokers, net	Due to brokers, net	5,641		(2,995)		Due to brokers, net	2,088		8,287
Net cash provided by (used in) investing activities	Net cash provided by (used in) investing activities	713,461		(713,319)		Net cash provided by (used in) investing activities	(590,296)		428,454

Cash Flows from Financing Activities:	Cash Flows from Financing Activities:					Cash Flows from Financing Activities:
Net proceeds from the issuance of common stock(1)	Net proceeds from the issuance of common stock(1)	95,537		70,035		Net proceeds from the issuance of common stock(1)	0		95,537
Offering costs paid	Offering costs paid	(253)		(462)		Offering costs paid	0		(253)
Repurchase of common stock	Repurchase of common stock	(3,056)		(782)		Repurchase of common stock	0		(3,035)
Dividends paid	Dividends paid	(50,642)		(39,226)		Dividends paid	(15,273)		(21,024)
Contributions from non-controlling interests	Contributions from non-controlling interests	9,134		16,876		Contributions from non-controlling interests	1,159		3,487
Distributions to non-controlling interests	Distributions to non-controlling interests	(7,961)		(17,250)		Distributions to non-controlling interests	(5,923)		(4,798)
Proceeds from issuance of Other secured borrowings	Proceeds from issuance of Other secured borrowings	45,963		28,490		Proceeds from issuance of Other secured borrowings	20,634		31,913
Principal payments on Other secured borrowings	Principal payments on Other secured borrowings	(59,893)		(51,439)		Principal payments on Other secured borrowings	(7,990)		(10,662)
Borrowings under repurchase agreements	Borrowings under repurchase agreements	3,445,412		6,110,390		Borrowings under repurchase agreements	1,495,139		1,856,666
Repayments of repurchase agreements	Repayments of repurchase agreements	(4,423,440)		(5,540,301)		Repayments of repurchase agreements	(1,043,777)		(2,267,741)
Proceeds from issuance of Other secured borrowings, at fair value	Proceeds from issuance of Other secured borrowings, at fair value	205,357		70,988		Proceeds from issuance of Other secured borrowings, at fair value	211,187		0
Debt issuance costs paid		0		(1,034)
Due from brokers, net	Due from brokers, net	2,620		(3,826)		Due from brokers, net	(34,815)		(73,544)
Due to brokers, net	Due to brokers, net	(238)		3,086		Due to brokers, net	(1,506)		571
Net cash provided by (used in) financing activities	Net cash provided by (used in) financing activities	(741,460)		645,545		Net cash provided by (used in) financing activities	618,835		(392,883)
Net Increase (Decrease) in Cash, Cash Equivalents, and Restricted Cash	Net Increase (Decrease) in Cash, Cash Equivalents, and Restricted Cash	54,481		(11,655)		Net Increase (Decrease) in Cash, Cash Equivalents, and Restricted Cash	37,703		64,438
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	72,477		45,081		Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	111,822		72,477
Cash, Cash Equivalents, and Restricted Cash, End of Period	Cash, Cash Equivalents, and Restricted Cash, End of Period	$	126,958	$	33,426	Cash, Cash Equivalents, and Restricted Cash, End of Period	$	149,525	$	136,915

See Notes to Condensed Consolidated Financial Statements

Table of Contents

											ELLINGTON FINANCIAL INC.	CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (CONTINUED)	(UNAUDITED)
		Nine-Month Period Ended					Three-Month Period Ended
		September 30, 2020		September 30, 2019			March 31, 2021		March 31, 2020
(In thousands)	(In thousands)	Expressed in U.S. Dollars				(In thousands)	Expressed in U.S. Dollars
Supplemental disclosure of cash flow information:	Supplemental disclosure of cash flow information:					Supplemental disclosure of cash flow information:
Interest paid	Interest paid	$	54,958	$	58,298	Interest paid	$	12,660	$	24,126
Income tax paid	Income tax paid	505		142		Income tax paid	(7)		0
Dividends payable	Dividends payable	5,299		4,833		Dividends payable	5,740		7,952
Contributions from non-controlling interests (non-cash)		2,340		0
Distributions to non-controlling interests (non-cash)		(2,340)		0
Transfers from mortgage loans to real estate owned (non-cash)	Transfers from mortgage loans to real estate owned (non-cash)	2,198		18,314		Transfers from mortgage loans to real estate owned (non-cash)	12,554		1,422
Transfers from mortgage loans to investments in unconsolidated entities (non-cash)	Transfers from mortgage loans to investments in unconsolidated entities (non-cash)	10,833		0		Transfers from mortgage loans to investments in unconsolidated entities (non-cash)	12,600		10,833
Purchase of investments (non-cash)		0		(2,975)
Purchase of loans (non-cash)	Purchase of loans (non-cash)	(6,270)		0		Purchase of loans (non-cash)	(800)		(6,270)
Principal payments on Other secured borrowings, at fair value (non-cash)	Principal payments on Other secured borrowings, at fair value (non-cash)	(138,608)		(78,887)		Principal payments on Other secured borrowings, at fair value (non-cash)	(92,930)		(44,704)
Proceeds received from Other secured borrowings, at fair value (non-cash)	Proceeds received from Other secured borrowings, at fair value (non-cash)	27,735		148,547		Proceeds received from Other secured borrowings, at fair value (non-cash)	39,321		0
Proceeds from issuance of Other secured borrowings (non-cash)	Proceeds from issuance of Other secured borrowings (non-cash)	6,270		0		Proceeds from issuance of Other secured borrowings (non-cash)	800		6,270
Proceeds from principal payments of investments (non-cash)	Proceeds from principal payments of investments (non-cash)	138,608		78,887		Proceeds from principal payments of investments (non-cash)	92,930		44,704
Repayments of repurchase agreements (non-cash)	Repayments of repurchase agreements (non-cash)	(27,288)		(148,158)		Repayments of repurchase agreements (non-cash)	(38,782)		0
Repayment of senior notes (non-cash)		0		(86,000)
Issuance of senior notes (non-cash)		0		86,000

(1)Net of underwriters' discounts.

See Notes to Condensed Consolidated Financial Statements

Table of Contents

ELLINGTON FINANCIAL INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~September 30, 2020~~March 31, 2021

(UNAUDITED)

1. Organization and Investment Objective

Ellington Financial Inc., formerly known as Ellington Financial LLC, was originally formed as a Delaware limited liability company on July 9, 2007 and commenced operations on August 17, 2007. On February 28, 2019, Ellington Financial LLC filed a certificate of conversion with the Secretary of State of the State of Delaware (the "Secretary") to convert from a Delaware limited liability company to a Delaware corporation (the "Conversion") and change its name to Ellington Financial Inc. The Conversion became effective on March 1, 2019, and upon effectiveness, each of Ellington Financial LLC's existing common shares representing limited liability company interests, no par value, converted into one issued and outstanding, fully paid and nonassessable share of common stock, $0.001 par value per share, of Ellington Financial Inc. In connection with the Conversion, Ellington Financial Inc.'s Board of Directors (the "Board of Directors") approved Ellington Financial Inc.'s Certificate of Incorporation (which was also filed with the Secretary) and Bylaws.

Ellington Financial Operating Partnership LLC (the "Operating Partnership"), a ~~98.8%~~98.7% owned consolidated subsidiary of Ellington Financial Inc., was formed as a Delaware limited liability company on December 14, 2012 and commenced operations on January 1, 2013. All of Ellington Financial Inc.'s operations and business activities are conducted through the Operating Partnership. Ellington Financial Inc., the Operating Partnership, and their consolidated subsidiaries are hereafter collectively referred to as the "Company." All intercompany accounts are eliminated in consolidation.

The Company conducts its operations to qualify and be taxed as a real estate investment trust, or "REIT," under the Internal Revenue Code of 1986, as amended (the "Code"), and has elected to be taxed as a corporation effective January 1, 2019. ~~The Company has elected to be taxed as a REIT for U.S. federal income tax purposes.~~ In anticipation of the Company's intended election to be taxed as a REIT under the Code beginning with its 2019 taxable year (the "REIT Election"), the Company implemented an internal restructuring as of December 31, 2018. As part of this restructuring, the Company moved certain of its non-REIT-qualifying investments and financial derivatives to taxable REIT subsidiaries or, "TRSs," and disposed of certain of its investments in non-REIT-qualifying investments and financial derivatives.

The Company invests in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, or "RMBS," commercial mortgage-backed securities, or "CMBS," consumer loans and asset-backed securities, or "ABS," including ABS backed by consumer loans, collateralized loan obligations, or "CLOs," non-mortgage- and mortgage-related derivatives, equity investments in loan origination companies, and other strategic investments.

Ellington Financial Management LLC (the "Manager") is an SEC-registered investment adviser that serves as the Manager to the Company pursuant to the terms of its Seventh Amended and Restated Management Agreement (the "Management Agreement"), which was approved by the Board of Directors effective March 13, 2018. The Manager is an affiliate of Ellington Management Group, L.L.C. ("Ellington"), an investment management firm that is registered as both an investment adviser and a commodity pool operator. In accordance with the terms of the Management Agreement, the Manager implements the investment strategy and manages the business and operations on a day-to-day basis for the Company and performs certain services for the Company, subject to oversight by the Board of Directors.

~~COVID-19 Impact~~

During the first quarter of 2020, there was a worldwide outbreak of a novel coronavirus disease, or "COVID-19." The outbreak was declared a pandemic by the World Health Organization and numerous countries, including the United States, have responded by instituting quarantines or lockdowns, imposing restrictions on travel, restrictions on the ability of individuals to assemble in groups, and restrictions on the ability of certain businesses to operate, all of which have resulted in significant disruptions in the U.S. and global economies. In mid-March 2020, adverse economic conditions related to the COVID-19 pandemic began to impact the Company's financial position and results of operations. The COVID-19 pandemic has contributed to volatility, dislocations in the financial markets, and illiquidity. As a result, during the first quarter of 2020 the Company received margin calls under its repurchase agreements that were higher than typical historical levels. During the second and third quarters, prices for most credit assets, which are assets for which the principal and interest payments are not guaranteed by a U.S. government agency or a U.S. government-sponsored entity, stabilized, and market volatility subsided, and as a result our margin calls reverted to more typical levels. We satisfied all margin calls during the nine-month period ended September 30, 2020.

Actions by the U.S. Federal Reserve starting in the second half of March 2020 helped stabilize the market for certain assets, including RMBS for which the principal and interest payments are guaranteed by a U.S. government agency or a U.S. government-sponsored entity, or "Agency RMBS," and investment-grade corporate bonds, while other sectors, including non-

~~Table of Contents~~

investment-grade CMBS and CLOs, noticeably lagged. In light of the heightened levels of market volatility and systemic liquidity risk experienced during the first quarter of 2020, the Company proactively reduced the size of its Agency RMBS portfolio, thereby bolstering its liquidity and lowering its leverage. In the second quarter, the Company resumed making new credit and Agency RMBS investments, but as of September 30, 2020, its investment portfolios were smaller and its debt-to-equity ratio lower than prior to the outbreak of COVID-19, and the Company maintained a higher cash balance.

~~The Company's management team has implemented business continuity plans, and the Company, the Manager, and Ellington continue to be fully operational in a largely work-from-home environment.~~

2. Significant Accounting Policies

(A) Basis of Presentation: The Company's unaudited ~~interim~~ condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, or "U.S. GAAP," and Regulation S-X. The condensed consolidated financial statements include the accounts of the Company, the Operating Partnership, its subsidiaries, and variable interest entities, or "VIEs," for which the Company is deemed to be the primary beneficiary. All intercompany balances and transactions have been eliminated. The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and those differences could be material (particularly in light of the significant volatility, lack of pricing transparency, and market dislocations that have been caused by the ~~COVID-19~~novel coronavirus disease, or "COVID-19," pandemic, and associated responses to the pandemic). In management's opinion, all material adjustments considered necessary for a fair statement of the Company's ~~interim~~ condensed consolidated financial statements have been included and are only of a normal recurring nature. Interim results are not necessarily indicative of the results that may be expected for the entire fiscal year. The information included in the condensed consolidated financial statements and notes thereto should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, ~~2019 and Part II. Item 1A—Risk Factors,~~ ~~included in the Company's Quarterly Report on Form 10-Q, as amended, for the three-month period ended March 31,~~ 2020.

~~The Company adopted ASC 946,~~ ~~Financial Services—Investment Companies~~ ("ASC 946") upon its commencement of operations in August 2007, and applied U.S. GAAP for investment companies. In connection with the Company's internal restructuring and the Company's intention to qualify as a REIT for the year ended December 31, 2019, the Company determined that, effective January 1, 2019, it no longer qualified for investment company accounting in accordance with ASC 946-10-25, and has prospectively discontinued its use. The Company elected the fair value option, or "FVO," for, and therefore the Company continued to measure at fair value, those of its assets and liabilities it had previously measured at fair value and for which such election is permitted, as provided for under ASC 825, ~~Financial Instruments~~ ("ASC 825"). Due to the prospective application of a change in accounting as required under ASC 946-10-25-2, the Company determined that the presentation of its condensed consolidated financial statements for periods beginning after December 31, 2018 are not comparable to the condensed consolidated financial statements previously prepared for prior periods for which the Company applied ASC 946.

~~Reclassification and Presentation~~

~~Effective January 1, 2019, the Company prospectively discontinued its application of ASC 946. Upon its change in status, the following significant changes and elections were made:~~

•~~Investments in securities are now accounted for in accordance with ASC 320,~~ ~~Investments—Debt and Equity Securities~~ ~~("ASC 320");~~

•The Company elected the FVO as provided for under ASC 825-10-25-4 for all eligible financial instruments for which the Company had previously measured at fair value, including investments in securities, loans, financial derivatives, and certain of the Company's secured borrowings. As a result, all changes in the fair value of such financial instruments will continue to be recorded in earnings on the Company's Condensed Consolidated Statement of Operations;

•Real estate owned, or "REO," is not eligible for the FVO election. As a result, REO is carried at the lower of cost or fair value. The Company's cost basis in any REO that was previously measured at fair value under ASC 946 was adjusted on January 1, 2019 to equal the fair value of such investment as of December 31, 2018;

•~~The Company elected not to designate its financial derivatives as hedging instruments in accordance with ASC 815,~~ ~~Derivatives and Hedging~~ ~~("ASC 815"). As a result, all changes in the fair value of financial derivatives will continue to be recorded in earnings on the Company's Condensed Consolidated Statement of Operations;~~

•Forward settling to-be-announced mortgage-backed-securities, or "TBAs," are no longer classified as investments. TBAs will be classified as financial derivatives, with the difference between the forward contract price and the market

108

Table of Contents

~~value of the TBA position as of the reporting date included in Unrealized gains (losses) on financial derivatives, net, on the Condensed Consolidated Statement of Operations; and~~

•~~The Company is required to account for certain of its equity investments under ASC 323-10,~~ ~~Investments—Equity Method and Joint Ventures~~ ("ASC 323-10"). The Company has elected the FVO for such equity investments and changes in fair value will be reported in Earnings (losses) from investments in unconsolidated entities, on the Condensed Consolidated Statement of Operations.

(B) Valuation: The Company applies ASC 820-10, Fair Value Measurement ("ASC 820") to its holdings of financial instruments. ASC 820 establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the observability of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows:

•Level 1—inputs to the valuation methodology are observable and reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Currently, the types of financial instruments the Company generally includes in this category are listed equities and exchange-traded derivatives;

•Level 2—inputs to the valuation methodology other than quoted prices included in Level 1 are observable for the asset or liability, either directly or indirectly. Currently, the types of financial instruments that the Company generally includes in this category are ~~Agency~~ RMBS, for which the principal and interest payments are guaranteed by a U.S. government agency or a U.S. government-sponsored entity, or "Agency RMBS," U.S. Treasury securities and sovereign debt, certain non-Agency RMBS, CMBS, CLOs, corporate debt, and actively traded derivatives such as interest rate swaps, foreign currency forwards, and other over-the-counter derivatives; and

•Level 3—inputs to the valuation methodology are unobservable and significant to the fair value measurement. The types of financial instruments that the Company generally includes in this category are certain RMBS, CMBS, CLOs, ABS, credit default swaps, or "CDS," on individual ABS, and total return swaps on distressed corporate debt, in each case where there is less price transparency. Also included in this category are residential and commercial mortgage loans, consumer loans, and private corporate debt and equity investments.

For certain financial instruments, the various inputs that management uses to measure fair value may fall into different levels of the fair value hierarchy. For each such financial instrument, the determination of which category within the fair value hierarchy is appropriate is based on the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the various inputs that management uses to measure fair value, with the highest priority given to inputs that are observable and reflect quoted prices (unadjusted) for identical assets or liabilities in active markets (Level 1), and the lowest priority given to inputs that are unobservable and significant to the fair value measurement (Level 3). The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the financial instrument. The Company may use valuation techniques consistent with the market and income approaches to measure the fair value of its financial instruments. The market approach uses third-party valuations and information obtained from market transactions involving identical or similar financial instruments. The income approach uses projections of the future economic benefit of an instrument to determine its fair value, such as in the discounted cash flow methodology. The inputs or methodology used for valuing financial instruments are not necessarily an indication of the risk associated with investing in these financial instruments. The leveling of each financial instrument is reassessed at the end of each period. Transfers between levels of the fair value hierarchy are assumed to occur at the end of the reporting period.

Summary Valuation Techniques

For financial instruments that are traded in an "active market," the best measure of fair value is the quoted market price. However, many of the Company's financial instruments are not traded in an active market. Therefore, management generally uses third-party valuations when available. If third-party valuations are not available, management uses other valuation techniques, such as the discounted cash flow methodology. The following are summary descriptions, for various categories of financial instruments, of the valuation methodologies management uses in determining fair value of the Company's financial instruments in such categories. Management utilizes such methodologies to assign a fair value (the estimated price that, in an orderly transaction at the valuation date, would be received to sell an asset, or paid to transfer a liability, as the case may be) to each such financial instrument.

For mortgage-backed securities, or "MBS," ~~TBAs,~~forward settling to-be-announced mortgage-backed-securities, or "TBAs," CLOs, and corporate debt and equity, management seeks to obtain at least one third-party valuation, and often obtains multiple valuations when available. Management has been able to obtain third-party valuations on the vast majority of these instruments and expects to continue to solicit third-party valuations in the future. Management generally values each financial instrument at the average of third-party valuations received and not rejected as described below. Third-party valuations are not binding, management may adjust the valuations it receives (e.g., downward adjustments for odd lots), and management may challenge or reject a valuation when, based on its validation criteria, management determines that such valuation is unreasonable or erroneous. Furthermore, based on its validation criteria,

~~Table of Contents~~

management may determine that the average of the third-party valuations received for a given financial instrument does not result in what management believes to be the fair value of such instrument, and in such circumstances management may override this average with its own good faith valuation. The validation criteria may take into account output from management's own models, recent trading activity in the same or similar instruments, and valuations received from third parties. The use of proprietary models requires the use of a significant amount of judgment and the application of various assumptions including, but not limited to, assumptions concerning future prepayment rates and default rates. Given their relatively high level of price transparency, Agency RMBS pass-throughs are typically classified as

Table of Contents

Level 2. Non-Agency RMBS, CMBS, Agency interest only and inverse interest only RMBS, CLOs, and corporate bonds are generally classified as either Level 2 or Level 3 based on analysis of available market data and/or third-party valuations. The Company's investments in distressed corporate debt can be in the form of loans as well as total return swaps on loans. These investments, as well as related non-listed equity investments, are generally designated as Level 3 assets. Valuations for total return swaps are typically based on prices of the underlying loans received from third-party pricing services. Private equity investments are generally classified as Level 3. Furthermore, the methodology used by the third-party valuation providers is reviewed at least annually by management, so as to ascertain whether such providers are utilizing observable market data to determine the valuations that they provide.

For residential and commercial mortgage loans and consumer loans, management determines fair value by taking into account both external pricing data, which includes third-party valuations, and internal pricing models. Management has obtained third-party valuations on the majority of these investments and expects to continue to solicit third-party valuations in the future. In determining fair value for non-performing mortgage loans, management evaluates third-party valuations, if applicable, as well as management's estimates of the value of the underlying real estate, using information including general economic data, broker price opinions, or "BPOs," recent sales, property appraisals, and bids. In determining fair value for performing mortgage loans and consumer loans, management evaluates third-party valuations, if applicable, as well as discounted cash flows of the loans based on market assumptions. Cash flow assumptions typically include projected default and prepayment rates and loss severities, and may include adjustments based on appraisals and BPOs. Mortgage and consumer loans are classified as Level 3.

The Company has securitized certain mortgage loans that are not deemed "qualified mortgage," or "QM," loans under the rules of the Consumer Financial Protection Bureau, or "non-QM loans." The Company's securitized non-QM loans are held as part of a collateralized financing entity, or "CFE." A CFE is a VIE that holds financial assets, issues beneficial interests in those assets, and has no more than nominal equity, and for which the issued beneficial interests have contractual recourse only to the related assets of the CFE. ASC 810, Consolidation ("ASC 810") allows the Company to elect to measure both the financial assets and financial liabilities of the CFE using the more observable of the fair value of the financial assets and the fair value of the financial liabilities of the CFE. The Company has elected the ~~FVO~~fair value option, or "FVO," for initial and subsequent recognition of the debt issued by its consolidated securitization trusts and has determined that each consolidated securitization trust meets the definition of a CFE; see Note 10 "Securitization Transactions—Residential Mortgage Loan Securitizations" for further discussion on the Company's securitization trusts. The Company has determined the inputs to the fair value measurement of the financial liabilities of each of its CFEs to be more observable than those of the financial assets and, as a result, has used the fair value of the financial liabilities of each of the CFEs to measure the fair value of the financial assets of each of the CFEs. The fair value of the debt issued by each CFE is typically valued using ~~discounted cash flows~~both external pricing data, which includes third-party valuations, and ~~other market data.~~internal pricing models. The securitized non-QM loans, which are assets of the CFEs, are included in Loans, at fair value, on the Company's Condensed Consolidated Balance Sheet. The debt issued by the CFEs is included in Other secured borrowings, at fair value, on the Company's Condensed Consolidated Balance Sheet. Unrealized gains (losses) from changes in fair value of Other secured borrowings, at fair value, are included in Other, net, on the Company's Condensed Consolidated Statement of Operations. The securitized non-QM loans and the debt issued by the Company's CFEs are both classified as Level 3.

For financial derivatives with greater price transparency, such as CDS on asset-backed indices, CDS on corporate indices, certain options on the foregoing, and total return swaps on publicly traded equities or indices, market-standard pricing sources are used to obtain valuations; these financial derivatives are generally classified as Level 2. Interest rate swaps, swaptions, and foreign currency forwards are typically valued based on internal models that use observable market data, including applicable interest rates and foreign currency rates in effect as of the measurement date; the model-generated valuations are then typically compared to counterparty valuations for reasonableness. These financial derivatives are also generally classified as Level 2. Financial derivatives with less price transparency, such as CDS on individual ABS, are generally valued based on internal models, and are classified as Level 3. In the case of CDS on individual ABS, the valuation process typically starts with an estimation of the value of the underlying ABS. In valuing its financial derivatives, the Company also considers the creditworthiness of both the Company and its counterparties, along with collateral provisions contained in each financial derivative agreement.

Investments in private operating entities, such as loan originators, are valued based on available metrics, such as relevant market multiples and comparable company valuations, company specific-financial data including actual and projected results, and independent third party valuation estimates. These investments are classified as Level 3.

~~Table of Contents~~

The Company's repurchase and reverse repurchase agreements are carried at cost, which approximates fair value. Repurchase and reverse repurchase agreements are classified as Level 2, based on the adequacy of the collateral and their short term nature.

Table of Contents

The Company's valuation process, including the application of validation criteria, is ~~overseen~~directed by the Manager's Valuation Committee (the "Valuation Committee")., and overseen by the Company's audit committee. The Valuation Committee includes senior level executives from various departments within the Manager, and each quarter, the Valuation Committee reviews and approves the valuations of the Company's financial instruments. The valuation process also includes a monthly review by the Company's third-party administrator. The goal of this review is to replicate various aspects of the Company's valuation process based on the Company's documented procedures.

Because of the inherent uncertainty of valuation, the estimated fair value of the Company's financial instruments may differ significantly from the values that would have been used had a ready market for the financial instruments existed, and the differences could be material to the Company's condensed consolidated financial statements.

(C) Accounting for Securities: Purchases and sales of investments in securities are generally recorded on trade date, and realized and unrealized gains and losses are calculated based on identified cost. Investments in securities are recorded in accordance with ASC 320, Investments—Debt and Equity Securities ("ASC 320") or ASC 325-40, Beneficial Interests in Securitized Financial Assets ("ASC 325-40"). The Company generally classifies its securities as available-for-sale. The Company has chosen to elect the FVO pursuant to ASC 825,Financial Instruments ("ASC 825") for its investments in securities. Electing the FVO allows the Company to record changes in fair value in the Condensed Consolidated Statement of Operations, as a component of Unrealized gains (losses) on securities and loans, net, which, in management's view, more appropriately reflects the results of operations for a particular reporting period as all investment activities will be recorded in a similar manner.

Many of the Company's investments in securities, such as MBS and CLOs, are issued by entities that are deemed to be VIEs. For the majority of such investments, the Company has determined it is not the primary beneficiary of such VIEs and therefore has not consolidated such VIEs. The Company's maximum risk of loss in these unconsolidated VIEs is generally limited to the fair value of the Company's investment in the VIE.

The Company evaluates its investments in interest only securities to determine whether they meet the requirements for classification as financial derivatives under ASC ~~815.~~815, Derivatives and Hedging ("ASC 815"). For interest only securities, where the holder is entitled only to a portion of the interest payments made on the mortgages underlying certain MBS, and inverse interest only securities, which are interest only securities whose coupon has an inverse relationship to its benchmark rate, such as LIBOR, the Company has determined that such investments do not meet the requirements for treatment as financial derivatives and are classified as securities.

~~Periods after January 1, 2020—For periods subsequent to the Company's application of~~The Company applies the principles of ASU 2016-13, Financial Instruments—Credit Losses ("ASU 2016-13")~~, as discussed below, the Company~~ and evaluates the cost basis of its investments in securities on at least a quarterly basis, under ASC 326-30, Financial Instruments—Credit Losses: Available-for-Sale Debt Securities ("ASC 326-30"). When the fair value of a security is less than its amortized cost basis as of the balance sheet date, the security's cost basis is considered impaired. The Company must evaluate the decline in the fair value of the impaired security and determine whether such decline resulted from a credit loss or non-credit related factors. In its assessment of whether a credit loss exists, the Company compares the present value of estimated future cash flows of the impaired security with the amortized cost basis of such security. The estimated future cash flows reflect those that a "market participant" would use and typically include assumptions related to fluctuations in interest rates, prepayment speeds, default rates, collateral performance, and the timing and amount of projected credit losses, as well incorporating observations of current market developments and events. Cash flows are discounted at an interest rate equal to the current yield used to accrete interest income. If the present value of estimated future cash flows is less than the amortized cost basis of the security, an expected credit loss exists and is included in Unrealized gains (losses) on securities and loans, net, on the Condensed Consolidated Statement of Operations. If it is determined as of the financial reporting date that all or a portion of a security's cost basis is not collectible, then the Company will recognize a realized loss to the extent of the adjustment to the security's cost basis. This adjustment to the amortized cost basis of the security is reflected in Net realized gains (losses) on securities and loans, net, on the ~~Consolidated Statement of Operations.~~

~~Periods prior to January 1, 2020—~~For periods prior to the Company's adoption of ASU 2016-13, the Company evaluated the cost basis of its investments in securities for other-than-temporary impairment, or "OTTI," on at least a quarterly basis.

When the fair value of a security was less than its amortized cost basis as of the balance sheet date, the security's cost basis was considered impaired, and the impairment was designated as either temporary or other-than-temporary. When a security's cost basis was impaired, an OTTI was considered to have occurred if (i) the Company intended to sell the security, (ii) it was more likely than not that the Company would have been required to sell the security before recovery of its amortized cost basis, or (iii) the Company did not expect to recover the security's amortized cost basis, even if the Company did not intend to sell the security and it was not more likely than not that the Company would have been required to sell the security.

~~Table of Contents~~

Additionally, for securities accounted for under ASC 325-40, an impairment of the cost basis was recorded when there was an adverse change in the expected cash flows to be received and the fair value of the security was less than its carrying amount. Any resulting OTTI adjustments made to the cost basis of the security were reflected in Realized gains (losses) on securities and loans, net, on the Condensed Consolidated Statement of Operations.

(D) Accounting for Loans: The Company's loan portfolio primarily consists of residential mortgage, commercial mortgage, and consumer loans. The Company's loans are accounted for under ASC 310-10, Receivables, and are classified as held-for-investment when the Company has the intent and ability to hold such loans for the foreseeable future or to maturity/payoff. When the Company has the intent to sell loans, such loans will be classified as held-for-sale. Mortgage loans held-for-sale are accounted for under ASC 948-310, Financial services—mortgage banking. The Company may aggregate its loans into pools based on common risk characteristics at purchase. The Company has chosen to elect the FVO pursuant to ASC 825 for its loan portfolios. Loans are recorded at fair value on the Condensed Consolidated Balance Sheet and changes in fair value are recorded in earnings on the Condensed Consolidated Statement of Operations as a component of Unrealized gains (losses) on securities and loans, net. The Company generates income from fees on certain loans, generally commercial mortgage loans, that it originates and holds for investment, including origination and exit fees. Such fee income is recorded when earned and

Table of Contents

included in Other, net on the Condensed Consolidated Statement of Operations. Transfers between held-for-investment and held-for-sale occur once the Company's intent to sell the loans changes.

For residential and commercial mortgage loans, the Company generally accrues interest payments. Such loans are typically moved to non-accrual status if the loan becomes 90 days or more delinquent. The Company does not accrue interest payments on its consumer loans; interest payments are recorded upon receipt. Once consumer loans are more than 120 days past due, the Company will generally charge off such loans. The Company evaluates its charged-off loans and determines collectibility, if any, on such loans.

The Company evaluates the collectibility of both interest and principal on each of its loan investments and whether the cost basis of the loan is impaired. A loan's cost basis is impaired when, based on current information and market developments, it is probable that the Company will be unable to collect all amounts due according to the existing contractual terms. When a loan's cost basis is impaired, the Company does not record an allowance for loan loss as it elected the FVO on all of its loan investments.

~~Periods after January 1, 2020—For periods subsequent to~~Consistent with the Company's application of the principles of ASU 2016-13, in its assessment of whether a credit loss exists, the Company compares the present value of the amount expected to be collected on the impaired loan with the amortized cost basis of such loan. If the present value of the amount expected to be collected on the impaired loan is less than the amortized cost basis of such loan, an expected credit loss exists and is included in Unrealized gains (losses) on securities and loans, net, on the Condensed Consolidated Statement of Operations. If it is determined as of the financial reporting date that all or a portion of a loan's cost basis is not collectible, then the Company will recognize a realized loss to the extent of the adjustment to the loan's cost basis. This adjustment to the amortized cost basis of the loan is reflected in Realized gains (losses) on securities and loans, net, on the ~~Consolidated Statement of Operations.~~

~~Periods prior to January 1, 2020~~—For periods prior to the Company's application of the principles of ASU 2016-13, the Company recognized impairments through an adjustment to the amortized cost basis; the Company recognized a realized loss in the period such adjustment was made, which is included in Realized gains (losses) on securities and loans, net, on the Condensed Consolidated Statement of Operations.

(E) Interest Income: The Company amortizes premiums and accretes discounts on its debt securities. Coupon interest income on fixed-income investments is generally accrued based on the outstanding principal balance or notional value and the current coupon rate.

For debt securities that are deemed to be of high credit quality at the time of purchase (generally Agency RMBS, exclusive of interest only securities), premiums and discounts are amortized/accreted into interest income over the life of such securities using the effective interest method. For such securities whose cash flows vary depending on prepayments, an effective yield retroactive to the time of purchase is periodically recomputed based on actual prepayments and changes in projected prepayment activity, and a catch-up adjustment, or "Catch-up Premium Amortization Adjustment," is made to amortization to reflect the cumulative impact of the change in effective yield.

For debt securities (generally non-Agency RMBS, CMBS, ABS, CLOs, and interest only securities) that are deemed not to be of high credit quality at the time of purchase, interest income is recognized based on the effective interest method. For purposes of estimating future expected cash flows, management uses assumptions including, but not limited to, assumptions for future prepayment rates, default rates, and loss severities (each of which may in turn incorporate various macro-economic assumptions, such as future housing prices, GDP growth rates, and unemployment rates). These assumptions are re-evaluated

~~Table of Contents~~

not less than quarterly. Changes in projected cash flows may result in prospective changes in the yield/interest income recognized on such securities based on the updated expected future cash flows.

For each loan purchased with the expectation that both interest and principal will be paid in full, the Company generally amortizes or accretes any premium or discount over the life of the loan utilizing the effective interest method. However, based on current information and market developments, the Company re-assesses the collectibility of interest and principal, and generally designates a loan as in non-accrual status either when any payments have become 90 or more days past due, or when, in the opinion of management, it is probable that the Company will be unable to collect either interest or principal in full. Once a loan is designated as in non-accrual status, as long as principal is still expected to be collectible in full, interest payments are recorded as interest income only when received (i.e., under the cash basis method); accruals of interest income are only resumed when the loan becomes contractually current and performance is demonstrated to be resumed. However, if principal is not expected to be collectible in full, the cost recovery method is used (i.e., no interest income is recognized, and all payments received—whether contractually interest or principal—are applied to cost).

~~Periods after January 1, 2020~~—Certain of the Company's debt securities and loans, at the date of acquisition, have experienced or are expected to experience more-than-insignificant deterioration in credit quality since origination. ~~For periods subsequent to~~Consistent with the Company's application of the principles of ASU 2016-13, if at the date of acquisition for a particular asset the Company projects a significant difference between contractual cash flows and expected cash flows, it establishes an initial estimate for credit losses as an upward adjustment to the acquisition cost of the asset for the purpose of calculating interest income using the effective yield method.

~~Periods prior to January 1, 2020—Prior to the Company's application~~Table of the principles of ASU 2016-13, for each loan acquired that had evidence of credit deterioration since origination and the expectation that either principal or interest would not be paid in full, interest income was generally recognized using the effective interest method for so long as the cash flows could be reasonably estimated. Here, instead of amortizing the purchase discount (i.e., the excess of the unpaid principal balance over the purchase price) over the life of the loan, the Company effectively amortized the accretable yield (i.e., the excess of the Company's estimate of the total cash flows to be collected over the life of the loan over the purchase price). Not less than quarterly, the Company updated its estimate of the cash flows expected to be collected over the life of the loan, and applied revised yields prospectively.Contents

In estimating future cash flows on the Company's debt securities, there are a number of assumptions that are subject to significant uncertainties and contingencies, including, in the case of MBS, assumptions relating to prepayment rates, default rates, loan loss severities, and loan repurchases. These estimates require the use of a significant amount of judgment.

(F) Investments in unconsolidated entities: The Company has made and may in the future make non-controlling equity investments in various entities, such as loan originators. Such investments are generally in the form of preferred and/or common equity, or membership interests. In certain cases, the Company can exercise significant influence over the entity (e.g. by having representation on the entity's board of directors) but the requirements for consolidation under ASC 810 are not met; in such cases the Company is required to account for such equity investments under ASC ~~323-10.~~323-10, Investments—Equity Method and Joint Ventures ("ASC 323-10"). The Company has chosen to elect the FVO pursuant to ASC 825 for its investments in unconsolidated entities, which, in management's view, more appropriately reflects the results of operations for a particular reporting period, as all investment activities will be recorded in a similar manner. The period change in fair value of the Company's investments in unconsolidated entities is recorded on the Condensed Consolidated Statement of Operations in Earnings (losses) from investments in unconsolidated entities.

(G) ~~REO~~Real Estate Owned "REO": When the Company obtains possession of real property in connection with a foreclosure or similar action, the Company de-recognizes the associated mortgage loan according to ASU 2014-04, Reclassification of Residential Real Estate Collateralized Consumer Mortgage Loans upon Foreclosure ("ASU 2014-04"). Under the provisions of ASU 2014-04, the Company is deemed to have received physical possession of real estate property collateralizing a mortgage loan when it obtains legal title to the property upon completion of a foreclosure or when the borrower conveys all interest in the property to it through a deed in lieu of foreclosure or similar legal agreement. The Company's initial cost basis in REO is equal to the fair value of the real estate associated with the foreclosed mortgage loan, less expected costs to sell. REO valuations are reflected at the lower of cost or fair value. The fair value of such REO is typically based on management's estimates which generally use information including general economic data, BPOs, recent sales, property appraisals, and bids, and takes into account the expected costs to sell the property. REO recorded at fair value on a non-recurring basis are classified as Level 3.

(H) Securities Sold Short: The Company may purchase or engage in short sales of U.S. Treasury securities and sovereign debt to mitigate the potential impact of changes in interest rates and/or foreign exchange rates on the performance of its portfolio. When the Company sells securities short, it typically satisfies its security delivery settlement obligation by borrowing or purchasing the security sold short from the same or a different counterparty. When borrowing a security sold short from a counterparty, the Company generally is required to deliver cash or securities to such counterparty as collateral for the

~~Table of Contents~~

Company's obligation to return the borrowed security. The Company has chosen to elect the FVO pursuant to ASC 825 for its securities sold short. Electing the FVO allows the Company to record changes in fair value in the Condensed Consolidated Statement of Operations, which, in management's view, more appropriately reflects the results of operations for a particular reporting period as all securities activities will be recorded in a similar manner. As such, securities sold short are recorded at fair value on the Condensed Consolidated Balance Sheet and the period change in fair value is recorded in current period earnings on the Condensed Consolidated Statement of Operations as a component of Unrealized gains (losses) on securities and loans, net. A realized gain or loss will be recognized upon the termination of a short sale if the market price is less or greater than the original sale price. Such realized gain or loss is recorded on the Company's Condensed Consolidated Statement of Operations in Realized gains (losses) on securities and loans, net.

(I) Financial Derivatives: The Company enters into various types of financial derivatives subject to its investment guidelines, which include restrictions associated with ~~qualifying and~~ maintaining qualification as a REIT. The Company's financial derivatives are predominantly subject to bilateral collateral arrangements or clearing in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, or the "Dodd-Frank Act." The Company may be required to deliver or receive cash or securities as collateral upon entering into derivative transactions. In addition, changes in the ~~relative~~ value of derivative transactions may require the Company or the counterparty to post or receive additional collateral. In the case of cleared derivatives, the clearinghouse becomes the Company's counterparty and a futures commission merchant acts as an intermediary between the Company and the clearinghouse with respect to all facets of the related transaction, including the posting and receipt of required collateral. Cash collateral received by the Company is included in Due to brokers, on the Condensed Consolidated Balance Sheet. Conversely, cash collateral posted by the Company is included in Due from brokers, on the Condensed Consolidated Balance Sheet. The types of derivatives primarily utilized by the Company are swaps, TBAs, futures, options, and forwards.

Swaps: The Company may enter into various types of swaps, including interest rate swaps, credit default swaps, and total return swaps. The primary risk associated with the Company's interest rate swap activity is interest rate risk. The primary risk associated with the Company's credit default swaps and total return swaps is credit risk.

The Company is subject to interest rate risk exposure in the normal course of pursuing its investment objectives. Primarily to help mitigate interest rate risk, the Company enters into interest rate swaps. Interest rate swaps are contractual

Table of Contents

agreements whereby one party pays a floating interest rate on a notional principal amount and receives a fixed-rate payment on the same notional principal, or vice versa, for a fixed period of time. Interest rate swaps change in value with movements in interest rates. The Company also enters into interest rate swaps whereby the Company pays one floating rate and receives a different floating rate, or "basis swaps."

The Company enters into credit default swaps. A credit default swap is a contract under which one party agrees to compensate another party for the financial loss associated with the occurrence of a "credit event" in relation to a "reference amount" or notional value of a "reference asset" (usually a bond, loan, or an index or basket of bonds or loans). The definition of a credit event may vary from contract to contract. A credit event may occur (i) when the reference asset (or underlying asset, in the case of a reference asset that is an index or basket) fails to make scheduled principal or interest payments to its holders, (ii) with respect to credit default swaps referencing mortgage/asset-backed securities and indices, when the reference asset (or underlying asset, in the case of a reference asset that is an index or basket) is downgraded below a certain rating level, or (iii) with respect to credit default swaps referencing corporate entities and indices, upon the bankruptcy of the obligor of the reference asset (or underlying obligor, in the case of a reference asset that is an index). The Company typically writes (sells) protection to take a "long" position with respect to the underlying reference assets, or purchases (buys) protection to take a "short" position with respect to the underlying reference assets or to hedge exposure to other investment holdings.

The Company enters into total return swaps in order to take a "long" or "short" position with respect to an underlying reference asset. The Company is subject to market price volatility of the underlying reference asset. A total return swap involves commitments to pay interest in exchange for a market-linked return based on a notional value. To the extent that the total return of the corporate debt, security, group of securities or index underlying the transaction exceeds or falls short of the offsetting interest obligation, the Company will receive a payment from or make a payment to the counterparty.

Swaps change in value with movements in interest rates, credit quality, or total return of the reference securities. During the term of swap contracts, changes in value are recognized as unrealized gains or losses on the Condensed Consolidated Statement of Operations. When a contract is terminated, the Company realizes a gain or loss equal to the difference between the proceeds from (or cost of) the closing transaction and the Company's basis in the contract, if any. Periodic payments or receipts required by swap agreements are recorded as unrealized gains or losses when accrued and realized gains or losses when received or paid. Upfront payments paid and/or received by the Company to open swap contracts are recorded as an asset and/or liability on the Condensed Consolidated Balance Sheet and are recorded as a realized gain or loss on the termination date.

~~Table of Contents~~

TBA Securities: The Company transacts in the forward settling TBA market. A TBA position is a forward contract for the purchase ("long position") or sale ("short position") of Agency RMBS at a predetermined price, face amount, issuer, coupon, and maturity on an agreed-upon future delivery date. For each TBA contract and delivery month, a uniform settlement date for all market participants is determined by the Securities Industry and Financial Markets Association. The specific Agency RMBS to be delivered into the contract at the settlement date are not known at the time of the transaction. The Company typically does not take delivery of TBAs, but rather enters into offsetting transactions and settles the associated receivable and payable balances with its counterparties. The Company uses TBAs to mitigate interest rate risk, usually by taking short positions. The Company also invests in TBAs as a means of acquiring additional exposure to Agency RMBS, or for speculative purposes, including holding long positions.

TBAs are accounted for by the Company as financial derivatives. The difference between the forward contract price and the market value of the TBA position as of the reporting date is included in Unrealized gains (losses) on financial derivatives, net, on the Condensed Consolidated Statement of Operations.

Futures Contracts: A futures contract is an exchange-traded agreement to buy or sell an asset for a set price on a future date. The Company enters into Eurodollar and/or U.S. Treasury security futures contracts to hedge its interest rate risk. The Company may also enter into various other futures contracts, including equity index futures and foreign currency futures. Initial margin deposits are made upon entering into futures contracts and can generally be either in the form of cash or securities. During the period the futures contract is open, changes in the value of the contract are recognized as unrealized gains or losses by marking-to-market to reflect the current market value of the contract. Variation margin payments are made or received periodically, depending upon whether unrealized losses or gains are incurred. When the contract is closed, the Company records a realized gain or loss equal to the difference between the proceeds of the closing transaction and the Company's basis in the contract.

Options: The Company may purchase or write put or call options contracts or enter into swaptions. The Company enters into options contracts typically to help mitigate overall market, credit, or interest rate risk depending on the type of options contract. However, the Company also enters into options contracts from time to time for speculative purposes. When the Company purchases an options contract, the option asset is initially recorded at an amount equal to the premium paid, if any, and is subsequently marked-to-market. Premiums paid for purchasing options contracts that expire unexercised are recognized

Table of Contents

on the expiration date as realized losses. If an options contract is exercised, the premium paid is subtracted from the proceeds of the sale or added to the cost of the purchase to determine whether the Company has realized a gain or loss on the related transaction. When the Company writes an options contract, the option liability is initially recorded at an amount equal to the premium received, if any, and is subsequently marked-to-market. Premiums received for writing options contracts that expire unexercised are recognized on the expiration date as realized gains. If an options contract is exercised, the premium received is subtracted from the cost of the purchase or added to the proceeds of the sale to determine whether the Company has realized a gain or loss on the related investment transaction. When the Company enters into a closing transaction, the Company will realize a gain or loss depending upon whether the amount from the closing transaction is greater or less than the premiums paid or received. The Company may also enter into options contracts that contain forward-settling premiums. In this case, no money is exchanged upfront. Instead, the agreed-upon premium is paid by the buyer upon expiration of the option, regardless of whether or not the option is exercised.

Forward Currency Contracts: A forward currency contract is an agreement between two parties to purchase or sell a specific quantity of currency with the delivery and settlement at a specific future date and exchange rate. During the period the forward currency contract is open, changes in the value of the contract are recognized as unrealized gains or losses. When the contract is settled, the Company records a realized gain or loss equal to the difference between the proceeds of the closing transaction and the Company's basis in the contract.

Financial derivative assets are included in Financial derivatives—assets, at fair value, on the Condensed Consolidated Balance Sheet. Financial derivative liabilities are included in Financial derivatives—liabilities, at fair value, on the Condensed Consolidated Balance Sheet. The Company has chosen to elect the FVO pursuant to ASC 825 for its financial derivatives. Electing the FVO allows the Company to record changes in fair value in the Condensed Consolidated Statement of Operations, which, in management's view, more appropriately reflects the results of operations for a particular reporting period as all securities activities will be recorded in a similar manner. Changes in unrealized gains and losses on financial derivatives are included in Unrealized gains (losses) on financial derivatives, net, on the Condensed Consolidated Statement of Operations. Realized gains and losses on financial derivatives are included in Realized gains (losses) on financial derivatives, net, on the Condensed Consolidated Statement of Operations.

(J) Cash and Cash Equivalents: Cash and cash equivalents include cash and short term investments with original maturities of three months or less at the date of acquisition. Cash and cash equivalents typically include amounts held in interest bearing overnight accounts and amounts held in money market funds, and these balances generally exceed insured limits. The

~~Table of Contents~~

Company holds its cash at institutions that it believes to be highly creditworthy. Restricted cash represents cash that the Company can use only for specific purposes. See Note 18 for further discussion of restricted cash balances.

(K) Repurchase Agreements: The Company enters into repurchase agreements with third-party broker-dealers whereby it sells securities under agreements to be repurchased at an agreed-upon price and date. The Company accounts for repurchase agreements as collateralized borrowings, with the initial sale price representing the amount borrowed, and with the future repurchase price consisting of the amount borrowed plus interest, at the implied interest rate of the repurchase agreement, on the amount borrowed over the term of the repurchase agreement. The interest rate on a repurchase agreement is based on competitive rates (or competitive market spreads, in the case of agreements with floating interest rates) at the time such agreement is entered into. When the Company enters into a repurchase agreement, the lender establishes and maintains an account containing cash and/or securities having a value not less than the repurchase price, including accrued interest, of the repurchase agreement. Repurchase agreements are carried at their contractual amounts, which approximate fair value as the debt is short-term in nature.

(L) Reverse Repurchase Agreements: The Company enters into reverse repurchase agreement transactions whereby it purchases securities under agreements to resell at an agreed-upon price and date. In general, securities received pursuant to reverse repurchase agreements are delivered to counterparties of short sale transactions. The interest rate on a reverse repurchase agreement is based on competitive rates (or competitive market spreads, in the case of agreements with floating interest rates) at the time such agreement is entered into. Assets held pursuant to reverse repurchase agreements are reflected as assets on the Condensed Consolidated Balance Sheet. Reverse repurchase agreements are carried at their contractual amounts, which approximates fair value due to their short-term nature.

Repurchase and reverse repurchase agreements that are conducted with the same counterparty may be reported on a net basis if they meet the requirements of ASC 210-20, Balance Sheet Offsetting. There are no repurchase and reverse repurchase agreements reported on a net basis in the Company's condensed consolidated financial statements.

(M) Transfers of Financial Assets: The Company enters into transactions whereby it transfers financial assets to third parties. Upon such a transfer of financial assets, the Company will sometimes retain or acquire interests in the related assets. The Company evaluates transferred assets pursuant to ASC 860-10, Transfers of Financial Assets, or "ASC 860-10," which

Table of Contents

requires that a determination be made as to whether a transferor has surrendered control over transferred financial assets. That determination must consider the transferor's continuing involvement in the transferred financial asset, including all arrangements or agreements made contemporaneously with, or in contemplation of, the transfer, even if they were not entered into at the time of the transfer. When a transfer of financial assets does not qualify as a sale, ASC 860-10 requires the transfer to be accounted for as a secured borrowing with a pledge of collateral. ASC 860-10 is a standard that requires the Company to exercise significant judgment in determining whether a transaction should be recorded as a "sale" or a "financing."

(N) Variable Interest Entities: VIEs are entities in which: (i) the equity investors do not have the characteristics of a controlling financial interest, or (ii) there is insufficient equity to permit the entity to finance its activities without additional subordinated financial support from other parties. Consolidation of a VIE is required by the entity that is deemed to be the primary beneficiary of the VIE. The Company evaluates all of its interests in VIEs for consolidation under ASC 810. The primary beneficiary is generally the party with both (i) the power to direct the activities of the VIE that most significantly impact its economic performance, and (ii) the obligation to absorb losses and the right to receive benefits from the VIE which could be potentially significant to the VIE.

When the Company has an interest in an entity that has been determined to be a VIE, the Company assesses whether it is deemed to be the primary beneficiary of the VIE. The Company will only consolidate a VIE for which it has concluded it is the primary beneficiary. To assess whether the Company has the power to direct the activities of a VIE that most significantly impact the VIE's economic performance, the Company considers all facts and circumstances, including its role in establishing the VIE and its ongoing rights and responsibilities. This assessment includes (i) identifying the activities that most significantly impact the VIE's economic performance; and (ii) identifying which party, if any, has power over those activities. To assess whether the Company has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE, it considers all of its economic interests, including debt and/or equity investments, as well as other arrangements deemed to be variable interests in the VIE. These assessments to determine whether the Company is the primary beneficiary require significant judgment. In instances where the Company and its related parties have interests in a VIE, the Company considers whether there is a single party in the related party group that meets the criteria to be deemed the primary beneficiary. If one party within the related party group meets such criteria, that reporting entity would be deemed to be the primary beneficiary of the VIE and no further analysis is needed. If no party within the related party group on its own meets the criteria to be deemed the primary beneficiary, but the related party group as a whole meets such criteria, the determination of the primary beneficiary within the related party group requires significant judgment. The Company performs analysis, which is based upon qualitative as well as quantitative factors, such as the relationship of the VIE to each of the members of the

~~Table of Contents~~

related party group, as well as the significance of the VIE's activities to those members, with the objective of determining which party is most closely associated with the VIE.

The Company performs ongoing reassessments of (i) whether any entities previously evaluated have become VIEs, based on certain events, and therefore subject to assessment to determine whether consolidation is appropriate, and (ii) whether changes in the facts and circumstances regarding the Company's involvement with a VIE causes its consolidation conclusion regarding the VIE to change. See Note 9 and Note 13 for further information on the Company's consolidated VIEs.

The Company's maximum amount at risk is generally limited to the Company's investment in the VIE. The Company is generally not contractually required to provide and has not provided any form of financial support to the VIEs.

The Company holds beneficial interests in certain securitization trusts that are considered VIEs. The beneficial interests in these securitization trusts are represented by certificates issued by the trusts. The securitization trusts have been structured as pass-through entities that receive principal and interest payments on the underlying collateral and distribute those payments to the certificate holders, which include both third-party investors and the Company. The certificates held by the Company typically include some or all of the most subordinated tranches. The assets held by the trusts are restricted in that they can only be used to fulfill the obligations of the related trust. In certain cases, the design and structure of the securitization trust is such that the Company effectively retains control of the assets as well as the activities that most significantly impact the economic performance of the trust. In such cases, the Company is determined to be the primary beneficiary, and the Company consolidates the trust and all intercompany transactions are eliminated in consolidation. In cases where the Company does not effectively retain control of the assets of, or have the power to direct the activities that most significantly impact the economic performance of, the related trust, it does not consolidate the trust. See Note 10 for further discussion of the Company's securitization trusts.

(O) Offering Costs/Underwriters' Discount: Offering costs and underwriters' discount are generally charged against stockholders' equity ~~as incurred.~~upon the completion of a capital raise. Offering costs typically include legal, accounting, and other fees associated with the cost of raising capital.

Table of Contents

(P) Debt Issuance Costs: Debt issuance costs associated with debt for which the Company has elected the FVO are expensed at the issuance of the debt, and are included in Investment related expenses—Other on the Condensed Consolidated Statement of Operations. Costs associated with the issuance of debt for which the Company has not elected the FVO are deferred and amortized over the life of the debt, which approximates the effective interest rate method, and are included in Interest expense on the Condensed Consolidated Statement of Operations. Deferred debt issuance costs are presented on the Condensed Consolidated Balance Sheet as a direct deduction from the related debt liability, unless such deferred debt issuance costs are associated with borrowing facilities that are expected to have a future benefit, such as giving the Company the ability to access additional borrowings over the contractual term of the debt, in which case such deferred debt issuance costs are included in Other assets on the Condensed Consolidated Balance Sheet. Debt issuance costs include legal and accounting fees, purchasers' or underwriters' discount, as well as other fees associated with the cost of the issuance of the related debt.

(Q) Expenses: Expenses are recognized as incurred on the Condensed Consolidated Statement of Operations.

(R) Investment Related Expenses: Investment related expenses consist of expenses directly related to specific financial instruments. Such expenses generally include dividend expense on common stock sold short, servicing fees and corporate and escrow advances on mortgage and consumer loans, and various other expenses and fees related directly to the Company's financial instruments. The Company has elected the FVO for its investments, and as a result all investment related expenses are expensed as incurred and included in Investment related expenses on the Condensed Consolidated Statement of Operations.

(S) Investment Related Receivables: Investment related receivables on the Company's Condensed Consolidated Balance Sheet includes receivables for securities sold and interest and principal receivable on securities and loans.

(T) Long Term Incentive Plan Units: Long term incentive plan units of the Operating Partnership ("OP LTIP Units") have been issued to certain Ellington personnel dedicated or partially dedicated to the Company, certain of the Company's directors, as well as the Manager. Costs associated with OP LTIP Units issued to dedicated or partially dedicated personnel, or to the Company's directors, are measured as of the grant date based on the Company's closing stock price on the New York Stock Exchange and are amortized over the vesting period in accordance with ASC 718-10, Compensation—Stock Compensation. The vesting periods for OP LTIP Units are typically one year from issuance for non-executive directors, and are typically one year to two years from issuance for dedicated or partially dedicated personnel.

(U) Non-controlling interests: Non-controlling interests include interests in the Operating Partnership represented by units convertible into shares of the Company's common stock ("Convertible Non-controlling Interests"). Convertible Non-controlling Interests include both the OP LTIP Units and those common units ("OP Units") of the Operating Partnership not held by the Company (collectively, the "Convertible Non-controlling Interest Units"). Non-controlling interests also include the

~~Table of Contents~~

interests of joint venture partners in certain of our consolidated subsidiaries. The joint venture partners' interests are not convertible into shares of the Company's common stock. The Company adjusts the Convertible Non-controlling Interests to align their carrying value with their share of total outstanding Operating Partnership units, including both the OP Units held by the Company and the Convertible Non-controlling Interests. Any such adjustments are reflected in Adjustment to non-controlling interests, on the Condensed Consolidated Statement of Changes in Equity. See Note 15 for further discussion of non-controlling interests.

(V) Dividends: Dividends payable on shares of common stock and Convertible Non-controlling Interest Units are recorded on the declaration date.

(W) Shares Repurchased: Shares of common stock that are repurchased by the Company subsequent to issuance are immediately retired upon settlement and decrease the total number of shares of common stock issued and outstanding. The cost of such repurchases is charged against Additional paid-in-capital on the Company's Condensed Consolidated Balance Sheet.

(X) Earnings Per Share ("EPS"): Basic EPS is computed using the two class method by dividing net income (loss) after adjusting for the impact of Convertible Non-controlling Interests which are participating securities, by the weighted average number of shares of common stock outstanding calculated including Convertible Non-controlling Interests. Because the Company's Convertible Non-controlling Interests are participating securities, they are included in the calculation of both basic and diluted EPS.

(Y) Foreign Currency: The functional currency of the Company is U.S. dollars. Assets and liabilities denominated in foreign currencies are remeasured into U.S. dollars at current exchange rates at the following dates: (i) assets, liabilities, and unrealized gains/losses—at the valuation date; and (ii) income, expenses, and realized gains/losses—at the accrual/transaction date. The Company isolates the portion of realized and change in unrealized gain (loss) resulting from changes in foreign currency exchange rates on investments and financial derivatives from the fluctuations arising from changes in fair value of investments and financial derivatives held. Changes in realized and change in unrealized gain (loss) due to foreign currency are included in Other, net, on the Condensed Consolidated Statement of Operations.

Table of Contents

The Company's reporting currency is U.S. Dollars. If the Company has investments in unconsolidated entities that have a functional currency other than U.S. Dollars, the fair value is translated to U.S. dollars using the current exchange rate at the valuation date. The cumulative translation adjustment, if any, associated with the Company's investments in unconsolidated entities is recorded in accumulated other comprehensive income (loss), a component of consolidated stockholders' equity.

(Z) Income Taxes: The Company has elected to be taxed as a REIT under Sections 856 through 860 of the Code. As a REIT, the Company is generally not subject to corporate-level federal and state income tax on net income it distributes to its stockholders within the prescribed timeframes. To qualify as a REIT, the Company must meet a number of organizational and operational requirements, including distributing at least 90% of its annual taxable income to stockholders. Even if the Company qualifies as a REIT, it may be subject to certain federal, state, local and foreign taxes on its income and property, and to federal income and excise taxes on its undistributed taxable income. If the Company fails to qualify as a REIT, and does not qualify for certain statutory relief provisions, it will be subject to U.S. federal, state, and local income taxes and may be precluded from qualifying as a REIT for the four taxable years following the year in which the Company fails to qualify as a REIT.

As a REIT, if the Company fails to distribute in any calendar year (subject to specific timing rules for certain dividends paid in January) at least the sum of (i) 85% of its ordinary income for such year, (ii) 95% of its capital gain net income for such year, and (iii) any undistributed taxable income from the prior year, the Company would be subject to a non-deductible 4% excise tax on the excess of such required distribution over the sum of (i) the amounts actually distributed and (ii) the amounts of income retained and on which the Company has paid corporate income tax.

The Company elected to treat certain domestic and foreign subsidiaries as TRSs, and may in the future elect to treat other current or future subsidiaries as TRSs. In general, a TRS may hold assets and engage in activities that the Company cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. A domestic TRS may, but is not required to, declare dividends to the Company; such dividends will be included in the Company's taxable income/(loss) and may necessitate a distribution to the Company's stockholders. Conversely, if the Company retains earnings at the level of a domestic TRS, such earnings will increase the book equity of the consolidated entity. A domestic TRS is subject to U.S. federal, state, and local corporate income taxes. The Company has elected and may elect in the future to treat certain of its foreign corporate subsidiaries as TRSs and, accordingly, taxable income generated by these TRSs may not be subject to U.S. federal, state, and local corporate income taxation, but generally will be included in the Company's income on a current basis as Subpart F income, whether or not distributed. However, certain of the Company's foreign subsidiaries may be subject to income taxes in the relevant foreign jurisdictions.

~~Table of Contents~~

The Company's financial results are generally not expected to reflect provisions for current or deferred income taxes, except for any activities conducted through one or more TRSs that are subject to corporate income taxation.

The Company follows the authoritative guidance on accounting for and disclosure of uncertainty on tax positions, which requires management to determine whether a tax position of the Company is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For uncertain tax positions, the tax benefit to be recognized is measured as the largest amount of benefit that is more than 50% likely to be realized upon ultimate settlement. The Company did not have any unrecognized tax benefits resulting from tax positions related to the current period or its open tax years. In the normal course of business, the Company may be subject to examination by federal, state, local, and foreign jurisdictions, where applicable, for the current period and its open tax years. The Company may take positions with respect to certain tax issues which depend on legal interpretation of facts or applicable tax regulations. Should the relevant tax regulators successfully challenge any of such positions, the Company might be found to have a tax liability that has not been recorded in the accompanying condensed consolidated financial statements. Also, management's conclusions regarding the authoritative guidance may be subject to review and adjustment at a later date based on changing tax laws, regulations, and interpretations thereof.

(AA) Recent Accounting Pronouncements: In ~~August 2018, the Financial Accounting Standards Board, or "FASB," issued ASU 2018-13,~~ ~~Fair Value Measurement—Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement~~ ("ASU 2018-13"). This amends ASC 820 to remove or modify various current disclosure requirements related to fair value measurement. Additionally, ASU 2018-13 requires certain additional disclosures around fair value measurement. ASU 2018-13 is effective for annual periods beginning after December 15, 2019 and interim periods within those years, with early adoption permitted. Entities are permitted to early adopt any removed or modified disclosures and delay adoption of the additional disclosures until their effective date. The adoption of ASU 2018-13 did not have a material impact on the Company's condensed consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, which introduced a new model related to the accounting for credit losses on financial assets subject to credit losses and measured at amortized cost and certain off-balance sheet credit exposures. ASU 2016-13 is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. ASU 2016-13 amends the guidance which required an OTTI charge only when fair value is below the amortized cost of an asset. The length of time the fair value of an available-for-sale debt security has been below the amortized cost will no longer impact the determination of whether a credit loss exists; as a result, there is no longer an other-than-temporary impairment model. In addition, credit losses on available-for-sale debt securities will now be limited to the difference between the security's amortized cost basis and its fair value. The new debt security model will also require the use of an allowance to record estimated credit losses. While generally not applicable for financial assets for which the fair value option has been elected, the Company has applied the principles of ASU 2016-13 as described above. The adoption of ASU 2016-13 did not have a material impact on the Company's condensed consolidated financial statements.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform—Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04"), which provides optional guidance for a limited period meant to ease the potential burden in accounting for, or recognizing the effects of, reform to LIBOR and certain other reference rates. The standard is effective for all entities beginning on March 12, 2020 and may be elected over time. However, ASU 2020-04 is only applicable to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform, and that were entered into or evaluated prior to January 1, 2023. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2021-01"), which clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications apply to derivatives that are affected by the reform to LIBOR. The amendments in this update are effective immediately for all entities. ASU 2021-01 provides increased clarity as the Company continues to evaluate the transition of reference rates, and it is currently evaluating the impact that the adoption of ASU 2020-04 would have on ~~its~~the condensed consolidated financial statements.

2118

Table of Contents

3. Valuation

The tables below reflect the value of the Company's Level 1, Level 2, and Level 3 financial instruments that are measured at fair value on a recurring basis as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~

~~September 30,~~ 2020:

Description Level 1 Level 2 Level 3 Total
(In thousands)
Assets:
Securities, at fair value:
Agency RMBS $ 0 $ 907,715 $ 12,140 $ 919,855
Non-Agency RMBS 0 73,538 139,199 212,737
CMBS 0 62,206 42,809 105,015
CLOs 0 50,304 112,990 163,294
Asset-backed securities, backed by consumer loans 0 0 47,298 47,298
Corporate debt securities 0 0 2,207 2,207
Corporate equity securities 0 0 1,014 1,014
Loans, at fair value:
Residential mortgage loans 0 0 1,030,709 1,030,709
Commercial mortgage loans 0 0 252,231 252,231
Consumer loans 0 0 152,609 152,609
Corporate loans 0 0 7,063 7,063
Investment in unconsolidated entities, at fair value 0 0 95,803 95,803
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities 0 0 351 351
Credit default swaps on asset-backed indices 0 9,722 0 9,722
Credit default swaps on corporate bonds — 39 — 39
Credit default swaps on corporate bond indices 0 2,419 0 2,419
Interest rate swaps 0 13,790 0 13,790
TBAs 0 1,150 0 1,150
Total return swaps 0 0 105 105
Warrants 0 31 0 31
Futures 1 0 0 1
Forwards 0 256 0 256
Total assets $ 1 $ 1,121,170 $ 1,896,528 $ 3,017,699
Liabilities:
Securities sold short, at fair value:
Government debt $ 0 $ (51,032) $ 0 $ (51,032)
Corporate debt securities 0 (461) 0 (461)
Financial derivatives–liabilities, at fair value:
Credit default swaps on asset-backed indices 0 (142) 0 (142)
Credit default swaps on corporate bonds 0 (580) 0 (580)
Credit default swaps on corporate bond indices 0 (3,572) 0 (3,572)
Interest rate swaps 0 (29,774) 0 (29,774)
TBAs 0 (286) 0 (286)
Futures (331) 0 0 (331)
Forwards 0 (41) 0 (41)
Total return swaps 0 0 (88) (88)
Other secured borrowings, at fair value 0 0 (695,516) (695,516)
Total liabilities $ (331) $ (85,888) $ (695,604) $ (781,823)
March 31, 2021:


Description	Level 1		Level 2		Level 3		Total
	(In thousands)
Assets:
Securities, at fair value:
Agency RMBS	$	0	$	1,470,380	$	17,402	$	1,487,782
Non-Agency RMBS	0		73,430		127,329		200,759
CMBS	0		27,779		17,294		45,073
CLOs	0		68,814		37,585		106,399
Asset-backed securities, backed by consumer loans	0		0		59,473		59,473
Corporate debt securities	0		760		4,761		5,521
Corporate equity securities	0		0		4,120		4,120
Loans, at fair value:
Residential mortgage loans	0		0		1,280,637		1,280,637
Commercial mortgage loans	0		0		235,948		235,948
Consumer loans	0		0		52,705		52,705
Corporate loans	0		0		13,226		13,226
Investment in unconsolidated entities, at fair value	0		0		147,684		147,684
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	0		0		320		320
Credit default swaps on asset-backed indices	0		2,087		0		2,087
Credit default swaps on corporate bond indices	0		3,427		0		3,427
Interest rate swaps	0		10,703		0		10,703
TBAs	0		3,409		0		3,409
Total return swaps	0		0		2		2
Warrants	0		42		0		42
Futures	2,704		0		0		2,704
Forwards	0		388		0		388
Total assets	$	2,704	$	1,661,219	$	1,998,486	$	3,662,409
Liabilities:
Securities sold short, at fair value:
Government debt	$	0	$	(96,179)	$	0	$	(96,179)
Corporate debt securities	0		(219)		0		(219)
Financial derivatives–liabilities, at fair value:
Credit default swaps on asset-backed indices	0		(127)		0		(127)
Credit default swaps on corporate bonds	0		(682)		0		(682)
Credit default swaps on corporate bond indices	0		(5,128)		0		(5,128)
Interest rate swaps	0		(8,884)		0		(8,884)
TBAs	0		(4,076)		0		(4,076)
Futures	(163)		0		0		(163)
Forwards	0		(40)		0		(40)
Total return swaps	0		0		(338)		(338)
Other secured borrowings, at fair value	0		0		(911,256)		(911,256)
Total liabilities	$	(163)	$	(115,335)	$	(911,594)	$	(1,027,092)

2219

Table of Contents

December 31, ~~2019:~~2020:


Description	Description	Level 1		Level 2		Level 3		Total		Description	Level 1		Level 2		Level 3		Total
		(In thousands)									(In thousands)
Assets:	Assets:									Assets:
Securities, at fair value:	Securities, at fair value:									Securities, at fair value:
Agency RMBS	Agency RMBS	$	0	$	1,917,059	$	19,904	$	1,936,963	Agency RMBS	$	0	$	947,780	$	11,663	$	959,443
Non-Agency RMBS	Non-Agency RMBS	0		76,969		89,581		166,550		Non-Agency RMBS	0		76,276		127,838		204,114
CMBS	CMBS	0		95,063		29,805		124,868		CMBS	0		54,505		63,148		117,653
CLOs	CLOs	0		125,464		44,979		170,443		CLOs	0		70,171		111,100		181,271
Asset-backed securities, backed by consumer loans	Asset-backed securities, backed by consumer loans	0		0		48,610		48,610		Asset-backed securities, backed by consumer loans	0		0		44,925		44,925
Corporate debt securities	Corporate debt securities	0		0		1,113		1,113		Corporate debt securities	0		1,107		4,082		5,189
Corporate equity securities	Corporate equity securities	0		0		1,394		1,394		Corporate equity securities	0		0		1,590		1,590
Loans, at fair value:	Loans, at fair value:									Loans, at fair value:
Residential mortgage loans	Residential mortgage loans	0		0		932,203		932,203		Residential mortgage loans	0		0		1,187,069		1,187,069
Commercial mortgage loans	Commercial mortgage loans	0		0		274,759		274,759		Commercial mortgage loans	0		0		213,031		213,031
Consumer loans	Consumer loans	0		0		186,954		186,954		Consumer loans	0		0		47,525		47,525
Corporate loans	Corporate loans	0		0		18,510		18,510		Corporate loans	0		0		5,855		5,855
Investment in unconsolidated entities, at fair value	Investment in unconsolidated entities, at fair value	0		0		71,850		71,850		Investment in unconsolidated entities, at fair value	0		0		141,620		141,620
Financial derivatives–assets, at fair value:	Financial derivatives–assets, at fair value:									Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	Credit default swaps on asset-backed securities	0		0		993		993		Credit default swaps on asset-backed securities	0		0		347		347
Credit default swaps on asset-backed indices	Credit default swaps on asset-backed indices	0		3,319		0		3,319		Credit default swaps on asset-backed indices	0		2,184		0		2,184
Credit default swaps on corporate bonds		0		2		0		2
Credit default swaps on corporate bond indices	Credit default swaps on corporate bond indices	0		5,599		0		5,599		Credit default swaps on corporate bond indices	0		3,420		0		3,420
Interest rate swaps	Interest rate swaps	0		5,468		0		5,468		Interest rate swaps	0		8,519		0		8,519
TBAs	TBAs	0		596		0		596		TBAs	0		962		0		962
Total return swaps	Total return swaps	0		0		620		620		Total return swaps	0		0		9		9
Warrants										Warrants	0		36		0		36
Futures	Futures	148		0		0		148		Futures	2		0		0		2
Forwards		0		43		0		43
Total assets	Total assets	$	148	$	2,229,582	$	1,721,275	$	3,951,005	Total assets	$	2	$	1,164,960	$	1,959,802	$	3,124,764

Liabilities:	Liabilities:									Liabilities:
Securities sold short, at fair value:	Securities sold short, at fair value:									Securities sold short, at fair value:
Government debt	Government debt	$	0	$	(72,938)	$	0	$	(72,938)	Government debt	$	0	$	(38,424)	$	0	$	(38,424)
Corporate debt securities	Corporate debt securities	0		(471)		0		(471)		Corporate debt securities	0		(218)		0		(218)
Financial derivatives–liabilities, at fair value:	Financial derivatives–liabilities, at fair value:									Financial derivatives–liabilities, at fair value:
Credit default swaps on asset-backed indices	Credit default swaps on asset-backed indices	0		(250)		0		(250)		Credit default swaps on asset-backed indices	0		(130)		0		(130)
Credit default swaps on corporate bonds	Credit default swaps on corporate bonds	0		(1,693)		0		(1,693)		Credit default swaps on corporate bonds	0		(747)		0		(747)
Credit default swaps on corporate bond indices	Credit default swaps on corporate bond indices	0		(14,524)		0		(14,524)		Credit default swaps on corporate bond indices	0		(6,438)		0		(6,438)
Interest rate swaps	Interest rate swaps	0		(8,719)		0		(8,719)		Interest rate swaps	0		(15,174)		0		(15,174)
TBAs	TBAs	0		(1,012)		0		(1,012)		TBAs	0		(925)		0		(925)
Futures	Futures	(45)		0		0		(45)		Futures	(376)		0		0		(376)
Forwards	Forwards	0		(169)		0		(169)		Forwards	0		(279)		0		(279)
Total return swaps	Total return swaps	0		(773)		(436)		(1,209)		Total return swaps	0		0		(484)		(484)
Other secured borrowings, at fair value	Other secured borrowings, at fair value	0		0		(594,396)		(594,396)		Other secured borrowings, at fair value	0		0		(754,921)		(754,921)
Total liabilities	Total liabilities	$	(45)	$	(100,549)	$	(594,832)	$	(695,426)	Total liabilities	$	(376)	$	(62,335)	$	(755,405)	$	(818,116)

2320

Table of Contents

The following tables identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~

~~September 30,~~ 2020:

Fair Value Valuation
Technique Unobservable Input Range Weighted
Average
Description Min Max
(In thousands)
Non-Agency RMBS $ 85,183 Market Quotes Non Binding Third-Party Valuation $ 9.43 $ 314.93 $ 87.41
CMBS 41,602 Market Quotes Non Binding Third-Party Valuation 4.56 95.32 59.06
CLOs 88,907 Market Quotes Non Binding Third-Party Valuation 2.00 93.50 78.04
Agency interest only RMBS 3,503 Market Quotes Non Binding Third-Party Valuation 0.80 22.13 12.60
Corporate loans 7,063 Market Quotes Non Binding Third-Party Valuation 100.00 100.00 100.00
ABS backed by consumer loans 107 Market Quotes Non Binding Third-Party Valuation 96.01 97.58 96.80
Non-Agency RMBS 54,016 Discounted Cash Flows Yield 0.8 % 60.0 % 8.5 %
Projected Collateral Prepayments 13.5 % 77.6 % 59.2 %
Projected Collateral Losses 0.0 % 70.3 % 8.7 %
Projected Collateral Recoveries 0.0 % 46.5 % 10.3 %
Projected Collateral Scheduled Amortization 7.7 % 70.4 % 21.8 %
100.0 %
Non-Agency CMBS 1,207 Discounted Cash Flows Yield 23.1 % 25.7 % 23.7 %
Projected Collateral Losses 0.7 % 0.9 % 0.8 %
Projected Collateral Recoveries 1.9 % 3.8 % 3.4 %
Projected Collateral Scheduled Amortization 95.4 % 97.4 % 95.8 %
100.0 %
Corporate debt and equity 3,221 Discounted Cash Flows Yield 10.0 % 10.0 % 10.0 %
CLOs 24,083 Discounted Cash Flows Yield 6.7 % 85.2 % 20.1 %
Projected Collateral Prepayments 65.7 % 88.5 % 71.3 %
Projected Collateral Losses 4.4 % 20.9 % 17.0 %
Projected Collateral Recoveries 4.3 % 11.2 % 9.7 %
Projected Collateral Scheduled Amortization 0.0 % 2.8 % 2.0 %
100.0 %
ABS backed by consumer loans 47,191 Discounted Cash Flows Yield 14.0 % 23.6 % 14.1 %
Projected Collateral Prepayments 0.0 % 9.8 % 7.3 %
Projected Collateral Losses 1.0 % 34.7 % 16.3 %
Projected Collateral Scheduled Amortization 56.7 % 99.0 % 76.4 %
100.0 %
March 31, 2021:


	Fair Value		Valuation Technique	Unobservable Input	Range						Weighted Average
Description					Min			Max
	(In thousands)
Non-Agency RMBS	$	85,241	Market Quotes	Non Binding Third-Party Valuation	$	2.13		$	337.92		$	86.00
	42,088		Discounted Cash Flows
	127,329			Yield(1)	0.4		%	66.3		%	7.2		%
				Projected Collateral Prepayments	5.3		%	74.2		%	48.3		%
				Projected Collateral Losses	0		%	22.5		%	6.1		%
				Projected Collateral Recoveries	0.8		%	22.4		%	13.0		%
Non-Agency CMBS	11,177		Market Quotes	Non Binding Third-Party Valuation	$	4.65		$	98.25		$	38.62
	6,117		Discounted Cash Flows
	17,294			Yield	3.8		%	28.3		%	9.5		%
				Projected Collateral Losses	1.2		%	10.6		%	4.4		%
				Projected Collateral Recoveries	9.6		%	95.4		%	92.0		%
CLOs	23,370		Market Quotes	Non Binding Third-Party Valuation	$	2.00		$	95.00		$	71.18
	14,215		Discounted Cash Flows
	37,585			Yield	7.0		%	92.5		%	17.6		%
				Projected Collateral Prepayments	79.2		%	92.9		%	86.5		%
				Projected Collateral Losses	3.9		%	11.7		%	6.7		%
				Projected Collateral Recoveries	1.3		%	6.9		%	4.6		%
Agency interest only RMBS	4,026		Market Quotes	Non Binding Third-Party Valuation	$	0.66		$	18.45		$	12.50
	13,376		Option Adjusted Spread ("OAS")
	17,402			LIBOR OAS(2)(3)	16			2,918			719
				Projected Collateral Prepayments	9.2		%	100.0		%	66.0		%
ABS backed by consumer loans	87		Market Quotes	Non Binding Third-Party Valuation	$	96.92		$	98.58		$	97.61
	59,386		Discounted Cash Flows
	59,473			Yield	11.9		%	33.7		%	15.5		%
				Projected Collateral Prepayments	0.0		%	11.9		%	8.0		%
				Projected Collateral Losses	1.0		%	22.2		%	16.2		%
Corporate debt and equity	8,881		Discounted Cash Flows	Yield	5.0		%	12.2		%	9.8		%
Performing and re-performing residential mortgage loans	290,957		Discounted Cash Flows	Yield	1.3		%	59.4		%	5.6		%

2421

Table of Contents


(continued)		Fair Value			Valuation Technique		Unobservable Input	Range				Weighted Average
Description						Min		Max
				(In thousands)
Consumer loans		$	152,609		Discounted Cash Flows		Yield	9.0	%	12.0	%	10.0	%
							Projected Collateral Prepayments	0.0	%	37.1	%	12.9	%
							Projected Collateral Losses	1.1	%	86.6	%	10.7	%		Fair Value			Valuation Technique		Unobservable Input	Range						Weighted Average
Description														Description					Min		Max
(continued)														(continued)			(In thousands)
Securitized residential mortgage loans(4)(5)														Securitized residential mortgage loans(4)(5)	$	921,678		Market Quotes		Non Binding Third-Party Valuation	$	0.58		$	105.92		$	101.24
															39,654			Discounted Cash Flows
															961,332					Yield	1.1		%	9.2		%	4.6		%
Non-performing residential mortgage loans														Non-performing residential mortgage loans	28,348			Discounted Cash Flows		Yield	1.8		%	34.6		%	13.7		%
							Projected Collateral Scheduled Amortization	13.4	%	98.2	%	76.4	%							Recovery Amount	0.3		%	169.9		%	33.8		%
												100.0	%							Months to Resolution	1.0			105.8			36.8
Performing commercial mortgage loans	Performing commercial mortgage loans	228,560			Discounted Cash Flows		Yield	6.8	%	10.4	%	8.0	%	Performing commercial mortgage loans	201,683			Discounted Cash Flows		Yield	6.5		%	11.2		%	8.6		%
Non-performing commercial mortgage loans	Non-performing commercial mortgage loans	23,671			Discounted Cash Flows		Yield	9.5	%	16.2	%	12.5	%	Non-performing commercial mortgage loans	34,265			Discounted Cash Flows		Yield	7.5		%	9.4		%	9.2		%
							Months to Resolution	4.9		8.8		7.0								Recovery Amount	100.0		%	100.4		%	100.3		%
Performing and re-performing residential mortgage loans		245,027			Discounted Cash Flows		Yield	0.6	%	54.3	%	6.0	%
Securitized residential mortgage loans(1)(2)		760,420			Discounted Cash Flows		Yield	1.8	%	7.3	%	4.2	%
Non-performing residential mortgage loans		25,262			Discounted Cash Flows		Yield	1.5	%	28.4	%	10.3	%
							Months to Resolution	—		90.9		33.2								Months to Resolution	2.8			8.8			6.3
Consumer loans														Consumer loans	52,705			Discounted Cash Flows		Yield	5.5		%	48.7		%	9.5		%
																				Projected Collateral Prepayments	0.0		%	34.0		%	16.1		%
																				Projected Collateral Losses	0.6		%	86.6		%	10.0		%
Corporate loans														Corporate loans	13,167			Market Quotes		Non Binding Third-Party Valuation	$	100.00		$	100.00		$	100.00
															59			Discounted Cash Flows
															13,226					Yield	21.7		%	21.9		%	21.8		%
Investment in unconsolidated entities														Investment in unconsolidated entities	147,684			Enterprise Value		Equity Price-to-Book(6)(7)	1.0x			1.6x			1.2x
Total return swaps—asset	Total return swaps—asset	105			Discounted Cash Flows		Yield	11.7	%	20.8	%	12.7	%	Total return swaps—asset	2			Discounted Cash Flows		Yield	17.1		%	17.1		%	17.1		%
Credit default swaps on asset-backed securities	Credit default swaps on asset-backed securities	351			Net Discounted Cash Flows		Projected Collateral Prepayments	33.3	%	41.0	%	39.2	%	Credit default swaps on asset-backed securities	320			Net Discounted Cash Flows		Projected Collateral Prepayments	26.5		%	36.4		%	34.1		%
							Projected Collateral Losses	6.8	%	11.2	%	9.1	%							Projected Collateral Losses	6.7		%	10.1		%	8.3		%
							Projected Collateral Recoveries	13.6	%	18.3	%	15.2	%							Projected Collateral Recoveries	14.2		%	18.8		%	15.6		%
Total return swaps—liability														Total return swaps—liability	(338)			Discounted Cash Flows		Yield	20.6%			20.6%			20.6%
Other secured borrowings, at fair value(4)														Other secured borrowings, at fair value(4)	(911,256)			Market Quotes		Non Binding Third-Party Valuation	$	96.51		$	105.92		$	101.60
							Projected Collateral Scheduled Amortization	35.1	%	41.6	%	36.5	%							Yield(8)	1.2%			1.4%			1.3%
												100.0	%							Projected Collateral Prepayments	0%			83.3%			54.0%
Agency interest only RMBS		8,637			Option Adjusted Spread ("OAS")		LIBOR OAS(3)(4)	160		3,992		954
							Projected Collateral Prepayments	0.7	%	100.0	%	78.3	%
							Projected Collateral Scheduled Amortization	0.0	%	99.3	%	21.7	%
												100.0	%
Investment in unconsolidated entities		95,803			Enterprise Value		Equity Price-to-Book(5)	1.0x		4.0x		1.3x
Other secured borrowings, at fair value(1)(6)		(695,516)			Discounted Cash Flows		Yield	1.8%		3.3%		2.4%
Total return swaps—liability		(88)			Discounted Cash Flows		Yield	20.8%		20.8%		20.8%

(1)~~Securitized residential mortgage loans~~For the range minimum, the range maximum, and ~~Other secured borrowings, at~~the weighted average yield, excludes non-Agency RMBS with a negative yield, with a total fair value ~~represent financial assets and liabilities~~ of $0.6 million. Including these securities the ~~Company's CFEs as discussed in Note 2.~~weighted average yield was 6.9%.

(2)~~Includes $37.1 million of non-performing securitized residential mortgage loans.~~

~~(3)~~Shown in basis points.

~~(4)~~(3)For range minimum, range maximum, and the weighted average of LIBOR OAS, excludes Agency interest only securities with a negative LIBOR OAS, with a total fair value of ~~$1.4~~$3.7 million. Including these securities the weighted average was ~~596~~445 basis points.

~~(5)Represents an estimation of where market participants might value an enterprise on a price-to-book basis.~~

~~(6)~~For range minimum, range maximum, and the weighted average of yield, excludes Other secured borrowings, at fair value with a negative yield, with a total fair value of $(116.1) million. Including these borrowings the weighted average yield was 1.81%.

~~Table of Contents~~

~~December 31, 2019:~~

Fair Value Valuation
Technique Unobservable Input Range Weighted
Average
Description Min Max
(In thousands)
Non-Agency RMBS $ 38,754 Market Quotes Non Binding Third-Party Valuation $ 6.68 $ 144.79 $ 86.21
CMBS 29,630 Market Quotes Non Binding Third-Party Valuation 5.08 80.72 64.73
CLOs 38,220 Market Quotes Non Binding Third-Party Valuation 40.00 96.00 73.98
Agency interest only RMBS 3,753 Market Quotes Non Binding Third-Party Valuation 1.36 16.61 5.11
Corporate loans 6,010 Market Quotes Non Binding Third-Party Valuation 100.00 100.00 100.00
ABS backed by consumer loans 139 Market Quotes Non Binding Third-Party Valuation 95.47 96.78 96.12
Non-Agency RMBS 50,827 Discounted Cash Flows Yield 3.3 % 60.9 % 10.0 %
Projected Collateral Prepayments 0.8 % 72.0 % 49.3 %
Projected Collateral Losses 0.0 % 22.7 % 6.6 %
Projected Collateral Recoveries 0.0 % 32.4 % 6.9 %
Projected Collateral Scheduled Amortization 16.9 % 92.9 % 37.2 %
100.0 %
Non-Agency CMBS 175 Discounted Cash Flows Yield 10.0 % 10.0 % 10.0 %
Projected Collateral Prepayments 100.0 % 100.0 % 100.0 %
100.0 %
Corporate debt and equity 2,507 Discounted Cash Flows Yield 10.0 % 10.0 % 10.0 %
CLOs 6,759 Discounted Cash Flows Yield 14.0 % 41.9 % 26.2 %
Projected Collateral Prepayments 48.5 % 84.6 % 72.5 %
Projected Collateral Losses 11.7 % 36.4 % 19.9 %
Projected Collateral Recoveries 3.7 % 15.1 % 7.6 %
100.0 %
ABS backed by consumer loans 48,471 Discounted Cash Flows Yield 12.0 % 20.2 % 12.1 %
Projected Collateral Prepayments 0.0 % 11.2 % 9.7 %
Projected Collateral Losses 0.6 % 18.0 % 15.4 %
Projected Collateral Scheduled Amortization 71.3 % 99.4 % 74.9 %
100.0 %

~~Table of Contents~~

(continued) Fair Value Valuation
Technique Unobservable Input Range Weighted
Average
Description Min Max
(In thousands)
Consumer loans $ 186,954 Discounted Cash Flows Yield 7.0 % 10.0 % 8.1 %
Projected Collateral Prepayments 0.0 % 44.2 % 16.0 %
Projected Collateral Losses 3.0 % 84.5 % 8.6 %
Projected Collateral Scheduled Amortization 15.5 % 95.8 % 75.4 %
100.0 %
Corporate loans 12,500 Discounted Cash Flows Yield 15.0 % 18.0 % 16.8 %
Performing commercial mortgage loans 248,214 Discounted Cash Flows Yield 7.7 % 16.6 % 8.8 %
Non-performing commercial mortgage loans 26,545 Discounted Cash Flows Yield 9.8 % 14.7 % 12.4 %
Months to Resolution 1.1 23.0 11.4
Performing and re-performing residential mortgage loans 289,672 Discounted Cash Flows Yield 1.6 % 19.5 % 6.2 %
Securitized residential mortgage loans(1)(2)
628,415 Discounted Cash Flows Yield 3.2 % 4.3 % 3.6 %
Non-performing residential mortgage loans 14,116 Discounted Cash Flows Yield 1.0 % 26.6 % 9.1 %
Months to Resolution 1.1 165.4 54.6
Total return swaps—asset 620 Discounted Cash Flows Yield 8.5 % 27.7 % 11.5 %
Credit default swaps on asset-backed securities 993 Net Discounted Cash Flows Projected Collateral Prepayments 35.4 % 42.0 % 37.3 %
Projected Collateral Losses 4.2 % 12.4 % 10.2 %
Projected Collateral Recoveries 10.0 % 18.2 % 15.3 %
Projected Collateral Scheduled Amortization 36.2 % 41.5 % 37.2 %
100.0 %
Agency interest only RMBS 16,151 Option Adjusted Spread ("OAS")
LIBOR OAS(3)
93 3,527 701
Projected Collateral Prepayments 12.3 % 100.0 % 72.3 %
Projected Collateral Scheduled Amortization 0.0 % 87.7 % 27.7 %
100.0 %
Investment in unconsolidated entities 41,392 Enterprise Value
Equity Price-to-Book(4)
1.0x 4.7x 1.7x
Investment in unconsolidated entities 30,458 Discounted Cash Flows
Yield(5)
3.7% 14.8% 9.9%
Other secured borrowings, at fair value(1)
(594,396) Discounted Cash Flows Yield 2.9% 4.0% 3.3%
Total return swaps—liability (436) Discounted Cash Flows Yield 27.7% 27.7% 27.7%

~~(1)~~(4)Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFEs as discussed in Note 2.

~~(2)~~(5)Includes ~~$1.5~~$21.2 million of non-performing securitized residential mortgage loans.

~~(3)~~(6)Represents an estimation of where market participants might value an enterprise on a price-to-book basis.

(7)For the range minimum, the range maximum, and the weighted average equity price-to-book, excludes investments in unconsolidated entitiesof $3.4 million. Including these investments in unconsolidated entities the weighted average equity price-to-book was 2.1x.

(8)For the range minimum, the range maximum, and the weighted average yield, excludes other secured borrowings with a negative yield, with a total fair value of $(126.8) million. Including these securities the weighted average yield was 0.9%.

Table of Contents

December 31, 2020:


	Fair Value		Valuation Technique	Unobservable Input	Range						Weighted Average
Description					Min			Max
	(In thousands)
Non-Agency RMBS	$	70,619	Market Quotes	Non Binding Third-Party Valuation	$	9.53		$	204.61		$	85.70
	57,219		Discounted Cash Flows
	127,838			Yield(1)	0.7		%	52.6		%	7.4		%
				Projected Collateral Prepayments	0		%	99.1		%	45.3		%
				Projected Collateral Losses	0.4		%	72.6		%	18.4		%
				Projected Collateral Recoveries	0		%	79.1		%	16.8		%
Non-Agency CMBS	53,199		Market Quotes	Non Binding Third-Party Valuation	$	4.79		$	98.00		$	65.20
	9,949		Discounted Cash Flows
	63,148			Yield	3.7		%	26.3		%	8.7		%
				Projected Collateral Losses	0.7		%	10.7		%	3.6		%
				Projected Collateral Recoveries	72.4		%	96.1		%	90.6		%
CLOs	102,910		Market Quotes	Non Binding Third-Party Valuation	$	2.00		$	330.00		$	88.66
	8,190		Discounted Cash Flows
	111,100			Yield	3.4		%	35.4		%	10.5		%
				Projected Collateral Prepayments	41.2		%	97.7		%	65.7		%
				Projected Collateral Losses	1.7		%	28.9		%	11.2		%
				Projected Collateral Recoveries	0.6		%	15.2		%	7.9		%
Agency interest only RMBS	4,844		Market Quotes	Non Binding Third-Party Valuation	$	1.91		$	18.91		$	8.38
	6,819		Option Adjusted Spread ("OAS")
	11,663			LIBOR OAS(2)(3)	297			2,886			914
				Projected Collateral Prepayments	8.3		%	100.0		%	75.9		%
ABS backed by consumer loans	97		Market Quotes	Non Binding Third-Party Valuation	$	96.51		$	98.43		$	97.33
	44,828		Discounted Cash Flows
	44,925			Yield	12.6		%	27.5		%	15.6		%
				Projected Collateral Prepayments	0.0		%	11.6		%	7.7		%
				Projected Collateral Losses	1.0		%	21.1		%	17.1		%
Corporate debt and equity	5,672		Discounted Cash Flows	Yield	8.1		%	10.8		%	9.7		%
Performing and re-performing residential mortgage loans	338,265		Discounted Cash Flows	Yield	2.5		%	28.5		%	5.4		%
	15,659		Recent Transactions	Transaction Price	$	60.00		$	103.88		$	103.44
	353,924
Securitized residential mortgage loans(4)(5)	$	783,162	Market Quotes	Non Binding Third-Party Valuation	$	5.34		$	105.61		$	100.22
	18,182		Discounted Cash Flows
	801,343			Yield	0		%	38.7		%	4.4		%

Table of Contents


	Fair Value	Valuation Technique	Unobservable Input	Range						Weighted Average
Description				Min			Max
(Continued)	(In thousands)
Non-performing residential mortgage loans	31,802	Discounted Cash Flows	Yield	1.2		%	41.0		%	12.1		%
			Recovery Amount	0.9		%	1713.0		%	30.6		%
			Months to Resolution	0.0			106.6			30.0
Performing commercial mortgage loans	181,545	Discounted Cash Flows	Yield	3.7		%	9.7		%	8.1		%
Non-performing commercial mortgage loans	31,486	Discounted Cash Flows	Yield	8.6		%	14.6		%	10.8		%
			Recovery Amount	100.0		%	102.4		%	100.8		%
			Months to Resolution	1.8			5.8			3.7
Consumer loans	47,525	Discounted Cash Flows	Yield	7.8		%	28.1		%	11.2		%
			Projected Collateral Prepayments	0.0		%	36.0		%	17.3		%
			Projected Collateral Losses	0.9		%	86.6		%	9.4		%
Corporate loans	5,855	Market Quotes	Non Binding Third-Party Valuation	$	100.00		$	100.00		$	100.00
			Yield	21.1		%	21.1		%	21.1		%
Investment in unconsolidated entities	141,620	Enterprise Value	Equity Price-to-Book(6)	1.0x			6.2x			1.4x
Total return swaps—asset	9	Discounted Cash Flows	Yield	22.0		%	22.0		%	22.0		%
Credit default swaps on asset-backed securities	347	Net Discounted Cash Flows	Projected Collateral Prepayments	32.7		%	39.7		%	38.1		%
			Projected Collateral Losses	6.6		%	10.8		%	8.9		%
			Projected Collateral Recoveries	13.9		%	18.1		%	15.6		%
Total return swaps—liability	(484)	Discounted Cash Flows	Yield	16.8%			16.8%			16.8%
Other secured borrowings, at fair value(4)	(754,921)	Market Quotes	Non Binding Third-Party Valuation	$	85.37		$	105.61		$	102.04
			Yield	1.6%			3.0%			2.6%
			Projected Collateral Prepayments	0%			75.3%			48.7%

(1)For the range minimum, the range maximum, and the weighted average yield, excludes non-Agency RMBS with a negative yield, with a total fair value of $0.3 million. Including these securities the weighted average yield was 7.3%.

(2)Shown in basis points.

(3)For range minimum, range maximum, and the weighted average of LIBOR OAS, excludes Agency interest only securities with a negative LIBOR OAS, with a total fair value of $4.5 million. Including these securities the weighted average was 396 basis points.

(4)Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFEs as discussed in Note 2.

(5)Includes $26.4 million of non-performing securitized residential mortgage loans.

(6)Represent an estimation of where market participants might value an enterprise on a price-to-book basis.

~~(5)~~Represents the significant unobservable inputs used to fair value the financial instruments of the unconsolidated entity. The fair value of such financial instruments is the largest component of the valuation of such entity as a whole.

Third-party non-binding valuations are validated by comparing such valuations to internally generated prices based on the Company's models and, when available, to recent trading activity in the same or similar instruments.

~~Table of Contents~~

For those instruments valued using discounted and net discounted cash flows, collateral prepayments, losses, recoveries, and scheduled amortization are projected over the remaining life of the collateral and expressed as a percentage of the collateral's current principal balance. Averages are weighted based on the fair value of the related instrument. In the case of credit default swaps on asset-backed securities, averages are weighted based on each instrument's bond equivalent value. Bond equivalent value represents the investment amount of a corresponding position in the reference obligation, calculated as the difference between the outstanding principal balance of the underlying reference obligation and the fair value, inclusive of accrued interest, of the derivative contract. For those assets valued using the LIBOR Option Adjusted Spread ("LIBOR OAS") valuation methodology, cash flows are projected using the Company's models over multiple interest rate scenarios, and these projected cash flows are then discounted using the LIBOR rates implied by each interest rate scenario. The LIBOR OAS of an asset is then computed as the unique constant yield spread that, when added to all LIBOR rates in each interest rate scenario generated by the model, will equate (a) the expected present value of the projected asset cash flows over all model scenarios to (b) the actual current market price of the asset. LIBOR OAS is therefore model-dependent. Generally speaking, LIBOR OAS measures the additional yield spread over LIBOR that an asset provides at its current market price after taking into account any

Table of Contents

interest rate options embedded in the asset. The Company considers the expected timeline to resolution in the determination of fair value for its non-performing commercial and residential mortgage loans.

Material changes in any of the inputs above in isolation could result in a significant change to reported fair value measurements. Additionally, fair value measurements are impacted by the interrelationships of these inputs. For example, for instruments subject to prepayments and credit losses, such as non-Agency RMBS and consumer loans and ABS backed by consumer loans, a higher expectation of collateral prepayments will generally be accompanied by a lower expectation of collateral losses. Conversely, higher losses will generally be accompanied by lower prepayments. Because the Company's credit default swaps on asset-backed security holdings represent credit default swap contracts whereby the Company has purchased credit protection, such credit default swaps on asset-backed securities generally have the directionally opposite sensitivity to prepayments, losses, and recoveries as compared to the Company's long securities holdings. Prepayments do not represent a significant input for the Company's commercial mortgage-backed securities and commercial mortgage loans. Losses and recoveries do not represent a significant input for the Company's Agency RMBS interest only securities, given the guarantee of the issuing government agency or government-sponsored enterprise.

~~Table of Contents~~

The tables below includes a roll-forward of the Company's financial instruments for the ~~three- and nine-month~~three-month periods ended ~~September 30,~~March 31, 2021 and 2020 ~~and 2019~~ (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy.

Three-Month Period Ended ~~September 30,~~March 31, 2021


(In thousands)	Beginning Balance as of December 31, 2020		Accreted Discounts / (Amortized Premiums)		Net Realized Gain/ (Loss)		Change in Net Unrealized Gain/(Loss)		Purchases/Payments(1)		Sales/Issuances(2)		Transfers Into Level 3		Transfers Out of Level 3		Ending Balance as of March 31, 2021
Assets:
Securities, at fair value:
Agency RMBS	$	11,663	$	(1,121)	$	(26)	$	(136)	$	1,814	$	0	$	5,857	$	(649)	$	17,402
Non-Agency RMBS	127,838		679		(226)		(557)		20,742		(18,639)		1,998		(4,506)		127,329
CMBS	63,148		218		2,082		2,525		0		(39,705)		0		(10,974)		17,294
CLOs	111,100		734		912		5,334		1,812		(43,210)		1,511		(40,608)		37,585
Asset-backed securities backed by consumer loans	44,925		(657)		33		(485)		24,334		(8,677)		0		0		59,473
Corporate debt securities	4,082		0		180		5		1,027		(533)		0		0		4,761
Corporate equity securities	1,590		0		(385)		604		2,311		0		0		0		4,120
Loans, at fair value:
Residential mortgage loans	1,187,069		(2,470)		194		2,214		222,081		(128,451)		0		0		1,280,637
Commercial mortgage loans	213,031		9		436		(263)		57,166		(34,431)		0		0		235,948
Consumer loans	47,525		(1,843)		(1,265)		327		16,749		(8,788)		0		0		52,705
Corporate loan	5,855		0		0		0		7,371		0		0		0		13,226
Investments in unconsolidated entities, at fair value	141,620		0		128		6,507		12,870		(13,441)		0		0		147,684
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	347		0		26		(27)		4		(30)		0		0		320
Total return swaps	9		0		141		(6)		0		(142)		0		0		2
Total assets, at fair value	$	1,959,802	$	(4,451)	$	2,230	$	16,042	$	368,281	$	(296,047)	$	9,366	$	(56,737)	$	1,998,486
Liabilities:
Financial derivatives–liabilities, at fair value:
Total return swaps	$	(484)	$	0	$	(500)	$	146	$	500	$	0	$	0	$	0	$	(338)
Other secured borrowings, at fair value	(754,921)		0		0		1,243		92,930		(250,508)		0		0		(911,256)
Total liabilities, at fair value	$	(755,405)	$	0	$	(500)	$	1,389	$	93,430	$	(250,508)	$	0	$	0	$	(911,594)

(1)For Investments in unconsolidated entities, at fair value, amount represents contributions to investments in unconsolidated entities.

(2)For Investments in unconsolidated entities, at fair value, amount represents distributions from investments in unconsolidated entities.

Table of Contents

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Condensed Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at March 31, 2021, as well as Level 3 financial instruments disposed of by the Company during the three-month period ended March 31, 2021. For Level 3 financial instruments held by the Company at March 31, 2021, change in net unrealized gain (loss) of $3.2 million, $2.0 million, $6.3 million, $(33) thousand, $0.1 million, and $1.2 million, for the three-month period ended March 31, 2021 relate to securities, loans, investments in unconsolidated entities, financial derivatives–assets, financial derivatives–liabilities, and other secured borrowings, at fair value, respectively.

At March 31, 2021, the Company transferred $56.7 million of assets from Level 3 to Level 2 and $9.4 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.

Three-Month Period Ended March 31, 2020


(In thousands)	(In thousands)	Beginning Balance as of June 30, 2020		Accreted Discounts / (Amortized Premiums)		Net Realized Gain/ (Loss)		Change in Net Unrealized Gain/(Loss)		Purchases/Payments(1)		Sales/Issuances(2)		Transfers Into Level 3		Transfers Out of Level 3		Ending Balance as of September 30, 2020		(In thousands)	Beginning Balance as of December 31, 2019		Accreted Discounts / (Amortized Premiums)		Net Realized Gain/ (Loss)		Change in Net Unrealized Gain/(Loss)		Purchases/ Payments(1)		Sales/ Issuances(2)		Transfers Into Level 3		Transfers Out of Level 3		Ending Balance as of March 31, 2020
Assets:	Assets:																			Assets:
Securities, at fair value:	Securities, at fair value:																			Securities, at fair value:
Agency RMBS	Agency RMBS	$	12,907	$	(1,482)	$	494	$	280	$	3,490	$	(2,243)	$	2,621	$	(3,927)	$	12,140	Agency RMBS	$	19,904	$	(1,822)	$	(1)	$	2,807	$	5,259	$	0	$	1,088	$	(6,254)	$	20,981
Non-Agency RMBS	Non-Agency RMBS	128,607		884		(77)		2,610		21,138		(6,395)		10,895		(18,463)		139,199		Non-Agency RMBS	89,581		226		(136)		(11,533)		33,950		(14,395)		3,659		(7,155)		94,197
CMBS	CMBS	65,695		659		8		4,117		12,699		(8)		560		(40,921)		42,809		CMBS	29,805		207		1,386		(11,193)		31,025		(28,539)		4,071		(6,486)		20,276
CLOs	CLOs	136,466		1,962		(82)		1,920		2,241		(127)		6,483		(35,873)		112,990		CLOs	44,979		(318)		(21)		(20,261)		22,760		54		6,325		(9,714)		43,804
Asset-backed securities backed by consumer loans	Asset-backed securities backed by consumer loans	47,941		(1,435)		(4)		1,165		7,455		(7,824)		0		0		47,298		Asset-backed securities backed by consumer loans	48,610		(1,044)		(150)		(2,360)		16,271		(6,700)		0		0		54,627
Corporate debt securities	Corporate debt securities	1,951		0		296		509		28		(577)		0		0		2,207		Corporate debt securities	1,113		0		0		(96)		10		(417)		0		0		610
Corporate equity securities	Corporate equity securities	1,084		0		0		(73)		3		0		0		0		1,014		Corporate equity securities	1,394		0		0		(987)		305		0		0		0		712
Loans, at fair value:	Loans, at fair value:																			Loans, at fair value:
Residential mortgage loans	Residential mortgage loans	948,447		(2,009)		(146)		15,672		139,609		(70,864)		0		0		1,030,709		Residential mortgage loans	932,203		(458)		205		(24,323)		131,070		(99,325)		0		0		939,372
Commercial mortgage loans	Commercial mortgage loans	295,496		17		36		(6)		18,881		(62,193)		0		0		252,231		Commercial mortgage loans	274,759		(1)		860		(328)		87,567		(59,557)		0		0		303,300
Consumer loans	Consumer loans	166,681		(6,342)		(112)		(1,627)		28,554		(34,545)		0		0		152,609		Consumer loans	186,954		(7,470)		26		(5,751)		61,100		(40,056)		0		0		194,803
Corporate loan	Corporate loan	6,227		0		0		0		836		0		0		0		7,063		Corporate loan	18,510		0		0		0		104		(12,500)		0		0		6,114
Investments in unconsolidated entities, at fair value		72,553		0		62		11,381		15,307		(3,500)		0		0		95,803
Investment in unconsolidated entities, at fair value																				Investment in unconsolidated entities, at fair value	71,850		0		0		(6,497)		12,283		(12,239)		0		0		65,397
Financial derivatives–assets, at fair value:	Financial derivatives–assets, at fair value:																			Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	Credit default swaps on asset-backed securities	353		0		1		(2)		3		(4)		0		0		351		Credit default swaps on asset-backed securities	993		0		(994)		917		5		(568)		0		0		353
Total return swaps	Total return swaps	442		0		(129)		(338)		209		(79)		0		0		105		Total return swaps	620		0		191		(583)		0		(191)		0		0		37
Total assets, at fair value	Total assets, at fair value	$	1,884,850	$	(7,746)	$	347	$	35,608	$	250,453	$	(188,359)	$	20,559	$	(99,184)	$	1,896,528	Total assets, at fair value	$	1,721,275	$	(10,680)	$	1,366	$	(80,188)	$	401,709	$	(274,433)	$	15,143	$	(29,609)	$	1,744,583
Liabilities:	Liabilities:																			Liabilities:
Financial derivatives–assets, at fair value:
Financial derivatives–liabilities, at fair value:																				Financial derivatives–liabilities, at fair value:
Total return swaps	Total return swaps	$	(77)	$	0	$	4	$	(11)	$	(4)	$	0	$	0	$	0	$	(88)	Total return swaps	$	(436)	$	0	$	31	$	(403)	$	10	$	(41)	$	0	$	0	$	(839)
Other secured borrowings, at fair value	Other secured borrowings, at fair value	(742,688)		0		0		(5,178)		52,350		0		0		0		(695,516)		Other secured borrowings, at fair value	(594,396)		0		0		24		44,704		0		0		0		(549,668)
Total liabilities, at fair value	Total liabilities, at fair value	$	(742,765)	$	0	$	4	$	(5,189)	$	52,346	$	0	$	0	$	0	$	(695,604)	Total liabilities, at fair value	$	(594,832)	$	0	$	31	$	(379)	$	44,714	$	(41)	$	0	$	0	$	(550,507)

(1)For Investments in unconsolidated entities, at fair value, amount represents contributions to investments in unconsolidated entities.

(2)For Investments in unconsolidated entities, at fair value, amount represents distributions from investments in unconsolidated entities.

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Condensed Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at ~~September 30,~~March 31, 2020, as well as Level 3 financial instruments disposed of by the Company during the three-month period ended ~~September 30,~~March 31, 2020. For Level 3 financial instruments held by the Company at ~~September 30,~~March 31, 2020, change in net unrealized gain (loss) of ~~$9.3~~$(50.9) million, ~~$14.2~~$(30.4) million, ~~$11.3~~$(6.7) million, ~~$(0.3)~~$0.5 million, ~~$(11)~~

Table of Contents

$(0.8) million, and $24 thousand, ~~and $(5.2) million,~~ for the three-month period ended ~~September 30,~~March 31, 2020 relate to securities, loans, investments in unconsolidated entities, financial derivatives–assets, financial derivatives–liabilities, and other secured borrowings, at fair value, respectively.

At ~~September 30,~~March 31, 2020, the Company transferred ~~$99.2~~$29.6 million of assets from Level 3 to Level 2 and ~~$20.6~~$15.1 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.

~~Table of Contents~~

~~Three-Month Period Ended September 30, 2019~~

(In thousands) Beginning Balance as of
June 30, 2019 Accreted
Discounts /
(Amortized
Premiums) Net Realized
Gain/
(Loss) Change in Net
Unrealized
Gain/(Loss)
Purchases/
Payments(1)
Sales/
Issuances(2)
Transfers Into Level 3 Transfers Out of Level 3 Ending
Balance as of
September 30, 2019
Assets:
Securities, at fair value:
Agency RMBS $ 11,034 $ (1,164) $ (621) $ 696 $ 13,254 $ 0 $ 737 $ (437) $ 23,499
Non-Agency RMBS 96,790 (121) 7,836 (6,457) 6,483 (21,457) 5,808 (7,400) 81,482
CMBS 6,278 25 374 (302) 6,815 (1,474) 652 0 12,368
CLOs 17,222 (184) 1,158 184 0 (1,139) 15,287 (4,520) 28,008
Asset-backed securities backed by consumer loans 25,019 (611) (100) (320) 18,638 (3,310) 0 0 39,316
Corporate debt securities 4,081 0 (583) 142 6,425 (6,883) 0 0 3,182
Corporate equity securities 1,791 0 (768) (61) 1,316 0 0 0 2,278
Loans, at fair value:
Residential mortgage loans 663,880 (2,241) (400) 3,559 191,512 (58,582) 0 0 797,728
Commercial mortgage loans 260,034 (52) (1) 507 32,426 (32,288) 0 0 260,626
Consumer loans 162,609 (6,474) (1,055) 28 33,101 (36,510) 0 0 151,699
Corporate loans 5,000 0 0 0 10,790 0 0 0 15,790
Investment in unconsolidated entities, at fair value 69,676 0 (139) 2,935 9,643 (11,680) 0 0 70,435
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities 1,090 0 16 (12) 10 (26) 0 0 1,078
Total return swaps 87 0 (15) 148 0 15 0 0 235
Total assets, at fair value $ 1,324,591 $ (10,822) $ 5,702 $ 1,047 $ 330,413 $ (173,334) $ 22,484 $ (12,357) $ 1,487,724
Liabilities:
Financial derivatives–liabilities, at fair value:
Total return swaps $ 0 $ 0 $ 48 $ (214) $ 0 $ (48) $ 0 $ 0 $ (214)
Other secured borrowings, at fair value $ (475,816) $ 0 $ 0 $ (72) $ 37,259 $ 0 $ 0 $ 0 $ (438,629)
Total liabilities, at fair value $ (475,816) $ 0 $ 48 $ (286) $ 37,259 $ (48) $ 0 $ 0 $ (438,843)

~~(1)For Investments in unconsolidated entities, at fair value, amount represents contributions to investments in unconsolidated entities.~~

~~(2)For Investments in unconsolidated entities, at fair value, amount represents distributions from investments in unconsolidated entities.~~

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Condensed Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2019, as well as Level 3 financial instruments disposed of by the Company during the three-month period ended September 30, 2019. For Level 3 financial instruments held by the Company at September 30, 2019, change in net unrealized gain (loss) of $(4.7) million, $4.1 million, $3.3 million, $0.1 million, $(0.2) million, and $(0.1) million, for the three-month period ended September 30, 2019 relate to securities, loans, investments in unconsolidated entities, financial derivatives–assets, financial derivatives–liabilities, and other secured borrowings, at fair value, respectively.

At September 30, 2019, the Company transferred $12.4 million of assets from Level 3 to Level 2 and $22.5 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.

~~Table of Contents~~

~~Nine-Month Period Ended September 30, 2020~~

(In thousands) Beginning Balance as of
December 31, 2019 Accreted
Discounts /
(Amortized
Premiums) Net Realized
Gain/
(Loss) Change in Net
Unrealized
Gain/(Loss)
Purchases/Payments(1)
Sales/Issuances(2)
Transfers Into Level 3 Transfers Out of Level 3 Ending
Balance as of
September 30, 2020
Assets:
Securities, at fair value:
Agency RMBS $ 19,904 $ (6,072) $ 614 $ 2,803 $ 8,219 $ (3,295) $ 2,177 $ (12,210) $ 12,140
Non-Agency RMBS 89,581 1,113 303 (1,996) 61,933 (29,811) 22,974 (4,898) 139,199
CMBS 29,805 617 (867) (4,638) 51,432 (32,284) 7,828 (9,084) 42,809
CLOs 44,979 1,237 (7,586) (24,206) 47,730 0 53,462 (2,626) 112,990
Asset-backed securities backed by consumer loans 48,610 (3,584) (200) (1,501) 25,001 (21,028) 0 0 47,298
Corporate debt securities 1,113 0 504 991 3,450 (3,851) 0 0 2,207
Corporate equity securities 1,394 0 7 (741) 366 (12) 0 0 1,014
Loans, at fair value:
Residential mortgage loans 932,203 (4,414) (722) 7,008 340,842 (244,208) 0 0 1,030,709
Commercial mortgage loans 274,759 113 135 (140) 107,608 (130,244) 0 0 252,231
Consumer loans 186,954 (21,712) (97) (6,965) 104,872 (110,443) 0 0 152,609
Corporate loan 18,510 0 0 0 1,053 (12,500) 0 0 7,063
Investments in unconsolidated entities, at fair value 71,850 0 62 10,528 29,522 (16,159) 0 0 95,803
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities 993 0 (955) 915 29 (631) 0 0 351
Total return swaps 620 0 113 (515) 209 (322) 0 0 105
Total assets, at fair value $ 1,721,275 $ (32,702) $ (8,689) $ (18,457) $ 782,266 $ (604,788) $ 86,441 $ (28,818) $ 1,896,528
Liabilities:
Financial derivatives–liabilities, at fair value:
Total return swaps $ (436) $ 0 $ (501) $ 349 $ 500 $ 0 $ 0 $ 0 $ (88)
Other secured borrowings, at fair value (594,396) 0 0 (6,636) 138,608 (233,092) 0 0 (695,516)
Total liabilities, at fair value $ (594,832) $ 0 $ (501) $ (6,287) $ 139,108 $ (233,092) $ 0 $ 0 $ (695,604)

~~(1)For Investments in unconsolidated entities, at fair value, amount represents contributions to investments in unconsolidated entities.~~

~~(2)For Investments in unconsolidated entities, at fair value, amount represents distributions from investments in unconsolidated entities.~~

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Condensed Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2020, as well as Level 3 financial instruments disposed of by the Company during the nine-month period ended September 30, 2020. For Level 3 financial instruments held by the Company at September 30, 2020, change in net unrealized gain (loss) of $(56.3) million, $12 thousand, $10.2 million, $0.6 million, $(0.1) million, and $(6.6) million, for the nine-month period ended September 30, 2020 relate to securities, loans, investments in unconsolidated entities, financial derivatives–assets, financial derivatives–liabilities, and other secured borrowings, at fair value, respectively.

At September 30, 2020, the Company transferred $28.8 million of assets from Level 3 to Level 2 and $86.4 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.

~~Table of Contents~~

~~Nine-Month Period Ended September 30, 2019~~

(In thousands) Beginning Balance as of
January 1, 2019 Accreted
Discounts /
(Amortized
Premiums) Net Realized
Gain/
(Loss) Change in Net
Unrealized
Gain/(Loss)
Purchases/
Payments(1)
Sales/
Issuances(2)
Transfers Into Level 3 Transfers Out of Level 3 Ending
Balance as of
September 30, 2019
Assets:
Securities, at fair value:
Agency RMBS $ 7,293 $ (2,228) $ (1,228) $ 1,430 $ 14,854 $ (463) $ 4,708 $ (867) $ 23,499
Non-Agency RMBS 91,291 104 7,187 (4,482) 10,239 (27,514) 14,633 (9,976) 81,482
CMBS 803 (16) 76 (73) 7,937 (221) 3,862 0 12,368
CLOs 14,915 (670) (536) 1,889 816 (1,125) 15,287 (2,568) 28,008
Asset-backed securities backed by consumer loans 22,800 (1,580) (765) 537 28,189 (9,865) 0 0 39,316
Corporate debt securities 6,318 22 (928) 65 9,257 (11,552) 0 0 3,182
Corporate equity securities 1,534 0 (910) 337 1,317 0 0 0 2,278
Loans, at fair value:
Residential mortgage loans 496,829 (4,515) 1,554 7,717 452,958 (156,815) 0 0 797,728
Commercial mortgage loans 195,301 1,087 1,412 (1,844) 128,839 (64,169) 0 0 260,626
Consumer loans 183,961 (22,432) (4,565) 2,726 103,983 (111,974) 0 0 151,699
Corporate loan 0 0 0 0 15,790 0 0 0 15,790
Investment in unconsolidated entities, at fair value 72,298 276 1,545 5,125 40,097 (48,906) 0 0 70,435
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities 1,472 0 419 (394) 18 (437) 0 0 1,078
Total return swaps 0 0 1 235 0 (1) 0 0 235
Total assets, at fair value $ 1,094,815 $ (29,952) $ 3,262 $ 13,268 $ 814,294 $ (433,042) $ 38,490 $ (13,411) $ 1,487,724
Liabilities:
Financial derivatives–liabilities, at fair value:
Total return swaps $ 0 $ 0 $ 48 $ (214) $ 0 $ (48) $ 0 $ 0 $ (214)
Other secured borrowings, at fair value (297,948) 0 0 (32) 78,887 (219,536) 0 0 (438,629)
Total liabilities, at fair value $ (297,948) $ 0 $ 48 $ (246) $ 78,887 $ (219,584) $ 0 $ 0 $ (438,843)

~~(1)For Investments in unconsolidated entities, at fair value, amount represents contributions to investments in unconsolidated entities.~~

~~(2)For Investments in unconsolidated entities, at fair value, amount represents distributions from investments in unconsolidated entities.~~

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Condensed Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2019, as well as Level 3 financial instruments disposed of by the Company during the nine-month period ended September 30, 2019. For Level 3 financial instruments held by the Company at September 30, 2019, change in net unrealized gain (loss) of $(0.4) million, $10.2 million, $2.4 million, $(0.2) million, $(0.2) million, and $(32) thousand, for the nine-month period ended September 30, 2019 relate to securities, loans, investments in unconsolidated entities, financial derivatives–assets, financial derivatives–liabilities, and other secured borrowings, at fair value, respectively.

At September 30, 2019, the Company transferred $13.4 million of assets from Level 3 to Level 2 and $38.5 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources.

~~Table of Contents~~

The following table summarizes the estimated fair value of all other financial instruments not measured at fair value on a recurring basis as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~2020:


		As of									As of
		September 30, 2020				December 31, 2019					March 31, 2021				December 31, 2020
(In thousands)	(In thousands)	Fair Value		Carrying Value		Fair Value		Carrying Value		(In thousands)	Fair Value		Carrying Value		Fair Value		Carrying Value
Other financial instruments	Other financial instruments									Other financial instruments
Assets:	Assets:									Assets:
Cash and cash equivalents	Cash and cash equivalents	$	126,783	$	126,783	$	72,302	$	72,302	Cash and cash equivalents	$	149,350	$	149,350	$	111,647	$	111,647
Restricted cash	Restricted cash	175		175		175		175		Restricted cash	175		175		175		175
Due from brokers	Due from brokers	63,991		63,991		79,829		79,829		Due from brokers	91,814		91,814		63,147		63,147
Reverse repurchase agreements	Reverse repurchase agreements	47,041		47,041		73,639		73,639		Reverse repurchase agreements	96,783		96,783		38,640		38,640
Liabilities:	Liabilities:									Liabilities:
Repurchase agreements	Repurchase agreements	1,439,984		1,439,984		2,445,300		2,445,300		Repurchase agreements	1,909,511		1,909,511		1,496,931		1,496,931
Other secured borrowings	Other secured borrowings	142,674		142,674		150,334		150,334		Other secured borrowings	64,506		64,506		51,062		51,062
Senior notes, net	Senior notes, net	86,000		85,495		88,365		85,298		Senior notes, net	86,344		85,627		86,000		85,561
Due to brokers	Due to brokers	7,147		7,147		2,197		2,197		Due to brokers	5,337		5,337		5,059		5,059

Cash and cash equivalents generally includes cash held in interest bearing overnight accounts, for which fair value equals the carrying value, and investments which are liquid in nature, such as investments in money market accounts or U.S. Treasury Bills, for which fair value equals the carrying value; such assets are considered Level 1. Restricted cash includes cash held in a segregated account for which fair value equals the carrying value; such assets are considered Level 1. Due from brokers and Due to brokers include collateral transferred to or received from counterparties, along with receivables and payables for open and/or closed derivative positions. These receivables and payables are short term in nature and any collateral transferred consists primarily of cash; fair value of these items is approximated by carrying value and such items are considered Level 1. The Company's reverse repurchase agreements, repurchase agreements, and other secured borrowings are carried at cost, which approximates fair value due to their short term nature. Reverse repurchase agreements, repurchase agreements, and other secured borrowings are classified as Level 2 based on the adequacy of the collateral and their short term nature. ~~The~~ Senior notes, net are considered Level 3 liabilities given the relative unobservability of the most significant inputs to valuation estimation as well as the lack of trading activity of these instruments. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the estimated fair value of the Company's Senior notes was based on a third-party valuation.

3327

Table of Contents

4. Investment in Securities

The Company's securities portfolio primarily consists of Agency RMBS, non-Agency RMBS, CMBS, CLOs, ABS backed by consumer loans, and corporate debt and equity. The following tables detail the Company's investment in securities as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019.~~2020.

~~September 30, 2020:~~March 31, 2021:


								Gross Unrealized						Weighted Average												Gross Unrealized						Weighted Average
($ in thousands)	($ in thousands)	Current Principal		Unamortized Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon(1)		Yield		Life (Years)(2)	($ in thousands)	Current Principal		Unamortized Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon(1)		Yield		Life (Years)(2)
Long:	Long:																		Long:
Agency RMBS:	Agency RMBS:																		Agency RMBS:
15-year fixed-rate mortgages	15-year fixed-rate mortgages	$	69,491	$	2,641	$	72,132	$	1,890	$	(27)	$	73,995	3.31	%	1.89	%	3.38	15-year fixed-rate mortgages	$	177,384	$	8,396	$	185,780	$	1,680	$	(1,646)	$	185,814	2.64	%	1.28	%	4.45
20-year fixed-rate mortgages	20-year fixed-rate mortgages	587		39		626		29		0		655		4.71	%	2.94	%	3.88	20-year fixed-rate mortgages	52,654		3,140		55,794		45		(1,125)		54,714		2.48	%	1.09	%	5.37
30-year fixed-rate mortgages	30-year fixed-rate mortgages	625,882		30,133		656,015		26,286		(371)		681,930		4.06	%	2.42	%	4.06	30-year fixed-rate mortgages	1,037,659		55,060		1,092,719		19,811		(12,610)		1,099,920		3.32	%	1.92	%	6.03
Adjustable rate mortgages	Adjustable rate mortgages	6,751		173		6,924		123		(1)		7,046		3.65	%	2.15	%	3.35	Adjustable rate mortgages	5,526		145		5,671		136		0		5,807		3.48	%	2.60	%	4.14
Reverse mortgages	Reverse mortgages	94,741		5,466		100,207		4,317		0		104,524		4.02	%	2.36	%	5.10	Reverse mortgages	85,309		4,840		90,149		2,339		(12)		92,476		3.66	%	2.35	%	4.54
Interest only securities	Interest only securities	n/a		n/a		47,507		5,682		(1,484)		51,705		3.47	%	10.17	%	4.58	Interest only securities	n/a		n/a		44,867		6,034		(1,850)		49,051		3.47	%	9.39	%	5.39
Non-Agency RMBS	Non-Agency RMBS	336,997		(131,976)		205,021		12,488		(7,959)		209,550		3.16	%	6.35	%	4.68	Non-Agency RMBS	332,129		(142,479)		189,650		11,640		(4,677)		196,613		4.15	%	6.95	%	5.52
CMBS	CMBS	184,695		(62,938)		121,757		803		(24,307)		98,253		2.54	%	7.74	%	8.43	CMBS	79,301		(35,426)		43,875		1,329		(6,574)		38,630		2.72	%	8.54	%	7.72
Non-Agency interest only securities	Non-Agency interest only securities	n/a		n/a		8,367		1,832		(250)		9,949		1.17	%	16.73	%	2.75	Non-Agency interest only securities	n/a		n/a		8,918		1,861		(190)		10,589		1.08	%	8.56	%	5.16
CLOs	CLOs	n/a		n/a		211,236		1		(47,943)		163,294		3.25	%	8.48	%	3.84	CLOs	n/a		n/a		126,830		2,695		(23,126)		106,399		3.80	%	9.12	%	3.41
ABS backed by consumer loans	ABS backed by consumer loans	71,617		(24,277)		47,340		1,052		(1,094)		47,298		11.82	%	17.39	%	1.08	ABS backed by consumer loans	90,892		(31,149)		59,743		2,069		(2,339)		59,473		9.81	%	18.73	%	1.22
Corporate debt	Corporate debt	24,174		(23,187)		987		1,220		0		2,207		0	%	0	%	2.85	Corporate debt	26,861		(22,622)		4,239		1,302		(20)		5,521		1.34	%	7.58	%	2.63
Corporate equity	Corporate equity	n/a		n/a		1,604		160		(750)		1,014		n/a		n/a		n/a	Corporate equity	n/a		n/a		3,530		612		(22)		4,120		n/a		n/a		n/a
Total Long	Total Long	1,414,935		(203,926)		1,479,723		55,883		(84,186)		1,451,420		3.86	%	5.05	%	4.37	Total Long	1,887,715		(160,095)		1,911,765		51,553		(54,191)		1,909,127		3.53	%	3.76	%	5.43
Short:	Short:																		Short:
Corporate debt	Corporate debt	(450)		(6)		(456)		5		(10)		(461)		5.32	%	5.21	%	4.14	Corporate debt	(200)		(1)		(201)		0		(18)		(219)		5.11	%	4.67	%	6.17
U.S. Treasury securities	U.S. Treasury securities	(14,000)		(273)		(14,273)		0		(37)		(14,310)		0.63	%	0.41	%	6.21	U.S. Treasury securities	(62,750)		1,721		(61,029)		1,577		0		(59,452)		0.86	%	1.21	%	8.38
European sovereign bonds	European sovereign bonds	(36,280)		1,622		(34,658)		0		(2,064)		(36,722)		0.22	%	0.06	%	3.36	European sovereign bonds	(36,308)		1,682		(34,626)		0		(2,101)		(36,727)		0.22	%	0.06	%	2.86
Total Short	Total Short	(50,730)		1,343		(49,387)		5		(2,111)		(51,493)		0.39	%	0.21	%	4.16	Total Short	(99,258)		3,402		(95,856)		1,577		(2,119)		(96,398)		0.64	%	0.80	%	6.28
Total	Total	$	1,364,205	$	(202,583)	$	1,430,336	$	55,888	$	(86,297)	$	1,399,927	3.98	%	4.89	%	4.38	Total	$	1,788,457	$	(156,693)	$	1,815,909	$	53,130	$	(56,310)	$	1,812,729	3.68	%	3.62	%	5.38

(1)Weighted average coupon represents the weighted average coupons of the securities, rather than, in the case of collateralized securities, the coupon rates or loan rates on the underlying collateral.

(2)~~Average~~Expected average lives of MBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

3428

Table of Contents

December 31, ~~2019:~~2020:


								Gross Unrealized						Weighted Average												Gross Unrealized						Weighted Average
($ in thousands)	($ in thousands)	Current Principal		Unamortized Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon(1)		Yield		Life (Years)(2)	($ in thousands)	Current Principal		Unamortized Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon(1)		Yield		Life (Years)(2)
Long:	Long:																		Long:
Agency RMBS:	Agency RMBS:																		Agency RMBS:
15-year fixed-rate mortgages	15-year fixed-rate mortgages	$	314,636	$	6,369	$	321,005	$	2,604	$	(203)	$	323,406	3.05	%	2.28	%	3.05	15-year fixed-rate mortgages	$	67,875	$	2,543	$	70,418	$	1,832	$	(36)	$	72,214	3.30	%	1.83	%	3.24
20-year fixed-rate mortgages	20-year fixed-rate mortgages	804		49		853		24		0		877		4.62	%	2.99	%	4.80	20-year fixed-rate mortgages	50,131		3,097		53,228		182		0		53,410		2.57	%	1.08	%	4.46
30-year fixed-rate mortgages	30-year fixed-rate mortgages	1,358,762		64,846		1,423,608		13,821		(2,830)		1,434,599		4.20	%	2.95	%	6.63	30-year fixed-rate mortgages	626,021		30,738		656,759		25,765		(444)		682,080		3.99	%	2.35	%	4.17
Adjustable rate mortgages	Adjustable rate mortgages	9,651		315		9,966		90		(54)		10,002		3.99	%	2.03	%	4.09	Adjustable rate mortgages	6,171		159		6,330		124		0		6,454		3.66	%	2.27	%	3.42
Reverse mortgages	Reverse mortgages	122,670		8,133		130,803		2,023		(26)		132,800		4.43	%	2.78	%	6.67	Reverse mortgages	89,383		5,152		94,535		3,123		(29)		97,629		3.97	%	2.37	%	4.60
Interest only securities	Interest only securities	n/a		n/a		34,044		1,624		(389)		35,279		2.81	%	9.27	%	3.86	Interest only securities	n/a		n/a		43,406		5,808		(1,558)		47,656		3.36	%	10.01	%	4.85
Non-Agency RMBS	Non-Agency RMBS	274,353		(122,685)		151,668		12,549		(1,081)		163,136		3.41	%	7.25	%	5.31	Non-Agency RMBS	321,842		(131,083)		190,759		15,880		(5,549)		201,090		3.15	%	6.40	%	5.46
CMBS	CMBS	185,417		(67,961)		117,456		2,990		(480)		119,966		3.31	%	6.62	%	8.94	CMBS	188,085		(61,763)		126,322		1,655		(16,910)		111,067		2.71	%	7.47	%	8.09
Non-Agency interest only securities	Non-Agency interest only securities	n/a		n/a		6,517		1,817		(18)		8,316		1.10	%	8.18	%	4.14	Non-Agency interest only securities	n/a		n/a		8,123		1,792		(305)		9,610		1.17	%	18.85	%	3.49
CLOs	CLOs	n/a		n/a		169,238		4,219		(3,014)		170,443		5.05	%	9.62	%	4.75	CLOs	n/a		n/a		208,907		2,563		(30,199)		181,271		3.67	%	8.50	%	3.50
ABS backed by consumer loans	ABS backed by consumer loans	67,080		(19,154)		47,926		1,596		(912)		48,610		12.17	%	14.00	%	1.22	ABS backed by consumer loans	69,646		(24,936)		44,710		221		(6)		44,925		11.95	%	18.57	%	1.11
Corporate debt	Corporate debt	22,125		(21,241)		884		229		0		1,113		0	%	0	%	0.33	Corporate debt	27,083		(23,187)		3,896		1,296		(3)		5,189		2.13	%	6.75	%	3.10
Corporate equity	Corporate equity	n/a		n/a		1,242		152		0		1,394		n/a		n/a		n/a	Corporate equity	n/a		n/a		1,604		376		(390)		1,590		n/a		n/a		n/a
Total Long	Total Long	2,355,498		(151,329)		2,415,210		43,738		(9,007)		2,449,941		4.15	%	4.09	%	5.88	Total Long	1,446,237		(199,280)		1,508,997		60,617		(55,429)		1,514,185		3.84	%	4.88	%	4.45
Short:	Short:																		Short:
Corporate debt	Corporate debt	(450)		(6)		(456)		0		(15)		(471)		5.44	%	5.21	%	4.90	Corporate debt	(200)		(1)		(201)		0		(17)		(218)		5.09	%	4.67	%	6.42
U.S. Treasury securities		(63,140)		381		(62,759)		63		(298)		(62,994)		1.76	%	1.87	%	6.11
European sovereign bonds	European sovereign bonds	(9,759)		133		(9,626)		0		(318)		(9,944)		0.77	%	0.12	%	1.58	European sovereign bonds	(37,804)		3,163		(34,641)		0		(3,783)		(38,424)		0.23	%	0.06	%	3.11
Total Short	Total Short	(73,349)		508		(72,841)		63		(631)		(73,409)		1.65	%	1.66	%	5.49	Total Short	(38,004)		3,162		(34,842)		0		(3,800)		(38,642)		0.26	%	0.09	%	3.13
Total	Total	$	2,282,149	$	(150,821)	$	2,342,369	$	43,801	$	(9,638)	$	2,376,532	4.23	%	4.01	%	5.90	Total	$	1,408,233	$	(196,118)	$	1,474,155	$	60,617	$	(59,229)	$	1,475,543	3.92	%	4.77	%	4.49

3529

Table of Contents

The following tables detail weighted average life of the Company's Agency RMBS as of ~~September 30, 2020~~March 31, 2021 and December 31 ~~2019.~~2020.

~~September 30, 2020:~~March 31, 2021:


($ in thousands)	($ in thousands)	Agency RMBS						Agency Interest Only Securities						($ in thousands)	Agency RMBS						Agency Interest Only Securities
Estimated Weighted Average Life(1)	Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(2)		Fair Value		Amortized Cost		Weighted Average Coupon(2)		Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(2)		Fair Value		Amortized Cost		Weighted Average Coupon(2)
Less than three years	Less than three years	$	150,492	$	146,624	4.26	%	$	8,893	$	8,267	3.90	%	Less than three years	$	79,755	$	77,736	4.44	%	$	6,335	$	5,597	3.81	%
Greater than three years and less than seven years	Greater than three years and less than seven years	706,422		678,227		3.95	%	39,604		36,038		3.63	%	Greater than three years and less than seven years	1,145,288		1,135,139		3.27	%	35,542		33,166		3.87	%
Greater than seven years and less than eleven years	Greater than seven years and less than eleven years	11,236		11,053		3.01	%	1,048		1,049		0.28	%	Greater than seven years and less than eleven years	213,688		217,238		2.53	%	4,416		4,269		0.84	%
Greater than eleven years	Greater than eleven years	0		0		0	%	2,160		2,153		0.78	%	Greater than eleven years	0		0		0	%	2,758		1,835		1.16	%
Total	Total	$	868,150	$	835,904	3.99	%	$	51,705	$	47,507	3.47	%	Total	$	1,438,731	$	1,430,113	3.22	%	$	49,051	$	44,867	3.47	%

(1)~~Average~~Expected average lives of RMBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

(2)Weighted average coupon represents the weighted average coupons of the securities, rather than the coupon rates or loan rates on the underlying collateral.

December 31, ~~2019:~~2020:


($ in thousands)	($ in thousands)	Agency RMBS						Agency Interest Only Securities						($ in thousands)	Agency RMBS						Agency Interest Only Securities
Estimated Weighted Average Life(1)	Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(2)		Fair Value		Amortized Cost		Weighted Average Coupon(2)		Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(2)		Fair Value		Amortized Cost		Weighted Average Coupon(2)
Less than three years	Less than three years	$	188,593	$	187,099	3.39	%	$	9,011	$	8,611	3.35	%	Less than three years	$	139,059	$	135,844	4.15	%	$	8,143	$	7,314	3.99	%
Greater than three years and less than seven years	Greater than three years and less than seven years	961,839		953,031		4.25	%	25,334		24,512		2.66	%	Greater than three years and less than seven years	770,173		742,946		3.79	%	32,669		29,362		3.74	%
Greater than seven years and less than eleven years	Greater than seven years and less than eleven years	713,862		708,805		3.89	%	934		921		1.90	%	Greater than seven years and less than eleven years	2,555		2,480		3.01	%	5,165		5,063		1.04	%
Greater than eleven years	Greater than eleven years	37,390		37,300		3.51	%	0		0		0	%	Greater than eleven years	0		0		0	%	1,679		1,667		0.83	%
Total	Total	$	1,901,684	$	1,886,235	4.02	%	$	35,279	$	34,044	2.81	%	Total	$	911,787	$	881,270	3.84	%	$	47,656	$	43,406	3.36	%

(2)Weighted average coupon represents the weighted average coupons of the securities, rather than the coupon rates or loan rates on the underlying collateral.

~~Table of Contents~~

The following tables detail weighted average life of the Company's long non-Agency RMBS, CMBS, and CLOs and other securities as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019.~~2020.

~~September 30, 2020:~~March 31, 2021:


($ in thousands)	($ in thousands)	Non-Agency RMBS and CMBS						Non-Agency IOs						CLOs and Other Securities(2)						($ in thousands)	Non-Agency RMBS and CMBS						Non-Agency IOs						CLOs and Other Securities(2)
Estimated Weighted Average Life(1)	Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)		Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)
Less than three years	Less than three years	$	80,873	$	77,739	3.67	%	$	4,079	$	2,685	0.55	%	$	61,222	$	63,694	9.43	%	Less than three years	$	56,973	$	54,090	3.53	%	$	4,649	$	3,333	0.94	%	$	100,024	$	105,291	6.89	%
Greater than three years and less than seven years	Greater than three years and less than seven years	106,561		102,374		3.38	%	5,870		5,682		1.47	%	150,175		193,955		3.38	%	Greater than three years and less than seven years	102,383		97,457		4.85	%	4,600		4,266		1.44	%	71,369		85,521		4.06	%
Greater than seven years and less than eleven years	Greater than seven years and less than eleven years	96,327		119,267		2.48	%	0		0		0	%	1,402		1,914		0	%	Greater than seven years and less than eleven years	56,309		61,353		2.67	%	0		0		0	%	0		0		0	%
Greater than eleven years	Greater than eleven years	24,042		27,398		1.04	%	0		0		0	%	0		0		0	%	Greater than eleven years	19,578		20,625		3.79	%	1,340		1,319		0.30	%	0		0		0	%
Total	Total	$	307,803	$	326,778	2.93	%	$	9,949	$	8,367	1.17	%	$	212,799	$	259,563	4.84	%	Total	$	235,243	$	233,525	3.88	%	$	10,589	$	8,918	1.08	%	$	171,393	$	190,812	5.63	%

(1)Expected average lives of MBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

(2)Other Securities includes asset-backed securities, backed by consumer loans and corporate debt.

(3)Weighted average coupon represents the weighted average coupons of the securities, rather than the coupon rates or loan rates on the underlying collateral.

Table of Contents

December 31, 2020:


($ in thousands)	Non-Agency RMBS and CMBS						Non-Agency IOs						CLOs and Other Securities(2)
Estimated Weighted Average Life(1)	Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)		Fair Value		Amortized Cost		Weighted Average Coupon(3)
Less than three years	$	58,350	$	54,339	3.39	%	$	5,163	$	3,754	0.92	%	$	89,235	$	90,869	7.73	%
Greater than three years and less than seven years	114,815		109,161		3.45	%	4,447		4,369		1.37	%	139,830		163,670		3.69	%
Greater than seven years and less than eleven years	109,519		123,782		2.74	%	0		0		0	%	2,320		2,974		1.14	%
Greater than eleven years	29,473		29,799		1.46	%	0		0		0	%	0		0		0	%
Total	$	312,157	$	317,081	2.98	%	$	9,610	$	8,123	1.17	%	$	231,385	$	257,513	5.09	%

(2)Other Securities includes asset-backed securities, backed by consumer loans, corporate debt, and U.S. Treasury securities.

(3)Weighted average coupon represents the weighted average coupons of the securities, rather than the coupon rates or loan rates on the underlying collateral.

~~December 31, 2019:~~

($ in thousands) Non-Agency RMBS and CMBS Non-Agency IOs
CLOs and Other Securities(2)
Estimated Weighted Average Life(1)
Fair Value Amortized Cost
Weighted Average Coupon(3)
Fair Value Amortized Cost
Weighted Average Coupon(3)
Fair Value Amortized Cost
Weighted Average Coupon(3)
Less than three years $ 50,120 $ 48,213 2.73 % $ 439 $ 401 1.37 % $ 54,446 $ 54,090 11.11 %
Greater than three years and less than seven years 87,436 79,326 4.42 % 7,877 6,116 1.08 % 157,384 155,651 5.38 %
Greater than seven years and less than eleven years 127,533 123,924 3.31 % 0 0 0 % 8,336 8,307 0 %
Greater than eleven years 18,013 17,661 0.81 % 0 0 0 % 0 0 0 %
Total $ 283,102 $ 269,124 3.37 % $ 8,316 $ 6,517 1.10 % $ 220,166 $ 218,048 6.60 %

~~(1)~~Average lives of MBS are generally shorter than stated contractual maturities. Average lives are affected by the contractual maturities of the underlying mortgages, scheduled periodic payments of principal, and unscheduled prepayments of principal.

~~(2)Other Securities includes asset-backed securities, backed by consumer loans, corporate debt, and U.S. Treasury securities.~~

~~(3)Weighted average coupon represents the weighted average coupons of the securities, rather than the coupon rates or loan rates on the underlying collateral.~~

~~Table of Contents~~

The following tables detail the components of interest income by security type for the ~~three- and nine-month~~three-month periods ended ~~September 30, 2020~~March 31, 2021 and ~~2019:~~2020:

Three-Month Period Ended
(In thousands) September 30, 2020 September 30, 2019
Security Type Coupon Interest Net Amortization Interest Income Coupon Interest Net Amortization Interest Income
Agency RMBS $ 14,117 $ (7,454) $ 6,663 $ 16,026 $ (6,290) $ 9,736
Non-Agency RMBS and CMBS 3,311 1,911 5,222 3,383 430 3,813
CLOs 2,256 2,179 4,435 3,480 (627) 2,853
Other securities(1)
2,970 (1,435) 1,535 1,670 (611) 1,059
Total $ 22,654 $ (4,799) $ 17,855 $ 24,559 $ (7,098) $ 17,461


		Nine-Month Period Ended													Three-Month Period Ended
(In thousands)	(In thousands)	September 30, 2020						September 30, 2019						(In thousands)	March 31, 2021						March 31, 2020
Security Type	Security Type	Coupon Interest		Net Amortization		Interest Income		Coupon Interest		Net Amortization		Interest Income		Security Type	Coupon Interest		Net Amortization		Interest Income		Coupon Interest		Net Amortization		Interest Income
Agency RMBS	Agency RMBS	$	47,632	$	(25,516)	$	22,116	$	42,681	$	(15,883)	$	26,798	Agency RMBS	$	14,352	$	(7,600)	$	6,752	$	20,912	$	(8,844)	$	12,068
Non-Agency RMBS and CMBS	Non-Agency RMBS and CMBS	10,995		4,001		14,996		10,514		1,666		12,180		Non-Agency RMBS and CMBS	3,756		1,467		5,223		4,053		713		4,766
CLOs	CLOs	11,662		1,543		13,205		11,391		(1,138)		10,253		CLOs	2,536		944		3,480		5,419		(1,011)		4,408
Other securities(1)	Other securities(1)	8,992		(3,584)		5,408		4,706		(1,528)		3,178		Other securities(1)	3,533		(657)		2,876		2,925		(1,045)		1,880
Total	Total	$	79,281	$	(23,556)	$	55,725	$	69,292	$	(16,883)	$	52,409	Total	$	24,177	$	(5,846)	$	18,331	$	33,309	$	(10,187)	$	23,122

(1)Other securities includes ABS backed by consumer loans, corporate debt securities, and U.S. Treasury securities.

For the three-month periods ended ~~September 30,~~March 31, 2021 and 2020, ~~and 2019,~~ the Catch-Up Premium Amortization Adjustment was ~~$0.3~~$(0.1) million and ~~$(1.5) million, respectively. For the nine-month periods ended September 30, 2020 and 2019, the Catch-Up Premium Amortization Adjustment was $(4.4) million and $(2.9)~~$(1.1) million, respectively.

The following tables present proceeds from sales and the resulting realized gains and (losses) of the Company's securities for the ~~three- and nine-month~~three-month periods ended ~~September 30, 2020~~March 31, 2021 and ~~2019.~~2020.


		Three-Month Period Ended																	Three-Month Period Ended
(In thousands)	(In thousands)	September 30, 2020								September 30, 2019(1)								(In thousands)	March 31, 2021								March 31, 2020
Security Type	Security Type	Proceeds(2)		Gross Realized Gains		Gross Realized Losses(3)		Net Realized Gain (Loss)		Proceeds(2)		Gross Realized Gains		Gross Realized Losses(3)		Net Realized Gain (Loss)		Security Type	Proceeds(1)		Gross Realized Gains		Gross Realized Losses(2)		Net Realized Gain (Loss)		Proceeds(1)		Gross Realized Gains		Gross Realized Losses		Net Realized Gain (Loss)
Agency RMBS	Agency RMBS	$	10,675	$	2,467	$	(564)	$	1,903	$	331,572	$	4,511	$	(34)	$	4,477	Agency RMBS	$	71,737	$	424	$	(395)	$	29	$	1,285,482	$	9,221	$	(2,813)	$	6,408
Non-Agency RMBS and CMBS	Non-Agency RMBS and CMBS	17,926		1,669		(171)		1,498		16,496		9,606		(341)		9,265		Non-Agency RMBS and CMBS	123,208		6,609		(1,365)		5,244		77,802		8,496		(1,056)		7,440
CLOs	CLOs	0		0		256		256		2,060		1,287		27		1,314		CLOs	85,575		1,184		(191)		993		34,542		1,122		(23)		1,099
Other securities~~(4)~~(3)	Other securities~~(4)~~(3)	11,861		373		(74)		299		138,000		63		(220)		(157)		Other securities~~(4)~~(3)	9,306		512		(303)		209		120,991		637		(200)		437
Total	Total	$	40,462	$	4,509	$	(553)	$	3,956	$	488,128	$	15,467	$	(568)	$	14,899	Total	$	289,826	$	8,729	$	(2,254)	$	6,475	$	1,518,817	$	19,476	$	(4,092)	$	15,384

(1)~~Conformed to current period presentation.~~

~~(2)~~Includes proceeds on sales of securities not yet settled as of period end.

~~(3)~~(2)Excludes realized losses of ~~$(2.5) million and $(10.1)~~$(1.2) million for the three-month ~~periods~~period ended ~~September 30, 2020 and 2019, respectively,~~March 31, 2021, related to adjustments to the cost basis of certain securities for which the Company has determined all or a portion of such securities cost basis to be uncollectible.

~~(4)~~(3)Other securities includes ABS backed by consumer loans, corporate debt and equity, exchange-traded equity, and U.S. Treasury securities.

3831

Table of Contents

Nine-Month Period Ended
(In thousands) September 30, 2020
September 30, 2019(1)
Security Type
Proceeds(2)
Gross Realized Gains Gross Realized Losses Net Realized Gain (Loss)
Proceeds(2)
Gross Realized Gains
Gross Realized Losses(3)
Net Realized Gain (Loss)
Agency RMBS $ 1,438,469 $ 15,982 $ (3,369) $ 12,613 $ 719,082 $ 6,954 $ (1,950) $ 5,004
Non-Agency RMBS and CMBS 116,349 11,081 (3,880) 7,201 165,180 11,356 (3,835) 7,521
CLOs 41,714 1,122 (2,928) (1,806) 58,157 1,169 (816) 353
Other securities(4)
169,172 1,273 (329) 944 602,443 801 (1,206) (405)
Total $ 1,765,704 $ 29,458 $ (10,506) $ 18,952 $ 1,544,862 $ 20,280 $ (7,807) $ 12,473

~~(1)Conformed to current period presentation.~~

~~(2)Includes proceeds on sales of securities not yet settled as of period end.~~

~~(3)~~Excludes realized losses of $(16.3) million and $(16.1) million, for the nine-month periods ended September 30, 2020 and 2019, respectively, related to adjustments to the cost basis of certain securities for which the Company has determined all or a portion of such securities cost basis to be uncollectible.

~~(4)Other securities includes ABS backed by consumer loans, corporate debt and equity, exchange-traded equity, and U.S. Treasury securities.~~

The following ~~table presents~~tables present the fair value and gross unrealized losses of our long securities, excluding those where there are expected credit losses as of the balance sheet date in relation to such securities' cost bases, by length of time that such securities have been in an unrealized loss position at ~~September 30,~~March 31, 2021 and December 31, 2020.

~~September 30, 2020:~~March 31, 2021:


(In thousands)	(In thousands)	Less than 12 Months				Greater than 12 Months				Total				(In thousands)	Less than 12 Months				Greater than 12 Months				Total
Security Type	Security Type	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Security Type	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Agency RMBS	Agency RMBS	$	138,286	$	(673)	$	1,881	$	(112)	$	140,167	$	(785)	Agency RMBS	$	806,309	$	(15,549)	$	629	$	(33)	$	806,938	$	(15,582)
Non-Agency RMBS and CMBS	Non-Agency RMBS and CMBS	18,887		(1,560)		1,665		(84)		20,552		(1,644)		Non-Agency RMBS and CMBS	1,048		(103)		16,209		(1,563)		17,257		(1,666)
CLOs	CLOs	10,204		(10,069)		54		0		10,258		(10,069)		CLOs	1,864		(16)		1,364		(886)		3,228		(902)
Other securities(1)	Other securities(1)	647		(431)		0		0		647		(431)		Other securities(1)	0		(5)		0		0		0		(5)
Total	Total	$	168,024	$	(12,733)	$	3,600	$	(196)	$	171,624	$	(12,929)	Total	$	809,221	$	(15,673)	$	18,202	$	(2,482)	$	827,423	$	(18,155)

(1)Other securities includes ABS backed by consumer loans and corporate debt and equity ~~and U.S. Treasury~~ securities.

~~The following table presents the fair value and gross unrealized losses of our long securities by length of time that such securities have been in an unrealized loss position at December 31, 2019.~~

December 31, ~~2019:~~2020:


(In thousands)	(In thousands)	Less than 12 Months				Greater than 12 Months				Total				(In thousands)	Less than 12 Months				Greater than 12 Months				Total
Security Type	Security Type	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Security Type	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Agency RMBS	Agency RMBS	$	328,968	$	(1,503)	$	125,095	$	(1,999)	$	454,063	$	(3,502)	Agency RMBS	$	126,926	$	(981)	$	832	$	(44)	$	127,758	$	(1,025)
Non-Agency RMBS and CMBS	Non-Agency RMBS and CMBS	88,495		(880)		27,218		(699)		115,713		(1,579)		Non-Agency RMBS and CMBS	20,474		(2,616)		2,599		(348)		23,073		(2,964)
CLOs	CLOs	37,354		(1,911)		9,245		(1,103)		46,599		(3,014)		CLOs	5,279		(753)		1,196		(1,131)		6,475		(1,884)
Other securities(1)	Other securities(1)	16,562		(852)		1,380		(60)		17,942		(912)		Other securities(1)	1,107		(8)		0		0		1,107		(8)
Total	Total	$	471,379	$	(5,146)	$	162,938	$	(3,861)	$	634,317	$	(9,007)	Total	$	153,786	$	(4,358)	$	4,627	$	(1,523)	$	158,413	$	(5,881)

(1)Other securities includes ABS backed by consumer loans, corporate debt and equity, and U.S. Treasury securities.

As described in Note 2, the Company evaluates the cost basis of its securities for impairment on at least a quarterly basis. As of ~~September 30,~~March 31, 2021 and December 31, 2020, the Company had expected future credit losses, which it tracks for purposes of calculating interest income, of ~~$28.4~~$19.7 million and $24.9 million, respectively, related to adverse changes in estimated future cash flows on its ~~securities, primarily due to the economic impact of the COVID-19 pandemic.~~securities. Certain of the Company's securities, at the date of acquisition, have experienced or are expected to experience more-than-insignificant deterioration in credit quality since origination and the Company has established an initial estimate for credit losses on such securities; as of ~~September 30,~~March 31, 2021 and December 31, 2020, the estimated credit losses on such securities was ~~$4.0 million. As of September 30, 2020, the~~$0.6 million and $2.6 million, respectively. The Company has determined for certain securities that a portion of such

~~Table of Contents~~

securities cost basis is not collectible; for the ~~three- and nine-month periods~~three-month period ended ~~September 30, 2020,~~March 31, 2021, the Company recognized realized losses on these securities of ~~$(2.5)~~$1.2 million, ~~and $(16.3) million, respectively,~~ which are reflected in Net realized gains (losses) on securities and loans, net, on the Condensed Consolidated Statement of Operations.

~~For~~ No such realized losses were recognized for the ~~three- and nine-month periods~~three-month period ended September 30, 2019, the Company recognized an impairment charge of $10.1 million and $16.1 million, respectively, on the cost basis of its securities, which is included in Realized gains (losses) on securities and loans, net, on the Condensed Consolidated Statement of Operations.March 31, 2020.

5. Investment in Loans

The Company invests in various types of loans, such as residential mortgage, commercial mortgage, consumer, and corporate loans. As discussed in Note 2, the Company has elected the FVO for its investments in loans. The following table is a summary of the Company's investments in loans as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~2020:


		As of									As of
(In thousands)	(In thousands)	September 30, 2020				December 31, 2019				(In thousands)	March 31, 2021				December 31, 2020
Loan Type	Loan Type	Unpaid Principal Balance		Fair Value		Unpaid Principal Balance		Fair Value		Loan Type	Unpaid Principal Balance		Fair Value		Unpaid Principal Balance		Fair Value
Residential mortgage loans	Residential mortgage loans	$	1,004,980	$	1,030,709	$	911,705	$	932,203	Residential mortgage loans	$	1,236,923	$	1,280,637	$	1,150,303	$	1,187,069
Commercial mortgage loans	Commercial mortgage loans	252,305		252,231		277,870		274,759		Commercial mortgage loans	235,077		235,948		212,716		213,031
Consumer loans	Consumer loans	150,062		152,609		179,743		186,954		Consumer loans	51,488		52,705		48,180		47,525
Corporate loans	Corporate loans	7,063		7,063		18,415		18,510		Corporate loans	13,226		13,226		5,855		5,855
Total	Total	$	1,414,410	$	1,442,612	$	1,387,733	$	1,412,426	Total	$	1,536,714	$	1,582,516	$	1,417,054	$	1,453,480

Table of Contents

The Company is subject to credit risk in connection with its investments in loans. The two primary components of credit risk are default risk, which is the risk that a borrower fails to make scheduled principal and interest payments, and severity risk, which is the risk of loss upon a borrower default on a mortgage loan or other secured or unsecured loan. Severity risk includes the risk of loss of value of the property or other asset, if any, securing the loan, as well as the risk of loss associated with taking over the property or other asset, if any, including foreclosure costs. Credit risk in our loan portfolio can be amplified by exogenous shocks impacting our borrowers such as man-made or natural disasters, including the COVID-19 pandemic.

The following table provides details, by accrual status, for loans that are 90 days or more past due as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~2020:

As of
September 30, 2020 December 31, 2019
(In thousands) Unpaid Principal Balance Fair Value Unpaid Principal Balance Fair Value
90 days or more past due—non-accrual status
Residential mortgage loans $ 67,121 $ 64,414 $ 22,092 $ 19,401
Commercial mortgage loans 23,750 23,671 28,936 26,545
Consumer loans 1,284 1,131 5,633 5,225

~~Table of Contents~~


	As of
	March 31, 2021				December 31, 2020
(In thousands)	Unpaid Principal Balance		Fair Value		Unpaid Principal Balance		Fair Value
90 days or more past due—non-accrual status
Residential mortgage loans	$	54,588	$	50,646	$	64,509	$	60,381
Commercial mortgage loans	34,373		34,265		44,233		44,052
Consumer loans	900		665		1,015		930

Residential Mortgage Loans

The tables below detail certain information regarding the Company's residential mortgage loans as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019.~~2020.

~~September 30, 2020:~~March 31, 2021:


								Gross Unrealized						Weighted Average												Gross Unrealized						Weighted Average
($ in thousands)	($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield		Life (Years)(1)	($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield		Life (Years)(1)
Residential mortgage loans, held-for-investment(2)	Residential mortgage loans, held-for-investment(2)	$	996,429	$	8,676	$	1,005,105	$	21,504	$	(4,355)	$	1,022,254	6.23	%	5.15	%	1.66	Residential mortgage loans, held-for-investment(2)	$	1,236,923	$	18,997	$	1,255,920	$	29,604	$	(4,887)	$	1,280,637	6.12	%	4.21	%	1.34
Residential mortgage loans, held-for-sale		8,551		(863)		7,688		793		(26)		8,455		4.73	%	6.04	%	5.50
Total		$	1,004,980	$	7,813	$	1,012,793	$	22,297	$	(4,381)	$	1,030,709	6.22	%	5.16	%	1.70

(1)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

(2)Includes ~~$760.4~~$961.3 million of non-QM loans that have been securitized and are held in consolidated securitization trusts. Such loans had ~~$17.5~~$27.5 million and $(0.2) million of gross unrealized gains and gross unrealized losses, respectively; such unrealized gains (losses) are ~~presented on a gross basis~~included on the Company's Condensed Consolidated Statement of ~~Operations.~~Operations in Unrealized gains (losses) on securities and loans, net. See Residential Mortgage Loan Securitizations in Note 10 for additional information.

December 31, ~~2019:~~2020:


								Gross Unrealized						Weighted Average												Gross Unrealized						Weighted Average
($ in thousands)	($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield		Life (Years)(1)	($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield		Life (Years)(1)
Residential mortgage loans, held-for-investment(2)	Residential mortgage loans, held-for-investment(2)	$	911,705	$	9,354	$	921,059	$	13,082	$	(1,938)	$	932,203	6.44	%	5.79	%	1.90	Residential mortgage loans, held-for-investment(2)	$	1,150,303	$	14,263	$	1,164,566	$	27,892	$	(5,389)	$	1,187,069	6.19	%	5.60	%	1.90

(1)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

(2)Includes ~~$628.4~~$801.3 million of non-QM loans that have been securitized and are held in consolidated securitization trusts.

Such loans had $24.8 million and $(0.1) million of gross unrealized gains and gross unrealized losses, respectively; such unrealized gains (losses) are included on the Company's Condensed Consolidated Statement of Operations in Unrealized gains (losses) on securities and loans, net. See Residential Mortgage Loan Securitizations in Note 10 for additional information.

4133

Table of Contents

The table below summarizes the geographic distribution of the real estate collateral underlying the Company's residential mortgage loans as a percentage of total outstanding unpaid principal balance as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~2020:


Property Location by U.S. State	Property Location by U.S. State	September 30, 2020		December 31, 2019		Property Location by U.S. State	March 31, 2021		December 31, 2020
California	California	44.0	%	46.6	%	California	42.8	%	43.1	%
Florida	Florida	13.8	%	11.9	%	Florida	15.5	%	14.8	%
Texas	Texas	10.4	%	11.9	%	Texas	9.9	%	10.2	%
Colorado	Colorado	2.8	%	3.2	%	Colorado	2.8	%	3.1	%
Massachusetts	Massachusetts	2.6	%	2.9	%	Massachusetts	2.8	%	2.6	%
Oregon	Oregon	2.4	%	2.2	%	Oregon	2.2	%	2.2	%
Arizona	Arizona	1.9	%	2.4	%	Arizona	2.2	%	2.0	%
Nevada						Nevada	2.1	%	1.9	%
Illinois						Illinois	1.9	%	1.8	%
Utah	Utah	1.9	%	1.9	%	Utah	1.6	%	1.7	%
Illinois		1.8	%	1.7	%
New York						New York	1.6	%	1.6	%
Washington						Washington	1.3	%	1.4	%
New Jersey	New Jersey	1.8	%	1.1	%	New Jersey	1.2	%	1.4	%
Nevada		1.7	%	1.6	%
Washington		1.6	%	1.6	%
New York		1.3	%	1.3	%
Georgia						Georgia	1.2	%	1.3	%
North Carolina	North Carolina	1.2	%	0	%	North Carolina	1.2	%	1.1	%
Georgia		1.1	%	0	%
Connecticut						Connecticut	1.1	%	0.9	%
Maryland	Maryland	1.0	%	1.1	%	Maryland	0.9	%	1.0	%
Connecticut		1.0	%	0	%
Other	Other	7.7	%	8.6	%	Other	7.7	%	7.9	%
		100.0	%	100.0	%		100.0	%	100.0	%

The following table presents information on the Company's residential mortgage loans by re-performing or non-performing status, as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019.~~2020.


		As of									As of
		September 30, 2020				December 31, 2019					March 31, 2021				December 31, 2020
(In thousands)	(In thousands)	Unpaid Principal Balance		Fair Value		Unpaid Principal Balance		Fair Value		(In thousands)	Unpaid Principal Balance		Fair Value		Unpaid Principal Balance		Fair Value
Re-performing	Re-performing	$	23,002	$	21,572	$	27,663	$	25,323	Re-performing	$	17,185	$	15,821	$	18,120	$	16,741
Non-performing	Non-performing	64,710		62,343		17,757		15,580		Non-performing	53,289		49,586		62,009		58,169

As described in Note 2, the Company evaluates the cost basis of its residential mortgage loans for impairment on at least a quarterly basis. ~~At September 30,~~As of March 31, 2021 and December 31, 2020, the Company had expected future credit losses, which it tracks for purposes of calculating interest income, of ~~$2.6~~$1.6 million and $2.2 million, respectively, related to adverse changes in estimated future cash flows on its residential mortgage loans, primarily due to the economic impact of the COVID-19 pandemic. Certain of the Company's residential mortgage loans, at the date of acquisition, have experienced or are expected to experience more-than-insignificant deterioration in credit quality since origination and the Company has established an initial estimate for credit losses on such loans; as of ~~September 30,~~both March 31, 2021 and December 31, 2020, the estimated credit losses on such loans was ~~$0.4~~$0.2 million. The Company has determined for certain of its residential mortgage loans that a portion of such loans' cost basis is not collectible; for the ~~three- and nine-month periods~~three-month period ended ~~September 30, 2020,~~March 31, 2021, the Company recognized realized losses on these loans of ~~$51~~$33 thousand, ~~and $(0.5) million,~~ which are reflected in Net realized gains (losses) on securities and loans, net, on the Condensed Consolidated Statement of Operations.

~~For~~ No such realized losses were recognized for the ~~three- and nine-month periods~~three-month period ended September 30, 2019, the Company recognized an impairment charge of $0.3 million and $0.7 million, on the cost basis of its residential mortgage loans, which is included in Realized gains (losses) on securities and loans, net, on the Condensed Consolidated Statement of Operations.March 31, 2020.

As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Company had residential mortgage loans that were in the process of foreclosure with a fair value of ~~$11.1~~$16.4 million and ~~$10.9~~$14.9 million, respectively.

4234

Table of Contents

Commercial Mortgage Loans

The tables below detail certain information regarding the Company's commercial mortgage loans as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~

~~September 30,~~ 2020:

Gross Unrealized Weighted Average
($ in thousands) Unpaid Principal Balance Premium (Discount) Amortized Cost Gains Losses Fair Value Coupon
Yield(1)
Life (Years)(2)
Commercial mortgage loans, held-for-investment $ 252,305 $ (122) $ 252,183 $ 535 $ (487) $ 252,231 8.25 % 8.14 % 0.77
March 31, 2021:


							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield(1)		Life (Years)(2)
Commercial mortgage loans, held-for-investment	$	235,077	$	1,110	$	236,187	$	216	$	(455)	$	235,948	8.19	%	8.19	%	0.83

(1)Excludes non-performing commercial mortgage loans, in non-accrual status, with a fair value of ~~$23.8~~$34.3 million.

(2)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

December 31, ~~2019:~~2020:


								Gross Unrealized						Weighted Average												Gross Unrealized						Weighted Average
($ in thousands)	($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield(1)		Life (Years)(2)	($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield(1)		Life (Years)(2)
Commercial mortgage loans, held-for-investment	Commercial mortgage loans, held-for-investment	$	277,870	$	(3,302)	$	274,568	$	253	$	(62)	$	274,759	7.65	%	8.58	%	1.07	Commercial mortgage loans, held-for-investment	$	212,716	$	290	$	213,006	$	479	$	(454)	$	213,031	8.38	%	8.28	%	0.62

(1)Excludes commercial mortgage loans, held at par in non-accrual status, with a fair value of ~~$10.7~~$31.5 million.

(2)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

The table below summarizes the geographic distribution of the real estate collateral underlying the Company's commercial mortgage loans as a percentage of total outstanding unpaid principal balance as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~2020:


Property Location by U.S. State	Property Location by U.S. State	September 30, 2020		December 31, 2019		Property Location by U.S. State	March 31, 2021		December 31, 2020
Florida	Florida	17.6	%	31.7	%	Florida	27.6	%	23.8	%
New York	New York	16.5	%	17.7	%	New York	16.6	%	15.2	%
Pennsylvania		11.5	%	0	%
Connecticut	Connecticut	9.3	%	8.2	%	Connecticut	10.9	%	11.2	%
Ohio						Ohio	8.8	%	7.3	%
Missouri	Missouri	6.6	%	4.6	%	Missouri	7.6	%	7.9	%
Ohio		6.1	%	0	%
Massachusetts						Massachusetts	5.9	%	6.1	%
California	California	5.7	%	0	%	California	5.7	%	5.9	%
Massachusetts		5.2	%	4.7	%
New Jersey		4.9	%	13.3	%
Arizona	Arizona	3.7	%	3.8	%	Arizona	4.2	%	4.3	%
Virginia	Virginia	3.6	%	6.8	%	Virginia	4.1	%	4.2	%
Indiana	Indiana	2.4	%	2.1	%	Indiana	2.7	%	2.8	%
North Carolina	North Carolina	2.0	%	1.8	%	North Carolina	2.1	%	2.2	%
Nevada	Nevada	1.6	%	1.5	%	Nevada	1.8	%	1.9	%
Tennessee		1.6	%	1.5	%
Illinois	Illinois	1.3	%	1.2	%	Illinois	1.3	%	1.4	%
Other		0.4	%	1.1	%
New Jersey						New Jersey	0.7	%	5.8	%
		100.0	%	100.0	%		100.0	%	100.0	%

As of ~~September 30, 2020,~~March 31, 2021, the Company had 24 non-performing commercial mortgage loans with an unpaid principal balance and fair value of ~~$23.8~~$34.4 million and ~~$23.7~~$34.3 million, respectively. As of December 31, ~~2019,~~2020, the Company had 3 non-performing commercial mortgage loans with an unpaid principal balance and fair value of ~~$28.9~~$31.8 million and ~~$26.5~~$31.5 million, respectively.

~~Table of Contents~~

As described in Note 2, the Company evaluates the cost basis of its commercial mortgage loans for impairment on at least a quarterly basis. ~~At September 30,~~As of both March 31, 2021 and December 31, 2020, the expected future credit losses, which itthe Company tracks for purposes of calculating interest income, of $0.4 million, related to adverse changes in estimated future cash flows on its commercial mortgage loans. ~~For the three- and nine-month periods ended September 30, 2019, the Company did not recognize any impairment charge on the cost basis~~

Table of ~~its commercial mortgage loans.~~Contents

As of ~~September 30,~~December 31, 2020, the Company had 1 commercial mortgage loans with a fair value of $10.5 million that was in the process of foreclosure. The Company did not have any commercial mortgage loans ~~that were~~ in the process of ~~foreclosure. As~~foreclosure as of ~~December~~March 31, ~~2019, the Company had 2 commercial mortgage loans with a fair value of $16.0 million that were in the process of foreclosure.~~2021.

Consumer Loans

The tables below detail certain information regarding the Company's consumer loans as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~

~~September 30,~~ 2020:

Gross Unrealized Weighted Average
($ in thousands) Unpaid Principal Balance Premium (Discount) Amortized Cost Gains Losses
Fair Value(1)
Life (Years)(2)
Delinquency (Days)
Consumer loans, held-for-investment $ 150,062 $ 7,347 $ 157,409 $ 1,430 $ (6,230) $ 152,609 0.88 4
March 31, 2021:


							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value(1)		Life (Years)(2)	Delinquency (Days)
Consumer loans, held-for-investment	$	51,488	$	1,616	$	53,104	$	990	$	(1,389)	$	52,705	1.04	4

(1)Includes ~~$0.6~~$0.5 million of charged-off loans for which the Company has determined that it is probable the servicer will be able to collect principal and interest.

(2)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

December 31, ~~2019:~~2020:


								Gross Unrealized						Weighted Average									Gross Unrealized						Weighted Average
($ in thousands)	($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value(1)		Life (Years)(2)	Delinquency (Days)	($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value(1)		Life (Years)(2)	Delinquency (Days)
Consumer loans, held-for-investment	Consumer loans, held-for-investment	$	179,743	$	5,027	$	184,770	$	2,561	$	(377)	$	186,954	0.82	4	Consumer loans, held-for-investment	$	48,180	$	72	$	48,252	$	1,160	$	(1,887)	$	47,525	1.04	7

(1)Includes $0.6 million of charged-off loans for which the Company has determined that it is probable the servicer will be able to collect principal and interest.

(2)Average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

The table below provides details on the delinquency status as a percentage of total unpaid principal balance of the Company's consumer loans, which the Company uses as an indicator of credit quality, as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~2020:


Days Past Due	Days Past Due	September 30, 2020		December 31, 2019		Days Past Due	March 31, 2021		December 31, 2020
Current	Current	96.2	%	95.3	%	Current	95.2	%	90.4	%
30-59 Days	30-59 Days	1.6	%	2.1	%	30-59 Days	2.0	%	3.4	%
60-89 Days	60-89 Days	1.1	%	1.4	%	60-89 Days	1.4	%	3.3	%
90-119 Days	90-119 Days	0.8	%	1.2	%	90-119 Days	1.3	%	2.8	%
>120 Days	>120 Days	0.3	%	0	%	>120 Days	0.1	%	0.1	%
		100.0	%	100.0	%		100.0	%	100.0	%

During the three-month periods ended ~~September 30,~~March 31, 2021 and 2020, ~~and 2019,~~ the Company charged off ~~$3.9~~$3.6 million and $4.9 million, respectively, of unpaid principal balance of consumer loans that were greater than 120 days delinquent. During each of the nine-month periods ended September 30, 2020 and 2019, the Company charged off $13.9 million of unpaid principal balance of consumer loans that were greater than 120 days delinquent. As of ~~both September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Company held charged-off consumer loans with an aggregate fair value of $0.5 million and $0.6 million, respectively, for which the Company has determined that it is probable the servicer will be able to collect principal and interest.

~~Table of Contents~~

As described in Note 2, the Company evaluates the cost basis of its consumer loans for impairment on at least a quarterly basis. ~~At September 30,~~As of March 31, 2021 and December 31, 2020, the Company had expected future credit losses, which it tracks for purposes of calculating interest income, of ~~$4.7~~$1.3 million and $2.9 million, respectively, on its consumer loans. The Company has determined for certain of its consumer loans that a portion of such loans' cost basis is not collectible; for ~~each of~~ the ~~three- and nine-month periods~~three-month period ended ~~September 30, 2020,~~March 31, 2021, the Company recognized realized losses on these loans of ~~$0.1~~$1.3 million. No such realized losses were recognized for the three-month period ended March, 31, 2020.

~~For the three- and nine-month periods ended September 30, 2019, the Company recognized an impairment charge~~

Table of $1.1 million and $4.6 million, respectively, on the cost basis of its consumer loan pools, which is included in Realized gains (losses) on securities and loans, net, on the Condensed Consolidated Statement of Operations.Contents

Corporate Loans

The tables below detail certain information regarding the Company's corporate loans as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~

~~September 30,~~ 2020:

Weighted Average
($ in thousands) Unpaid
Principal Balance Fair Value Rate Remaining Term (Years)
Corporate loans, held-for-investment(1)
$ 7,063 $ 7,063 19.43 % 1.98
March 31, 2021:


					Weighted Average
($ in thousands)	Unpaid Principal Balance		Fair Value		Rate		Remaining Term (Years)
Corporate loans, held-for-investment(1)	$	13,226	$	13,226	21.02	%	3.13

(1)See Note 21 for further details on the Company's unfunded commitments related to certain of its corporate loans.

December 31, ~~2019:~~2020:


						Weighted Average								Weighted Average
($ in thousands)	($ in thousands)	Unpaid Principal Balance		Fair Value		Rate		Remaining Term (Years)	($ in thousands)	Unpaid Principal Balance		Fair Value		Rate		Remaining Term (Years)
Corporate loans, held-for-investment~~(2)~~(1)	Corporate loans, held-for-investment~~(2)~~(1)	$	18,415	$	18,510	17.62	%	0.87	Corporate loans, held-for-investment~~(2)~~(1)	$	5,855	$	5,855	20.00	%	1.75

(1)~~See Note 13 for further details on the Company's transactions involving a loan originator in which the Company also holds an equity investment.~~

~~(2)~~See Note 21 for further details on the Company's unfunded commitments related to certain of its corporate loans.

6. Investments in Unconsolidated Entities

The Company has various equity investments in entities where it has the ability to exert significant influence over such entity, but does not control such entity. In these cases the criteria for consolidation have not been met and the Company is required to account for such investments under ASC 323-10; the Company has elected the FVO for its investments in unconsolidated entities. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Company's investments in unconsolidated entities had an aggregate fair value of ~~$95.8~~$147.7 million and ~~$71.9~~$141.6 million, respectively, which is included on the Condensed Consolidated Balance Sheet in Investments in unconsolidated entities, at fair value. For the ~~three-month~~three month periods ended ~~September 30,~~March 31, 2021 and 2020, ~~and 2019,~~ the Company recognized ~~$11.4~~$6.6 million and ~~$2.8~~$(6.5) million, respectively, in Earnings (losses) from investments in unconsolidated entities, on its Condensed Consolidated Statement of ~~Operations. For the nine-month periods ended September 30,~~Operations, primarily related to its investment in mortgage loan originators. As of March 31, 2021 and December 31, 2020, ~~and 2019,~~ the Company ~~recognized $10.6~~had non-controlling equity interests in three loan originators with an aggregate fair value of $82.5 million and ~~$6.9~~$79.5 million, ~~respectively, in Earnings (losses) from investments in unconsolidated entities, on its Condensed Consolidated Statement of Operations.~~respectively. Certain of the entities that the Company accounts for under ASC 323-10 are deemed to be VIEs, and the maximum amount at risk is generally limited to the Company's investment in the VIE. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the fair value of the Company's investments in unconsolidated entities that have been deemed to be VIEs was ~~$37.1~~$14.0 million and ~~$28.5 million.~~$13.6 million, respectively.

4537

Table of Contents

The following table provides details about the Company's investments in unconsolidated entities as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~2020:

Percentage Ownership
of Unconsolidated Entity

Investment in Unconsolidated Entity

Form of Investment

September 30, 2020

December 31, 2019

Investment in Unconsolidated Entity

Form of Investment

March 31, 2021

December 31, 2020

Longbridge Financial, LLC(1)

Preferred shares

49.7%

Longbridge Financial, LLC(1)

Preferred shares

49.7%

LendSure Mortgage Corp.(1)(2)

Common shares

49.9%

LendSure Mortgage Corp.(1)(2)

Common shares

49.9%

Elizon TCG SBC 2017-1(1)

Membership Interest

36.0%

Jepson Holdings Limited(1)

Membership Interest

30.1%

Jepson Holdings Limited(1)

Membership Interest

30.1%

Elizon AFG 2018-1 LLC(1)(3)(4)

Membership Interest

22.1%

13.4%

Elizon DB 2015-1 LLC~~(5)~~(4)

Membership Interest

8.5%

3.5%

Elizon DB 2015-1 LLC~~(5)~~(4)

Membership Interest

5.7%

8.9%

Other

Various

7.4%–51.0%

7.7%–51.0%

Elizon NM CRE 2020-1 LLC(1)(3)(5)

Membership Interest

26.2%

Other(6)(7)

Various

8.0%–56.3%

7.4%–56.3%

(1)See Note 13 for additional details on the Company's related party transactions.

(2)Excludes investment in warrants convertible into non-voting common shares; including such warrants the Company's additional non-voting stake in the entity was 15.0% as of ~~September 30,~~both March 31, 2021 and December 31, 2020. See Note 13 Related Party Transactions—Transactions Involving Certain Loan Originators for additional information.

(3)The Company has evaluated this entity and determined that it meets the definition of a VIE. The Company evaluated its interest in the VIE and determined that the Company does not have the power to direct the activities of the VIE and does not have control of the underlying assets, where applicable. As a result, the Company determined that it is not the primary beneficiary of this VIE and therefore has not consolidated the VIE.

(4)As discussed in Note 13 Related Party Transactions—Participation in Multi-Borrower Financing Facilities, the Company and the Affiliated Entities (as defined in Note 13) each consolidate their segregated ~~portions~~silos of the Joint Entity (as defined in Note 13). The Company's effective percentage ownership before the effects of consolidation of both its and the Affiliated Entities' respective segregated ~~portions~~silos of the Joint Entity, was ~~61.7%~~50.1% and ~~70.4%~~58.2% as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, respectively.

(5)As discussed in Note 13 Related Party Transactions—Participation in Multi-Borrower Financing Facilities, the Company and the Affiliated Entities (as defined in Note 13) each consolidate their segregated ~~portions~~silos of the Joint Entity (as defined in Note 13). The Company's effective percentage ownership before the effects of consolidation of both its and the Affiliated Entities' respective segregated ~~portions~~silos of the Joint Entity, was ~~53.1% and 48.7%~~42.5% as of ~~September 30, 2020~~March 31, 2021.

(6)Includes interest in Consumer Risk Retention Vehicle, as defined in Note 10—Participation in Multi-Seller Consumer Loan Securitization. The Company has evaluated this entity and ~~December 31, 2019, respectively.~~

~~For~~determined that it does not meet the ~~nine-month period ended September 30, 2020,~~definition of a VIE. The Company evaluated its interest in the entity under the voting interest model outlined in ASC 810, and has determined that the Company ~~recognized unrealized gains that may be deemed to be significant in relation to~~does not control this entity. As a result, the Company has not consolidated the entity. See Note 10 for additional details on the Company's ~~net income related to one of the Company's investments~~securitization transactions.

(7)Includes interest in an unconsolidated entity, a mortgage originator. For the three-month periods ended September 30, 2020 and 2019, the Company recognized $8.9 million and $2.1 million, respectively of unrealized gains includedwarehouse facilities; see Note 13—Participation in Earnings (losses) from investments in unconsolidated entities on the Condensed Consolidated Statement of Operations. For the nine-month periods ended September 30, 2020 and 2019, the Company recognized $13.2 million and $0.6 million, respectively of unrealized gains included in Earnings (losses) from investments in unconsolidated entities on the Condensed Consolidated Statement of Operations. The following table provides a summary of the results of operations of this entityCLO Transactions, for ~~the three- and nine-month periods ended September 30, 2020 and 2019.~~

Three-Month Period Ended Nine-Month Period Ended
(In thousands) September 30, 2020 September 30, 2019 September 30, 2020 September 30, 2019
Revenue $ 4,827 $ 6,957 $ 10,030 $ 14,486
Net income (loss) $ 15,962 $ 4,739 $ 28,901 $ 3,074

additional details.

~~Table of Contents~~

7. Real Estate Owned

As discussed in Note 2, the Company obtains possession of REO as a result of foreclosures on the associated mortgage loans. The following tables detail activity in the Company's carrying value of REO for the ~~three- and nine-month~~three-month periods ended ~~September 30, 2020~~March 31, 2021 and ~~2019:~~2020:


		Three-Month Period Ended							Three-Month Period Ended
		September 30, 2020			September 30, 2019				March 31, 2021			March 31, 2020
		Number of Properties	Carrying Value		Number of Properties	Carrying Value			Number of Properties	Carrying Value		Number of Properties	Carrying Value
			(In thousands)			(In thousands)				(In thousands)			(In thousands)
Beginning Balance (June 30, 2020 and June 30, 2019, respectively)		13	$	24,044	20	$	47,621
Beginning Balance (December 31, 2020 and 2019, respectively)								Beginning Balance (December 31, 2020 and 2019, respectively)	13	$	23,598	15	$	30,584
Transfers from mortgage loans	Transfers from mortgage loans	4	676		1	601		Transfers from mortgage loans	3	12,554		4	1,422
Capital expenditures and other adjustments to cost	Capital expenditures and other adjustments to cost		27			0		Capital expenditures and other adjustments to cost		473			114
Adjustments to record at the lower of cost or fair value	Adjustments to record at the lower of cost or fair value		147			6		Adjustments to record at the lower of cost or fair value		(790)			(683)
Disposals	Disposals	(1)	(100)		(7)	(3,805)		Disposals	(1)	(278)		(3)	(6,383)
Ending Balance (September 30, 2020 and September 30, 2019, respectively)		16	$	24,794	14	$	44,423
Ending Balance (March 31, 2021 and 2020, respectively)								Ending Balance (March 31, 2021 and 2020, respectively)	15	$	35,557	16	$	25,054

Nine-Month Period Ended
September 30, 2020 September 30, 2019
Number of Properties Carrying Value Number of Properties Carrying Value
(In thousands) (In thousands)
Beginning Balance (December 31, 2019 and January 1, 2019, respectively) 15 $ 30,584 20 $ 30,778
Transfers from mortgage loans 9 2,198 5 18,314
Capital expenditures and other adjustments to cost 153 240
Adjustments to record at the lower of cost or fair value (813) (257)
Disposals (8) (7,328) (11) (4,652)
Ending Balance (September 30, 2020 and September 30, 2019, respectively) 16 $ 24,794 14 $ 44,423

During the three-month period ended ~~September 30, 2020,~~March 31, 2021, the Company sold 1 REO property, realizing a net gain (loss) of approximately ~~$(18)~~$61 thousand. During the three-month ~~period~~ ended ~~September 30, 2019,~~March 31, 2020, the Company sold 73 REO properties, realizing a net gain (loss) of approximately $1.2 million. During the nine-month period ended September 30, 2020, the Company sold 8 REO properties, realizing a net gain (loss) of approximately $0.1 million. During the nine-month period ended September 30, 2019, the Company sold 11 REO properties, realizing a net gain (loss) of approximately $1.2$0.4 million. Such realized gains (losses) are included in R~~ealized~~Realized gains (losses) on real estate owned, net, on the Company's Condensed Consolidated Statement of Operations. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019~~2020 all of the Company's REO had been obtained as a result of obtaining physical possession through foreclosure. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Company had REO measured at fair value on a non-recurring basis of ~~$18.4~~$23.0 million and ~~$19.4~~$22.4 million, respectively.

4738

Table of Contents

8. Financial Derivatives

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages certain risks associated with its investments and borrowings, including interest rate, credit, liquidity, and foreign exchange rate risk primarily by managing the amount, sources, and duration of its investments and borrowings, and through the use of derivative financial instruments. The Company's derivative financial instruments are used to manage differences in the amount, timing, and duration of its known or expected cash receipts and its known or expected cash payments principally related to its investments and borrowings.

The following table details the fair value of the Company's holdings of financial derivatives as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~2020:


		September 30, 2020		December 31, 2019			March 31, 2021		December 31, 2020
(In thousands)	(In thousands)					(In thousands)
Financial derivatives–assets, at fair value:	Financial derivatives–assets, at fair value:					Financial derivatives–assets, at fair value:
TBA securities purchase contracts	TBA securities purchase contracts	$	394	$	90	TBA securities purchase contracts	$	1	$	961
TBA securities sale contracts	TBA securities sale contracts	756		506		TBA securities sale contracts	3,408		1
Fixed payer interest rate swaps	Fixed payer interest rate swaps	5		3,914		Fixed payer interest rate swaps	5,331		125
Fixed receiver interest rate swaps	Fixed receiver interest rate swaps	13,785		1,554		Fixed receiver interest rate swaps	5,372		8,394
Credit default swaps on asset-backed securities	Credit default swaps on asset-backed securities	351		993		Credit default swaps on asset-backed securities	320		347
Credit default swaps on asset-backed indices	Credit default swaps on asset-backed indices	9,722		3,319		Credit default swaps on asset-backed indices	2,087		2,184
Credit default swaps on corporate bonds		39		2
Credit default swaps on corporate bond indices	Credit default swaps on corporate bond indices	2,419		5,599		Credit default swaps on corporate bond indices	3,427		3,420
Total return swaps	Total return swaps	105		620		Total return swaps	2		9
Futures	Futures	1		148		Futures	2,704		2
Forwards	Forwards	256		43		Forwards	388		0
Warrants	Warrants	31		0		Warrants	42		36
Total financial derivatives–assets, at fair value	Total financial derivatives–assets, at fair value	27,864		16,788		Total financial derivatives–assets, at fair value	23,082		15,479
Financial derivatives–liabilities, at fair value:	Financial derivatives–liabilities, at fair value:					Financial derivatives–liabilities, at fair value:
TBA securities purchase contracts	TBA securities purchase contracts	$	(156)	$	0	TBA securities purchase contracts	(3,915)		0
TBA securities sale contracts	TBA securities sale contracts	(130)		(1,012)		TBA securities sale contracts	(161)		(925)
Fixed payer interest rate swaps	Fixed payer interest rate swaps	(29,712)		(8,513)		Fixed payer interest rate swaps	(7,856)		(15,109)
Fixed receiver interest rate swaps	Fixed receiver interest rate swaps	(62)		(206)		Fixed receiver interest rate swaps	(1,028)		(65)
Credit default swaps on asset-backed indices	Credit default swaps on asset-backed indices	(142)		(250)		Credit default swaps on asset-backed indices	(127)		(130)
Credit default swaps on corporate bonds	Credit default swaps on corporate bonds	(580)		(1,693)		Credit default swaps on corporate bonds	(682)		(747)
Credit default swaps on corporate bond indices	Credit default swaps on corporate bond indices	(3,572)		(14,524)		Credit default swaps on corporate bond indices	(5,128)		(6,438)
Total return swaps	Total return swaps	(88)		(1,209)		Total return swaps	(338)		(484)
Futures	Futures	(331)		(45)		Futures	(163)		(376)
Forwards	Forwards	(41)		(169)		Forwards	(40)		(279)
Total financial derivatives–liabilities, at fair value	Total financial derivatives–liabilities, at fair value	(34,814)		(27,621)		Total financial derivatives–liabilities, at fair value	(19,438)		(24,553)
Total	Total	$	(6,950)	$	(10,833)	Total	$	3,644	$	(9,074)

4839

Table of Contents

Interest Rate Swaps

The following tables provide information about the Company's fixed payer interest rate swaps as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~

~~September 30,~~ 2020:

Weighted Average
Maturity Notional Amount Fair Value Pay Rate Receive Rate Remaining Years to Maturity
(In thousands)
2021 $ 17,500 $ (223) 2.75 % 0.23 % 0.47
2022 129,975 (1,952) 1.21 0.26 1.40
2023 146,012 (5,052) 1.50 0.24 2.67
2025 31,500 (902) 0.95 0.25 4.61
2026 28,104 (1,463) 1.25 0.22 5.74
2027 34,000 (89) 0.49 0.22 6.73
2028 32,942 (4,721) 2.40 0.23 7.59
2029 92,594 (9,789) 1.78 0.25 9.04
2030 68,463 (2,781) 1.10 0.25 9.44
2036 1,100 (84) 1.45 0.22 15.39
2049 5,796 (2,651) 2.89 0.30 28.28
Total $ 587,986 $ (29,707) 1.43 % 0.25 % 5.15
March 31, 2021:


					Weighted Average
Maturity	Notional Amount		Fair Value		Pay Rate		Receive Rate		Remaining Years to Maturity
	(In thousands)
2022	$	64,100	$	(503)	0.99	%	0.18	%	0.93
2023	361,650		(3,788)		0.74		0.19		2.00
2024	251,700		669		0.38		0.16		2.94
2025	38,192		(123)		0.92		0.18		4.21
2026	10,000		49		0.90		0.19		4.92
2027	9,732		464		0.49		0.19		6.24
2028	51,644		(52)		1.40		0.19		6.95
2029	19,152		(643)		1.98		0.20		8.30
2030	11,085		572		1.06		0.19		9.08
2031	53,945		1,412		1.46		0.15		9.92
2035	500		67		0.78		0.09		14.56
2036	1,100		84		1.45		0.19		14.89
2040	500		85		0.90		0.09		19.57
2049	5,796		(932)		2.89		0.24		27.78
2050	500		114		0.98		0.09		29.58
Total	$	879,596	$	(2,525)	0.79	%	0.18	%	3.59

December 31, ~~2019:~~2020:

Weighted Average
Maturity
Notional Amount(1)
Fair Value(1)
Pay Rate(2)(3)
Receive Rate(2)
Remaining Years to Maturity(4)
(In thousands)
2020 $ 68,607 $ (234) 1.74 % 1.93 % 0.24
2021 268,929 (419) 1.73 1.95 1.64
2022 31,350 9 1.65 1.93 2.14
2023 101,012 (1,265) 2.06 1.91 3.29
2024 13,000 99 1.56 1.89 4.90
2025 12,800 (24) n/a n/a 5.22
2026 59,902 1,946 1.24 1.94 6.50
2028 32,942 (1,634) 2.40 1.93 8.34
2029 136,838 (2,018) 2.02 1.96 9.61
2030 685 (32) 2.38 1.90 10.90
2036 1,100 87 1.45 1.94 16.14
2049 5,796 (1,114) 2.89 2.09 29.03
Total $ 732,961 $ (4,599) 1.83 % 1.94 % 4.31

~~(1)Includes forward-starting interest rate swaps with a notional amount of $20.9 million and fair value of $(41) thousand.~~

~~(2)Excludes forward-starting interest rate swaps.~~

~~(3)Including forward-starting interest rate swaps the total weighted average pay rate was 1.83%.~~

~~(4)Includes forward-starting interest rate swaps, all of which start within six months of period end.~~


					Weighted Average
Maturity	Notional Amount		Fair Value		Pay Rate		Receive Rate		Remaining Years to Maturity
	(In thousands)
2021	$	17,500	$	(231)	2.75	%	0.24	%	0.22
2022	96,533		(1,535)		1.19		0.22		1.14
2023	146,012		(4,770)		1.50		0.23		2.42
2025	66,503		(1,034)		0.73		0.21		4.75
2026	11,216		(458)		1.23		0.25		5.50
2027	9,732		60		0.49		0.24		6.48
2028	16,644		(2,169)		2.39		0.24		7.32
2029	22,744		(2,289)		1.94		0.23		8.61
2030	13,015		(369)		1.13		0.22		9.29
2035	500		15		0.78		0.09		14.81
2036	1,100		(47)		1.45		0.25		15.13
2040	500		20		0.90		0.09		19.82
2049	5,796		(2,208)		2.89		0.23		28.02
2050	500		31		0.98		0.09		29.82
Total	$	408,295	$	(14,984)	1.39	%	0.23	%	3.82

4940

Table of Contents

The following tables provide information about the Company's fixed receiver interest rate swaps as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~

~~September 30,~~ 2020:

Weighted Average
Maturity Notional Amount Fair Value Pay Rate Receive Rate Remaining Years to Maturity
(In thousands)
2021 $ 12,950 $ 201 0.23 % 1.75 % 0.96
2022 87,683 1,514 0.26 1.33 1.45
2023 48,657 2,234 0.23 2.00 2.51
2024 86,342 5,262 0.26 1.65 3.99
2025 39,685 226 0.24 0.44 4.66
2027 25,108 343 0.30 0.63 6.50
2029 9,800 1,030 0.24 1.78 9.02
2030 128,335 2,913 0.25 0.90 9.47
Total $ 438,560 $ 13,723 0.25 % 1.25 % 5.15
March 31, 2021:


					Weighted Average
Maturity	Notional Amount		Fair Value		Pay Rate		Receive Rate		Remaining Years to Maturity
	(In thousands)
2021	$	12,950	$	103	0.19	%	1.75	%	0.46
2022	53,974		887		0.19		1.85		0.92
2023	41,407		1,423		0.19		2.00		1.97
2024	76,342		2,959		0.22		1.57		3.55
2026	47,799		(725)		0.18		0.69		4.90
2031	3,500		(38)		0.19		1.63		9.95
2035	500		(66)		0.09		0.74		14.56
2040	500		(85)		0.09		0.84		19.57
2050	500		(114)		0.09		0.90		29.58
Total	$	237,472	$	4,344	0.20	%	1.54	%	2.99

December 31, ~~2019:~~2020:

Weighted Average
Maturity Notional Amount Fair Value Pay Rate Receive Rate Remaining Years to Maturity
(In thousands)
2021 $ 181,950 $ (49) 1.89 % 1.67 % 1.84
2022 53,974 441 1.91 1.85 2.17
2023 48,657 709 1.92 2.00 3.26
2024 11,342 306 2.09 2.33 4.23
2029 9,800 (59) 1.91 1.78 9.77
Total $ 305,723 $ 1,348 1.91 % 1.78 % 2.47


					Weighted Average
Maturity	Notional Amount		Fair Value		Pay Rate		Receive Rate		Remaining Years to Maturity
	(In thousands)
2021	$	12,950	$	205	0.24	%	1.75	%	0.71
2022	103,974		1,413		0.22		1.07		1.48
2023	48,657		2,209		0.24		2.00		2.26
2024	86,342		4,567		0.22		1.65		3.73
2035	500		(14)		0.09		0.74		14.81
2040	500		(20)		0.09		0.84		19.82
2050	500		(31)		0.09		0.90		29.82
Total	$	253,423	$	8,329	0.22	%	1.48	%	2.48

5041

Table of Contents

Credit Default Swaps

The following table provides information about the Company's credit default swaps as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~2020:


		As of											As of
		September 30, 2020					December 31, 2019						March 31, 2021					December 31, 2020
Type(1)	Type(1)	Notional		Fair Value		Weighted Average Remaining Term (Years)	Notional		Fair Value		Weighted Average Remaining Term (Years)	Type(1)	Notional		Fair Value		Weighted Average Remaining Term (Years)	Notional		Fair Value		Weighted Average Remaining Term (Years)
($ in thousands)	($ in thousands)											($ in thousands)
Asset:	Asset:											Asset:
Long:	Long:											Long:
Credit default swaps on asset-backed indices	Credit default swaps on asset-backed indices	$	416	$	6	17.25	$	695	$	10	23.80	Credit default swaps on asset-backed indices	$	555	$	6	24.01	$	395	$	5	16.99
Credit default swaps on corporate bonds		1,600		39		5.22	430		2		0.47
Credit default swaps on corporate bond indices	Credit default swaps on corporate bond indices	69,381		1,913		2.71	130,707		5,547		2.42	Credit default swaps on corporate bond indices	67,354		3,422		2.27	67,779		3,296		2.52
Short:	Short:											Short:
Credit default swaps on asset-backed securities	Credit default swaps on asset-backed securities	(955)		351		14.95	(2,640)		993		15.63	Credit default swaps on asset-backed securities	(927)		320		14.46	(957)		347		14.70
Credit default swaps on asset-backed indices	Credit default swaps on asset-backed indices	(30,668)		9,716		37.71	(63,515)		3,309		38.40	Credit default swaps on asset-backed indices	(13,705)		2,081		43.97	(12,888)		2,179		39.61
Credit default swaps on corporate bond indices	Credit default swaps on corporate bond indices	(10,036)		506		1.64	(1,997)		52		3.97	Credit default swaps on corporate bond indices	(1,642)		5		2.72	(2,173)		124		2.97
Liability:	Liability:											Liability:
Long:	Long:											Long:
Credit default swaps on asset-backed indices	Credit default swaps on asset-backed indices	480		(142)		32.61	344		(145)		29.35	Credit default swaps on asset-backed indices	293		(127)		28.03	479		(130)		32.36
Short:	Short:											Short:
Credit default swaps on asset-backed indices	Credit default swaps on asset-backed indices	(1)		0		29.25	(4,501)		(105)		40.31	Credit default swaps on asset-backed indices	(1)		0		28.76	(1)		0		29.00
Credit default swaps on corporate bonds	Credit default swaps on corporate bonds	(12,200)		(580)		3.71	(10,800)		(1,693)		3.92	Credit default swaps on corporate bonds	(8,400)		(682)		3.93	(8,400)		(747)		4.17
Credit default swaps on corporate bond indices	Credit default swaps on corporate bond indices	(126,983)		(3,572)		2.07	(250,088)		(14,524)		2.51	Credit default swaps on corporate bond indices	(93,661)		(5,128)		2.33	(110,624)		(6,438)		2.78
		$	(108,966)	$	8,237	11.71	$	(201,365)	$	(6,554)	14.88		$	(50,134)	$	(103)	13.90	$	(66,390)	$	(1,364)	10.25

(1)Long notional represents contracts where the Company has written protection and short notional represents contracts where the Company has purchased protection.

5142

Table of Contents

Futures

The following table provides information about the Company's long and short positions in futures as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~2020:


		As of											As of
		September 30, 2020					December 31, 2019						March 31, 2021					December 31, 2020
Description	Description	Notional Amount		Fair Value		Remaining Months to Expiration	Notional Amount		Fair Value		Remaining Months to Expiration	Description	Notional Amount		Fair Value		Remaining Months to Expiration	Notional Amount		Fair Value		Remaining Months to Expiration
		(In thousands)					(In thousands)						(In thousands)					(In thousands)
Assets:	Assets:											Assets:
Short Contracts:	Short Contracts:											Short Contracts:
U.S. Treasury futures	U.S. Treasury futures	$	(300)	$	1	2.73	$	0	$	0	—	U.S. Treasury futures	$	(178,500)	$	2,704	2.98	$	(300)	$	2	2.70
Liabilities:	Liabilities:											Liabilities:
Long Contracts:	Long Contracts:											Long Contracts:
U.S. Treasury futures	U.S. Treasury futures	$	1,900	$	(31)	2.73	0		0		—	U.S. Treasury futures	1,900		(163)		2.73	1,900		(9)		2.70
Short Contracts:	Short Contracts:											Short Contracts:
U.S. Treasury futures	U.S. Treasury futures	(165,600)		(300)		3.00	(16,000)		148		2.77	U.S. Treasury futures	0		0		—	(178,200)		(367)		2.94
Eurodollar futures		0		0		—	(14,000)		(45)		4.05
Total, net	Total, net	$	(164,000)	$	(330)	3.00	$	(30,000)	$	103	3.37	Total, net	$	(176,600)	$	2,541	2.98	$	(176,600)	$	(374)	2.94

Warrants

The following table provides information about the Company's warrants contracts to purchase shares as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~2020:

September 30, 2020

As of December, 31, 2019

March 31, 2021

December 31, 2020

Description

Number of Shares Underlying Warrant

Fair Value

Remaining Years to Expiration

Number of Shares Underlying Warrant

Fair Value

Remaining Years to Expiration

Description

Number of Shares Underlying Warrant

Fair Value

Remaining Years to Expiration

Number of Shares Underlying Warrant

Fair Value

Remaining Years to Expiration

(In thousands)

Warrants

1,546

2.08

1,515

2.82

Warrants

1,897

2.15

1,897

2.40

TBAs

The Company transacts in the forward settling TBA market. Pursuant to these TBA transactions, the Company agrees to purchase or sell, for future delivery, Agency RMBS with certain principal and interest terms and certain types of underlying collateral, but the particular Agency RMBS to be delivered is not identified until shortly before the TBA settlement date. TBAs are generally liquid, have quoted market prices, and represent the most actively traded class of MBS. The Company uses TBAs to mitigate interest rate risk, usually by taking short positions. The Company also invests in TBAs as a means of acquiring additional exposure to Agency RMBS, or for investment purposes, including holding long positions.

The Company does not generally take delivery of TBAs; rather, it settles the associated receivable and payable with its trading counterparties on a net basis. Transactions with the same counterparty for the same TBA that result in a reduction of the position are treated as extinguished.

5243

Table of Contents

As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Company had outstanding TBA purchase and sale contracts as follows:


		September 30, 2020								December 31, 2019									March 31, 2021								December 31, 2020
TBA Securities	TBA Securities	Notional Amount(1)		Cost Basis(2)		Market Value(3)		Net Carrying Value(4)		Notional Amount(1)		Cost Basis(2)		Market Value(3)		Net Carrying Value(4)		TBA Securities	Notional Amount(1)		Cost Basis(2)		Market Value(3)		Net Carrying Value(4)		Notional Amount(1)		Cost Basis(2)		Market Value(3)		Net Carrying Value(4)
(In thousands)	(In thousands)																	(In thousands)
Purchase contracts:	Purchase contracts:																	Purchase contracts:
Assets	Assets	$	100,890	$	103,882	$	104,276	$	394	$	40,100	$	40,585	$	40,675	$	90	Assets	$	10,000	$	10,039	$	10,040	$	1	$	149,990	$	155,008	$	155,969	$	961
Liabilities	Liabilities	68,000		71,370		71,214		(156)		0		0		0		0		Liabilities	174,890		178,474		174,559		(3,915)		0		0		0		0
		168,890		175,252		175,490		238		40,100		40,585		40,675		90			184,890		188,513		184,599		(3,914)		149,990		155,008		155,969		961
Sale contracts:	Sale contracts:																	Sale contracts:
Assets	Assets	(401,722)		(428,049)		(427,293)		756		(319,981)		(332,080)		(331,574)		506		Assets	(810,574)		(850,708)		(847,300)		3,408		(4,400)		(4,765)		(4,764)		1
Liabilities	Liabilities	(86,845)		(91,369)		(91,499)		(130)		(773,749)		(806,568)		(807,580)		(1,012)		Liabilities	(108,046)		(115,775)		(115,936)		(161)		(499,667)		(531,034)		(531,959)		(925)
		(488,567)		(519,418)		(518,792)		626		(1,093,730)		(1,138,648)		(1,139,154)		(506)			(918,620)		(966,483)		(963,236)		3,247		(504,067)		(535,799)		(536,723)		(924)
Total TBA securities, net	Total TBA securities, net	$	(319,677)	$	(344,166)	$	(343,302)	$	864	$	(1,053,630)	$	(1,098,063)	$	(1,098,479)	$	(416)	Total TBA securities, net	$	(733,730)	$	(777,970)	$	(778,637)	$	(667)	$	(354,077)	$	(380,791)	$	(380,754)	$	37

(1)Notional amount represents the principal balance of the underlying Agency RMBS.

(2)Cost basis represents the forward price to be paid (received) for the underlying Agency RMBS.

(3)Market value represents the current market value of the underlying Agency RMBS (on a forward delivery basis) as of period end.

(4)Net carrying value represents the difference between the market value of the TBA contract as of period end and the cost basis, and is reported in Financial derivatives-assets, at fair value and Financial derivatives-liabilities, at fair value on the Condensed Consolidated Balance Sheet.

Gains and losses on the Company's derivative contracts for the ~~three- and nine-month~~three-month periods ended ~~September 30,~~March 31, 2021 and 2020 ~~and 2019~~ are summarized in the tables below:

Three-Month Period Ended ~~September 30, 2020:~~March 31, 2021:


Derivative Type	Derivative Type	Primary Risk Exposure	Net Realized Gains (Losses) on Periodic Settlements of Interest Rate Swaps		Net Realized Gains (Losses) on Financial Derivatives Other Than Periodic Settlements of Interest Rate Swaps(1)		Net Realized Gains (Losses) on Financial Derivatives(1)		Change in Net Unrealized Gains (Losses) on Accrued Periodic Settlements of Interest Rate Swaps		Change in Net Unrealized Gains (Losses) on Financial Derivatives Other Than on Accrued Periodic Settlements of Interest Rate Swaps(2)		Change in Net Unrealized Gains (Losses) on Financial Derivatives(2)		Derivative Type	Primary Risk Exposure	Net Realized Gains (Losses) on Periodic Settlements of Interest Rate Swaps		Net Realized Gains (Losses) on Financial Derivatives Other Than Periodic Settlements of Interest Rate Swaps(1)		Net Realized Gains (Losses) on Financial Derivatives(1)		Change in Net Unrealized Gains (Losses) on Accrued Periodic Settlements of Interest Rate Swaps		Change in Net Unrealized Gains (Losses) on Financial Derivatives Other Than on Accrued Periodic Settlements of Interest Rate Swaps(2)		Change in Net Unrealized Gains (Losses) on Financial Derivatives(2)
(In thousands)	(In thousands)														(In thousands)
Interest rate swaps	Interest rate swaps	Interest Rate	$	(1,150)	$	(29)	$	(1,179)	$	516	$	1,104	$	1,620	Interest rate swaps	Interest Rate	$	(816)	$	447	$	(369)	$	410	$	7,675	$	8,085
Credit default swaps on asset-backed securities	Credit default swaps on asset-backed securities	Credit			1		1				(1)		(1)		Credit default swaps on asset-backed securities	Credit			26		26				(27)		(27)
Credit default swaps on asset-backed indices	Credit default swaps on asset-backed indices	Credit			(239)		(239)				503		503		Credit default swaps on asset-backed indices	Credit			1,069		1,069				(958)		(958)
Credit default swaps on corporate bond indices	Credit default swaps on corporate bond indices	Credit			(1,067)		(1,067)				(1,059)		(1,059)		Credit default swaps on corporate bond indices	Credit			(924)		(924)				528		528
Credit default swaps on corporate bonds	Credit default swaps on corporate bonds	Credit			(93)		(93)				(334)		(334)		Credit default swaps on corporate bonds	Credit			(72)		(72)				66		66
Total return swaps	Total return swaps	Credit			(125)		(125)				(348)		(348)		Total return swaps	Credit			(341)		(341)				139		139
TBAs	TBAs	Interest Rate			2,367		2,367				(744)		(744)		TBAs	Interest Rate			5,319		5,319				(703)		(703)
Futures	Futures	Interest Rate			(402)		(402)				52		52		Futures	Interest Rate			1,017		1,017				2,915		2,915
Forwards	Forwards	Currency			(898)		(898)				33		33		Forwards	Currency			88		88				627		627
Warrants															Warrants	Equity Market/Credit			0		0				5		5
Total	Total		$	(1,150)	$	(485)	$	(1,635)	$	516	$	(794)	$	(278)	Total		$	(816)	$	6,629	$	5,813	$	410	$	10,267	$	10,677

(1)Includes realized gain/(loss) on transactions involving foreign-currency-denominated financial derivatives in the amount of ~~$(15)~~$18 thousand for the three-month period ended ~~September 30,~~March 31, 2021, which is included on the Condensed Consolidated Statement of Operations in Other, net.

(2)Includes foreign currency remeasurement on financial derivatives in the amount of $(34) thousand for the three-month period ended March 31, 2021, which is included on the Condensed Consolidated Statement of Operations in Other, net.

Table of Contents

Three-Month Period Ended March 31, 2020:


Derivative Type	Primary Risk Exposure	Net Realized Gains (Losses) on Periodic Settlements of Interest Rate Swaps		Net Realized Gains (Losses) on Financial Derivatives Other Than Periodic Settlements of Interest Rate Swaps(1)		Net Realized Gains (Losses) on Financial Derivatives(1)		Change in Net Unrealized Gains (Losses) on Accrued Periodic Settlements of Interest Rate Swaps		Change in Net Unrealized Gains (Losses) on Financial Derivatives Other Than on Accrued Periodic Settlements of Interest Rate Swaps(2)		Change in Net Unrealized Gains (Losses) on Financial Derivatives(2)
(In thousands)
Interest rate swaps	Interest Rate	$	143	$	(6,384)	$	(6,241)	$	(111)	$	(20,020)	$	(20,131)
Credit default swaps on asset-backed securities	Credit			(994)		(994)				917		917
Credit default swaps on asset-backed indices	Credit			(556)		(556)				12,524		12,524
Credit default swaps on corporate bond indices	Credit			579		579				4,116		4,116
Credit default swaps on corporate bonds	Credit			94		94				1,527		1,527
Total return swaps	Credit			(1,571)		(1,571)				(213)		(213)
TBAs	Interest Rate			(3,173)		(3,173)				(5,423)		(5,423)
Futures	Interest Rate			(1,122)		(1,122)				(6,115)		(6,115)
Forwards	Currency			592		592				253		253
Warrants	Equity Market/Credit			0		0				20		20
Options	Credit			0		0				2,558		2,558
Total		$	143	$	(12,535)	$	(12,392)	$	(111)	$	(9,856)	$	(9,967)

(1)Includes realized gain/(loss) on transactions involving foreign-currency-denominated financial derivatives in the amount of $14 thousand for the three-month period ended March 31, 2020, which is included on the Condensed Consolidated Statement of Operations in Other, net.

(2)Includes foreign currency remeasurement on financial derivatives in the amount of ~~$20 thousand for the three-month period ended September 30, 2020, which is included on the Condensed Consolidated Statement of Operations in Other, net.~~

~~Table of Contents~~

~~Three-Month Period Ended September 30, 2019~~

Derivative Type Primary
Risk
Exposure Net Realized Gains (Losses) on Periodic Settlements of Interest Rate Swaps
Net Realized Gains (Losses) on Financial Derivatives Other Than Periodic Settlements of Interest Rate Swaps(1)
Net Realized Gains (Losses) on Financial Derivatives(1)
Change in Net Unrealized Gains (Losses) on Accrued Periodic Settlements of Interest Rate Swaps
Change in Net Unrealized Gains (Losses) on Financial Derivatives Other Than on Accrued Periodic Settlements of Interest Rate Swaps(2)
Change in Net Unrealized Gains (Losses) on Financial Derivatives(2)
(In thousands)
Interest rate swaps Interest Rate $ 82 $ 34 $ 116 $ 171 $ (2,598) $ (2,427)
Credit default swaps on asset-backed securities Credit 16 16 (12) (12)
Credit default swaps on asset-backed indices Credit (261) (261) (81) (81)
Credit default swaps on corporate bond indices Credit (1,113) (1,113) 909 909
Credit default swaps on corporate bonds Credit (259) (259) 268 268
Total return swaps Equity Market/Credit 251 251 (716) (716)
TBAs Interest Rate (5,067) (5,067) 1,542 1,542
Futures Interest Rate/Currency (3,551) (3,551) 1,627 1,627
Forwards Currency 525 525 379 379
Total $ 82 $ (9,425) $ (9,343) $ 171 $ 1,318 $ 1,489

~~(1)Includes realized gain/(loss) on transactions involving foreign-currency-denominated financial derivatives in the amount of~~ $17 thousand for the three-month period ended ~~September 30, 2019, which is included on the Condensed Consolidated Statement of Operations in Other, net.~~

~~(2)~~Includes foreign currency remeasurement on financial derivatives in the amount of $16 thousand for the three-month period ended September 30, 2019, which is included on the Condensed Consolidated Statement of Operations in Other, net.

~~Table of Contents~~

~~Nine-Month Period Ended September 30, 2020:~~

Derivative Type Primary
Risk
Exposure Net Realized Gains (Losses) on Periodic Settlements of Interest Rate Swaps
Net Realized Gains (Losses) on Financial Derivatives Other Than Periodic Settlements of Interest Rate Swaps(1)
Net Realized Gains (Losses) on Financial Derivatives(1)
Change in Net Unrealized Gains (Losses) on Accrued Periodic Settlements of Interest Rate Swaps
Change in Net Unrealized Gains (Losses) on Financial Derivatives Other Than on Accrued Periodic Settlements of Interest Rate Swaps(2)
Change in Net Unrealized Gains (Losses) on Financial Derivatives(2)
(In thousands)
Interest rate swaps Interest Rate $ (1,900) $ (8,761) $ (10,661) $ 541 $ (16,373) $ (15,832)
Credit default swaps on asset-backed securities Credit (955) (955) 915 915
Credit default swaps on asset-backed indices Credit 3,660 3,660 7,642 7,642
Credit default swaps on corporate bond indices Credit (550) (550) 3,080 3,080
Credit default swaps on corporate bonds Credit 356 356 711 711
Total return swaps Credit (2,180) (2,180) 607 607
TBAs Interest Rate (6,778) (6,778) 1,280 1,280
Futures Interest Rate (7,866) (7,866) (434) (434)
Forwards Currency (616) (616) 343 343
Warrants Equity Market/Credit 0 0 (382) (382)
Options Credit (100) (100) 0 0
Total $ (1,900) $ (23,790) $ (25,690) $ 541 $ (2,611) $ (2,070)

~~(1)Includes realized gain/(loss) on transactions involving foreign-currency-denominated financial derivatives in the amount of $12 thousand for the nine-month period ended September 30,~~March 31, 2020, ~~which is included on the Condensed Consolidated Statement of Operations in Other, net.~~

~~(2)~~Includes foreign currency remeasurement on financial derivatives in the amount of $39 thousand for the nine-month period ended September 30, 2020, which is included on the Condensed Consolidated Statement of Operations in Other, net.

~~Table of Contents~~

~~Nine-Month Period Ended September 30, 2019:~~

Derivative Type Primary
Risk
Exposure Net Realized Gains (Losses) on Periodic Settlements of Interest Rate Swaps
Net Realized Gains (Losses) on Financial Derivatives Other Than Periodic Settlements of Interest Rate Swaps(1)
Net Realized Gains (Losses) on Financial Derivatives(1)
Change in Net Unrealized Gains (Losses) on Accrued Periodic Settlements of Interest Rate Swaps
Change in Net Unrealized Gains (Losses) on Financial Derivatives Other Than on Accrued Periodic Settlements of Interest Rate Swaps(2)
Change in Net Unrealized Gains (Losses) on Financial Derivatives(2)
(In thousands)
Interest rate swaps Interest Rate $ 852 $ (1,117) $ (265) $ (60) $ (11,915) $ (11,975)
Credit default swaps on asset-backed securities Credit 419 419 (394) (394)
Credit default swaps on asset-backed indices Credit (1,245) (1,245) (832) (832)
Credit default swaps on corporate bond indices Credit (4,387) (4,387) (1,026) (1,026)
Credit default swaps on corporate bonds Credit (764) (764) 1,110 1,110
Total return swaps Equity Market/Credit (1,046) (1,046) (681) (681)
TBAs Interest Rate (17,183) (17,183) 3,680 3,680
Futures Interest Rate/Currency (8,365) (8,365) 761 761
Forwards Currency 1,068 1,068 228 228
Options Interest Rate (35) (35) 1 1
Total $ 852 $ (32,655) $ (31,803) $ (60) $ (9,068) $ (9,128)

~~(1)~~Includes realized gain/(loss) on transactions involving foreign-currency-denominated financial derivatives in the amount of $47 thousand for the nine-month period ended September 30, 2019, which is included on the Condensed Consolidated Statement of Operations in Other, net.

~~(2)Includes foreign currency remeasurement on financial derivatives in the amount of $8 thousand for the nine-month period ended September 30, 2019,~~ which is included on the Condensed Consolidated Statement of Operations in Other, net.

The table below details the average notional values of the Company's financial derivatives, using absolute value of month end notional values, for the ~~nine-month period~~three month-period ended ~~September 30, 2020~~March 31, 2021 and the year ended December 31, ~~2019:~~2020:


Derivative Type	Derivative Type	Nine-Month Period Ended September 30, 2020		Year Ended December 31, 2019		Derivative Type	Three-Month Period Ended March 31, 2021		Year Ended December 31, 2020
(In thousands)	(In thousands)					(In thousands)
TBAs						TBAs	$	1,017,245	$	713,634
Interest rate swaps	Interest rate swaps	$	1,078,808	$	731,941	Interest rate swaps	795,247		1,009,110
TBAs		732,048		973,331
Credit default swaps	Credit default swaps	290,822		399,316		Credit default swaps	190,584		277,990
Futures						Futures	180,400		149,538
Forwards						Forwards	24,177		26,413
Total return swaps	Total return swaps	7,819		39,434		Total return swaps	4,181		6,975
Futures		143,440		167,708
Warrants						Warrants	1,897		1,570
Options	Options	1,950		19,825		Options	0		1,500
Forwards		36,935		30,930
Warrants		1,543		2,222

From time to time the Company enters into credit derivative contracts for which the Company sells credit protection ("written credit derivatives"). As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, all of the Company's open written credit derivatives were credit default swaps on either mortgage/asset-backed indices (ABX and CMBX indices) or corporate bond indices (CDX), collectively referred to as credit indices, or on individual corporate bonds, for which the Company receives periodic payments at fixed rates from credit protection buyers, and is obligated to make payments to the credit protection buyer upon the occurrence of a "credit event" with respect to underlying reference assets.

5645

Table of Contents

Written credit derivatives held by the Company at ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019~~2020 are summarized below:


Credit Derivatives	Credit Derivatives	September 30, 2020		December 31, 2019		Credit Derivatives	March 31, 2021		December 31, 2020
(In thousands)	(In thousands)					(In thousands)
Fair Value of Written Credit Derivatives, Net	Fair Value of Written Credit Derivatives, Net	$	1,816	$	5,414	Fair Value of Written Credit Derivatives, Net	$	3,301	$	3,171
Fair Value of Purchased Credit Derivatives Offsetting Written Credit Derivatives with Third Parties (1)		0		(3,248)
Notional Value of Written Credit Derivatives (2)		71,877		132,176
Notional Value of Purchased Credit Derivatives Offsetting Written Credit Derivatives with Third Parties (1)		0		(81,637)
Notional Value of Written Credit Derivatives (1)						Notional Value of Written Credit Derivatives (1)	68,202		68,653

(1)~~Offsetting transactions with third parties include purchased credit derivatives which have the same reference obligation.~~

~~(2)~~The notional value is the maximum amount that a seller of credit protection would be obligated to pay, and a buyer of credit protection would receive, upon occurrence of a "credit event." Movements in the value of credit default swap transactions may require the Company or the counterparty to post or receive collateral. Amounts due or owed under credit derivative contracts with an International Swaps and Derivatives Association, or "ISDA," counterparty may be offset against amounts due or owed on other credit derivative contracts with the same ISDA counterparty. As a result, the notional value of written credit derivatives involving a particular underlying reference asset or index has been reduced (but not below zero) by the notional value of any contracts where the Company has purchased credit protection on the same reference asset or index with the same ISDA counterparty.

A credit default swap on a credit index or a corporate bond typically terminates at the stated maturity date in the case of corporate indices or bonds, or, in the case of ABX and CMBX indices, the date that all of the reference assets underlying the index are paid off in full, retired, or otherwise cease to exist. Implied credit spreads may be used to determine the market value of such contracts and are reflective of the cost of buying/selling credit protection. Higher spreads would indicate a greater likelihood that a seller will be obligated to perform (i.e., make protection payments) under the contract. In situations where the credit quality of the underlying reference assets has deteriorated, the percentage of notional values that would be paid up front to enter into a new such contract ("points up front") is frequently used as an indication of credit risk. Credit protection sellers entering the market in such situations would expect to be paid points up front corresponding to the approximate fair value of the contract. For the Company's written credit derivatives that were outstanding at ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, implied credit spreads on such contracts ranged between ~~53.2~~28.1 and ~~382.3~~264.4 basis points and ~~10.9~~40.0 and ~~440.0~~274.8 basis points, respectively. Excluded from these spread ranges are contracts outstanding for which the individual spread is greater than 2,000 basis points. The Company believes that these contracts would be quoted based on estimated points up front. The total fair value of contracts with individual implied credit spreads in excess of 2,000 basis points was $(0.1) million as of both ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019.~~2020. Estimated points up front on these contracts as of ~~September 30,~~both March 31, 2021 and December 31, 2020 ranged between ~~54.2~~56.2 and ~~85.2 and as of December 31, 2019 estimated points up front on these contracts was 57.0.~~85.2. Total net up-front payments (paid) or received relating to written credit derivatives outstanding at ~~September 30, 2020~~both March 31, 2021 and December 31, ~~2019~~2020 were ~~$(2.1) million and $(3.3) million, respectively.~~$(2.0) million.

5746

Table of Contents

9. Consolidated VIEs

As discussed in Note 2, the Company has interests in entities that it has determined to be VIEs. The following table summarizes the assets and liabilities of the Company's consolidated VIEs that are included on the Company's Condensed Consolidated Balance Sheet as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019.~~

(In thousands)
September 30, 2020 (1)
December 31, 2019 (1)
Assets
Cash and cash equivalents $ 1,152 $ 6,016
Restricted cash 175 175
Securities, at fair value 46,857 47,923
Loans, at fair value 1,423,035 1,393,916
Investments in unconsolidated entities, at fair value 6,289 5,641
Real estate owned 24,794 30,584
Investment related receivables 43,542 28,668
Other assets 2,250 6,191
Total Assets $ 1,548,094 $ 1,519,114
Liabilities
Repurchase agreements $ 260,310 $ 302,791
Investment related payables 0 3,275
Other secured borrowings 142,674 150,334
Other secured borrowings, at fair value 695,516 594,396
Interest payable 402 1,247
Accrued expenses and other liabilities 1,301 2,279
Total Liabilities 1,100,203 1,054,322
Total Stockholders' Equity 422,217 440,394
Non-controlling interests 25,674 24,400
Total Equity 447,891 464,794
Total Liabilities and Equity $ 1,548,094 $ 1,519,116

~~(1)~~2020. See Note 10 and Note 13 for additional information on the Company's consolidated VIEs.


(In thousands)	March 31, 2021		December 31, 2020
Assets
Cash and cash equivalents	$	661	$	701
Restricted cash	175		175
Securities, at fair value	59,162		44,523
Loans, at fair value	1,556,716		1,435,067
Investments in unconsolidated entities, at fair value	10,642		6,345
Real estate owned	35,557		23,598
Investment related receivables	40,669		24,824
Other assets	2,511		2,001
Total Assets	$	1,706,093	$	1,537,234
Liabilities
Repurchase agreements	$	267,429	$	275,019
Other secured borrowings	64,506		51,062
Other secured borrowings, at fair value	911,256		754,921
Interest payable	359		776
Accrued expenses and other liabilities	952		1,103
Total Liabilities	1,244,502		1,082,881
Total Stockholders' Equity	441,115		430,554
Non-controlling interests	20,476		23,799
Total Equity	461,591		454,353
Total Liabilities and Equity	$	1,706,093	$	1,537,234

10. Securitization Transactions

Participation in CLO Transactions

Since June 2017, an affiliate of Ellington has sponsored four CLO securitization transactions (the "Ellington-sponsored CLO Securitizations"), collateralized by corporate loans and managed by an affiliate of Ellington (the "CLO Manager"). Ellington, the Company, several other affiliates of Ellington, and in certain cases, third parties, participated in the Ellington-sponsored CLO Securitizations (collectively, the "CLO Co-Participants").

Pursuant to each Ellington-sponsored CLO Securitization, a newly formed securitization trust (each a "CLO Issuer") issued various classes of notes, which were in turn sold to unrelated third parties and the applicable CLO Co-Participants.

The CLO Issuers are each deemed to be a VIE. The Company evaluates its interests in the CLO Issuers under ASC 810, and while the Company retains credit risk in each of the securitization trusts through its beneficial ownership of a portion of the subordinated interests of each of the securitization trusts, which are the first to absorb credit losses on the securitized assets, the Company does not retain control of these assets or the power to direct the activities of the CLO Issuers that most significantly impact the CLO Issuers' economic performance. As a result, the Company determined that it is not the primary beneficiary of the CLO Issuers, and therefore the Company has not consolidated the CLO Issuers. The Company's maximum amount at risk is limited to the Company's investment in each of the CLO Issuers. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the fair value of the Company's investment in the notes issued by the CLO Issuers was ~~$13.8~~$20.3 million and ~~$39.7~~$17.3 million, respectively.

See Note 13 for further details on the Company's participation in CLO transactions.

5847

Table of Contents

Residential Mortgage Loan Securitizations

Since November 2017, the Company, through certain wholly owned subsidiaries (each, a "Sponsor"), has sponsored several securitizations of non-QM loans. In each case, the applicable Sponsor transferred a pool of non-QM loans (each, a Collateral Pool") to a wholly owned entity (each, a "Depositor") and on the closing date such loans were deposited into newly created securitization trusts (collectively, the "Issuing Entities"). Pursuant to the securitizations, the Issuing Entities issued various classes of mortgage pass-through certificates (the "Certificates") which are backed by the cash flows from the underlying non-QM loans.

Under the Dodd-Frank Act, sponsors of securitizations are generally required to retain at least 5% of the economic interest in the credit risk of the securitized assets (the "Risk Retention Rules"). In order to comply with the Risk Retention Rules, in each securitization, the ~~applicable Sponsor~~Company purchased and intends to hold, at a minimum, the requisite amount of the most subordinated classes of Certificates and the excess cash flow certificates. The applicable Sponsor also purchased the Certificates entitled to excess servicing fees in each securitization, while the remaining classes of Certificates were purchased by unrelated parties.

Notwithstanding that the Certificates carry final scheduled distribution dates ~~of October 25, 2047~~in June 2059 or later, the applicable Depositor may, at its sole option, purchase all of the outstanding Certificates (an "Optional Redemption") following the earlier of (1) the applicable anniversary of the closing date (typically two or three years) of the respective securitization or (2) the date on which the aggregate unpaid principal balance of the applicable Collateral Pool has declined below 30% of the aggregate unpaid principal balance of the applicable Collateral Pool as of the date as of which such loans were originally transferred to the applicable Issuing Entity. The purchase price that the Depositor is required to pay in connection with an Optional Redemption is equal to the sum of the unpaid principal balance of each class of Certificates as of the redemption date and any accrued and unpaid interest thereon. In light of these Optional Redemption rights held by the applicable Depositor, the transfers of non-QM loans to each of the Issuing Entities do not qualify as sales under ASC 860-10.

In the event that certain breaches of representations or warranties are discovered with respect to any underlying non-QM loans, the Company could be required to repurchase or replace such loans.

Each Sponsor also serves as the servicing administrator of its respective securitization, for which it is entitled to receive a monthly fee equal to one-twelfth of the product of (a) 0.03% and (b) the unpaid principal balance of the underlying non-QM loans as of the first day of the related due period. Each Sponsor in its role as servicing administrator provides direction and consent for certain loss mitigation activities to the third-party servicer of the underlying non-QM loans. In certain circumstances, the servicing administrator will be required to reimburse the servicer for principal and interest advances and servicing advances made by the servicer.

In light of the Company's retained interests in each of the securitizations, together with the Optional Redemption rights and the Company's ability to direct the third-party servicer regarding certain loss mitigation activities, the Company is deemed to be the primary beneficiary of the Issuing Entities, which are VIEs, and has consolidated the Issuing Entities. Interest income from these loans and the expenses related to the servicing of these loans are included in Interest income and Investment related expenses—Servicing expense, respectively, on the Condensed Consolidated Statement of Operations.

The Issuing Entities each meet the definition of a CFE as defined in Note 2, and as a result the assets of each of the Issuing Entities have been valued using the fair value of the liabilities of the respective Issuing Entity, as such liabilities have been assessed to be more observable than such assets.

The debt of the Issuing Entities is included in Other secured borrowings, at fair value, on the Condensed Consolidated Balance Sheet and is shown net of the Certificates held by the Company. ~~In November 2019, the Company exercised its Optional Redemption right with respect to Ellington Financial Mortgage Trust 2017-1.~~

5948

Table of Contents

The following table details the Company's outstanding consolidated residential mortgage loan securitizations:


Issuing Entity	Issuing Entity	Closing Date	Principal Balance of Loans Transferred to the Depositor		Total Face Amount of Certificates Issued			Issuing Entity	Closing Date	Principal Balance of Loans Transferred to the Depositor		Total Face Amount of Certificates Issued
			(In thousands)							(In thousands)
Ellington Financial Mortgage Trust 2018-1		11/18	$	232,518	$	232,518	(1)
Ellington Financial Mortgage Trust 2019-1	Ellington Financial Mortgage Trust 2019-1	6/19	226,913		226,913		(2)	Ellington Financial Mortgage Trust 2019-1	6/19	$	226,913	$	226,913	(1)
Ellington Financial Mortgage Trust 2019-2	Ellington Financial Mortgage Trust 2019-2	11/19	267,255		267,255		(3)	Ellington Financial Mortgage Trust 2019-2	11/19	267,255		267,255		(2)
Ellington Financial Mortgage Trust 2020-1	Ellington Financial Mortgage Trust 2020-1	6/20	259,273		259,273		(4)	Ellington Financial Mortgage Trust 2020-1	6/20	259,273		259,273		(3)
Ellington Financial Mortgage Trust 2020-2								Ellington Financial Mortgage Trust 2020-2	11/20	219,732		219,732		(4)
Ellington Financial Mortgage Trust 2021-1								Ellington Financial Mortgage Trust 2021-1	2/21	251,771		251,771		(5)

(1)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 5.7% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $1.3 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

~~(2)~~In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 6.1% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $1.2 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

~~(3)~~(2)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 6.4% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $1.7 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

~~(4)~~(3)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 8.0% of the fair value of all Certificates issued. Additionally, the Sponsor purchased another subordinated class of Certificates with an aggregate value equal to 3.5% of the fair value of all Certificates issued as of the settlement ~~date.~~date; the Company subsequently sold such securities to a third party. Finally, the Sponsor also purchased, for an aggregate purchase price of $1.9 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

(4)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 7.6% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $1.4 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

(5)In order to comply with the Risk Retention Rules, the Sponsor purchased the two most subordinated classes of Certificates and the excess cash flow certificates, with an aggregate value as of the settlement date equal to 5.8% of the fair value of all Certificates issued. The Sponsor also purchased, for an aggregate purchase price of $1.6 million, the Certificates entitled to excess servicing fees, while the remaining classes of Certificates were purchased by unrelated third parties.

The following table details the assets and liabilities of the consolidated securitization trusts included in the Company's Condensed Consolidated Balance Sheet as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~2020:


(In thousands)	(In thousands)	September 30, 2020		December 31, 2019		(In thousands)	March 31, 2021		December 31, 2020
Assets:	Assets:					Assets:
Loans, at fair value	Loans, at fair value	$	760,420	$	628,415	Loans, at fair value	$	961,332	$	801,343
Real estate owned		658		658
Investment related receivables	Investment related receivables	5,793		10,409		Investment related receivables	23,103		15,544
Liabilities:	Liabilities:					Liabilities:
Other secured borrowings, at fair value	Other secured borrowings, at fair value	695,516		594,396		Other secured borrowings, at fair value	911,256		754,921

Participation in Multi-Seller Consumer Loan Securitization

In November 2020, the Company participated in a securitization whereby the Company, together with another entity managed by Ellington (the "Consumer Co-Participant"), sold consumer loans with an aggregate unpaid principal balance of approximately $205.1 million to a newly formed securitization trust (the "Consumer Securitization Issuer"). Of the $205.1 million in loans sold to the Consumer Securitization Issuer, the Company's share was 56.3% while the Consumer Co-Participant's share was 43.7%. The transfer was accounted for as a sale in accordance with ASC 860-10. Pursuant to the securitization, the Consumer Securitization Issuer issued senior and subordinated notes in the principal amounts of $158.4 million and $35.2 million, respectively. Trust certificates representing beneficial ownership of the Issuer were also issued. In connection with the transaction, and through a jointly owned newly formed entity (the "Consumer Risk Retention Vehicle"), the Company and the Consumer Co-Participant acquired certain of the subordinated notes as well as the trust certificates in the Issuer. The Company and the co-participant acquired 56.3% and 43.7%, respectively, of the interests in the Consumer Risk Retention Vehicle. As of March 31, 2021, the Company's total interest in the Consumer Risk Retention Vehicle, for which the Company has elected the FVO, was 56.3%, or $21.6 million. As of December 31, 2020, the Company's total interest in the Consumer Risk Retention Vehicle, for which the Company has elected the FVO, was 56.3% or $19.1 million. The fair value of the Consumer Risk Retention Vehicle is included on the Condensed Consolidated Balance Sheet in Investments in unconsolidated entities, at fair value.

Table of Contents

The notes and trust certificates issued by the Consumer Securitization Issuer are backed by the cash flows from the underlying consumer loans. If there are breaches of representations and warranties with respect to any underlying consumer loans, the Company could, under certain circumstances, be required to repurchase or replace such loans. Absent such breaches, the Company has no obligation to repurchase or replace any underlying consumer loans that become delinquent or otherwise default. In addition, another affiliate of Ellington acts as the administrator for the securitization and is paid a monthly fee for its services.

The Consumer Securitization Issuer is deemed to be a VIE. The Company has evaluated its interest in the Consumer Securitization Issuer under ASC 810, and while the Company retains credit risk in the securitization trust through its beneficial ownership of most of the subordinated interests of the securitization trust, which are the first to absorb credit losses on the securitized assets, neither the Company nor the Consumer Risk Retention Vehicle retains control of these assets or the power to direct the activities of the Consumer Securitization Issuer that most significantly impact the Consumer Securitization Issuer's economic performance. As a result, the Company determined that neither the Company nor the Consumer Risk Retention Vehicle is the primary beneficiary of the Consumer Securitization Issuer, and therefore the Company has not consolidated the Consumer Securitization Issuer. Additionally, the Company evaluated its interest in the Consumer Risk Retention Vehicle, which does not meet the criteria to be deemed a VIE, under the voting interest model provided by ASC 810 and determined the Company does not control the Consumer Risk Retention Vehicle. As a result, the Company has not consolidated the Consumer Risk Retention Vehicle.

11. Borrowings

Secured Borrowings

The Company's secured borrowings consist of repurchase agreements, Other secured borrowings, and Other secured borrowings, at fair value. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Company's total secured borrowings were ~~$2.3~~$2.9 billion and ~~$3.2~~$2.3 billion, respectively.

Repurchase Agreements

The Company enters into repurchase agreements. A repurchase agreement involves the sale of an asset to a counterparty together with a simultaneous agreement to repurchase the transferred asset or similar asset from such counterparty at a future date. The Company accounts for its repurchase agreements as collateralized borrowings, with the transferred assets effectively serving as collateral for the related borrowing. The Company's repurchase agreements typically range in term from 30 to 180 days, although the Company also has repurchase agreements that provide for longer or shorter terms. The principal economic terms of each repurchase agreement—such as loan amount, interest rate, and maturity date—are typically negotiated on a transaction-by-transaction basis. Other terms and conditions, such as those relating to events of default, are typically governed under the Company's master repurchase agreements. Absent an event of default, the Company maintains beneficial ownership of the transferred securities during the term of the repurchase agreement and receives the related principal and interest payments. Interest rates on these borrowings are generally fixed based on prevailing rates corresponding to the terms of the borrowings, and for most repurchase agreements, interest is generally paid at the termination of the repurchase agreement, at which time the Company may enter into a new repurchase agreement at prevailing market rates with the same counterparty, repay that counterparty and possibly negotiate financing terms with a different counterparty, or choose to no longer finance the

~~Table of Contents~~

related asset. Some repurchase agreements provide for periodic payments of interest, such as monthly payments. In response to a decline in the fair value of the transferred securities, whether as a result of changes in market conditions, security paydowns, or other factors, repurchase agreement counterparties will typically make a margin call, whereby the Company will be required to post additional securities and/or cash as collateral with the counterparty in order to re-establish the agreed-upon collateralization requirements. In the event of increases in fair value of the transferred securities, the Company can generally require the counterparty to post collateral with it in the form of cash or securities. The Company is generally permitted to sell or re-pledge any securities posted by the counterparty as collateral; however, upon termination of the repurchase agreement, or other circumstance in which the counterparty is no longer required to post such margin, the Company must return to the counterparty the same security that had been posted.

At any given time, the Company seeks to have its outstanding borrowings under repurchase agreements with several different counterparties in order to reduce the exposure to any single counterparty. The Company had outstanding borrowings under repurchase agreements with 24 counterparties as of ~~September 30, 2020 as compared to 28 counterparties as of~~both March 31, 2021 and December 31, ~~2019.~~2020.

As of ~~September 30, 2020,~~March 31, 2021, remaining days to maturity on the Company's open repurchase agreements ranged from 1 day to 608 days. Interest rates on the Company's open repurchase agreements ranged from 0.22% to 5.24% as of September 30, 2020. As of December 31, 2019, remaining days to maturity on the Company's open repurchase agreements ranged from 2 days to 882672 days. Interest rates on the Company's open repurchase agreements ranged from 0.15% to ~~5.20%~~5.00% as of March 31, 2021. As of December 31, 2020, remaining days to maturity on the Company's open repurchase agreements ranged from 4 days to 516 days. Interest rates on the Company's open repurchase agreements ranged from 0.20% to 5.00% as of December 31, ~~2019.~~2020.

Table of Contents

The following table details the Company's outstanding borrowings under repurchase agreements for Agency RMBS and credit assets (which can include non-Agency RMBS, CMBS, CLOs, consumer loans, corporate debt, residential mortgage loans, and commercial mortgage loans and REO), by remaining maturity as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019:~~2020:


		September 30, 2020					December 31, 2019						March 31, 2021					December 31, 2020
				Weighted Average					Weighted Average						Weighted Average					Weighted Average
Remaining Maturity	Remaining Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity	Remaining Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity	Outstanding Borrowings		Interest Rate		Remaining Days to Maturity
Agency RMBS:	Agency RMBS:	(In thousands)					(In thousands)					Agency RMBS:	(In thousands)					(In thousands)
30 Days or Less	30 Days or Less	$	241,423	0.31	%	17	$	511,996	2.08	%	17	30 Days or Less	$	223,518	0.23	%	16	$	265,556	0.28	%	17
31-60 Days	31-60 Days	418,573		0.27	%	44	744,387		1.93	%	47	31-60 Days	549,479		0.20	%	43	385,141		0.25	%	44
61-90 Days	61-90 Days	107,446		0.45	%	72	594,738		1.96	%	76	61-90 Days	182,827		0.29	%	73	174,586		0.28	%	70
91-120 Days	91-120 Days	5,675		1.35	%	99	10,270		2.24	%	93	91-120 Days	7,520		1.03	%	92	0		0	%	—
121-150 Days												121-150 Days	152,660		0.20	%	135	2,692		0.27	%	126
151-180 Days	151-180 Days	17,237		0.29	%	168	3,082		2.67	%	171	151-180 Days	79,809		0.20	%	168	59,857		0.32	%	162
181-360 Days	181-360 Days	93,432		0.30	%	287	0		0	%	—	181-360 Days	240,693		0.21	%	326	34,030		0.32	%	252
Total Agency RMBS	Total Agency RMBS	883,786		0.31	%	69	1,864,473		1.98	%	48	Total Agency RMBS	1,436,506		0.22	%	107	921,862		0.27	%	57
Credit:	Credit:											Credit:
30 Days or Less	30 Days or Less	40,785		2.14	%	10	16,549		3.38	%	25	30 Days or Less	14,646		1.87	%	14	37,795		2.11	%	17
31-60 Days	31-60 Days	98,068		2.85	%	45	104,491		3.14	%	48	31-60 Days	147,187		3.03	%	42	84,554		2.23	%	50
61-90 Days	61-90 Days	113,027		2.54	%	77	138,837		3.03	%	73	61-90 Days	103,919		1.81	%	76	152,426		2.11	%	75
91-120 Days	91-120 Days	154,379		2.79	%	106	0		0	%	—	91-120 Days	78,396		2.22	%	106	89,931		2.47	%	106
121-150 Days	121-150 Days	6,015		3.29	%	134	7,460		3.89	%	123	121-150 Days	0		0	%	—	66,412		4.75	%	125
151-180 Days	151-180 Days	13,750		3.23	%	167	31,498		3.87	%	173	151-180 Days	5,877		3.75	%	168	11,063		2.27	%	165
181-360 Days	181-360 Days	81,933		4.83	%	228	186,661		3.80	%	250	181-360 Days	41,885		2.98	%	256	38,640		2.90	%	289
> 360 Days	> 360 Days	48,241		3.05	%	608	95,331		4.52	%	678	> 360 Days	81,095		2.85	%	446	94,248		2.99	%	447
Total Credit Assets	Total Credit Assets	556,198		3.04	%	145	580,827		3.61	%	229	Total Credit Assets	473,005		2.57	%	149	575,069		2.69	%	155
Total	Total	$	1,439,984	1.37	%	98	$	2,445,300	2.37	%	91	Total	$	1,909,511	0.80	%	118	$	1,496,931	1.20	%	94

Repurchase agreements involving underlying investments that the Company sold prior to period end, for settlement following period end, are shown using their ~~original~~contractual maturity dates even though such repurchase agreements may be expected to be terminated early upon settlement of the sale of the underlying investment.

As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the fair value of investments transferred as collateral under outstanding borrowings under repurchase agreements was ~~$1.783~~$2.160 billion and ~~$2.763~~$1.831 billion, respectively. Collateral transferred under outstanding borrowings under repurchase agreements as of March 31, 2021 and December 31, ~~2019~~2020 include investments in the amount of

~~Table of Contents~~

~~$64.7~~ $4.9 million and $1.4 million, respectively, that were sold prior to period end but for which such sale had not yet settled. In addition, as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Company posted net cash collateral of ~~$27.7~~$66.1 million and ~~$31.0 million, respectively, as well as posting additional securities with a fair value of $28 thousand and $0.2~~$28.9 million, respectively, to its counterparties.

Amount at risk represents the excess, if any, for each counterparty of the fair value of collateral held by such counterparty over the amounts outstanding under repurchase agreements. As of both ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, there was no single counterparty for which the amount at risk relating to our repurchase agreements was greater than 10% of total equity.

Other Secured Borrowings

~~In February 2018, the~~The Company has entered into agreements to finance a portfolio of unsecured loans through a recourse secured borrowing facility. The facility has a term ending in February ~~2021.~~2022. The facility accrues interest on a floating-rate basis. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Company had outstanding borrowings under this facility in the amount of ~~$10.5~~$6.7 million and ~~$16.0~~$8.7 million, respectively, which is included under the caption Other secured borrowings, on the Company's Condensed Consolidated Balance Sheet. The effective interest rate, inclusive of related deferred financing costs, was ~~2.28%~~2.11% and ~~3.85%~~2.30% as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019.~~2020. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the fair value of unsecured loans collateralizing this borrowing was ~~$13.9~~$9.3 million and ~~$22.3~~$11.5 million, respectively. There are a number of covenants, including several financial covenants, associated with this borrowing; as of ~~September 30, 2020,~~March 31, 2021, the Company was in compliance with all of its covenants.

~~In November 2019, the~~

Table of Contents

The Company ~~amended its~~has a non-recourse secured borrowing facility that is used to finance a portfolio of unsecured loans. The facility includes a reinvestment period ending in ~~December 2020~~March 2022 (or earlier following an early amortization event), whereby the Company can vary its borrowings based on the size of its portfolio, subject to certain maximum limits. Following the reinvestment period, the facility will begin to amortize based on the collections from the underlying loans. The facility accrues interest on a floating rate basis. As of ~~September 30, 2020~~March 31, 2021 and December ~~2019,~~31, 2020, the Company had outstanding borrowings under this facility in the amount of ~~$95.7~~$14.6 million and ~~$102.5~~$7.0 million, respectively, which is included under the caption Other secured borrowings, on the Company's Condensed Consolidated Balance Sheet. The effective interest rate on this facility, inclusive of any related deferred financing costs, was ~~2.53%~~2.25% and ~~4.01%~~2.25%, as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, respectively. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the fair value of unsecured loans collateralizing this borrowing was ~~$132.4~~$41.0 million and ~~$144.1~~$31.8 million, respectively. There are a number of covenants, including several financial covenants, associated with this borrowing; as of ~~September 30,~~both March 31, 2021 and December 31, 2020, the Company was in compliance with all of its covenants.

~~In December 2019, the~~The Company has entered into an agreement to finance a portfolio of ABS backed by consumer loans through a recourse secured borrowing facility. The facility includes a revolving borrowing period ending in ~~June 2021~~September 2022 (or earlier following a trigger event), whereby the Company can vary its borrowings based on the size of its portfolio, subject to certain maximum limits. Following the revolving borrowing period, the facility amortizes, with a final termination date in ~~June 2023.~~September 2024. The facility accrues interest on a floating rate basis. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Company had outstanding borrowings under this facility in the amount of ~~$30.2~~$35.7 million and ~~$31.8~~$28.7 million, respectively, which is included under the caption Other secured borrowings, on the Company's Condensed Consolidated Balance Sheet.The effective interest rate on this facility, inclusive of related deferred financing costs, was ~~5.20%~~5.12% and ~~5.23%~~5.22% as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, respectively. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the fair value of ABS backed by consumer loans collateralizing this borrowing was ~~$46.9~~$52.8 million and ~~$47.9~~$44.5 million, respectively. There are a number of covenants, including several financial covenants, associated with this borrowing; as of ~~September 30,~~both March 31, 2021 and December 31, 2020, the Company was in compliance with all of its covenants.

The Company has completed securitization transactions, as discussed in Note 10, whereby it financed portfolios of non-QM loans. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the fair value of the Company's outstanding liabilities associated with these securitization transactions was ~~$695.5~~$911.3 million and ~~$594.4~~$754.9 million, respectively, representing the fair value of the securitization trust certificates held by third parties as of such date, and is included on the Company's Condensed Consolidated Balance Sheet in Other secured borrowings, at fair value. The weighted average coupon of the Certificates held by third parties was ~~2.91%~~2.11% and ~~3.19%~~2.43% as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, respectively. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the fair value of non-QM loans ~~and the carrying value of REO~~ held in the consolidated securitization trusts was ~~$761.1~~$961.3 million and ~~$629.1~~$801.3 million, respectively.

In March 2020, the Company entered into a participation agreement with an unrelated third-party, the "Junior Participant," whereby the Company transferred to the Junior Participant an interest in a small balance commercial mortgage loan, the "Partial Loan," (together with the Company's interest, the "Whole Commercial Loan"). The Partial Loan is subordinate to the interest in the loan held by the Company. In accordance with ASC 860-10, the Partial Loan transferred to the Junior Participant does not meet the definition of a participating interest and, as a result, the Company does not recognize the transfer of the Partial Loan to the Junior Participant as a sale. The Company has recorded the Whole Commercial Loan in Loans, at fair value, on the

~~Table of Contents~~

Condensed Consolidated Balance Sheet. As of ~~September 30,~~March 31, 2021 and December 31, 2020, the fair value of the Whole Commercial Loan was ~~$16.9 million.~~$18.0 million and $17.3 million, respectively. The Company's liability to the Junior Participant as of ~~September 30,~~both March 31, 2021 and December 31, 2020, was ~~$6.3~~$7.5 million and $6.7 million, respectively, and is included in Other secured borrowings on the Company's Condensed Consolidated Balance Sheet. Under the terms of the participation agreement, the Junior Participant is entitled to a portion of the cashflows of the underlying commercial mortgage loan.

Unsecured Borrowings

Senior Notes

~~On August 18, 2017, the~~The Company has issued $86.0 million in aggregate principal amount of unsecured senior notes (the "Old Senior Notes"). The total net proceeds to the Company from the issuance of the Old Senior Notes was approximately $84.7 million, after deducting debt issuance costs. The Old Senior Notes had an interest rate of 5.25%, subject to adjustment based on changes in the ratings, if any, of the Old Senior Notes. On February 13, 2019, in connection with the REIT Election, the Company exchanged all $86.0 million in principal amount of the Old Senior Notes for new unsecured long-term debt, ~~jointly~~which is structured as a joint and ~~severally co-issued~~several co-issuance by certain of ~~its~~the Company's consolidated subsidiaries and fully guaranteed by the Company (the "Senior Notes"). At any time, the Company is permitted to add others of its consolidated subsidiaries as co-issuers of the Senior Notes. The Senior Notes bear interest at a rate of 5.50%, subject to adjustment based on changes, if any, in the ratings of the Senior Notes. Interest on the Senior Notes is payable semi-annually in arrears on March 1 and September 1 of each year. The Senior Notes mature on September 1, 2022. The Company may redeem the Senior Notes, at its option, in whole or in part, prior to March 1, 2022 at a price equal to 100% of the principal amount thereof, plus the applicable "make-whole" premium as of the applicable date of redemption. At any time on or after March 1, 2022, the Company may redeem the Senior Notes, in whole or in part, at a redemption price equal to 100% of the aggregate principal amount of the Senior Notes to be redeemed, plus accrued and unpaid interest. The Senior Notes are carried at amortized cost. There are a number of covenants, including several

Table of Contents

financial covenants, associated with the Senior Notes. As of ~~September 30, 2020~~both March 31, 2021 and December 31, ~~2019,~~2020, the Company was in compliance with all of its covenants.

The Company amortizes debt issuance costs over the life of the associated debt; the amortized portion of debt issuance costs is included in Interest expense on the Condensed Consolidated Statement of Operations. The Senior Notes have an effective interest rate of 5.80%, inclusive of debt issuance costs.

The Senior Notes are unsecured and are effectively subordinated to secured indebtedness of the Company, to the extent of the value of the collateral securing such indebtedness.

Schedule of Principal Repayments

The following table details the Company's principal repayment schedule, over the next 5 years, for outstanding borrowings as of ~~September 30, 2020:~~March 31, 2021:


Year	Year	Repurchase Agreements(1)		Other Secured Borrowings(2)		Senior Notes(1)		Total		Year	Repurchase Agreements(1)		Other Secured Borrowings(2)		Senior Notes(1)		Total
(In thousands)	(In thousands)									(In thousands)
Next Twelve Months	Next Twelve Months	$	1,391,743	$	523,802	$	0	$	1,915,545	Next Twelve Months	$	1,828,416	$	458,602	$	0	$	2,287,018
Year 2	Year 2	48,241		91,199		86,000		225,440		Year 2	81,095		260,649		86,000		427,744
Year 3	Year 3	0		261,991		0		261,991		Year 3	0		282,449		0		282,449
Year 4	Year 4	0		0		0		0		Year 4	0		0		0		0
Year 5	Year 5	0		0		0		0		Year 5	0		0		0		0
Total	Total	$	1,439,984	$	876,992	$	86,000	$	2,402,976	Total	$	1,909,511	$	1,001,700	$	86,000	$	2,997,211

(1)Reflects the Company's contractual principal repayment dates.

(2)Includes ~~$734.3~~$937.2 million of expected principal repayments related to the Company's consolidated residential mortgage loan securitizations, which are projected based upon the underlying assets' expected repayments and may be prior to the stated contractual maturities.

12. Income Taxes

The Company has elected to be taxed as a REIT under the Code. A REIT is generally not subject to U.S. federal, state, and local income tax on the portion of its income that is distributed to its owners if it distributes at least 90% of its REIT taxable income within the prescribed time frames, determined without regard to the deduction for dividends paid and excluding any net capital gains. The Company intends to operate in a manner which will allow it to continue to meet the requirements for qualification as a REIT. Accordingly, Ellington Financial Inc. does not believe that it will be subject to U.S. federal, state, and local income tax on the portion of its net taxable income that is distributed to its stockholders as long as certain asset, income, and share ownership tests are met.

~~Table of Contents~~

Certain foreign and domestic subsidiaries of the Company have elected to be treated as TRSs and therefore are taxed as corporations for U.S. federal, state, and local income tax purposes. To the extent that those entities incur, or are expected to incur, U.S. federal, state, or local income taxes, or foreign income taxes, such taxes are recorded in the Company's condensed consolidated financial statements.

In response to the negative economic impact of the COVID-19 pandemic, the Coronavirus Aid, Relief, and Economic Security Act, or the "CARES Act," was signed into law on March 27, 2020, and provided for significant stimulus spending and included numerous tax provisions. As of September 30, 2020, there was no material impact on the Company's tax provision as a result of the CARES Act; however, the Company continues to monitor and evaluate the impact of the CARES Act and other COVID-19-related legislation.

The Company accounts for income taxes in accordance with ASC 740, Income Taxes., or "ASC 740." Deferred income taxes reflect the net tax effects of temporary differences that may exist between the carrying amounts of assets and liabilities under U.S. GAAP and the carrying amounts used for income tax purposes. For the three-month periods ended ~~September 30,~~March 31, 2021 and 2020, ~~and 2019,~~ the Company recorded an income tax expense (benefit) of ~~$2.5~~$2.0 million and ~~$2 thousand,~~$(0.5) million, respectively. ~~For the nine-month periods ended September 30, 2020 and 2019, the Company recorded an~~The increase in income tax expense ~~of $3.5 million~~for the three-month period ended March 31, 2021, was primarily due to an increase in deferred tax liabilities related to net realized and ~~$0.4 million, respectively.~~unrealized gains on investments held in a domestic TRS.

13. Related Party Transactions

The Company is party to the Management Agreement (which may be amended from time to time), pursuant to which the Manager manages the assets, operations, and affairs of the Company, in consideration of which the Company pays the Manager management and incentive fees. The descriptions of the Base Management Fees and Incentive Fees are detailed below.

Table of Contents

Base Management Fees

The Operating Partnership pays the Manager 1.50% per annum of total equity of the Operating Partnership calculated in accordance with U.S. GAAP as of the end of each fiscal quarter (before deductions for base management fees and incentive fees payable with respect to such fiscal quarter), provided that total equity is adjusted to exclude one-time events pursuant to changes in U.S. GAAP, as well as non-cash charges after discussion between the Manager and the Company's independent directors, and approval by a majority of the Company's independent directors in the case of non-cash charges.

Pursuant to the Management Agreement, if the Company invests at issuance in the equity of any collateralized debt obligation that is managed, structured, or originated by Ellington or one of its affiliates, or if the Company invests in any other investment fund or other investment for which Ellington or one of its affiliates receives management, origination, or structuring fees, then, unless agreed otherwise by a majority of the Company's independent directors, the base management and incentive fees payable by the Company to its Manager will be reduced by an amount equal to the applicable portion (as described in the Management Agreement) of any such management, origination, or structuring fees.

For the three-month period ended ~~September 30, 2020,~~March 31, 2021, the total base management fee incurred was ~~$3.0~~$3.3 million, consisting of ~~$3.2~~$3.5 million of total gross base management fee incurred, less $0.2 million of management fee rebates. For the three-month period ended ~~September 30, 2019,~~March 31, 2020, the total base management fee incurred was ~~$1.9~~$2.4 million consisting of ~~$2.4~~$2.9 million of total gross base management fee incurred, less $0.5 million of management fee rebates. For the nine-month period ended September 30, 2020, the total base management fee incurred was $8.3 million, consisting of $9.2 million of total gross base management fee incurred, less $0.9 million of management fee rebates. For the nine-month period ended September 30, 2019, the total base management fee incurred was $5.3 million consisting of $6.8 million of total gross base management fee incurred, less $1.5 million of management fee rebates. See "—Participation in CLO Transactions" below for details on management fee rebates.

Incentive Fees

The Manager is entitled to receive a quarterly incentive fee equal to the positive excess, if any, of (i) the product of (A) 25% and (B) the excess of (1) Adjusted Net Income (described below) for the Incentive Calculation Period (which means such fiscal quarter and the immediately preceding three fiscal quarters) over (2) the sum of the Hurdle Amounts (described below) for the Incentive Calculation Period, over (ii) the sum of the incentive fees already paid or payable for each fiscal quarter in the Incentive Calculation Period preceding such fiscal quarter.

For purposes of calculating the incentive fee, "Adjusted Net Income" for the Incentive Calculation Period means the net increase in equity from operations of the Operating Partnership, after all base management fees but before any incentive fees for such period, and excluding any non-cash equity compensation expenses for such period, as reduced by any Loss Carryforward (as described below) as of the end of the fiscal quarter preceding the Incentive Calculation Period.

For purposes of calculating the incentive fee, the "Loss Carryforward" as of the end of any fiscal quarter is calculated by

~~Table of Contents~~

determining the excess, if any, of (1) the Loss Carryforward as of the end of the immediately preceding fiscal quarter over (2) the Company's net increase in equity from operations (expressed as a positive number) or net decrease in equity from operations (expressed as a negative number) of the Operating Partnership for such fiscal quarter. As of ~~September 30,~~both March 31, 2021 and December 31, 2020, there was ~~a Loss Carryforward of $46.3 million. There was~~ 0 Loss ~~Carryforward as of December 31, 2019.~~Carryforward.

For purposes of calculating the incentive fee, the "Hurdle Amount" means, with respect to any fiscal quarter, the product of (i) one-fourth of the greater of (A) 9% and (B) 3% plus the 10-year U.S. Treasury rate for such fiscal quarter, (ii) the sum of (A) the weighted average gross proceeds per share of all common stock and OP Unit issuances since inception of the Company and up to the end of such fiscal quarter, with each issuance weighted by both the number of shares of common stock and OP Units issued in such issuance and the number of days that such issued shares of common stock and OP Units were outstanding during such fiscal quarter, using a first-in first-out basis of accounting (i.e. attributing any share of common stock and OP Unit repurchases to the earliest issuances first) and (B) the result obtained by dividing (I) retained earnings attributable to shares of common stock and OP Units at the beginning of such fiscal quarter by (II) the average number of shares of common stock and OP Units outstanding for each day during such fiscal quarter, and (iii) the sum of (x) the average number of shares of common stock and long term incentive plan units of the Company outstanding for each day during such fiscal quarter, and (y) the average number of Convertible Non-controlling Interests outstanding for each day during such fiscal quarter. For purposes of determining the Hurdle Amount, issuances of common stock, and Convertible Non-controlling Interests (a) as equity incentive awards, (b) to the Manager as part of its base management fee or incentive fee and (c) to the Manager or any of its affiliates in privately negotiated transactions, are excluded from the calculation. The payment of the incentive fee will be in a combination of shares of common stock and cash, provided that at least 10% of any quarterly payment will be made in shares of common stock.

The Company did not accrue an incentive fee for ~~any~~either of the ~~three- or nine-month~~three-month periods ended ~~September 30,~~March 31, 2021 or 2020, ~~and 2019,~~ since on a rolling four quarter basis, the Company's income did not exceed the prescribed hurdle amount.

Table of Contents

Termination Fees

The Management Agreement requires the Company to pay a termination fee to the Manager in the event of (1) the Company's termination or non-renewal of the Management Agreement without cause or (2) the Company's termination of the Management Agreement based on unsatisfactory performance by the Manager that is materially detrimental to the Company or (3) the Manager's termination of the Management Agreement upon a default by the Company in the performance of any material term of the Management Agreement. Such termination fee will be equal to the amount of three times the sum of (i) the average annual quarterly base management fee amounts paid or payable with respect to the 2 12-month periods ending on the last day of the latest fiscal quarter completed on or prior to the date of the notice of termination or non-renewal and (ii) the average annual quarterly incentive fee amounts paid or payable with respect to the 2 12-month periods ending on the last day of the latest fiscal quarter completed on or prior to the date of the notice of termination or non-renewal.

Expense Reimbursement

Under the terms of the Management Agreement the Company is required to reimburse the Manager for operating expenses related to the Company that are incurred by the Manager, including expenses relating to legal, accounting, due diligence, other services, and all other costs and expenses. The Company's reimbursement obligation is not subject to any dollar limitation. Expenses will be reimbursed in cash within 60 days following delivery of the expense statement by the Manager; provided, however, that such reimbursement may be offset by the Manager against amounts due to the Company from the Manager. The Company will not reimburse the Manager for the salaries and other compensation of the Manager's personnel except that the Company will be responsible for expenses incurred by the Manager in employing certain dedicated or partially dedicated personnel as further described below.

The Company reimburses the Manager for the allocable share of the compensation, including, without limitation, wages, salaries, and employee benefits paid or reimbursed, as approved by the Compensation Committee of the Board of Directors to certain dedicated or partially dedicated personnel who spend all or a portion of their time managing the Company's affairs, based upon the percentage of time devoted by such personnel to the Company's affairs. In their capacities as officers or personnel of the Manager or its affiliates, such personnel will devote such portion of their time to the Company's affairs as is necessary to enable the Company to operate its business.

For the ~~nine-month~~three-month periods ended ~~September 30,~~March 31, 2021 and 2020, ~~and 2019,~~ the Company reimbursed the Manager ~~$7.4~~$4.1 million and ~~$8.2~~$2.7 million, respectively, for previously incurred operating expenses. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the outstanding payable to the Manager for operating expenses was ~~$2.4~~$1.6 million and ~~$2.0~~$2.5 million, respectively, which are included in Accrued expenses and other liabilities on the Condensed Consolidated Balance Sheet.

~~Table of Contents~~

Transactions Involving Certain Loan Originators

As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the loan originators in which the Company holds equity investments represent related parties. Transactions that have been entered into with these related party ~~mortgage~~loan originators are summarized below.

The Company is a party to a mortgage loan purchase and sale flow agreement, with a mortgage originator in which the Company holds ana non-controlling equity investment, whereby the Company purchases residential mortgage loans that satisfy certain specified criteria. The Company has also provided a $5.0 million line of credit to the mortgage originator. Under the terms of this line of credit, the Company has agreed to make advances to the mortgage originator solely for the purpose of funding specifically identified residential mortgage loans designated for sale to the Company. To the extent the advances are drawn by the mortgage originator, it must pay interest, at a rate of 15% per annum, on the outstanding balance of each advance from the date the advance is made until such advance is repaid in full. The mortgage originator is required to repay advances in full no later than two business days following the date that the Company purchases the related residential mortgage loans from the mortgage originator. As of both ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, there were 0 advances outstanding. The Company has also entered into two agreements whereby it guarantees the performance of such mortgage originator under third-party master repurchase agreements. See Note 21, Commitments and Contingencies, for further information on the Company's guarantees of the third-party borrowing arrangements. Additionally, in August 2020, the Company entered into a commitment agreement whereby the Company committed to purchase $150 million of residential mortgage loans that meet specified criteria, or the "Commitment Agreement." As of ~~September 30, 2020,~~March 31, 2021, the Company had purchased the entire $150 million of eligible residential mortgage loans under the terms of the Commitment Agreement. In connection with the Commitment Agreement, the Company also entered into an agreement whereby the Company would be entitled to receive warrants proportionally as it satisfied its purchase commitment under the Commitment Agreement to purchase a maximum of 9.329 million shares of non-voting common stock. As of ~~September 30, 2020,~~March 31, 2021, the Company has received warrants for the maximum 9.329 million shares; such warrants have a fair value of ~~$2.8~~$4.2 million and $3.6 million as of ~~September 30,~~March 31, 2021 and December 31, 2020, respectively, and are included in Investments in unconsolidated entities on the Condensed Consolidated Balance Sheet.

Table of Contents

The Company, through a related party of Ellington, or the "Loan Purchaser," is a party to a consumer loan purchase and sale flow agreement with a consumer loan originator in which the Company holds an investment in preferred stock and warrants to purchase additional preferred stock, whereby the Loan Purchaser purchases consumer loans that satisfy certain specified criteria. The Company has investments in participation certificates related to consumer loans titled in the name of the Loan Purchaser. Through its participation certificates, the Company has beneficial interests in the loan cash flows, net of servicing-related fees and expenses. The total fair value of the Company's participation certificates was ~~$46.9~~$52.8 million and ~~$47.9~~$44.5 million as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, respectively.

In May 2019 the Company entered into a note purchase agreement whereby it agreed to lend up to $5.0 million to a mortgage originator ("the Initial Note") in which the Company also holds an equity investment. The Initial Note carried an interest rate of 15% per annum on the outstanding balance. In July and December 2019, the Company amended the note purchase agreement whereby it agreed to lend an additional $5.0 million and $2.5 million, respectively, (the "Additional Notes") to the mortgage originator. The Additional Notes each carried an interest rate of 18% per annum. As of December 31, 2019, the aggregate outstanding balance on the Initial Note and the Additional Notes was $12.5 million. In January 2020, the Initial Note and the Additional Notes were repaid. The Initial Note and the Additional Notes are classified as Corporate loans and included in Loans, at fair value on the Condensed Consolidated Balance Sheet.

Consumer, Residential, and Commercial Loan Transactions with Affiliates

The Company purchases certain of its consumer loans through an affiliate, or the "Purchasing Entity." The Purchasing Entity has entered into purchase agreements, open-ended in duration, with third party consumer loan originators whereby it has agreed to purchase eligible consumer loans. The amount of loans purchased under these purchase agreements is dependent on, among other factors, the amount of loans originated in any given period by the selling originators. The Company and certain other affiliates of Ellington have entered into agreements with the Purchasing Entity whereby the Company and each of ~~the~~those other affiliates of Ellington have agreed to purchase their allocated portion (subject to monthly determination based on available capital and other factors) of the eligible loans acquired by the Purchasing Entity under each purchase agreement. Immediately after the Purchasing Entity purchases beneficial interests in the loans, the Company and other affiliates of Ellington purchase such beneficial interests from the Purchasing Entity, at the same price paid by the Purchasing Entity. During the ~~nine-month~~three-month periods ended ~~September 30,~~March 31, 2021 and 2020, ~~and 2019,~~ the Company purchased loans under these agreements with an aggregate principal balance of ~~$84.7~~$11.9 million and ~~$72.4~~$48.1 million, respectively. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the estimated remaining contingent purchase obligations of the Company under these purchase agreements was approximately ~~$77.1~~$66.4 million and ~~$287.1~~$13.0 million, respectively, in principal balance.

The Company's beneficial interests in the consumer loans purchased through the Purchasing Entity are evidenced by

~~Table of Contents~~

participation certificates issued by trusts that hold legal title to the loans. These trusts are owned by a related party of Ellington and were established to hold such loans. Through its participation certificates, the Company participates in the cash flows of the underlying loans held by each trust. The total amount of consumer loans underlying the Company's participation certificates and held in the related party trusts was ~~$151.7~~$50.8 million and ~~$185.4~~$45.1 million as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, respectively.

The Company has beneficial interests in residential mortgage loans and REO held in a trust owned by a related party of Ellington. Through these beneficial interests, the Company participates in the cash flows of the underlying loans held by such trust. The total amount of residential mortgage loans and REO underlying the Company's beneficial interests and held in the related party trust was ~~$272.4~~$321.1 million and ~~$304.8~~$387.4 million as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, respectively.

The Company is a co-investor in certain small balance commercial mortgage loans with several other investors, including an unrelated third party and various affiliates of Ellington. These loans are beneficially owned by a consolidated subsidiary of the Company. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the aggregate fair value of the small balance commercial loans was ~~$33.6~~$34.4 million and ~~$29.5~~$34.0 million, respectively. As of ~~September 30,~~March 31, 2021, the non-controlling interests held by the unrelated third party and the Ellington affiliates were $2.8 million and $6.1 million, respectively. As of December 31, 2020, the non-controlling interests held by the unrelated third party and the Ellington affiliates were $4.1 million and $8.9 million, respectively. As of December 31, 2019, the non-controlling interests held by the unrelated third party and the Ellington affiliates were $3.6 million and $7.0 million, respectively. As of December 31, 2019, the Company had a payable to an Ellington affiliate in the amount of $0.7 million, which is included in Accrued expenses and other liabilities on the Condensed Consolidated Balance Sheet. The Company did not have any payables to or receivables from the Ellington affiliates as of September 30, 2020.

The Company is also a co-investor in certain small balance commercial mortgage loans and REO with other investors, including various unrelated third parties and various affiliates of Ellington. Each co-investor in a particular loan has an interest in the limited liability company that owns such loan or REO. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the aggregate fair value of the Company's investments in the jointly owned limited liability companies was approximately ~~$30.4~~$38.7 million and ~~$17.3~~$33.9 million, respectively. Such investments are included in Investments in unconsolidated entities, on the Condensed Consolidated Balance Sheet.

The consumer, residential mortgage, and certain commercial mortgage loans that are the subject of the foregoing loan transactions are held in trusts, each of which the Company has determined to be a VIE. The Company has evaluated each of these VIEs and determined that the Company has the power to direct the activities of each VIE that most significantly impact such VIE's economic performance and the Company has the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. As a result the Company has determined it is the primary beneficiary of each of these VIEs and has consolidated each VIE.

Equity Investment in Unconsolidated Entity

The Company was a co-investor, together with other affiliates of Ellington, in Jepson Holdings Limited, the parent of an entity (the "Right Holder Entity") that held a call right (the "Call Right") to a European mortgage loan securitization (the "Initial

Table of Contents

Securitization"). The Right Holder Entity issued notes (the "Right Holder Notes") to the Company and its affiliates, and to an unrelated third party.

In March 2019, the Right Holder Entity assigned the Call Right to a newly formed entity, which exercised the Call Right and re-securitized the underlying European mortgage loan assets of the Initial Securitization through a new securitization trust (the "New Securitization"). In exchange for assigning the Call Right, the Right Holder Entity received a combination of (i) cash and (ii) certain notes issued by the New Securitization (the "New Securitization Notes"). The Right Holder Entity fully repaid the unrelated third party's Right Holder Note with a combination of cash and New Securitization Notes. The Right Holder Notes held by the Company and its affiliates were also fully repaid with cash and New Securitization Notes. Certain of the New Securitization Notes were distributed to the Company and its affiliates on a pro rata basis. The Right Holder Entity is expected to continue to hold certain of the New Securitization Notes in order to comply with European risk retention rules. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Company's equity investment in Jepson Holdings Limited had a fair value of ~~$1.7~~$1.9 million and ~~$1.9~~$1.8 million, respectively. See Note 6 for additional details on this equity investment.

Participation in Multi-Borrower Financing Facilities

The Company is a co-participant with certain other entities managed by Ellington or its affiliates (the "Affiliated Entities") in various entities (each, a "Joint Entity"), which were formed in order to facilitate the financing of small balance commercial mortgage loans, residential mortgage loans, and REO (collectively, the "Mortgage Loan and REO Assets"), through repurchase agreements. Each Joint Entity has a master repurchase agreement with a particular financing counterparty.

~~Table of Contents~~

In connection with the financing of the Mortgage Loan and REO Assets under repurchase agreements, each of the Company and the Affiliated Entities transferred certain of their respective Mortgage Loan and REO Assets to one of the Joint Entities in exchange for its pro rata share of the financing proceeds that the respective Joint Entity received from the financing counterparty. While the Company's Mortgage Loan and REO Assets were transferred to the Joint Entity, the Company's Mortgage Loan and REO Assets and the related debt were not derecognized for financial reporting purposes, in accordance with ASC 860-10, because the Company continued to retain the risks and rewards of ownership of its Mortgage Loan and REO Assets. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Joint Entities had aggregate outstanding issued debt under the repurchase agreements in the amount of ~~$258.0~~$296.0 million and ~~$350.6~~$192.3 million, respectively. The Company's segregated ~~portion~~silo of this debt as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019~~2020 was ~~$135.9~~$147.8 million and ~~$174.4~~$116.1 million, respectively, and is included under the caption Repurchase agreements on the Company's Condensed Consolidated Balance Sheet. To the extent that there is a default under the repurchase agreements, all of the assets of each respective Joint Entity, including those beneficially owned by any non-defaulting owners of such Joint Entity, could be used to satisfy the outstanding obligations under such repurchase agreement. As of ~~September 30, 2020~~both March 31, 2021 and December 31, ~~2019,~~2020, no party to any of the repurchase agreements was in default.

Each of the Joint Entities has been determined to be a VIE. The Company has evaluated each of these VIEs and determined that it continued to retain the risks and rewards of ownership of certain of the Mortgage Loan and REO Assets, where such Mortgage Loan and REO Assets and the related debt are segregated for the Company and each of the Affiliated Entities. On account of the segregation of certain of each co-participant's assets and liabilities within each of the Joint Entities, as well as the retention by each co-participant of control over its segregated Mortgage Loan and REO Assets within the Joint Entities, the Company has determined that it is the primary beneficiary of, and has consolidated its segregated ~~portion~~silo of assets and liabilities within, each of the Joint Entities. See Note 9 and Note 11 for additional information.

Participation in CLO Transactions

As discussed in Note 10, the Company participated in a number of CLO securitization transactions, all managed by the CLO Manager.

The CLO Manager is entitled to receive management and incentive fees in accordance with the respective management agreements between the CLO Manager and the respective CLO Issuers. In accordance with the Management Agreement, the Manager rebates to the Company the portion of the management fees payable by each CLO Issuer to the CLO Manager that are allocable to the Company's participating interest in the unsecured subordinated notes issued by such CLO Issuer. For the three-month periods ended ~~September 30,~~March 31, 2021 and 2020, ~~and 2019,~~ the amount of such management fee rebates was $0.2 million and $0.5 ~~million, respectively. For the nine-month periods ended September 30, 2020 and 2019, the amount of such management fee rebates was $0.9 million and $1.5~~ million, respectively.

In addition, from time to time, the Company along with various other affiliates of Ellington, and in certain cases various third parties, advance funds in the form of loans ("Initial Funding Loans") to securitization vehicles to enable them to establish warehouse facilities for the purpose of acquiring the assets to be securitized. Pursuant to the terms of the warehouse facilities and the Initial Funding Loans, the applicable securitization trust is required, at the closing of each respective CLO securitization, first to repay the warehouse facility, then to repay the Initial Funding Loans, and then to distribute interest earned, net of any necessary reserves and/or interest expense, and the aggregate realized or unrealized gains, if any, on assets

Table of Contents

purchased into the warehouse facility. In the event that such CLO securitization fails to close, the assets held by the respective securitization vehicle would, subject to a cure period, be liquidated. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Company's investment in such warehouse facilities was ~~$5.4~~$2.1 million and ~~$8.1~~$6.1 million, respectively, which are included on the Condensed Consolidated Balance Sheet in Investments in unconsolidated entities.

During the ~~three- and nine-month~~three-month periods ended ~~September 30,~~March 31, 2021 and 2020, ~~and 2019,~~ the Company purchased various underperforming corporate debt and equity securities from certain of the Ellington-sponsored CLO Securitizations at market prices determined through the procedures set forth in the indentures of the respective Ellington-sponsored CLO Securitization. The total amount of such debt and equity securities purchased during the three-month period ended September 30, 2019 was $6.8 million; no such securities were purchased during the three-month period ended September 30, 2020. The total amount of such debt and equity securities purchased during the nine-monththree month periods ended ~~September 30,~~March 31, 2021 and 2020 ~~and 2019~~ was ~~$1.6~~$2.3 million and ~~$6.8~~$0.3 million, respectively.

14. Long-Term Incentive Plan Units

OP LTIP Units subject to the Company's incentive plans are generally exercisable by the holder at any time after vesting. Each OP LTIP Unit is convertible into an OP Unit on a one-for-one basis. Subject to certain conditions, the OP Units are redeemable by the holder for an equivalent number of shares of common stock of the Company or for the cash value of such shares of common stock, at the Company's election. Costs associated with the OP LTIP Units issued under the Company's incentive plans are measured as of the grant date and expensed ratably over the vesting period. Total expense associated with

~~Table of Contents~~

OP LTIP Units issued under the Company's incentive plans for each of the three-month periods ended ~~September 30,~~March 31, 2021 and 2020 ~~and 2019~~ was $0.2 million and $0.1 million, respectively. Total expense associated with OP LTIP Units issued under the Company's incentive plans for the nine-month periods ended September 30, 2020 and 2019 was $0.5 million and $0.3 million, respectively.million.

On March ~~4, 2020,~~3, 2021, the Company's Board of Directors authorized the issuance of ~~14,811~~17,231 OP LTIP Units to certain of Ellington's personnel dedicated to the Company pursuant to the Company's 2017 Equity Incentive Plan.

On September 10, 2020, the Company's Board of Directors authorized the issuance of 22,840 OP LTIP Units to certain of its directors pursuant to the Company's 2017 Equity Incentive Plan. These OP LTIP Units will vest and become non-forfeitable on September 9, 2021.

The below table details unvested OP LTIP Units as of ~~September 30, 2020:~~March 31, 2021:

Grant Recipient

Number of OP LTIP Units Granted

Grant Date

Vesting Date(1)

Directors:

22,840

September 10, 2020

September 9, 2021

Dedicated or partially dedicated personnel:

~~12,818~~

~~December 13, 2019~~

~~December 13, 2020~~

10,067

December 13, 2019

December 13, 2021

~~8,691~~18,211

December ~~11, 2018~~

~~December 11, 2020~~

~~4,977~~

~~March 4,~~17, 2020

December ~~31, 2020~~17, 2021

9,834

March 4, 2020

December 31, 2021

3,697

March 3, 2021

December 31, 2021

14,598

December 17, 2020

December 17, 2022

13,534

March 3, 2021

December 31, 2022

Total unvested OP LTIP Units at ~~September 30, 2020~~March 31, 2021

~~69,227~~92,781

(1)Date at which such OP LTIP Units will vest and become non-forfeitable.

The following tables summarize issuance and exercise activity of OP LTIP Units for the ~~three- and nine-month~~three-month periods ended ~~September 30, 2020~~March 31, 2021 and ~~2019:~~2020:

Three-Month Period Ended
September 30, 2020 September 30, 2019
Manager Director/
Employee Total Manager Director/
Employee Total
OP LTIP Units Outstanding (June 30, 2020 and 2019, respectively) 365,518 195,009 560,527 375,000 146,371 521,371
Granted 0 22,840 22,840 0 14,552 14,552
Exercised 0 (3,638) (3,638) 0 (3,610) (3,610)
OP LTIP Units Outstanding (September 30, 2020 and 2019, respectively) 365,518 214,211 579,729 375,000 157,313 532,313
OP LTIP Units Unvested and Outstanding (September 30, 2020 and 2019, respectively) 0 69,227 69,227 0 37,821 37,821
OP LTIP Units Vested and Outstanding (September 30, 2020 and 2019, respectively) 365,518 144,984 510,502 375,000 119,492 494,492


	Three-Month Period Ended
	March 31, 2021			March 31, 2020
	Manager	Director/ Employee	Total	Manager	Director/ Employee	Total
OP LTIP Units Outstanding (December 31, 2020 and 2019, respectively)	365,518	247,020	612,538	365,518	180,198	545,716
Granted	0	17,231	17,231	0	14,811	14,811
Exercised	0	0	0	0	0	0
OP LTIP Units Outstanding (March 31, 2021 and 2020, respectively)	365,518	264,251	629,769	365,518	195,009	560,527
OP LTIP Units Unvested and Outstanding (March 31, 2021 and 2020, respectively)	0	92,781	92,781	0	60,939	60,939
OP LTIP Units Vested and Outstanding (March 31, 2021 and 2020, respectively)	365,518	171,470	536,988	365,518	134,070	499,588

6958

Table of Contents

Nine-Month Period Ended
September 30, 2020 September 30, 2019
Manager Director/
Employee Total Manager Director/
Employee Total
OP LTIP Units Outstanding (December 31, 2019 and January 1, 2019, respectively) 365,518 180,198 545,716 375,000 146,371 521,371
Granted 0 37,651 37,651 0 14,552 14,552
Exercised 0 (3,638) (3,638) 0 (3,610) (3,610)
OP LTIP Units Outstanding (September 30, 2020 and 2019, respectively) 365,518 214,211 579,729 375,000 157,313 532,313
OP LTIP Units Unvested and Outstanding (September 30, 2020 and 2019, respectively) 0 69,227 69,227 0 37,821 37,821
OP LTIP Units Vested and Outstanding (September 30, 2020 and 2019, respectively) 365,518 144,984 510,502 375,000 119,492 494,492

There were an aggregate of ~~1,794,021~~1,743,981 and ~~1,832,309~~1,761,212 shares of common stock of the Company underlying awards, including OP LTIP Units, available for future issuance under the Company's 2017 Equity Incentive Plan as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, respectively.

15. Non-controlling Interests

Operating Partnership

Non-controlling interests include the Convertible Non-controlling Interests in the Operating Partnership owned by an affiliate of our Manager, our directors, and certain current and former Ellington employees and their related ~~parties. On December 31, 2018,~~parties in the ~~Company redeemed 503,988 outstanding long term incentive plan units~~form of ~~the Company and exchanged them on a one-for-one basis for~~ OP LTIP Units. Income allocated to Convertible Non-controlling Interests is based on the non-controlling interest owners' ownership percentage of the Operating Partnership during the period, calculated using a daily weighted average of all shares of common stock of the Company and Convertible Non-controlling Interests outstanding during the period. Holders of Convertible Non-controlling Interests are entitled to receive the same distributions that holders of shares of common stock of the Company receive. Convertible Non-controlling Interests are non-voting with respect to matters as to which holders of common stock of the Company are entitled to vote.

On March 2, 2020, certain related parties of current Ellington employees converted 129,516 OP Units into shares of common stock.

As ~~September 30, 2020,~~of March 31, 2021, the Convertible Non-controlling Interests consisted of the outstanding ~~579,729~~629,769 OP LTIP Units and 48,409 OP Units, and represented an interest of approximately ~~1.2%~~1.3% in the Operating Partnership. As of December 31, ~~2019,~~2020, the Convertible Non-controlling Interests consisted of the outstanding ~~545,716~~612,538 OP LTIP Units and ~~177,925~~48,409 OP Units, and represented an interest of approximately ~~1.6%~~1.3% in the Operating Partnership. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, non-controlling interests related to all outstanding Convertible Non-controlling Interests was ~~$10.4~~$12.4 million and ~~$13.4~~$11.7 million, respectively.

Joint Venture Interests

Non-controlling interests also include the interests of joint venture partners in various consolidated subsidiaries of the Company. These subsidiaries hold the Company's investments in certain commercial mortgage loans and REO. The joint venture partners participate in the income, expense, gains and losses of such subsidiaries as set forth in the related operating agreements of the subsidiaries. The joint venture partners make capital contributions to the subsidiaries as new approved investments are purchased by the subsidiaries, and are generally entitled to distributions when investments are sold or otherwise disposed of. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the joint venture partners' interests in subsidiaries of the Company were ~~$26.6~~$21.0 million and ~~$25.9~~$24.5 million, respectively.

The joint venture partners' interests are not convertible into shares of common stock of the Company or OP Units, nor are the joint venture partners entitled to receive distributions that holders of shares of common stock of the Company receive.

~~Table of Contents~~

16. Equity

Preferred Stock

The Company has authorized 100,000,000 shares of preferred stock, $0.001 par value per share. As of both ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, there were 4,600,000 shares of 6.750% Series A Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, $0.001 par value per share ("Series A Preferred Stock") outstanding.

The Company's Series A Preferred Stock ranks senior to its common stock and Convertible Non-controlling Interests with respect to the payment of dividends and the distribution of assets upon a voluntary or involuntary liquidation, dissolution or winding up of the Company. Additionally, the Company's Series A Preferred Stock has no stated maturity and is not subject to any sinking fund or mandatory redemption. The Series A Preferred Stock is not redeemable by the Company prior to October 30, 2024, except under circumstances where it is necessary to allow the Company to maintain its qualification as a REIT for U.S. federal income tax purposes and except in certain instances upon the occurrence of a change of control. Holders of the Company's Series A Preferred Stock generally do not have any voting rights.

Holders of the Series A Preferred Stock are entitled to receive cumulative cash dividends (i) from and including the original issue date to, but excluding, October 30, 2024, at a fixed rate equal to 6.750% per annum of the $25.00 per share liquidation preference and (ii) from and including October 30, 2024, at a floating rate equal to three-month LIBOR plus a spread of 5.196% per annum of the $25.00 per share liquidation preference. Dividends are payable quarterly in arrears on or about the 30th day of each January, April, July, and ~~October, commencing with the first dividend payment on January 30, 2020, which the Board of Directors declared in December 2019.~~October. As of ~~September 30, 2020~~both March 31, 2021 and December 31, ~~2019,~~2020, the total amount of cumulative preferred dividends in arrears was $1.3 ~~million and $1.5 million, respectively.~~million.

Table of Contents

Common Stock

The Company has authorized 100,000,000 shares of common stock, $0.001 par value per share. The Board of Directors may authorize the issuance of additional shares, subject to the approval of the holders of at least a majority of the shares of common stock then outstanding present in person or represented by proxy at a meeting of the stockholders. As of ~~September 30, 2020~~both March 31, 2021 and December 31, ~~2019,~~2020, there were 43,781,684 ~~and 38,647,943, respectively,~~ shares of common stock outstanding.

On January 24, 2020, the Company completed a follow-on offering of 5,290,000 shares of its common stock, of which 690,000 shares were issued pursuant to the exercise of the underwriters' option. The issuance and sale of the 5,290,000 shares of common stock generated net proceeds, after underwriters' discount and offering costs, of $95.3 million.

The following table summarizes issuance, repurchase, and other activity with respect to the Company's common stock for the ~~three- and nine-month~~three-month periods ended ~~September 30, 2020~~March 31, 2021 and ~~2019:~~2020:


		Three-Month Period Ended		Nine-Month Period Ended			Three-Month Period Ended
		September 30, 2020	September 30, 2019	September 30, 2020	September 30, 2019		March 31, 2021	March 31, 2020
Shares of Common Stock Outstanding (6/30/2020, 6/30/2019, 12/31/2019 and 1/1/2019, respectively)		43,779,924	29,745,776	38,647,943	29,796,601
Shares of Common Stock Outstanding (December 31, 2020 and 2019, respectively)						Shares of Common Stock Outstanding (December 31, 2020 and 2019, respectively)	43,781,684	38,647,943
Share Activity:	Share Activity:					Share Activity:
Shares of common stock issued	Shares of common stock issued	0	4,025,000	5,290,000	4,025,000	Shares of common stock issued	0	5,290,000
Shares of common stock issued in connection with incentive fee payment	Shares of common stock issued in connection with incentive fee payment	0	0	637	0	Shares of common stock issued in connection with incentive fee payment	0	637
Shares of common stock repurchased	Shares of common stock repurchased	(1,878)	0	(290,050)	(50,825)	Shares of common stock repurchased	0	(288,172)
OP Units exercised	OP Units exercised	3,638	3,610	133,154	3,610	OP Units exercised	0	129,516
Shares of Common Stock Outstanding (9/30/2020, 9/30/2019, 9/30/2020, 9/30/2019, respectively)		43,781,684	33,774,386	43,781,684	33,774,386
Shares of Common Stock Outstanding (March 31, 2021 and 2020, respectively)						Shares of Common Stock Outstanding (March 31, 2021 and 2020, respectively)	43,781,684	43,779,924

If all Convertible Non-controlling Interests that have been previously issued were to become fully vested and exchanged for shares of common stock as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Company's issued and outstanding shares of common stock would increase to ~~44,409,822~~44,459,862 and ~~39,371,584~~44,442,631 shares, respectively.

On June 13, 2018, the Board of Directors approved the adoption of a share repurchase program under which the Company is authorized to repurchase up to 1.55 million shares of common stock. The program, which is open-ended in duration, allows the Company to make repurchases from time to time on the open market or in negotiated transactions,

~~Table of Contents~~

including under Rule 10b5-1 plans. Repurchases are at the Company's discretion, subject to applicable law, share availability, price and financial performance, among other considerations. During the three-month period ended ~~September 30,~~March 31, 2020, the Company repurchased ~~1,878~~288,172 shares at an average price per share of ~~$11.00~~$10.53 and a total cost of ~~$21 thousand. The Company did not repurchase any~~$3.0 million; no repurchases of common shares were made during the three-month period ended September 30, 2019. During the nine-month period ended September 30, 2020, the Company repurchased 290,050 shares at an average price per share of $10.54 and a total cost of $3.1 million. During the nine-month period ended September 30, 2019, the Company repurchased 50,825 shares at an average price per share of $15.39 and a total cost of $0.8 million.March 31, 2021. From inception of the current repurchase plan through ~~September 30, 2020,~~March 31, 2021, the Company repurchased 701,965 shares at an average price per share of $13.36 and a total cost of $9.4 million.

Table of Contents

17. Earnings Per Share

The components of the computation of basic and diluted EPS are as follows:


		Three-Month Period Ended				Nine-Month Period Ended					Three-Month Period Ended
(In thousands except share amounts)	(In thousands except share amounts)	September 30, 2020		September 30, 2019		September 30, 2020		September 30, 2019		(In thousands except share amounts)	March 31, 2021		March 31, 2020
Net income (loss) attributable to common stockholders	Net income (loss) attributable to common stockholders	$	46,203	$	17,293	$	(45,917)	$	45,345	Net income (loss) attributable to common stockholders	$	37,856	$	(129,398)
Add: Net income (loss) attributable to Convertible Non-controlling Interests(1)	Add: Net income (loss) attributable to Convertible Non-controlling Interests(1)	647		387		(916)		1,079		Add: Net income (loss) attributable to Convertible Non-controlling Interests(1)	577		(2,055)
Net income (loss) attributable to common stockholders and Convertible Non-controlling Interests	Net income (loss) attributable to common stockholders and Convertible Non-controlling Interests	46,850		17,680		(46,833)		46,424		Net income (loss) attributable to common stockholders and Convertible Non-controlling Interests	38,433		(131,453)
Dividends Paid:	Dividends Paid:									Dividends Paid:
Common stockholders	Common stockholders	(11,821)		(14,185)		(42,514)		(43,038)		Common stockholders	(13,134)		(19,748)
Convertible Non-controlling Interests	Convertible Non-controlling Interests	(166)		(309)		(627)		(1,021)		Convertible Non-controlling Interests	(200)		(309)
Total dividends paid to common stockholders and Convertible Non-controlling Interests	Total dividends paid to common stockholders and Convertible Non-controlling Interests	(11,987)		(14,494)		(43,141)		(44,059)		Total dividends paid to common stockholders and Convertible Non-controlling Interests	(13,334)		(20,057)
Undistributed (Distributed in excess of) earnings:	Undistributed (Distributed in excess of) earnings:									Undistributed (Distributed in excess of) earnings:
Common stockholders	Common stockholders	34,382		3,108		(88,431)		2,307		Common stockholders	24,722		(149,146)
Convertible Non-controlling Interests	Convertible Non-controlling Interests	481		78		(1,543)		58		Convertible Non-controlling Interests	377		(2,364)
Total undistributed (distributed in excess of) earnings attributable to common stockholders and Convertible Non-controlling Interests	Total undistributed (distributed in excess of) earnings attributable to common stockholders and Convertible Non-controlling Interests	$	34,863	$	3,186	$	(89,974)	$	2,365	Total undistributed (distributed in excess of) earnings attributable to common stockholders and Convertible Non-controlling Interests	$	25,099	$	(151,510)
Weighted average shares outstanding (basic and diluted):	Weighted average shares outstanding (basic and diluted):									Weighted average shares outstanding (basic and diluted):
Weighted average shares of common stock outstanding	Weighted average shares of common stock outstanding	43,779,134		32,835,652		43,387,168		30,787,634		Weighted average shares of common stock outstanding	43,781,684		42,598,138
Weighted average Convertible Non-controlling Interest Units outstanding	Weighted average Convertible Non-controlling Interest Units outstanding	613,319		735,789		635,836		734,186		Weighted average Convertible Non-controlling Interest Units outstanding	666,499		685,500
Weighted average shares of common stock and Convertible Non-controlling Interest Units outstanding	Weighted average shares of common stock and Convertible Non-controlling Interest Units outstanding	44,392,453		33,571,441		44,023,004		31,521,820		Weighted average shares of common stock and Convertible Non-controlling Interest Units outstanding	44,448,183		43,283,638
Basic earnings per share of common stock and Convertible Non-controlling Interest Unit:	Basic earnings per share of common stock and Convertible Non-controlling Interest Unit:									Basic earnings per share of common stock and Convertible Non-controlling Interest Unit:
Distributed	Distributed	$	0.27	$	0.42	$	0.97	$	1.39	Distributed	$	0.30	$	0.45
Undistributed (Distributed in excess of)	Undistributed (Distributed in excess of)	0.79		0.11		(2.03)		0.08		Undistributed (Distributed in excess of)	0.56		(3.49)
		$	1.06	$	0.53	$	(1.06)	$	1.47		$	0.86	$	(3.04)
Diluted earnings per share of common stock and Convertible Non-controlling Interest Unit:	Diluted earnings per share of common stock and Convertible Non-controlling Interest Unit:									Diluted earnings per share of common stock and Convertible Non-controlling Interest Unit:
Distributed	Distributed	$	0.27	$	0.42	$	0.97	$	1.39	Distributed	$	0.30	$	0.45
Undistributed (Distributed in excess of)	Undistributed (Distributed in excess of)	0.79		0.11		(2.03)		0.08		Undistributed (Distributed in excess of)	0.56		(3.49)
		$	1.06	$	0.53	$	(1.06)	$	1.47		$	0.86	$	(3.04)

(1)For the three-month periods ended ~~September 30,~~March 31, 2021 and 2020, ~~and 2019,~~ excludes net income (loss) of $0.9 million and $1.0 million, respectively, attributable to joint venture partners, which have non-participating interests as described in Note 15. For the nine-month periods ended September 30, 2020 and 2019, excludes net income (loss) of $2.8 million and $2.4$1.2 million, respectively, attributable to joint venture partners, which have non-participating interests as described in Note 15.

~~Table of Contents~~

18. Restricted Cash

The Company is required to maintain a specific cash balance in a segregated account pursuant to a flow consumer loan purchase and sale agreement. As of both ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Company's restricted cash balance related to the flow consumer loan purchase and sale agreement was $0.2 million.

19. Offsetting of Assets and Liabilities

The Company generally records financial instruments at fair value as described in Note 2. Financial instruments are generally recorded on a gross basis on the Condensed Consolidated Balance Sheet. In connection with the vast majority of its derivative, reverse repurchase and repurchase agreements, and the related trading agreements, the Company and its counterparties are required to pledge collateral. Cash or other collateral is exchanged as required with each of the Company's counterparties in connection with open derivative positions, and reverse repurchase and repurchase agreements.

Table of Contents

The following tables present information about certain assets and liabilities representing financial instruments as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019.~~2020. The Company has not entered into master netting agreements with any of its counterparties. Certain of the Company's reverse repurchase and repurchase agreements and financial derivative transactions are governed by underlying agreements that generally provide a right of net settlement, as well as a right of offset in the event of default or in the event of a bankruptcy of either party to the transaction.

~~September 30, 2020:~~March 31, 2021:


Description	Description	Amount of Assets (Liabilities) Presented in the Condensed Consolidated Balance Sheet(1)		Financial Instruments Available for Offset		Financial Instruments Transferred or Pledged as Collateral(2)(3)		Cash Collateral (Received) Pledged(2)(3)		Net Amount		Description	Amount of Assets (Liabilities) Presented in the Condensed Consolidated Balance Sheet(1)		Financial Instruments Available for Offset		Financial Instruments Transferred or Pledged as Collateral(2)(3)		Cash Collateral (Received) Pledged(2)(3)		Net Amount
(In thousands)	(In thousands)											(In thousands)
Assets	Assets											Assets
Financial derivatives–assets	Financial derivatives–assets	$	27,864	$	(16,646)	$	0	$	(6,469)	$	4,749	Financial derivatives–assets	$	23,082	$	(14,703)	$	0	$	(2,919)	$	5,460
Reverse repurchase agreements	Reverse repurchase agreements	47,041		(47,041)		0		0		0		Reverse repurchase agreements	96,783		(96,783)		0		0		0
Liabilities	Liabilities											Liabilities
Financial derivatives–liabilities	Financial derivatives–liabilities	(34,814)		16,646		0		18,088		(80)		Financial derivatives–liabilities	(19,438)		14,703		0		969		(3,766)
Repurchase agreements	Repurchase agreements	(1,439,984)		1,439,984		(27,744)		27,744		0		Repurchase agreements	(1,909,511)		1,909,511		(28,884)		28,884		0

(1)In the Company's Condensed Consolidated Balance Sheet, all balances associated with repurchase agreements, reverse repurchase agreements, and financial derivatives are presented on a gross basis.

(2)For the purpose of this presentation, for each row the total amount of financial instruments transferred or pledged and cash collateral (received) or pledged may not exceed the applicable gross amount of assets or (liabilities) as presented here. Therefore, the Company has reduced the amount of financial instruments transferred or pledged as collateral related to the Company's repurchase agreements and cash collateral pledged on the Company's financial derivative liabilities. Total financial instruments transferred or pledged as collateral on the Company's repurchase agreements as of ~~September 30, 2020~~March 31, 2021 was ~~$1.8~~$2.2 billion. As of ~~September 30, 2020,~~March 31, 2021, total cash collateral on financial derivative assets and liabilities excludes excess net cash collateral pledged (received) of ~~$3.1~~$17.7 million and ~~$7.8~~$1.8 million, respectively.

(3)When collateral is pledged to or pledged by a counterparty, it is often pledged or posted with respect to all positions with such counterparty, and in such cases such collateral cannot be specifically identified as relating to a particular asset or liability. As a result, in preparing the above tables, the Company has made assumptions in allocating pledged or posted collateral among the various rows.

~~Table of Contents~~

December 31, ~~2019:~~2020:


Description	Description	Amount of Assets (Liabilities) Presented in the Condensed Consolidated Balance Sheet(1)		Financial Instruments Available for Offset		Financial Instruments Transferred or Pledged as Collateral(2)(3)		Cash Collateral (Received) Pledged(2)(3)		Net Amount		Description	Amount of Assets (Liabilities) Presented in the Condensed Consolidated Balance Sheet(1)		Financial Instruments Available for Offset		Financial Instruments Transferred or Pledged as Collateral(2)(3)		Cash Collateral (Received) Pledged(2)(3)		Net Amount
(In thousands)	(In thousands)											(In thousands)
Assets	Assets											Assets
Financial derivatives–assets	Financial derivatives–assets	$	16,788	$	(12,755)	$	0	$	(807)	$	3,226	Financial derivatives–assets	$	15,479	$	(12,579)	$	0	$	(1,404)	$	1,496
Reverse repurchase agreements	Reverse repurchase agreements	73,639		(73,639)		0		0		0		Reverse repurchase agreements	38,640		(38,640)		0		0		0
Liabilities	Liabilities											Liabilities
Financial derivatives–liabilities	Financial derivatives–liabilities	(27,621)		12,755		0		12,233		(2,633)		Financial derivatives–liabilities	(24,553)		12,579		0		10,694		(1,280)
Repurchase agreements	Repurchase agreements	(2,445,300)		73,639		2,340,656		31,005		0		Repurchase agreements	(1,496,931)		1,496,931		(28,884)		28,884		0

(1)In the Company's Condensed Consolidated Balance Sheet, all balances associated with repurchase agreements, reverse repurchase agreements, and financial derivatives are presented on a gross basis.

(2)For the purpose of this presentation, for each row the total amount of financial instruments transferred or pledged and cash collateral (received) or pledged may not exceed the applicable gross amount of assets or (liabilities) as presented here. Therefore, the Company has reduced the amount of financial instruments transferred or pledged as collateral related to the Company's repurchase agreements and cash collateral pledged on the Company's financial derivative liabilities. Total financial instruments transferred or pledged as collateral on the Company's repurchase agreements as of December 31, ~~2019~~2020 was ~~$2.8~~$1.8 billion. As of December 31, ~~2019,~~2020, total cash collateral on financial derivative assets and liabilities excludes excess net cash collateral pledged of ~~$4.3~~$4.5 million and ~~$23.4~~$10.3 million, respectively.

Table of Contents

20. Counterparty Risk

The Company is exposed to concentrations of counterparty risk. It seeks to mitigate such risk by diversifying its exposure among various counterparties, when appropriate. The following table summarizes the Company's exposure to counterparty risk as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019.~~2020.

~~September 30, 2020:~~March 31, 2021:


		Amount of Exposure		Number of Counterparties with Exposure	Maximum Percentage of Exposure to a Single Counterparty(1)			Amount of Exposure		Number of Counterparties with Exposure	Maximum Percentage of Exposure to a Single Counterparty(1)
		(In thousands)						(In thousands)
Cash and cash equivalents	Cash and cash equivalents	$	126,783	10	28.5	%	Cash and cash equivalents	$	149,350	7	26.1	%
Collateral on repurchase agreements held by dealers(2)	Collateral on repurchase agreements held by dealers(2)	1,810,825		24	18.6	%	Collateral on repurchase agreements held by dealers(2)	2,226,054		24	16.6	%
Due from brokers	Due from brokers	63,991		22	35.4	%	Due from brokers	91,814		23	25.4	%
Receivable for securities sold(3)	Receivable for securities sold(3)	5,086		2	87.0	%	Receivable for securities sold(3)	5,147		3	95.8	%

(1)Each counterparty is a large creditworthy financial institution.

(2)Includes securities, loans, and REO as well as cash posted as collateral for repurchase agreements.

(3)Included in Investment related receivables on the Condensed Consolidated Balance Sheet.

December 31, ~~2019:~~2020:


		Amount of Exposure		Number of Counterparties with Exposure	Maximum Percentage of Exposure to a Single Counterparty(1)			Amount of Exposure		Number of Counterparties with Exposure	Maximum Percentage of Exposure to a Single Counterparty(1)
		(In thousands)						(In thousands)
Cash and cash equivalents	Cash and cash equivalents	$	72,302	11	42.2	%	Cash and cash equivalents	$	111,647	8	40.1	%
Collateral on repurchase agreements held by dealers(2)	Collateral on repurchase agreements held by dealers(2)	2,793,696		28	13.8	%	Collateral on repurchase agreements held by dealers(2)	1,860,059		24	15.3	%
Due from brokers	Due from brokers	79,829		24	30.9	%	Due from brokers	63,147		22	28.9	%
Receivable for securities sold(3)	Receivable for securities sold(3)	69,995		5	62.3	%	Receivable for securities sold(3)	1,416		2	94.5	%

(1)Each counterparty is a large creditworthy financial institution.

(2)Includes securities, loans, and REO as well as cash posted as collateral for repurchase agreements.

(3)Included in Investment related receivables on the Condensed Consolidated Balance Sheet.

~~Table of Contents~~

21. Commitments and Contingencies

The Company provides current directors and officers with a limited indemnification against liabilities arising in connection with the performance of their duties to the Company.

In the normal course of business the Company may also enter into contracts that contain a variety of representations, warranties, and general indemnifications. The Company's maximum exposure under these arrangements, including future claims that may be made against the Company that have not yet occurred, is unknown. The Company has not incurred any costs to defend lawsuits or settle claims related to these indemnification agreements. As of both ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the Company has no liabilities recorded for these agreements.

The Company's maximum risk of loss from credit events on its securities (excluding Agency securities, which are guaranteed by the issuing government agency or government-sponsored enterprise), loans, and investments in unconsolidated entities is limited to the amount paid for such investment.

Commitments and Contingencies Related to Investments in Residential Mortgage Loans

In connection with certain of the Company's investments in residential mortgage loans, the Company has unfunded commitments in the amount of ~~$3.2~~$8.4 million and ~~$5.2~~$4.7 million as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, respectively.

Commitments and Contingencies Related to Investments in Mortgage Loan Originators

In connection with certain of its investments in mortgage loan originators, the Company has outstanding commitments and contingencies as described below.

As described in Note 13, the Company is party to a flow mortgage loan purchase and sale agreement with a mortgage loan originator. The Company has entered into two agreements whereby it guarantees the performance of this mortgage loan

Table of Contents

originator under master repurchase agreements. The Company's maximum guarantees are capped at $25.0 million. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the mortgage loan originator had ~~$17.3~~$6.3 million and ~~$0.4~~$5.3 million, respectively, of outstanding borrowings under the agreements guaranteed by the Company. The Company's obligations under these arrangements are deemed to be guarantees under ASC 460-10. The Company has elected the FVO for its guarantees, which are included in Accrued expenses and other liabilities on the Condensed Consolidated Balance Sheet. As of both ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the estimated fair value of such guarantees was insignificant.

Commitments and Contingencies Related to Corporate Loans

The Company has investments in certain corporate loans whereby the borrowers can request additional funds under the respective agreements. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019~~2020, the Company had unfunded commitments related to such investments in the amount of ~~$1.5~~$4.3 million and ~~$1.9~~$0.1 million, respectively.

The Company has extended a line of credit whereby the borrower can draw funds up to $1.0 million. As of March 31, 2021, the Company had unfunded commitments related to such line of credit in the amount of $0.9 million.

22. Subsequent Events

On ~~October 7, 2020,~~April 4, 2021, the Board of Directors approved a dividend in the amount of ~~$0.09~~$0.14 per share of common stock payable on ~~November~~May 25, ~~2020~~2021 to stockholders of record as of ~~October~~April 30, ~~2020~~2021 and a dividend in the amount of $0.421875 per share of Series A Preferred Stock payable on ~~October~~April 30, ~~2020~~2021 to stockholders of record as of ~~October~~April 19, ~~2020.~~2021.

On ~~November 2, 2020,~~May 6, 2021, the Board of Directors approved a dividend in the amount of ~~$0.10~~$0.15 per share of common stock payable on ~~December 28, 2020~~June 25, 2021 to stockholders of record as of ~~November 30, 2020.~~May 28, 2021.

7564

Table of Contents

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Except where the context suggests otherwise, references in this Quarterly Report on Form 10-Q to "EFC," "we," "us," and "our" refer to ~~(i)~~ Ellington Financial Inc. and its consolidated subsidiaries, including Ellington Financial Operating Partnership LLC, our operating partnership subsidiary, which we refer to as our "Operating ~~Partnership,~~Partnership." following our conversion to a corporation effective March 1, 2019 (our "corporate conversion"), and (ii) Ellington Financial LLC and its consolidated subsidiaries, including our Operating Partnership, before our corporate conversion. References in this Quarterly Report on Form 10-Q to (1) "common shares" refer to (i) our common shares representing limited liability company interests, previously outstanding prior to our corporate conversion, and (ii) shares of our common stock outstanding after our corporate conversion and (2) "common shareholders" refer to (i) holders of our common shares representing limited liability company interests prior to our corporate conversion, and (ii) holders of shares of our common stock after our corporate conversion. We conduct all of our operations and business activities through our Operating Partnership. Our "Manager" refers to Ellington Financial Management LLC, our external manager, "Ellington" refers to Ellington Management Group, L.L.C. and its affiliated investment advisory firms, including our Manager, and "Manager Group" refers collectively to officers and directors of EFC, and partners and affiliates of Ellington (including families and family trusts of the foregoing). In certain instances, references to our Manager and services to be provided to us by our Manager may also include services provided by Ellington and its other affiliates from time to time.

Special Note Regarding Forward-Looking Statements

When used in this Quarterly Report on Form 10-Q, in future filings with the Securities and Exchange Commission, or the "SEC," or in press releases or other written or oral communications, statements which are not historical in nature, including those containing words such as "believe," "expect," "anticipate," "estimate," "project," "plan," "continue," "intend," "should," "would," "could," "goal," "objective," "will," "may," "seek," or similar expressions, are intended to identify "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, or the "Securities Act," and Section 21E of the Securities Exchange Act of 1934, as amended, or the "Exchange Act," and, as such, may involve known and unknown risks, uncertainties, and assumptions.

Forward-looking statements are based on our beliefs, assumptions, and expectations of our future operations, business strategies, performance, financial condition, liquidity and prospects, taking into account information currently available to us. These beliefs, assumptions, and expectations are subject to risks and uncertainties and can change as a result of many possible events or factors, not all of which are known to us. If a change occurs, our business, financial condition, liquidity, results of operations and strategies may vary materially from those expressed or implied in our forward-looking statements. The following factors are examples of those that could cause actual results to vary from our forward-looking statements: changes in interest rates and the market value of our ~~securities;~~investments; market volatility; changes in the prepayment rates on the mortgage loans underlying the securities owned by us for which the principal and interest payments are guaranteed by a U.S. government agency or a U.S. government-sponsored entity; increased rates of default and/or decreased recovery rates on our assets; our ability to borrow to finance our assets; changes in government regulations affecting our business; our ability to maintain our exclusion from registration under the Investment Company Act of 1940, as amended, or the "Investment Company Act"; our ability to ~~qualify and~~ maintain our qualification as a real estate investment trust, or "REIT"; and risks associated with investing in real estate assets, including changes in business conditions and the general economy, such as those resulting from the economic effects related to the COVID-19 pandemic, and associated responses to the pandemic. These and other risks, uncertainties and factors, including the risk factors described under Item 1A of our Annual Report on Form 10-K, ~~and Part II. Item 1A. of our Quarterly Report on Form 10-Q, as amended, for the three-month period ended March 31, 2020,~~ could cause our actual results to differ materially from those projected or implied in any forward-looking statements we make. All forward-looking statements speak only as of the date on which they are made. New risks and uncertainties arise over time, and it is not possible to predict those events or how they may affect us. Except as required by law, we are not obligated to, and do not intend to, update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Executive Summary

We invest in a diverse array of real-estate-related and other financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, or "RMBS," commercial mortgage-backed securities, or "CMBS," consumer loans and asset-backed securities, or "ABS," including ABS backed by consumer loans, collateralized loan obligations, or "CLOs," non-mortgage- and mortgage-related derivatives, equity investments in loan origination companies, and other strategic investments. We are externally managed and advised by our Manager, an affiliate of Ellington. Ellington is a registered investment adviser with a ~~25-year~~26-year history of investing in the Agency and credit markets.

We conduct all of our operations and business activities through the Operating Partnership. As of ~~September 30, 2020,~~March 31, 2021, we have an ownership interest of approximately ~~98.8%~~98.7% in the Operating Partnership. The remaining ownership interest of approximately ~~1.2%~~1.3% in the Operating Partnership represents the interests in the Operating Partnership that are owned by an

~~Table of Contents~~

affiliate of our Manager, our directors, and certain current and former Ellington employees and their related parties, and is reflected in our financial statements as a non-controlling interest.

Our primary objective is to generate attractive, risk-adjusted total returns for our stockholders. We seek to attain this objective by utilizing an opportunistic strategy to make investments, without restriction as to ratings, structure, or position in the capital structure, that we believe compensate us appropriately for the risks associated with them rather than targeting a specific yield. Our evaluation of the potential risk-adjusted return of any potential investment typically involves weighing the potential returns of such investment under a variety of economic scenarios against the perceived likelihood of the various

Table of Contents

scenarios. Potential investments subject to greater risk (such as those with lower credit ratings and/or those with a lower position in the capital structure) will generally require a higher potential return to be attractive in comparison to investment alternatives with lower potential return and a lower degree of risk. However, at any particular point in time, depending on how we perceive the market's pricing of risk both generally and across sectors, we may favor higher-risk assets or we may favor lower-risk assets, or a combination of the two, in the interests of portfolio diversification or other considerations.

Through ~~September 30, 2020,~~March 31, 2021, our credit portfolio, which includes all of our investments other than RMBS for which the principal and interest payments are guaranteed by a U.S. government agency or a U.S. government-sponsored entity, or "Agency RMBS," has been the primary driver of our risk and return, and we expect that this will continue in the near- to medium-term. For more information on our targeted assets, see "—Our Targeted Asset Classes" below. We believe that Ellington's capabilities allow our Manager to identify attractive assets in these classes, value these assets, monitor and forecast the performance of these assets, and opportunistically hedge our risk with respect to these assets.

We continue to maintain a highly leveraged portfolio of Agency RMBS to take advantage of opportunities in that market sector, to help maintain our exclusion from registration as an investment company under the Investment Company Act, and to help ~~qualify as well as~~ maintain our qualification as a REIT. Unless we acquire very substantial amounts of whole mortgage loans or there are changes to the rules and regulations applicable to us under the Investment Company Act and/or to our qualification as a REIT, we expect that we will ~~always~~continue to maintain some amount of Agency RMBS.

The strategies that we employ are intended to capitalize on opportunities in the current market environment. Subject to maintaining our qualification as a REIT, we intend to adjust our strategies to changing market conditions by shifting our asset allocations across various asset classes as credit and liquidity trends evolve over time. We believe that this flexibility, combined with Ellington's experience, will help us generate more consistent returns on our capital throughout changing market cycles.

Subject to maintaining our qualification as a REIT, we opportunistically hedge our credit risk, interest rate risk, and foreign currency risk; however, at any point in time we may choose not to hedge all or a portion of these risks, and we will generally not hedge those risks that we believe are appropriate for us to take at such time, or that we believe would be impractical or prohibitively expensive to hedge.

We also use leverage in our credit strategy, albeit significantly less leverage than that used in our Agency RMBS strategy. Through ~~September 30, 2020,~~March 31, 2021, we financed the vast majority of our Agency RMBS assets, and a portion of our credit assets, through repurchase agreements, which we sometimes refer to as "repos," which we account for as collateralized borrowings. We expect to continue to finance the vast majority of our Agency RMBS through the use of repos. In addition to financing assets through repos, we also enter into other secured borrowing transactions, which are accounted for as collateralized borrowings, to finance certain of our loan assets. We have also obtained, through the securitization markets, term financing for certain of our non-qualified mortgage, or "non-QM," loans, certain of our consumer loans, and certain of our leveraged corporate loans. Additionally, we have issued unsecured long-term debt.

As of ~~September 30, 2020,~~March 31, 2021, outstanding borrowings under repos and Total other secured borrowings (which include Other secured borrowings and Other secured borrowings, at fair value, as presented on our Condensed Consolidated Balance Sheet) were ~~$2.3~~$2.9 billion, of which approximately ~~39%~~50%, or ~~$883.8 million,~~$1.4 billion, relates to our Agency RMBS holdings. The remaining outstanding borrowings relate to our credit portfolio.

As of ~~September 30, 2020,~~March 31, 2021, we also had $86.0 million outstanding of unsecured long-term debt, maturing in September of 2022, or the "Senior Notes." The Senior Notes bear interest at a rate of 5.50%, subject to adjustment based on changes, if any, in the ratings of the Senior Notes. The indenture governing the Senior Notes contains a number of covenants, including several financial covenants. The Senior Notes were issued in connection with an exchange of our previously issued unsecured long-term debt (the "Old Senior Notes") on February 13, 2019 (the "Note Exchange"), in connection with our intended election to be taxed as a REIT. At the time of the Note Exchange, the Senior Notes wereare rated A by Egan-Jones Rating Company1. See Note 11 of the notes to our condensed consolidated financial statements for further detail on the Senior Notes.

1A rating is not a recommendation to buy, sell or hold securities. Ratings may be subject to revision or withdrawal at any time by the assigning rating organization. Each rating should be evaluated independently of any other rating.

7766

Table of Contents

~~See Note 11 of the notes to our condensed consolidated financial statements for further detail on the Senior Notes and the Note Exchange.~~

As of ~~September 30, 2020,~~March 31, 2021, our book value per share of common stock, calculated using Total Stockholders' Equity less the aggregate liquidation preference of outstanding preferred stock, was ~~$16.45.~~$18.16. Our debt-to-equity ratio was ~~2.7:~~3.1:1 as of ~~September 30, 2020.~~March 31, 2021. Our debt-to-equity ratio does not account for liabilities other than debt financings and does not include debt associated with securitization transactions accounted for as sales. Our recourse debt-to-equity ratio was ~~1.7:~~2.0:1 as of ~~September 30, 2020.~~

~~On January 24, 2020, we completed a follow-on offering~~March 31, 2021. Adjusted for unsettled purchases and sales, the debt-to-equity ratio and total recourse debt-to-equity ratio were 3.2:1 and 2.0:1, respectively as of 5,290,000 shares of our common stock, of which 690,000 shares were issued pursuant to the exercise of the underwriters' option. The issuance and sale of such common shares generated net proceeds, after underwriters' discount and offering costs, of $95.3 million.

During the nine-month period ended September 30, 2020 we repurchased 290,050 shares of our common stock at an average price per share of $10.54 and a total cost of $3.1 million. In addition to making discretionary repurchases, we from time to time use 10b5-1 plans to increase the number of trading days available to implement these repurchases.March 31, 2021.

We elected to be taxed as a REIT under the Internal Revenue Code of 1986, as amended, or "the Code," ~~upon the filing of~~commencing with our ~~tax return for the~~ taxable year ended December 31, 2019. Provided that we maintain our qualification as a REIT, we generally will not be subject to U.S. federal, state, and local income tax on our REIT taxable income that is currently distributed to our stockholders. Any taxes paid by a domestic taxable REIT subsidiary, or "TRS," will reduce the cash available for distribution to our stockholders. REITs are subject to a number of organizational and operational requirements, including a requirement that they currently distribute at least 90% of their annual REIT taxable income excluding net capital gains.

On February 28, 2019, we filed a certificate of conversion with the Secretary of State of the State of Delaware (the "Secretary of State") to convert from a Delaware limited liability company to a Delaware corporation (the "Conversion") and change our name to Ellington Financial Inc. (the "Corporation"). The Conversion became effective on March 1, 2019, and upon effectiveness, each of our existing common shares representing limited liability company interests, no par value, converted into one issued and outstanding, fully paid and nonassessable share of common stock, $0.001 par value per share, of the Corporation.

Our Targeted Asset Classes

Our targeted asset classes currently include investments in the U.S. and Europe (as applicable) in the categories listed below. Subject to maintaining our qualification as a REIT, we expect to continue to invest in these targeted asset classes. Also, we expect to continue to hold certain of our targeted assets through one or more TRSs. As a result, a portion of the income from such assets will be subject to U.S. federal and certain state corporate income ~~tax.~~taxes, as applicable.

7867

Table of Contents

Asset Class

Principal Assets

Agency RMBS

Whole pool pass-through certificates;

Partial pool pass-through certificates;

Agency collateralized mortgage obligations, or "CMOs," including interest only securities, or "IOs," principal only securities, or "POs," inverse interest only securities, or "IIOs"; and

CLOs

Retained tranches from CLO securitizations, including participating in the accumulation of the underlying assets for such securitization by providing capital to the vehicle accumulating assets; and

Other CLO debt and equity tranches.

CMBS and Commercial Mortgage Loans

CMBS; and

Commercial mortgage loans and other commercial real estate debt.

Consumer Loans and ABS

Consumer loans;

ABS, including ABS backed by consumer loans; and

Retained tranches from securitizations to which we have contributed assets.

Mortgage-Related Derivatives

To-Be-Announced mortgage pass-through certificates, or "TBAs";

Credit default swaps, or "CDS," on individual RMBS, on the ABX, CMBX and PrimeX indices and on other mortgage-related indices; and

Other mortgage-related derivatives.

Non-Agency RMBS

RMBS backed by prime jumbo, Alt-A, non-QM, manufactured housing, and subprime mortgages;

RMBS backed by fixed rate mortgages, Adjustable rate mortgages, or "ARMs," Option-ARMs, and Hybrid ARMs;

RMBS backed by ~~one or more~~ mortgages on single-family-rental properties;

RMBS backed by first lien and second lien mortgages;

Investment grade and non-investment grade securities;

Senior and subordinated securities;

IOs, POs, IIOs, and inverse floaters;

Collateralized debt obligations, or "CDOs";

RMBS backed by European residential mortgages, or "European RMBS"; and

Retained tranches from securitizations in which we have participated.

Residential Mortgage Loans

Residential non-performing mortgage loans, or "NPLs";

Re-performing loans, or "RPLs," which generally are loans that were modified and/or formerly NPLs where the borrower has resumed making payments in some form or amount;

Residential "transition loans," such as residential bridge loans and residential "fix-and-flip" loans;

Non-QM loans; and

Retained tranches from securitizations to which we have contributed assets.

Other

Real estate, including commercial and residential real property;

Strategic debt and/or equity investments in loan originators and mortgage-related entities;

Corporate debt and equity securities and corporate loans;

Mortgage servicing rights, or "MSRs";

Credit risk transfer securities, or "CRTs"; and

Other non-mortgage-related derivatives.

7968

Table of Contents

Agency RMBS

Our Agency RMBS assets consist primarily of whole pool (and to a lesser extent, partial pool) pass-through certificates, the principal and interest of which are guaranteed by a federally chartered corporation, such as the Federal National Mortgage Association, or "Fannie Mae," the Federal Home Loan Mortgage Corporation, or "Freddie Mac," or the Government National Mortgage Association, within the U.S. Department of Housing and Urban Development, or "Ginnie Mae," and which are backed by ARMs, Hybrid ARMs, or fixed-rate mortgages. In addition to investing in pass-through certificates which are backed by traditional mortgages, we have also invested in Agency RMBS backed by reverse mortgages. Reverse mortgages are mortgage loans for which neither principal nor interest is due until the borrower dies, the home is sold, or other trigger events occur. Mortgage pass-through certificates are securities representing undivided interests in pools of mortgage loans secured by real property where payments of both interest and principal, plus prepaid principal, on the securities are made monthly to holders of the security, in effect "passing through" monthly payments made by the individual borrowers on the mortgage loans that underlie the securities, net of fees paid to the issuer/guarantor and servicers of the securities. Whole pool pass-through certificates are mortgage pass-through certificates that represent the entire ownership of (as opposed to merely a partial undivided interest in) a pool of mortgage loans.

Our Agency RMBS assets are typically concentrated in specified pools. Specified pools are fixed-rate Agency pools consisting of mortgages with special characteristics, such as mortgages with low loan balances, mortgages backed by investor properties, mortgages originated through the government-sponsored "Making Homes Affordable" refinancing programs, and mortgages with various other characteristics. Our Agency strategy also includes RMBS that are backed by ARMs or Hybrid ARMs and reverse mortgages, and CMOs, including IOs, POs, and IIOs.

CLOs

CLOs are a form of asset-backed security collateralized by syndicated corporate loans. We have retained, and may retain in the future, tranches from CLO securitizations for which we have participated in the accumulation of the underlying assets, typically by providing capital to a vehicle accumulating assets for such CLO securitization. Such vehicles may enter into warehouse financing facilities in order to facilitate such accumulation. Securitizations can effectively provide us with long-term, locked-in financing on the related collateral pool, with an effective cost of funds well below the expected yield on the collateral pool. Our CLO holdings may include both debt and equity interests.

CMBS

We acquire CMBS, which are securities collateralized by mortgage loans on commercial properties. The majority of CMBS issued are fixed rate securities backed by fixed rate loans made to multiple borrowers on a variety of property types, though single-borrower CMBS and floating rate CMBS have also been issued.

The majority of CMBS utilize senior/subordinate structures, similar to those found in non-Agency RMBS. Subordination levels vary so as to provide for one or more AAA credit ratings on the most senior classes, with less senior securities rated investment grade and non-investment grade, including a first loss component which is typically unrated. This first loss component is commonly referred to as the "B-piece," which is the most subordinated (and therefore highest yielding and riskiest) tranche of a CMBS securitization. Much of our focus within the CMBS sector has been on B-pieces, but we also acquire other CMBS with more senior credit priority.

Commercial Mortgage Loans and Other Commercial Real Estate Debt

We acquire commercial mortgage loans, which are loans secured by liens on commercial properties, including hotel, industrial, multi-family, office and retail properties. Loans may be fixed or floating rate and will generally ~~range~~have maturities ranging from ~~two~~one to ten years. We typically acquire first lien loans but may also acquire subordinated loans. As of ~~September 30, 2020,~~March 31, 2021, all of our commercial mortgage loans were first lien loans. Commercial real estate debt typically limits the borrower's right to freely prepay for a period of time through provisions such as prepayment fees, lockout, yield maintenance, or defeasance provisions. Some of the commercial mortgage loans that we acquire may be non-performing, underperforming, or otherwise distressed; these loans are typically acquired at a discount both to their unpaid principal balances and to the value of the underlying real estate.

We also participate in the origination of "bridge" loans, which have shorter terms and higher interest rates than more traditional commercial mortgage loans. Bridge loans are typically secured by properties in transition, where the borrower is in the process of either re-developing or stabilizing operations at the property. Properties securing these loans may include multi-family, retail, office, industrial, and other commercial property types.

Within both our loan acquisition and loan origination strategies, we generally focus on smaller balance loans and/or loan packages that are less-competitively-bid. These loans typically have balances that are less than $20 million, and are secured by

8069

Table of Contents

real estate and, in some cases, a personal guarantee from the borrower.

Consumer Loans and ABS

We acquire U.S. consumer whole loans and ABS, including ABS backed by U.S. consumer loans. Our U.S. consumer loan portfolio primarily consists of unsecured loans, but also includes secured auto loans. We are currently purchasing newly originated consumer loans under flow agreements with originators, as well as seasoned consumer loans in the secondary market, and we continue to evaluate new opportunities. ~~We seek to purchase newly originated consumer loans from originators that have demonstrated disciplined underwriting with a significant focus on regulatory compliance and sound lending practices.~~

TBAs and Other Mortgage-Related Derivatives

In addition to investing in specified pools of Agency RMBS, ~~subject to our satisfying the requirements for qualification as a REIT,~~ we utilize TBA transactions, whereby we agree to purchase or sell, for future delivery, Agency RMBS with certain principal and interest terms and certain types of underlying collateral, but the particular Agency RMBS to be delivered is not identified until shortly before the TBA settlement date. TBAs are liquid and have quoted market prices and represent the most actively traded class of mortgage-backed securities, or "MBS." TBA trading is based on the assumption that mortgage pools that are eligible to be delivered at TBA settlement are fungible and thus the specific mortgage pools to be delivered do not need to be explicitly identified at the time a trade is initiated.

We generally engage in TBA transactions for purposes of managing certain risks associated with our investment strategies. Other than with respect to TBA transactions entered into by our TRSs, most of our TBA transactions are treated for tax purposes as hedging transactions used to hedge indebtedness incurred to acquire or carry real estate assets, or "qualifying liability hedges." The principal risks that we use TBAs to mitigate are interest rate and yield spread risks. For example, we may hedge the interest rate and/or yield spread risk inherent in our long Agency RMBS by taking short positions in TBAs that are similar in character. Alternatively, we may opportunistically engage in TBA transactions because we find them attractive in their own right, from a relative value perspective or otherwise. For accounting purposes, in accordance with generally accepted accounting principles in the United States of America, or "U.S. GAAP," we classify TBA transactions as derivatives.

We also take long and short positions in various other mortgage-related derivative instruments, including mortgage-related credit default swaps. A credit default swap is a credit derivative contract in which one party (the protection buyer) pays an ongoing periodic premium (and often an upfront payment as well) to another party (the protection seller) in return for compensation for default (or similar credit event) by a reference entity. In this case, the reference entity can be an individual MBS or an index of several MBS, such as an ABX, PrimeX, or CMBX index. Payments from the protection seller to the protection buyer typically occur if a credit event takes place. A credit event can be triggered by, among other things, the reference entity's failure to pay its principal obligations or a severe ratings downgrade of the reference entity.

Non-Agency RMBS

We acquire non-Agency RMBS backed by prime jumbo, Alt-A, non-QM, manufactured housing, subprime residential, and single-family-rental mortgage loans. Our non-Agency RMBS holdings can include investment-grade and non-investment grade classes, including non-rated classes.

Non-Agency RMBS are generally debt obligations issued by private originators of, or investors in, residential mortgage loans. Non-Agency RMBS generally are issued as CMOs and are backed by pools of whole mortgage loans or by mortgage pass-through certificates. Non-Agency RMBS generally are securitized in senior/subordinated structures, or in excess spread/over-collateralization structures. In senior/subordinated structures, the subordinated tranches generally absorb all losses on the underlying mortgage loans before any losses are borne by the senior tranches. In excess spread/over-collateralization structures, losses are first absorbed by any existing over-collateralization, then borne by subordinated tranches and excess spread, which represents the difference between the interest payments received on the mortgage loans backing the RMBS and the interest due on the RMBS debt tranches, and finally by senior tranches and any remaining excess spread.

We also have acquired, and may acquire in the future, European RMBS, including retained tranches from European RMBS securitizations in which we have participated.

Residential Mortgage Loans

Our residential mortgage loans include newly originated non-QM loans, residential transition loans, as well as legacy residential NPLs and RPLs. A non-QM loan is not necessarily high-risk, or subprime, but is instead a loan that does not conform to the complex Qualified Mortgage, or "QM," rules of the Consumer Financial Protection Bureau. For example, many non-QM loans are made to creditworthy borrowers who cannot provide traditional documentation for income, such as borrowers who are self-employed. There is also demand from certain creditworthy borrowers for loans above the QM 43%

~~Table of Contents~~

debt-to-income ratio limit that still meet all ability-to-repay standards. We hold an equity investment in a non-QM originator,

Table of Contents

and to date we have purchased the vast majority of our non-QM loans from this originator, although we could potentially purchase a greater share of non-QM loans from other sources in the future.

The residential transition loans that we originate or purchase include: (i) "fix and flip" loans, which are made to real estate investors for the purpose of acquiring residential homes, making value-add improvements to such homes, and reselling the newly rehabilitated homes for a potential profit, and (ii) loans made to real estate investors for a "business purpose," such as purchasing a rental investment property, financing or refinancing a fully rehabilitated home awaiting sale, or securing short-term financing pending qualification for longer-term lower-rate financing. Our residential transition loans are secured by non-owner occupied properties, and are typically structured as fixed-rate, interest-only loans with terms to maturity between 6 and 24 months. Our underwriting guidelines focus on both the "as is" and "as repaired" property values, borrower experience as a real estate investor, and asset verification.

We remain active in the market for residential NPLs and RPLs. The market for large residential NPL and RPL pools has remained highly concentrated, with the great majority having traded to only a handful of large players who typically securitize the residential NPLs and RPLs that they purchase. As a result, we have continued to focus our acquisitions on less-competitively-bid, and more attractively-priced mixed legacy pools sourced from motivated sellers.

Other Investment Assets

Our other investment assets include real estate, including residential and commercial real property, strategic debt and/or equity investments in loan originators, corporate debt and equity securities, corporate loans, which can include litigation finance loans, CRTs, and other non-mortgage-related derivatives. We do not typically purchase real property directly; rather, our real estate ownership usually results from foreclosure activity with respect to our acquired residential and commercial loans. We have made, and in the future may make additional, investments in loan originators and other related entities in the form of debt and/or equity and, to date, our investments have represented non-controlling interests. We have also entered into flow agreements with certain of the loan originators in which we have invested. We have not yet acquired mortgage servicing rights directly, but we may do so in the future.

Hedging Instruments

Interest Rate Hedging

We opportunistically hedge our interest rate risk by using various hedging strategies, subject to ~~qualifying and~~ maintaining our qualification as a REIT. The interest rate hedging instruments that we use and may use in the future include, without limitation:

•TBAs;

•interest rate swaps (including floating-to-fixed, fixed-to-floating, floating-to-floating, or more complex swaps such as floating-to-inverse floating, callable or non-callable);

•CMOs;

•U.S. Treasury securities;

•swaptions, caps, floors, and other derivatives on interest rates;

•futures and forward contracts; and

•options on any of the foregoing.

Because fluctuations in short-term interest rates may expose us to fluctuations in the spread between the interest we earn on our investments and the interest we pay on our borrowings, we may seek to manage such exposure by entering into short positions in interest rate swaps. An interest rate swap is an agreement to exchange interest rate cash flows, calculated on a notional principal amount, at specified payment dates during the life of the agreement. Typically, one party pays a fixed interest rate and receives a floating interest rate and the other party pays a floating interest rate and receives a fixed interest rate. Each party's payment obligation is computed using a different interest rate. In an interest rate swap, the notional principal is generally not exchanged.

Credit Risk Hedging

We enter into credit-hedging positions in order to protect against adverse credit events with respect to our credit investments, subject to ~~qualifying and~~ maintaining our qualification as a REIT. Our credit hedging portfolio can vary significantly from period to period, and can encompass a wide variety of financial instruments, including corporate debt or equity-related instruments, RMBS- or CMBS-related instruments, or instruments involving other markets. Our hedging

~~Table of Contents~~

instruments can include both "single-name" instruments (i.e., instruments referencing one underlying entity or security) and hedging instruments referencing indices.

Table of Contents

Currently, our credit hedges consist primarily of financial instruments tied to corporate credit, such as CDS on corporate bond indices, short positions in and CDS on corporate bonds; and positions involving exchange traded funds, or "ETFs," of corporate bonds. Our credit hedges also currently include CDS tied to individual MBS or an index of several MBS, such as CDS on CMBS indices, or "CMBX."

Foreign Currency Hedging

To the extent that we hold instruments denominated in currencies other than U.S. dollars, we may enter into transactions to offset the potential adverse effects of changes in currency exchange rates, subject to ~~qualifying and~~ maintaining our qualification as a REIT. In particular, we may use currency forward contracts and other currency-related derivatives to mitigate this risk.

Trends and Recent Market Developments

Market Overview

•The U.S. Federal Reserve, or the "Federal Reserve," continued its accommodative monetary policy in the ~~third~~first quarter. At its ~~July~~January and ~~September~~March meetings, the Federal Reserve maintained its target range of 0.00%–0.25% for the federal funds rate, noting in ~~July~~March that ~~the "ongoing public health crisis will weigh heavily on~~“indicators of economic activity and employment have turned up recently, although the sectors most adversely affected by the pandemic remain weak.” Additionally, at both meetings, the Federal Reserve continued to direct the Open Market Desk to increase its holdings of Treasury securities by $80 billion per month, and ~~inflation in~~of Agency RMBS by $40 billion per month, "until substantial further progress has been made toward the near term, and poses considerable risks to the economic outlook over the medium term." It further noted that "the Committee expects to maintain this target range until it is confident that the economy has weathered recent events and is on track to achieve itsCommittee’s maximum employment and price stability goals."

Additionally, in August, the Federal Reserve announced that in order to support the labor market, it will target an average inflation target over time, rather than setting an absolute inflation target as with its previous policy, effectively allowing for periods of higher inflation without a counteracting interest rate increase. The announcement signaled a more dovish long-term stance.

•During the third quarter, the Federal Reserve extended, expanded or modified several of its liquidity support programs, citing the importance of the Federal Reserve’s efforts in supporting the economy, and noting that "improving financial conditions reflect, in part, policy measures implemented to support the economy and the flow of credit to U.S. households and businesses." The Federal Reserve Chairman Jerome Powell argued that additional stimulus measures should be implemented, stating in early October that "the expansion is still far from complete" and "too little support would lead to a weak recovery, creating unnecessary hardship"; but as of quarter end, negotiations for further stimulus measures had stalled in Congress and with the administration.

Also during the ~~third~~ quarter, the ~~Federal Reserve continued to purchase significant amounts~~U.S. Congress and the administration passed the American Rescue Plan Act of ~~U.S. Treasury securities, Agency RMBS,~~2021, which provided for an additional $1.9 trillion of COVID-related stimulus and ~~other eligible collateral, pursuant to the asset purchase programs it outlined earlier in the year.~~

~~Similar to the previous two quarters, central banks and governments around the globe continued to implement quantitative easing programs and stimulus packages during the third quarter.~~economic aid.

•In the ~~third~~first quarter, long-term interest rates rose significantly and the U.S. Treasury ~~yields~~yield curve continued to ~~hover near all-time lows while interest rate volatility remained muted. U.S. Treasury yields changed only slightly quarter over quarter,~~steepen, with the 10-year U.S. Treasury yield ~~finishing~~increasing 83 basis points to finish the ~~third~~ quarter at ~~0.68%~~1.74%, ~~virtually unchanged from~~and the ~~start of the quarter and only 14~~2-year U.S. Treasury yield up just 4 basis points ~~above~~to 0.16%. The yield spread between the ~~record low reached in March. The~~2-year and 10-year U.S. Treasury ~~yield traded within an extraordinarily tight 25-basis-point range~~increased to 158 basis points, which was its widest level since 2015, up from 79 basis points at year end. Interest rate volatility also increased during the quarter, ~~and~~with the MOVE ~~Index, which measures interest-rate volatility, hit an all-time low at the end of September.~~index reaching a 10-month high in February.

•~~Mortgage~~After declining to all-time lows over the course of 2020, mortgage rates ~~continued to decline~~reversed course during the ~~third~~first quarter ~~with the~~of 2021 as long-term interest rates rose. The Freddie Mac ~~Survey~~survey 30-year mortgage rate ~~decreasing by 23 basis points to close~~rose steadily throughout the quarter, increasing to 3.18% as of April 1st, as compared to 2.67% at ~~2.90%, after setting a new all-time low of 2.86%~~year end. Although still elevated on ~~September 10~~th~~. With the declining mortgage rates,~~an historical basis, refinancing applications ~~remain elevated. As of October 2~~nd,declined during the quarter, with the Mortgage Bankers Association's Refinance Index ~~was up 8% quarter over quarter~~decreasing 21.7% between January 1st and ~~50% year over year. Overall~~April 2nd of 2021. Still, overall Fannie Mae 30-year MBS prepayments ~~increased~~remained well above pre-pandemic levels, declining slightly from a CPR of ~~33.0 in June to 33.5 in July, before declining slightly to 32.8 in August, and then reaching a nearly 8-year high of~~ 35.1 in ~~September.~~December 2020 to 30.8 in January 2021, before increasing to 31.8 in February 2021 and 35.4 in March 2021.

•LIBOR rates, which drive many of our financing costs, ~~also~~ remained very low in the ~~third~~first quarter. One-month LIBOR decreased 13 basis ~~point~~points to end the quarter at ~~0.15%~~0.11%, and three-month LIBOR fell 74 basis points to ~~0.23%~~0.19%.

•~~After declining at an annualized rate of 5.0% in~~Real GDP grew for the ~~first quarter and then 31% in the second quarter, reflecting the negative impact of the COVID-19 pandemic and associated measures to contain it, U.S. real GDP bounced back in the~~

~~Table of Contents~~

~~third~~third-consecutive quarter, increasing at an estimated annualized rate of ~~33.1%. U.S. retail sales grew moderately during each month~~6.4% in the first quarter of 2021, following the ~~third quarter, but stagnant wages,~~sharp decline in the ~~persistence~~first half of 2020 related to the onset of the COVID-19 ~~pandemic, uncertainty around new stimulus measures, and an upcoming election, muddled~~pandemic. Meanwhile, the ~~picture.~~

•~~Unemployment claims totaled 14.1 million in the third quarter, down 63% from the second quarter but still well above historical averages. The~~ unemployment rate ~~dropped~~declined to ~~7.9%~~6.0% as of March 31, 2021, from 6.7% at ~~September 30~~th~~, down from 11.1% at June 30~~th ~~and 14.7% at the April 30~~th ~~peak.~~year end.

•Forbearance rates on residential mortgages ~~declined steadily during~~continued to decline in the ~~third quarter, driven by the economic recovery and an improving employment picture, even as many stimulus measures expired.~~first quarter. According to the Mortgage Bankers Association, the total forbearance rate decreased ~~during each month of the third quarter, declining~~to 5.0% at March 28, 2021 from ~~8.4%~~5.5% at ~~the end of June to 6.9% at the end of September.~~January 3, 2021.

•For the ~~third~~first quarter, the Bloomberg Barclays U.S. MBS Index generated a ~~positive~~negative return of ~~0.11%~~(1.10%), driven by rising interest rates, but a ~~negative~~positive excess return (on a ~~duration-adjusted~~duration adjusted basis) of ~~0.07%~~0.15% relative to the Bloomberg Barclays U.S. Treasury Index. The Bloomberg Barclays U.S. Corporate Bond Index generated a ~~gain~~negative return of ~~1.61% and an~~(4.65%), but a positive excess return of ~~1.46%~~0.95%, while the Bloomberg Barclays U.S. Corporate High Yield Bond Index generated a gain of ~~4.42%~~0.85%, and an excess return of ~~4.19%~~2.60%.

•The strong performance of U.S. equities continued into the ~~third~~first quarter of 2021, driven by ~~record-low interest rates,~~an improving economic picture, expectations of additional stimulus, ~~advances on COVID-19 treatments~~ and ~~a possible~~accelerating vaccine ~~as well as outperformance by the tech sector. In July, the tech-heavy NASDAQ composite index closed at an all-time high, while in August, the~~distribution. The S&P 500 ~~reversed all~~hit new record highs in each month of ~~its losses for~~ the year and reached a new all-time high as well. While performance waned in September amidst a tech selloff and dimming hopes for new stimulus, U.S. equities still posted a second consecutive strong quarter. Quarter over quarter, ~~the S&P 500 rose 8.5%,~~rising 5.8% overall, while the Dow Jones Industrial Average ("DJIA") ~~7.6%,~~increased 7.8% and the NASDAQ ~~11%.~~rose 2.8% quarter over quarter. The ~~CBOE Volatility Index, which measures expected moves in~~VIX volatility index spiked briefly at the ~~S&P 500 index, increased moderately in September but remained~~end of January, and again at ~~levels well below those seen in~~the end of February and early March, ~~and April.~~before declining into quarter end. Meanwhile, London's FTSE 100 index ~~decreased 4.9%~~increased 3.9% and the MSCI World global equity index rose ~~7.5%,~~4.5% quarter over ~~the same period.~~quarter.

~~Portfolio Overview and Outlook~~

In March 2020, in response to the market volatility associated with the outbreak of the COVID-19 pandemic, we had strategically reduced the size of our Agency portfolio in order to lower our leverage and enhance our liquidity position. We had also substantially suspended new investments in our credit strategies. High levels of market distress continued into April, and during that month, we further reduced the size of our Agency portfolio, and only resumed very limited purchase and sale activity in our credit portfolio. Beginning in May and June, with the markets stabilized, we fully resumed our investment activity in our credit and Agency portfolios.

Following our substantial suspension and then full resumption of new credit investments earlier in the year, and with our level of investment activity fully restored throughout the third quarter, our total long credit portfolio, including REO but excluding hedges and other derivative positions, increased approximately 5% to $2.095 billion as of September 30, 2020, as compared to $1.996 billion as of June 30, 2020. Excluding non-retained tranches of our consolidated non-QM securitization trusts, our total long credit portfolio increased approximately 12% in the third quarter, to $1.405 billion as of September 30, 2020, as compared to $1.257 billion as of June 30, 2020. The quarter-over-quarter increase in our total credit portfolio was driven by non-QM loan originations and purchases of CMBS and single-family-rental RMBS, partially offset by asset resolutions and net paydowns in the Company's small balance commercial mortgage, consumer loan, and residential transition loan portfolios. Our total long Agency RMBS portfolio increased slightly to $919.9 million as of September 30, 2020, from $913.2 billion as of June 30, 2020.

Despite the new purchase activity, the sizes of both our total long credit portfolio and Agency RMBS portfolio remained significantly smaller as of September 30, 2020, as compared to periods immediately prior to the onset of the COVID-19 pandemic and the related market volatility. We have chosen to keep our leverage ratios relatively low, and to maintain an enhanced liquidity position, in light of continued economic uncertainty. As of September 30, 2020, we had cash and cash equivalents of $126.8 million, along with unencumbered assets of approximately $305.8 million.

8472

Table of Contents

Portfolio Overview and Outlook

The following tables summarize the Company's investment portfolio as of March 31, 2021 and December 31, 2020.

Credit ~~Summary~~ Portfolio(1)


		September 30, 2020				June 30, 2020					March 31, 2021				December 31, 2020
($ in thousands)	($ in thousands)	Fair Value		% of Total Long Credit Portfolio		Fair Value		% of Total Long Credit Portfolio		($ in thousands)	Fair Value		% of Total Long Credit Portfolio		Fair Value		% of Total Long Credit Portfolio
Dollar Denominated:	Dollar Denominated:									Dollar Denominated:
CLOs(2)	CLOs(2)	$	165,954	7.9	%	$	156,158	7.8	%	CLOs(2)	$	104,201	4.8	%	$	181,229	8.3	%
CMBS	CMBS	105,015		5.0	%	77,815		3.9	%	CMBS	45,073		2.1	%	117,652		5.4	%
Commercial Mortgage Loans and REO(3)(4)		304,698		14.5	%	337,265		16.9	%
Consumer Loans and ABS Backed by Consumer Loans(2)		200,857		9.6	%	216,289		10.8	%
Corporate Debt and Equity and Corporate Loans		10,257		0.5	%	9,237		0.5	%
Debt and Equity Investments in Loan Origination Entities		57,009		2.7	%	44,277		2.2	%
Commercial mortgage loans and REO(3)(4)										Commercial mortgage loans and REO(3)(4)	308,368		14.1	%	269,287		12.4	%
Consumer loans and ABS backed by consumer loans(2)										Consumer loans and ABS backed by consumer loans(2)	134,441		6.1	%	112,077		5.1	%
Corporate debt and equity and corporate loans										Corporate debt and equity and corporate loans	22,840		1.0	%	12,606		0.6	%
Debt and equity investments in loan origination entities										Debt and equity investments in loan origination entities	82,482		3.8	%	79,536		3.7	%
Non-Agency RMBS	Non-Agency RMBS	166,787		8.0	%	154,928		7.8	%	Non-Agency RMBS	175,213		8.0	%	154,492		7.1	%
Residential Mortgage Loans and REO(3)		1,033,481		49.3	%	950,565		47.6	%
Residential mortgage loans and REO(3)										Residential mortgage loans and REO(3)	1,282,450		58.6	%	1,188,731		54.7	%
Non-Dollar Denominated:	Non-Dollar Denominated:									Non-Dollar Denominated:
CLOs(2)	CLOs(2)	2,693		0.1	%	2,583		0.1	%	CLOs(2)	4,313		0.2	%	6,108		0.3	%

Consumer Loans and ABS Backed by Consumer Loans		333		—	%	395		—	%
Corporate Debt and Equity		27		—	%	25		—	%
Consumer loans and ABS backed by consumer loans										Consumer loans and ABS backed by consumer loans	224		—	%	306		—	%
Corporate debt and equity										Corporate debt and equity	27		—	%	28		—	%
RMBS(5)	RMBS(5)	47,663		2.4	%	46,722		2.4	%	RMBS(5)	27,470		1.3	%	51,388		2.4	%
Total Long Credit		$	2,094,774	100.0	%	$	1,996,259	100.0	%
Total Long Credit Portfolio										Total Long Credit Portfolio	$	2,187,102	100.0	%	$	2,173,440	100.0	%
Less: Non-retained tranches of consolidated securitization trusts										Less: Non-retained tranches of consolidated securitization trusts	888,509				739,670
Total Long Credit Portfolio excluding non-retained tranches of consolidated securitization trusts										Total Long Credit Portfolio excluding non-retained tranches of consolidated securitization trusts	$	1,298,593			$	1,433,770

(1)This information does not include U.S. Treasury securities, interest rate swaps, TBA positions, or other hedge positions.

(2)Includes equity investments in securitization-related vehicles.

(3)~~As discussed in Note 2 of the notes to condensed consolidated financial statements,~~ REO is not considered a financial instrument and, as a result, is included at the lower of cost or fair ~~value.~~value, as discussed in Note 2 of the notes to condensed consolidated financial statements.

(4)Includes investments in unconsolidated entities holding small balance commercial mortgage loans and REO.

(5)Includes an investment in an unconsolidated entity holding European RMBS.

~~In our credit portfolio, net interest income~~Agency RMBS Portfolio


	March 31, 2021				December 31, 2020
($ in thousands)	Fair Value		% of Long Agency Portfolio		Fair Value		% of Long Agency Portfolio
Long Agency RMBS:
Fixed Rate	$	1,340,448	90.1	%	$	807,704	84.2	%
Floating Rate	5,807		0.4	%	6,454		0.7	%
Reverse Mortgages	92,476		6.2	%	97,629		10.2	%
IOs	49,051		3.3	%	47,656		4.9	%
Total Long Agency RMBS	$	1,487,782	100.0	%	$	959,443	100.0	%

During the first quarter, we significantly increased ~~quarter over quarter, driven by a larger portfolio and lower financing costs, and we also had significant net realized and unrealized gains. Each~~the sizes of our credit strategies contributed positively to results during the third quarter. Prices increased for our non-QM loans, CMBS, CLO, and non-Agency RMBS holdings, as liquidity continued to improve in these markets. Our small balance commercial mortgage, ~~loan,~~residential transition, and consumer loan ~~and residential transition mortgage loan portfolios not only exhibited resilient~~portfolios. Despite these increases, our total long credit performance and generated strong returns on equity, but also continued to return capital quickly for redeployment. We also benefited from extremely strong results for the quarter from our investments in loan originators.

~~Finally, with the strong performance of many credit sectors in the third quarter, our credit hedges detracted from performance.~~

~~Economic Impacts of COVID-19~~

~~Although many~~portfolio, excluding non-retained tranches of our ~~assets have continued~~consolidated non-QM securitization trusts, actually decreased by 9% quarter over quarter, to ~~recover in the third quarter, we still anticipate eventual principal losses on certain~~$1.299 billion as of ~~our credit assets~~March 31, 2021 from $1.434 billion as of December 31, 2020, as a result of opportunistic sales of CLOs, CMBS, and European RMBS, as well as the ~~economic impacts~~completion of ~~COVID-19. Such effects of these anticipated principal losses are reflected~~a non-QM loan securitization in ~~earnings in Unrealized gains (losses) on securities and loans, net on our Condensed Consolidated Statement of Operations, as we elect the fair value option on our securities and loans.~~

Furthermore, as has been widely reported, there has been a significant nationwide increase in loan delinquencies, forbearances, deferments, and modifications, and we are seeing the effects of this in some of our portfolios, although the effects moderated considerably during the third quarter as compared to the second quarter.

•~~Non-QM Loan Portfolio—~~Since the onset of the COVID-19 pandemic, we have worked with the servicer of our non-QM loans to develop a process to document and verify hardship due to the COVID-19 pandemic. We use this information to determine the suitability for a borrower to be granted forbearance, typically for a term lasting three months. We have also worked with the servicer to develop a process to evaluate the possible loss mitigation options in the event that a borrower, at the end of the forbearance period, cannot fully repay the forborne payments. SuchFebruary.

8573

Table of Contents

~~options may include various repayment plans, deferment plans, rate and/or term modifications, short sales, and principal reduction modifications.~~Over the same period, our total long Agency RMBS portfolio increased by 55% to $1.488 billion as of March 31, 2021 from $959.4 million as of December 31, 2020, as yield spread widening in that sector presented attractive investment opportunities.

As of ~~September 30, 2020, non-QM loans~~March 31, 2021, we had cash and cash equivalents of $149.4 million, along with ~~a unpaid principal balance~~unencumbered assets of ~~$9.8 million, or 1.1%~~approximately $467.3 million.

Credit Portfolio Performance Summary

Higher net interest income quarter over quarter, along with substantial net realized and unrealized gains, drove the strong performance of ~~our non-QM loan~~the credit portfolio ~~were~~for the three month period ended March 31, 2021. The increase in ~~forbearance; 42.2% of these loans in forbearance continued to make their regular payments and were current under the terms of their notes despite being in forbearance plans as of September 30, 2020.~~

•~~Small Balance Commercial Mortgage Loan Portfolio—In our~~net interest income was primarily driven by larger small balance commercial mortgage, residential transition, non-QM, and consumer loan ~~portfolio, we have granted short-term interest deferments to certain borrowers, with such deferred interest capitalized~~portfolios , as well as by lower financing costs, while the substantial realized and added to the outstanding principal balance of the loan. In certain other cases, we have granted loan modifications to permit the use of cash reserves to pay interest due on the loan. As of September 30, 2020, small balance commercial mortgage loans with an unpaid principal balance of $28.6 million, or 11.3%, of our small balance commercial mortgage loan portfolio that were current prior to March 2020, have entered into a deferment or modification agreement.

•~~Consumer Loan Portfolio—As of September 30, 2020, we have also seen a decrease in loan deferments~~unrealized gains occurred mainly in our ~~consumer loan portfolio. As of September 30, 2020, consumer loans with a unpaid principal balance of $20.8 million, or 13.9%, of~~CMBS, CLO, and non-QM strategies, as well as our ~~consumer loan~~equity investments in mortgage originators. While our UK non-conforming RMBS portfolio had entered into a deferment plan at some point between March and September of 2020. Of these loans that had entered into a deferment plan, we had received payments on 85.7% of them, based on unpaid principal balance,generated gains during quarter, our Euro-denominated RMBS portfolio generated losses. In addition, our credit hedges detracted from results, as ~~of September 30, 2020.~~credit yield spreads tightened during the quarter.

•~~Residential Transition Loan Portfolio—In our residential transition loan portfolio, we had no loans subject to forbearance, deferment, or modification plans as of September 30, 2020.~~

Supplemental Credit Portfolio Information

The table below details certain information regarding the Company's investments in commercial mortgage loans as of March 31, 2021:


							Gross Unrealized						Weighted Average
($ in thousands)	Unpaid Principal Balance		Premium (Discount)		Amortized Cost		Gains		Losses		Fair Value		Coupon		Yield(2)		Life (Years)(3)
Commercial mortgage loans, held-for-investment(1)	$	283,972	$	4,427	$	288,399	$	232	$	(3,573)	$	285,058	7.88	%	8.07	%	0.83

(1)Includes our allocable portion of small-balance commercial loans, based on our ownership percentage, held in variable interest entities. Our equity investments in such variable interest entities are included in Investments in unconsolidated entities, at fair value on the Condensed Consolidated Balance Sheet.

(2)Excludes commercial mortgage loans, in non-accrual status, with a fair value of $59.9 million.

(3)Expected average lives of loans are generally shorter than stated contractual maturities. Average lives are affected by scheduled periodic payments of principal and unscheduled prepayments of principal.

The table below summarizes our interests in commercial mortgage loans by property type of the underlying real estate collateral, as a percentage of total outstanding unpaid principal balance, as of ~~September 30, 2020:~~March 31, 2021:


Property Type	~~September 30, 2020~~March 31, 2021
Multifamily	~~32.0~~25.5	%
Hotel(1)	~~19.0~~19.6	%
Industrial(1)	~~16.0~~19.6	%
Mixed Use	~~11.0~~15.3	%
Retail	~~9.0~~9.4	%
Other(1)	~~13.0~~10.6	%
	100.0	%

In early 2020, there was a significant nationwide increase in loan delinquencies, forbearances, deferments, and modifications, as a result of the economic impacts of COVID-19. While we saw the effects of this in some of our portfolios, these effects moderated considerably during the second half of 2020. As of March 31, 2021, there were no material incremental effects from COVID-related forbearance or deferment activity in our non-QM, residential transition, consumer, or small balance commercial mortgage loan portfolios.

Agency RMBS Portfolio Performance Summary

September 30, 2020 June 30, 2020
($ in thousands) Fair Value % of Long Agency Portfolio Fair Value % of Long Agency Portfolio
Long Agency RMBS:
Fixed Rate $ 756,580 82.2 % $ 724,756 79.3 %
Floating Rate 7,046 0.8 % 7,899 0.9 %
Reverse Mortgages 104,524 11.4 % 131,535 14.4 %
IOs 51,705 5.6 % 49,007 5.4 %
Total Long Agency RMBS $ 919,855 100.0 % $ 913,197 100.0 %

Our Agency strategy generated a small net gain for the first quarter of 2021. During the quarter, long-term interest rates increased, actual and implied volatility rose, and the yield curve steepened. As a result, Agency RMBS durations extended and yield spreads widened, and most Agency RMBS prices declined sharply, particularly for lower coupon RMBS, which had the

8674

Table of Contents

~~Our~~greatest declines. The increase in long-term interest rates also reduced the demand for prepayment protection, which caused our prepayment-protected specified pools to further underperform. Meanwhile, the rise in long-term interest rates drove net gains on our interest rate hedges and Agency ~~strategy performed well~~interest-only securities, which along with net carry from the portfolio, more than offset the net losses on our long Agency RMBS holdings.

The declining pay-ups on our existing specified pool investments, together with our focus on low pay-up specified pools for our additional purchases during the quarter, ~~driven by increased net interest income and strong performance from our specified pools. During~~caused the ~~quarter, mortgage rates declined further and actual and expected prepayment rates rose, which benefited pay-ups on our prepayment-protected specified pools. Average~~average pay-ups on our specified pools ~~actually declined overall~~ to ~~2.25%~~decline to 1.02% as of ~~September 30, 2020,~~March 31, 2021, from ~~2.39%~~22.05% as of ~~June 30, 2020, but this decrease only occurred because our specified pool purchases during the quarter were primarily of low-pay-up specified pools.~~December 31, 2020. Pay-ups are price premiums for specified pools relative to their TBA counterparts.

During the quarter, we also increased our holdings of long TBAs held for investment, which we concentrated in current coupon production. These investments performed well, driven by Federal Reserve purchasing activity. Also during thefirst quarter, we continued to hedge interest rate risk, ~~in our Agency strategy,~~primarily through the use of interest rate swaps, and short positions in TBAs, U.S. Treasury securities, and futures. During the quarter, we substantially increased the size of our short TBA position, in conjunction with the increased size of our Agency RMBS portfolio. In addition, we continued to hold a portfolio of long TBAs for investment.

As of ~~September 30, 2020~~March 31, 2021 and ~~June 30,~~December 31, 2020, the weighted average net pass-through rate on our fixed-rate specified pools was ~~3.8%~~3.2% and ~~4.0%~~3.7%, respectively. Portfolio turnover for our Agency strategy, as measured by sales and excluding paydowns, was approximately ~~1.4%~~6% for the three-month period ended ~~September 30, 2020.~~March 31, 2021.

We expect to continue to target specified pools that, taking into account their particular composition and based on our prepayment projections, should: (1) generate attractive yields relative to other Agency RMBS and U.S. Treasury securities, (2) have less prepayment sensitivity to government policy shocks, and/or (3) create opportunities for trading gains once the market recognizes their value, which for newer pools may come only after several months, when actual prepayment experience can be observed. We believe that our research team, proprietary prepayment models, and extensive databases remain essential tools in our implementation of this strategy.

The following table summarizes the prepayment rates for our portfolio of fixed-rate specified pools (excluding those backed by reverse mortgages) for the three-month periods ended March 31, 2021, December 31, 2020, September 30, 2020, June 30, 2020, and March 31, ~~2020, December 31, 2019, and September 30, 2019.~~2020.

Three-Month Period Ended
September 30, 2020 June 30, 2020 March 31, 2020 December 31, 2019 September 30, 2019
Three-Month Constant Prepayment Rates(1)
22.0% 21.1% 20.1% 19.9% 15.7%


	Three-Month Period Ended
	March 31, 2021	December 31, 2020	September 30, 2020	June 30, 2020	March 31, 2020
Three-Month Constant Prepayment Rates(1)	23.4%	24.4%	22.0%	21.1%	20.1%

(1)Excludes Agency fixed-rate RMBS without any prepayment history.

2~~Conformed to current period calculation methodology.~~

8775

Table of Contents

The following table provides details about the composition of our portfolio of fixed-rate specified pools (excluding those backed by reverse mortgages) as of ~~September 30, 2020~~March 31, 2021 and ~~June 30,~~December 31, 2020:


			September 30, 2020					June 30, 2020							March 31, 2021					December 31, 2020
		Coupon (%)	Current Principal		Fair Value		Weighted Average Loan Age (Months)	Current Principal		Fair Value		Weighted Average Loan Age (Months)		Coupon (%)	Current Principal		Fair Value		Weighted Average Loan Age (Months)	Current Principal		Fair Value		Weighted Average Loan Age (Months)
			(In thousands)					(In thousands)							(In thousands)					(In thousands)
Fixed-rate Agency RMBS:	Fixed-rate Agency RMBS:												Fixed-rate Agency RMBS:
15-year fixed-rate mortgages:	15-year fixed-rate mortgages:												15-year fixed-rate mortgages:
		2.50–2.99	$	19,952	$	21,282	46	$	8,300	$	8,383	15		1.50–1.99	$	5,540	$	5,677	2	$	—	$	—	—
		3.00–3.49	15,236		16,018		15	6,243		6,572		34		2.00–2.49	55,235		56,739		3	—		—		—
		3.50–3.99	22,078		23,672		62	23,753		25,236		59		2.50–2.99	52,161		54,601		20	20,248		21,476		46
		4.00–4.49	7,549		8,077		49	8,590		9,191		46		3.00–3.49	32,681		34,692		10	13,714		14,405		20
		4.50–4.99	4,676		4,946		121	5,127		5,398		118		3.50–3.99	21,706		23,358		60	22,820		24,505		60
														4.00–4.49	6,302		6,762		55	6,878		7,366		51
														4.50–4.99	3,759		3,985		127	4,215		4,462		124
Total 15-year fixed-rate mortgages	Total 15-year fixed-rate mortgages		69,491		73,995		50	52,013		54,780		53	Total 15-year fixed-rate mortgages		177,384		185,814		21	67,875		72,214		51
20-year fixed-rate mortgages:	20-year fixed-rate mortgages:												20-year fixed-rate mortgages:
														2.00–2.49	2,989		3,028		4	—		—		—
														2.50–2.99	48,036		49,909		5	48,350		51,466		2
														4.00–4.49	1,063		1,144		34	1,204		1,292		31
		4.50–4.99	587		655		82	740		813		79		4.50–4.99	566		633		88	577		652		85
Total 20-year fixed-rate mortgages	Total 20-year fixed-rate mortgages		587		655		82	740		813		79	Total 20-year fixed-rate mortgages		52,654		54,714		7	50,131		53,410		4
30-year fixed-rate mortgages:	30-year fixed-rate mortgages:												30-year fixed-rate mortgages:
		2.50–2.99	12,492		13,138		2	—		—		—		2.00–2.49	2,449		2,446		5	—		—		—
		3.00–3.49	114,822		122,313		16	54,391		58,269		15		2.50–2.99	446,921		459,816		4	29,043		30,753		3
		3.50–3.99	135,962		147,768		45	143,401		155,556		42		3.00–3.49	127,994		134,468		20	122,851		130,817		18
		4.00–4.49	170,179		185,606		47	202,138		219,702		42		3.50–3.99	140,070		150,575		45	133,713		145,590		46
		4.50–4.99	117,661		129,787		43	130,536		143,461		40		4.00–4.49	156,027		170,198		50	169,080		184,495		48
		5.00–5.49	67,926		75,457		46	75,597		84,034		42		4.50–4.99	103,281		114,199		48	101,664		112,481		48
		5.50–5.99	5,191		5,946		58	5,409		6,103		57		5.00–5.49	55,404		61,845		50	63,240		70,533		46
		6.00–6.49	1,649		1,915		76	1,786		2,038		70		5.50–5.99	4,204		4,870		62	5,083		5,845		61
														6.00–6.49	1,309		1,503		92	1,347		1,566		90
Total 30-year fixed-rate mortgages	Total 30-year fixed-rate mortgages		625,882		681,930		39	613,258		669,163		39	Total 30-year fixed-rate mortgages		1,037,659		1,099,920		26	626,021		682,080		40
Total fixed-rate Agency RMBS	Total fixed-rate Agency RMBS		$	695,960	$	756,580	40	$	666,011	$	724,756	41	Total fixed-rate Agency RMBS		$	1,267,697	$	1,340,448	24	$	744,027	$	807,704	38

Our net Agency premium as a percentage of the fair value of our specified pool holdings is one metric that we use to measure the overall prepayment risk of our specified pool portfolio. Net Agency premium represents the total premium (excess of market value over outstanding principal balance) on our specified pool holdings less the total premium on related net short TBA positions. The lower our net Agency premium, the less we believe that our specified pool portfolio is exposed to market-wide increases in Agency RMBS prepayments. Our net Agency premium as a percentage of fair value of our specified pool holdings was approximately ~~5.2%~~2.3% and ~~5.5%~~4.8% as of ~~September 30, 2020~~March 31, 2021 and ~~June 30,~~December 31, 2020, respectively. These figures take into account the net short TBA positions that we use to hedge our specified pool holdings, which had a notional value of ~~$353.2~~$769.9 million and a fair value of ~~$378.9~~$817.0 million as of ~~September 30, 2020,~~March 31, 2021, as compared to a notional value of ~~$330.1~~$383.6 million and a fair value of ~~$354.2~~$412.2 million as of ~~June 30,~~December 31, 2020. Excluding these TBA hedging positions, our Agency premium as a percentage of fair value was approximately ~~8.1%~~5.6% and ~~8.3%~~7.9% as of ~~September 30, 2020~~March 31, 2021 and ~~June 30,~~December 31, 2020, respectively. Our Agency premium percentage and net Agency premium percentage may fluctuate from period to period based on a variety of factors, including market factors such as interest rates and mortgage rates, and, in the case of our net Agency premium

Table of Contents

percentage, based on the degree to which we hedge prepayment risk with short TBA positions. We believe that our focus on purchasing pools with specific prepayment characteristics provides a measure of protection against prepayments.

~~Table of Contents~~

Financing

The following table details our borrowings outstanding and debt-to-equity ratios as of ~~September 30, 2020~~March 31, 2021 and ~~June 30,~~December 31, 2020:


		As of					As of
($ in thousands)	($ in thousands)	September 30, 2020		June 30, 2020		($ in thousands)	March 31, 2021		December 31, 2020
Recourse(1) Borrowings:	Recourse(1) Borrowings:					Recourse(1) Borrowings:
Repurchase Agreements	Repurchase Agreements	$	1,319,634	$	1,147,725	Repurchase Agreements	$	1,745,716	$	1,364,090
Other Secured Borrowings	Other Secured Borrowings	40,764		46,289		Other Secured Borrowings	42,419		37,372
Senior Notes, at par	Senior Notes, at par	86,000		86,000		Senior Notes, at par	86,000		86,000
Total Recourse Borrowings	Total Recourse Borrowings	$	1,446,398	$	1,280,014	Total Recourse Borrowings	$	1,874,135	$	1,487,462
Debt-to-Equity Ratio Based on Total Recourse Borrowings(1)	Debt-to-Equity Ratio Based on Total Recourse Borrowings(1)	1.7:1		1.5:1		Debt-to-Equity Ratio Based on Total Recourse Borrowings(1)	2.0:1		1.6:1
Debt-to-Equity Ratio Based on Total Recourse Borrowings Excluding U.S. Treasury Securities	Debt-to-Equity Ratio Based on Total Recourse Borrowings Excluding U.S. Treasury Securities	1.7:1		1.5:1		Debt-to-Equity Ratio Based on Total Recourse Borrowings Excluding U.S. Treasury Securities	2.0:1		1.6:1
Non-Recourse(2) Borrowings:	Non-Recourse(2) Borrowings:					Non-Recourse(2) Borrowings:
Repurchase Agreements	Repurchase Agreements	$	120,350	$	146,824	Repurchase Agreements	$	163,795	$	132,841
Other Secured Borrowings	Other Secured Borrowings	101,910		109,800		Other Secured Borrowings	22,087		13,690
Other Secured Borrowings, at fair value(3)	Other Secured Borrowings, at fair value(3)	695,516		742,688		Other Secured Borrowings, at fair value(3)	911,256		754,921
Total Recourse and Non-Recourse Borrowings	Total Recourse and Non-Recourse Borrowings	$	2,364,174	$	2,279,326	Total Recourse and Non-Recourse Borrowings	$	2,971,273	$	2,388,914
Debt-to-Equity Ratio Based on Total Recourse and Non-Recourse Borrowings	Debt-to-Equity Ratio Based on Total Recourse and Non-Recourse Borrowings	2.7:1		2.7:1		Debt-to-Equity Ratio Based on Total Recourse and Non-Recourse Borrowings	3.1:1		2.6:1
Debt-to-Equity Ratio Based on Total Recourse and Non-Recourse Borrowings Excluding U.S. Treasury Securities	Debt-to-Equity Ratio Based on Total Recourse and Non-Recourse Borrowings Excluding U.S. Treasury Securities	2.7:1		2.7:1		Debt-to-Equity Ratio Based on Total Recourse and Non-Recourse Borrowings Excluding U.S. Treasury Securities	3.1:1		2.6:1

(1)As of ~~September 30, 2020~~March 31, 2021 and ~~June 30,~~December 31, 2020, excludes borrowings at certain unconsolidated entities that are recourse to us. Including such borrowings, our debt-to-equity ratio based on total recourse borrowings was ~~1.7:~~2.0:1 and 1.6:1 as of ~~September 30, 2020~~March 31, 2021 and ~~June 30,~~December 31, 2020, respectively.

(2)All of our non-recourse borrowings are secured by collateral. In the event of default under a non-recourse borrowing, the lender has a claim against the collateral but not any of the Operating Partnership's other assets. In the event of default under a recourse borrowing, the lender's claim is not limited to the collateral (if any).

(3)Relates to our non-QM loan securitizations, where we have elected the fair value option on the related debt.

Our debt-to-equity ratio including repos, Total other secured borrowings, and our Senior Notes, but excluding repos on U.S. Treasury securities, was ~~2.7:~~3.1:1 and 2.6:1 as of ~~both September 30,~~March 31, 2021 and December 31, 2020, ~~and June 30, 2020.~~respectively. Excluding repos on U.S. Treasury securities, our recourse debt-to-equity ratio ~~increased~~decreased to ~~1.7:~~2.0:1 as of ~~September 30, 2020,~~March 31, 2021, from ~~1.5:~~1.6:1 as of ~~June 30,~~December 31, 2020. The increases in our debt-to-equity ratios were primarily driven by increased borrowings related to our larger Agency RMBS portfolio.

Our debt-to-equity ratio may fluctuate period over period based on portfolio management decisions, market conditions, capital markets activities, and the timing of security purchase and sale transactions.

Our financing costs include interest expense related to our repo borrowings, Total other secured borrowings, and Senior Notes. The interest rates on our repo borrowings and Other secured borrowings are generally based on, or correlated with, LIBOR. For the three-month period ended ~~September 30, 2020,~~March 31, 2021, our average cost of funds decreased to ~~2.06%~~1.52%, compared to ~~2.35%~~1.88% for the three-month period ended ~~June 30,~~December 31, 2020. The period-over-period decline in our average cost of funds was due to ~~the recent declines in short-term interest rates;~~narrower financing spreads on our both our Agency and credit borrowings as well as a larger percentage of our ~~older, higher cost repo~~overall average borrowings ~~have matured, we have replaced them with repo borrowings priced based on current, lower cost borrowing rates.~~collateralized by Agency RMBS.

Critical Accounting ~~Policies~~

We adopted ASC 946 upon commencement of operations in August 2007, and applied U.S. GAAP for investment companies. In connection with our internal restructuring and our intention to qualify as a REIT for the year ended December 31, 2019, we have determined that, effective January 1, 2019, we no longer qualified for investment company accounting in accordance with ASC 946-10-25, and prospectively discontinued its use. We elected the fair value option for, and therefore we will continue to measure at fair value, those of our assets and liabilities for which such election is permitted, as provided for under ASC 825, ~~Financial Instruments~~ ~~("ASC 825").~~Estimates

Our interim unaudited condensed consolidated financial statements include the accounts of Ellington Financial Inc., its Operating Partnership, its subsidiaries, and variable interest entities, or "VIEs," for which the Company is deemed to be the primary beneficiary. All intercompany balances and transactions have been eliminated. Certain of our critical accounting policies require us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the ~~condensed~~ consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. We believe that all of the decisions and assessments upon which our ~~condensed~~

~~Table of Contents~~

consolidated financial statements are based were reasonable at the time made based upon information available to us at that time. We rely on the

Table of Contents

experience of our Manager and Ellington and analysis of historical and current market data in order to arrive at what we believe to be reasonable estimates. See Note 2 of the notes to our condensed consolidated financial statements for a complete discussion of our significant accounting policies. We have identified our most critical accounting policies to be the following:

Valuation: We have elected the fair value option for the vast majority of our assets and liabilities for which such election is permitted, as provided for under ASC 825, Financial Instruments ("ASC 825"). For financial instruments that are traded in an "active market," the best measure of fair value is the quoted market price. However, many of our financial instruments are not traded in an active market. Therefore, management generally uses third-party valuations when available. If third-party valuations are not available, management uses other valuation techniques, such as the discounted cash flow methodology. Summary descriptions, for various categories of financial instruments, of the valuation methodologies management uses in determining fair value of our financial instruments are detailed in Note 2 of the notes to our condensed consolidated financial statements. Management utilizes such methodologies to assign a good faith fair value (the estimated price that, in an orderly transaction at the valuation date, would be received to sell an asset, or paid to transfer a liability, as the case may be) to each such financial instrument.

See the notes to our condensed consolidated financial statements for more information on valuation techniques used by management in the valuation of our assets and liabilities.

Purchases and Sales of Investments and Investment Income: Purchase and sales transactions are generally recorded on trade date. Realized and unrealized gains and losses are calculated based on identified cost. We generally amortize premiums and accrete discounts on our fixed-income investments using the effective interest method.

See the notes to our condensed consolidated financial statements for more information on the assumptions and methods that we use to amortize purchase premiums and accrete purchase discounts.

Income Taxes: We made an election to be taxed as a REIT for U.S. federal income tax purposes commencing with our taxable year ended December 31, 2019. As a REIT, we generally are not subject to corporate-level federal and state income tax on net income we distribute to our stockholders within the prescribed timeframes. To qualify as a REIT, we must meet a number of organizational and operational requirements, including distributing at least 90% of our taxable income to our stockholders. Even if we qualify as a REIT, we may be subject to certain federal, state, local and foreign taxes on our income and property, and to federal income and excise taxes on our undistributed taxable income. If we fail to qualify as a REIT, and do not qualify for certain statutory relief provisions, we will be subject to U.S. federal, state, and local income taxes and may be precluded from qualifying as a REIT for the four taxable years following the year in which we fail to qualify as a REIT.

We elected to treat certain domestic and foreign subsidiaries as TRSs, and may in the future elect to treat other current or future subsidiaries as TRSs. In general, a TRS may hold assets and engage in activities that we cannot hold or engage in directly and generally may engage in any real estate or non-real estate-related business. A domestic TRS may, but is not required to, declare dividends to us; such dividends will be included in our taxable income/(loss) and may necessitate a distribution to our stockholders. Conversely, if we retain earnings at the level of a domestic TRS, such earnings will increase the book equity of the consolidated entity. A domestic TRS is subject to U.S. federal, state, and local corporate income taxes. We have elected and may elect in the future to treat certain of our foreign corporate subsidiaries as TRSs and, accordingly, taxable income generated by these TRSs may not be subject to U.S. federal, state, and local corporate income taxation, but generally will be included in our income on a current basis as Subpart F income, whether or not distributed. However, certain of our foreign subsidiaries may be subject to income taxes in the relevant foreign jurisdictions. Our financial results are generally not expected to reflect provisions for current or deferred income taxes, except for any activities conducted through one or more TRSs that are subject to corporate income taxation.

We follow the authoritative guidance on accounting for and disclosure of uncertainty on tax positions, which requires management to determine whether a tax position is more likely than not to be sustained upon examination by the applicable taxing authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For uncertain tax positions, the tax benefit to be recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. We did not have any unrecognized tax benefits resulting from tax positions related to the current period or our open tax years. In the normal course of business, we may be subject to examination by federal, state, local, and foreign jurisdictions, where applicable, for the current period and our open tax years. We may take positions with respect to certain tax issues which depend on legal interpretation of facts or applicable tax regulations. Should the relevant tax regulators successfully challenge any such positions, we might be found to have a tax liability that has not been recorded in the accompanying consolidated financial statements. Also, management's conclusions regarding the authoritative guidance may be subject to review and adjustment at a later date based on changing tax laws, regulations, and interpretations thereof.

See the notes to our condensed consolidated financial statements for additional details on income taxes.

Table of Contents

Recent Accounting Pronouncements

Refer to the notes to our condensed consolidated financial statements for a description of relevant recent accounting pronouncements.

~~Table of Contents~~

Financial Condition

The following table summarizes the fair value our investment portfolio(1) as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019.~~2020.


(In thousands)	(In thousands)	September 30, 2020		December 31, 2019		(In thousands)	March 31, 2021		December 31, 2020
Long:	Long:					Long:
Credit:	Credit:					Credit:
Dollar Denominated:	Dollar Denominated:					Dollar Denominated:
CLO(2)	CLO(2)	$	165,954	$	172,802	CLO(2)	$	104,201	$	181,229
CMBS	CMBS	105,015		124,693		CMBS	45,073		117,652
Commercial Mortgage Loans and REO(3)(4)	Commercial Mortgage Loans and REO(3)(4)	304,698		320,926		Commercial Mortgage Loans and REO(3)(4)	308,368		269,287
Consumer Loans and ABS backed by Consumer Loans(2)	Consumer Loans and ABS backed by Consumer Loans(2)	200,857		238,193		Consumer Loans and ABS backed by Consumer Loans(2)	134,441		112,077
Corporate Debt and Equity and Corporate Loans	Corporate Debt and Equity and Corporate Loans	10,257		20,987		Corporate Debt and Equity and Corporate Loans	22,840		12,606
Equity Investments in Loan Origination Entities	Equity Investments in Loan Origination Entities	57,009		41,393		Equity Investments in Loan Origination Entities	82,482		79,536
Non-Agency RMBS	Non-Agency RMBS	166,787		113,342		Non-Agency RMBS	175,213		154,492
Residential Mortgage Loans and REO(3)	Residential Mortgage Loans and REO(3)	1,033,481		933,870		Residential Mortgage Loans and REO(3)	1,282,450		1,188,731
Non-Dollar Denominated:	Non-Dollar Denominated:					Non-Dollar Denominated:
CLO(2)	CLO(2)	2,693		5,722		CLO(2)	4,313		6,108
CMBS		—		175

Consumer Loans and ABS backed by Consumer Loans	Consumer Loans and ABS backed by Consumer Loans	333		549		Consumer Loans and ABS backed by Consumer Loans	224		306
Corporate Debt and Equity	Corporate Debt and Equity	27		30		Corporate Debt and Equity	27		28
RMBS(5)	RMBS(5)	47,663		55,156		RMBS(5)	27,470		51,388
Agency:	Agency:					Agency:
Fixed-Rate Specified Pools	Fixed-Rate Specified Pools	756,580		1,758,882		Fixed-Rate Specified Pools	1,340,448		807,704
Floating-Rate Specified Pools	Floating-Rate Specified Pools	7,046		10,002		Floating-Rate Specified Pools	5,807		6,454
IOs	IOs	51,705		35,279		IOs	49,051		47,656
Reverse Mortgage Pools	Reverse Mortgage Pools	104,524		132,800		Reverse Mortgage Pools	92,476		97,629

Total Long	Total Long	$	3,014,629	$	3,964,801	Total Long	$	3,674,884	$	3,132,883
Short:	Short:					Short:
Credit:	Credit:					Credit:
Dollar Denominated:	Dollar Denominated:					Dollar Denominated:
Corporate Debt and Equity	Corporate Debt and Equity	$	(461)	$	(471)	Corporate Debt and Equity	$	(219)	$	(218)
Government Debt:	Government Debt:					Government Debt:
Dollar Denominated	Dollar Denominated	(14,310)		(62,994)		Dollar Denominated	(59,452)		—
Non-Dollar Denominated	Non-Dollar Denominated	(36,722)		(9,944)		Non-Dollar Denominated	(36,727)		(38,424)
Total Short	Total Short	$	(51,493)	$	(73,409)	Total Short	$	(96,398)	$	(38,642)

(1)For more detailed information about the investments in our portfolio, please see the notes to the condensed consolidated financial statements.

(2)Includes equity investments in securitization-related vehicles.

(3)REO is not eligible to elect the fair value option as described in Note 2 of the notes to the condensed consolidated financial statements and, as a result, is included at the lower of cost or fair value.

(4)Includes investments in unconsolidated entities holding small balance commercial mortgage loans and REO.

(5)Includes an investment in an unconsolidated entity holding European RMBS.

9179

Table of Contents

The following table summarizes our financial derivatives portfolio(1)(2) as of ~~September 30,~~March 31, 2021.



	Notional						Net Fair Value
(In thousands)	Long		Short		Net
Mortgage-Related Derivatives:
CDS on MBS and MBS Indices	$	848	$	(14,633)	$	(13,785)	$	2,280
Total Net Mortgage-Related Derivatives							2,280
Corporate-Related Derivatives:
CDS on Corporate Bonds and Corporate Bond Indices	67,354		(103,703)		(36,349)		(2,383)
Total Return Swaps on Corporate Bond Indices and Corporate Debt(3)	4,188		—		4,188		(336)

Warrants(4)	1,897		—		1,897		42
Total Net Corporate-Related Derivatives							(2,677)
Interest Rate-Related Derivatives:
TBAs	184,890		(918,620)		(733,730)		(667)
Interest Rate Swaps	237,472		(879,596)		(642,124)		1,819
U.S. Treasury Futures(5)	1,900		(178,500)		(176,600)		2,541

Total Interest Rate-Related Derivatives							3,693
Other Derivatives:
Foreign Currency Forwards(6)	—		(27,785)		(27,785)		348


Total Net Other Derivatives							348
Net Total							$	3,644

(1)For more detailed information about the financial derivatives in our portfolio, please refer to Note 8 of the notes to the condensed consolidated financial statements.

(2)In the table above, fair value of certain derivative transactions are shown on a net basis. The accompanying financial statements separate derivative transactions as either assets or liabilities. As of March 31, 2021, derivative assets and derivative liabilities were $23.1 million and $(19.4) million, respectively, for a net fair value of $3.6 million, as reflected in "Net Total" above.

(3)Notional value represents the face amount of the underlying asset.

(4)Notional represents the maximum number of shares available to be purchased upon exercise.

(5)Notional value represents the total face amount of U.S. Treasury securities underlying all contracts held. As of March 31, 2021, a total of 19 long and 1,558 short U.S. Treasury futures contracts were held.

(6)Short notional value represents U.S. Dollars to be received by us at the maturity of the forward contract.

Table of Contents

The following table summarizes our financial derivatives portfolio(1)(2) as of December 31, 2020.


						December 31, 2020
		Notional							Net Fair Value			Notional						Net Fair Value
(In thousands)	(In thousands)	Long		Short			Net				(In thousands)	Long		Short		Net
Mortgage-Related Derivatives:	Mortgage-Related Derivatives:										Mortgage-Related Derivatives:
CDS on MBS and MBS Indices	CDS on MBS and MBS Indices	$	896	$	(31,624)		$	(30,728)	$	9,931	CDS on MBS and MBS Indices	$	874	$	(13,846)	$	(12,972)	$	2,401
Total Net Mortgage-Related Derivatives	Total Net Mortgage-Related Derivatives								9,931		Total Net Mortgage-Related Derivatives							2,401
Corporate-Related Derivatives:	Corporate-Related Derivatives:										Corporate-Related Derivatives:
CDS on Corporate Bonds and Corporate Bond Indices	CDS on Corporate Bonds and Corporate Bond Indices	70,981		(149,219)			(78,238)		(1,694)		CDS on Corporate Bonds and Corporate Bond Indices	67,779		(121,197)		(53,418)		(3,765)
Total Return Swaps on Corporate Bond Indices and Corporate Debt(3)	Total Return Swaps on Corporate Bond Indices and Corporate Debt(3)	4,739		—			4,739		17		Total Return Swaps on Corporate Bond Indices and Corporate Debt(3)	4,161		—		4,161		(475)

Warrants(4)	Warrants(4)	1,546		—			1,546		31		Warrants(4)	1,897		—		1,897		36
Total Net Corporate-Related Derivatives	Total Net Corporate-Related Derivatives								(1,646)		Total Net Corporate-Related Derivatives							(4,204)
Interest Rate-Related Derivatives:	Interest Rate-Related Derivatives:										Interest Rate-Related Derivatives:
TBAs	TBAs	168,890		(488,567)			(319,677)		864		TBAs	149,990		(504,067)		(354,077)		37
Interest Rate Swaps	Interest Rate Swaps	438,560		(587,986)			(149,426)		(15,984)		Interest Rate Swaps	253,423		(408,295)		(154,872)		(6,655)
U.S. Treasury Futures(5)	U.S. Treasury Futures(5)	1,900		(165,900)			(164,000)		(330)		U.S. Treasury Futures(5)	1,900		(178,500)		(176,600)		(374)

Total Interest Rate-Related Derivatives	Total Interest Rate-Related Derivatives								(15,450)		Total Interest Rate-Related Derivatives							(6,992)
Other Derivatives:	Other Derivatives:										Other Derivatives:
Foreign Currency Forwards(6)	Foreign Currency Forwards(6)	—		(22,784)			(22,784)		215		Foreign Currency Forwards(6)	—		(22,330)		(22,330)		(279)

Total Net Other Derivatives	Total Net Other Derivatives								215		Total Net Other Derivatives							(279)
Net Total	Net Total								$	(6,950)	Net Total							$	(9,074)

(1)For more detailed information about the financial derivatives in our portfolio, please refer to Note 8 of the notes to condensed consolidated financial statements.

(2)In the table above, fair value of certain derivative transactions are shown on a net basis. The accompanying financial statements separate derivative transactions as either assets or liabilities. As of ~~September 30,~~December 31, 2020, derivative assets and derivative liabilities were ~~$27.9~~$15.5 million and ~~$(34.8)~~$(24.6) million, respectively, for a net fair value of ~~$(7.0)~~$(9.1) million, as reflected in "Net Total" above.

(3)Notional value represents the face amount of the underlying asset.

(4)Notional represents the maximum number of shares available to be purchased upon exercise.

(5)Notional value represents the total face amount of U.S. Treasury securities underlying all contracts held. As of ~~September 30,~~December 31, 2020, a total of 19 long and ~~1,432~~1,558 short U.S. Treasury futures contracts were held.

(6)Short notional value represents U.S. Dollars to be received by us at the maturity of the forward ~~contract.~~contract

~~Table~~As of ~~Contents~~

~~The following table summarizes~~March 31, 2021, our ~~financial derivatives portfolio(1)(2)~~ asCondensed Consolidated Balance Sheet reflected total assets of ~~December 31, 2019.~~

Notional Net
Fair Value
(In thousands) Long Short Net
Mortgage-Related Derivatives:
CDS on MBS and MBS Indices $ 1,039 $ (70,656) $ (69,617) $ 4,062
Total Net Mortgage-Related Derivatives 4,062
Corporate-Related Derivatives:
CDS on Corporate Bonds and Corporate Bond Indices 131,137 (262,885) (131,748) (10,616)
Total Return Swaps on Corporate Bond Indices and Corporate Debt(3)
7,359 (17,560) (10,201) (589)
Total Net Corporate-Related Derivatives (11,205)
Interest Rate-Related Derivatives:
TBAs 40,100 (1,093,730) (1,053,630) (416)
Interest Rate Swaps 305,723 (732,961) (427,238) (3,251)
U.S. Treasury Futures(4)
— (16,000) (16,000) 148
Eurodollar Futures(5)
— (14,000) (14,000) (45)
Total Interest Rate-Related Derivatives (3,564)
Other Derivatives:
Foreign Currency Forwards(6)
— (26,211) (26,211) (126)
Total Net Other Derivatives (126)
Net Total $ (10,833)

~~(1)For more detailed information about the financial derivatives in our portfolio, please refer to Note 8~~$4.1 billion and total liabilities of ~~the notes to condensed consolidated financial statements for the year ended December 31, 2019.~~

~~(2)In the table above, fair value of certain derivative transactions are shown on a net basis. The accompanying financial statements separate derivative transactions as either assets or liabilities.~~$3.2 billion. As of December 31, ~~2019, derivative assets and derivative liabilities were $16.8 million and $(27.6) million, respectively, for a net fair value of $(10.8) million, as reflected in "Net Total" above.~~

~~(3)Notional value represents the face amount of the underlying asset.~~

~~(4)Notional value represents the total face amount of U.S. Treasury securities underlying all contracts held. As of December 31, 2019, a total of 160 short U.S. Treasury futures contracts were held.~~

~~(5)Every $1,000,000 in notional value represents one contract.~~

~~Short notional value represents U.S. Dollars to be received by us at the maturity of the forward contract~~

~~As of September 30,~~ 2020, our Condensed Consolidated Balance Sheet reflected total assets of $3.4 billion and total liabilities of $2.5 ~~billion. As of December 31, 2019, our Condensed Consolidated Balance Sheet reflected total assets of $4.3 billion and total liabilities of $3.5~~ billion. Our investments in securities, loans, and unconsolidated entities, financial derivatives, and real estate owned included in total assets were ~~$3.0~~$3.7 billion and ~~$4.0~~$3.1 billion as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, respectively. Our investments in securities sold short and financial derivatives included in total liabilities were ~~$86.3~~$115.8 million and ~~$101.0~~$63.2 million as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, respectively. As of ~~September 30, 2020~~both March 31, 2021 and December 31, ~~2019,~~2020, investments in securities sold short consisted principally of short positions in sovereign bonds. We primarily use short positions in sovereign bonds and U.S. Treasury securities ~~which we primarily use~~ to hedge the risk of rising interest rates and foreign currency risk.

Typically, we hold a net short position in TBAs. The amounts of net short TBAs, as well as of other hedging instruments, may fluctuate according to the size of our investment portfolio as well as according to how we view market dynamics as favoring the use of one hedging instrument or another. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, we had a net short notional TBA position of ~~$0.3~~$0.7 billion and ~~$1.1~~$0.4 billion, respectively. The size of the net short notional TBA position ~~declined primarily because we covered TBA short positions~~increased in ~~connection~~conjunction with ~~sales~~the increased size of our Agency RMBS ~~and because~~portfolio. In addition, we slightly increased the notional amount of long TBAs held for ~~investment.~~investment as of March 31, 2021 as compared to December 31, 2020.

For a more detailed discussion of our investment portfolio, see "—Trends and Recent Market Developments—Portfolio Overview and Outlook" above.

We use mortgage-related credit derivatives primarily to hedge credit risk in certain credit strategies, although we also take net long positions in certain CDS on RMBS and CMBS indices. Our CDS on individual RMBS represent "single-name" positions whereby we have synthetically purchased credit protection on specific non-Agency RMBS bonds. As there is no longer an active market for CDS on individual RMBS, our portfolio in this sector continues to run off. We also use CDS on

Table of Contents

corporate bond indices, options thereon, and various other instruments as a means to hedge credit risk. As market conditions

~~Table of Contents~~

change, especially as the pricing of various credit hedging instruments changes in relation to our outlook on future credit performance, we continuously re-evaluate both the extent to which we hedge credit risk and the particular mix of instruments that we use to hedge credit risk.

We may hold long and/or short positions in corporate bonds or equities. Our long and short positions in corporate bonds or equities may serve as outright investments or portfolio hedges.

We use a variety of instruments to hedge interest rate risk in our portfolio, including non-derivative instruments such as U.S. Treasury securities and sovereign debt instruments, and derivative instruments such as interest rate swaps, TBAs, Eurodollar and U.S. Treasury futures, and options on the foregoing. The mix of instruments that we use to hedge interest rate risk may change materially from one period to the next.

We have also entered into foreign currency forward and futures contracts in order to hedge risks associated with foreign currency fluctuations.

We have entered into repos to finance many of our assets. We account for our repos as collateralized borrowings. As of ~~September 30,~~March 31, 2021 indebtedness outstanding on our repos was approximately $1.9 billion. As of March 31, 2021, our assets financed with repos consisted of Agency RMBS of $1.5 billion and credit assets of $709.6 million. As of March 31, 2021, outstanding indebtedness under repos was $1.4 billion for Agency RMBS and $473.0 million for credit assets. As of December 31, 2020 indebtedness outstanding on our repos was approximately ~~$1.4~~$1.5 billion. As of ~~September 30,~~December 31, 2020, our assets financed with repos consisted of Agency RMBS of ~~$915.1~~$947.0 million and credit assets of ~~$868.0~~$884.2 million. As of ~~September 30,~~December 31, 2020, outstanding indebtedness under repos was ~~$883.8~~$921.9 million for Agency RMBS and $556.2 million for credit assets. As of December 31, 2019 indebtedness outstanding on our repos was approximately $2.4 billion. As of December 31, 2019, our assets financed with repos consisted of Agency RMBS of $1.9 billion and credit assets of $830.3 million. As of December 31, 2019, outstanding indebtedness under repos was $1.9 billion for Agency RMBS and $580.8$575.1 million for credit assets. Our repos bear interest at rates that have historically moved in close relationship to LIBOR.

In addition to our repos, as of ~~September 30, 2020~~March 31, 2021 we had Total other secured borrowings of ~~$838.2~~$975.8 million, used to finance ~~$971.2 million~~$1.072 billion of non-QM loans, ~~and REO,~~ consumer loans and ABS backed by consumer loans, and small balance commercial mortgage loans. This compares to Total other secured borrowings of ~~$744.7~~$806.0 million as of December 31, ~~2019,~~2020, used to finance ~~$843.4~~$906.4 million of non-QM loans, ~~and REO, and~~ consumer loans and ABS backed by consumer loans, and small balance commercial mortgage loans. In addition to our secured borrowings, we had $86.0 million of Senior Notes outstanding as of both ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019.~~2020.

As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019~~2020 our debt-to-equity ratio was ~~2.7:~~3.1:1 and ~~3.8:~~2.6:1, respectively. Excluding repos on U.S. Treasury securities, our recourse debt-to-equity ratio was ~~1.7:~~2.0:1 as of ~~September 30, 2020~~March 31, 2021 as compared to ~~2.6:~~1.6:1 as of December 31, ~~2019.~~2020. See the discussion in "—Liquidity and Capital Resources" below for further information on our borrowings.

Equity

As of ~~September 30, 2020,~~March 31, 2021, our equity increased by approximately ~~$3.6~~$21.8 million to ~~$872.3~~$943.4 million from ~~$868.7~~$921.6 million as of December 31, ~~2019.~~2020. The increase principally consisted of net ~~proceeds from the issuance~~income of ~~common stock of $95.3~~$41.3 million and contributions from our non-controlling interests of ~~approximately $7.6~~$1.5 million. These increases were partially offset by ~~a net loss of $38.2 million,~~common and preferred dividends of ~~$49.0~~$15.3 million, and distributions to non-controlling interests of ~~approximately $9.6 million, and payments to repurchase shares of common stock of $3.1~~$5.9 million. Stockholders' equity, which excludes the non-controlling interests related to the minority interest in the Operating Partnership as well as the minority interests of our joint venture partners, was ~~$835.1~~$909.9 million as of ~~September 30, 2020.~~

March 31, 2021.

9482

Table of Contents

Results of Operations for the ~~Three- and Nine-Month~~Three-Month Periods Ended ~~September 30,~~March 31, 2021 and 2020 ~~and 2019~~

The following table summarizes our results of operations for the ~~three- and nine-month~~three-month periods ended ~~September 30, 2020~~March 31, 2021 and ~~2019:~~2020:


		Three-Month Period Ended				Nine-Month Period Ended					Three-Month Period Ended
(In thousands except per share amounts)	(In thousands except per share amounts)	September 30, 2020		September 30, 2019		September 30, 2020		September 30, 2019		(In thousands except per share amounts)		March 31, 2021		March 31, 2020
Interest Income (Expense)	Interest Income (Expense)									Interest Income (Expense)
Interest income	Interest income	$	43,075	$	39,985	$	134,463	$	114,548	Interest income		$	40,079	$	52,108
Interest expense	Interest expense	(12,937)		(19,954)		(49,713)		(57,275)		Interest expense		(11,342)		(22,090)
Net interest income	Net interest income	30,138		20,031		84,750		57,273		Net interest income		28,737		30,018
Other Income (Loss)	Other Income (Loss)									Other Income (Loss)
Realized and unrealized gains (losses) on securities and loans, net	Realized and unrealized gains (losses) on securities and loans, net	25,654		9,887		(67,753)		47,935		Realized and unrealized gains (losses) on securities and loans, net		2,495		(121,478)
Realized and unrealized gains (losses) on financial derivatives, net	Realized and unrealized gains (losses) on financial derivatives, net	(1,918)		(7,887)		(27,811)		(40,986)		Realized and unrealized gains (losses) on financial derivatives, net		16,506		(22,390)
Realized and unrealized gains (losses) on real estate owned, net	Realized and unrealized gains (losses) on real estate owned, net	104		1,143		(341)		670		Realized and unrealized gains (losses) on real estate owned, net		(731)		(7)
Other, net	Other, net	(2,747)		539		(1,503)		4,349		Other, net		1,960		1,679
Total other income (loss)	Total other income (loss)	21,093		3,682		(97,408)		11,968		Total other income (loss)		20,230		(142,196)
Expenses	Expenses									Expenses
Base management fee to affiliate (Net of fee rebates of $201, $503, $853, and $1,458, respectively)		2,981		1,942		8,330		5,324
Base management fee to affiliate (Net of fee rebates of $1,051 and $1,967, respectively)(1)										Base management fee to affiliate (Net of fee rebates of $1,051 and $1,967, respectively)(1)		3,277		2,443
Incentive fee to affiliate	Incentive fee to affiliate	—		—		—		—		Incentive fee to affiliate		—		—
Other investment related expenses	Other investment related expenses	3,578		3,287		12,805		11,917		Other investment related expenses		4,855		3,954
Other operating expenses	Other operating expenses	3,919		2,566		11,508		9,713		Other operating expenses		4,197		3,817
Total expenses	Total expenses	10,478		7,795		32,643		26,954		Total expenses		12,329		10,214
Net Income (Loss) before Income Tax Expense (Benefit) and Earnings (Losses) from Investments in Unconsolidated Entities	Net Income (Loss) before Income Tax Expense (Benefit) and Earnings (Losses) from Investments in Unconsolidated Entities	40,753		15,918		(45,301)		42,287		Net Income (Loss) before Income Tax Expense (Benefit) and Earnings (Losses) from Investments in Unconsolidated Entities		36,638		(122,392)
Income tax expense (benefit)	Income tax expense (benefit)	2,494		2		3,490		378		Income tax expense (benefit)		2,017		(547)
Earnings (losses) from investments in unconsolidated entities	Earnings (losses) from investments in unconsolidated entities	11,443		2,796		10,590		6,947		Earnings (losses) from investments in unconsolidated entities		6,635		(6,497)
Net Income (Loss)	Net Income (Loss)	49,702		18,712		(38,201)		48,856		Net Income (Loss)		41,256		(128,342)
Net income (loss) attributable to non-controlling interests	Net income (loss) attributable to non-controlling interests	1,559		1,419		1,894		3,511		Net income (loss) attributable to non-controlling interests		1,459		(885)
Dividends on preferred stock	Dividends on preferred stock	1,940		—		5,822		—		Dividends on preferred stock		1,941		1,941
Net Income (Loss) Attributable to Common Stockholders	Net Income (Loss) Attributable to Common Stockholders	$	46,203	$	17,293	$	(45,917)	$	45,345	Net Income (Loss) Attributable to Common Stockholders		$	37,856	$	(129,398)
Net Income (Loss) Per Common Share	Net Income (Loss) Per Common Share	$	1.06	$	0.53	$	(1.06)	$	1.47	Net Income (Loss) Per Common Share		$	0.86	$	(3.04)

(1)See Note 13 of the notes to the condensed consolidated financial statements for further details on management fee rebates.

Core Earnings

We calculate Core Earnings as U.S. GAAP net income (loss) as adjusted for: (i) realized and unrealized gain (loss) on securities and loans, REO, financial derivatives (excluding periodic settlements on interest rate swaps), other secured borrowings, at fair value, and foreign currency transactions; (ii) incentive fee to affiliate; (iii) Catch-up Premium Amortization Adjustment (as defined below); (iv) non-cash equity compensation expense; (v) provision for income taxes; and (vi) certain other income or loss items that are of a non-recurring nature. For certain investments in unconsolidated entities, we include the relevant components of net operating income in Core Earnings. The Catch-up Premium Amortization Adjustment is a quarterly adjustment to premium amortization triggered by changes in actual and projected prepayments on our Agency RMBS (accompanied by a corresponding offsetting adjustment to realized and unrealized gains and losses). The adjustment is calculated as of the beginning of each quarter based on our then-current assumptions about cashflows and prepayments, and can vary significantly from quarter to quarter.

Core Earnings is a supplemental non-GAAP financial measure. We believe that the presentation of Core Earnings provides a consistent measure of operating performance by excluding the impact of gains and losses and other adjustments

~~Table of Contents~~

listed above from operating results. We believe that Core Earnings provides information useful to investors because it is a metric that we use to assess our performance and to evaluate the effective net yield provided by our portfolio. In addition, we believe that presenting Core Earnings enables our investors to measure, evaluate, and compare our operating performance to that of our peers. However, because Core Earnings is an incomplete measure of our financial results and differs from net income (loss) computed in accordance with U.S. GAAP, it should be considered as supplementary to, and not as a substitute for, net income (loss) computed in accordance with U.S. GAAP.

Table of Contents

The following table reconciles, for the ~~three- and nine-month~~three-month periods ended ~~September 30,~~March 31, 2021 and 2020, ~~and 2019,~~ Core Earnings to the line on the our Condensed Consolidated Statement of Operations entitled Net Income (Loss), which we believe is the most directly comparable U.S. GAAP measure.


		Three-Month Period Ended				Nine-Month Period Ended					Three-Month Period Ended
(In thousands, except per share amounts)	(In thousands, except per share amounts)	September 30, 2020		September 30, 2019		September 30, 2020		September 30, 2019		(In thousands, except per share amounts)		March 31, 2021		March 31, 2020
Net income (loss)	Net income (loss)	$	49,702	$	18,712	$	(38,201)	$	48,856	Net income (loss)		$	41,256	$	(128,342)
Income tax expense (benefit)	Income tax expense (benefit)	2,494		2		3,490		378		Income tax expense (benefit)		2,017		(547)
Net income (loss) before income tax expense (benefit)	Net income (loss) before income tax expense (benefit)	52,196		18,714		(34,711)		49,234		Net income (loss) before income tax expense (benefit)		43,273		(128,889)
Adjustments:	Adjustments:									Adjustments:
Realized (gains) losses on securities and loans, net	Realized (gains) losses on securities and loans, net	(1,446)		(3,368)		2,335		3,460		Realized (gains) losses on securities and loans, net		(4,276)		(12,260)
Realized (gains) losses on financial derivatives, net	Realized (gains) losses on financial derivatives, net	1,620		9,360		25,702		31,850		Realized (gains) losses on financial derivatives, net		(5,795)		12,406
Realized (gains) losses on real estate owned, net	Realized (gains) losses on real estate owned, net	18		(1,165)		(121)		(1,205)		Realized (gains) losses on real estate owned, net		(61)		(350)
Unrealized (gains) losses on securities and loans, net	Unrealized (gains) losses on securities and loans, net	(24,208)		(6,519)		65,418		(51,395)		Unrealized (gains) losses on securities and loans, net		1,781		133,738
Unrealized (gains) losses on financial derivatives, net	Unrealized (gains) losses on financial derivatives, net	298		(1,473)		2,109		9,136		Unrealized (gains) losses on financial derivatives, net		(10,711)		9,984
Unrealized (gains) losses on real estate owned, net	Unrealized (gains) losses on real estate owned, net	(122)		22		462		535		Unrealized (gains) losses on real estate owned, net		792		357
Other realized and unrealized (gains) losses, net(1)	Other realized and unrealized (gains) losses, net(1)	4,217		1,112		5,850		672		Other realized and unrealized (gains) losses, net(1)		(602)		330
Net realized gains (losses) on periodic settlements of interest rate swaps	Net realized gains (losses) on periodic settlements of interest rate swaps	(1,150)		82		(1,900)		852		Net realized gains (losses) on periodic settlements of interest rate swaps		(816)		143
Net unrealized gains (losses) on accrued periodic settlements of interest rate swaps	Net unrealized gains (losses) on accrued periodic settlements of interest rate swaps	516		171		541		(60)		Net unrealized gains (losses) on accrued periodic settlements of interest rate swaps		410		(111)
Incentive fee to affiliate	Incentive fee to affiliate	—		—		—		—		Incentive fee to affiliate		—		—
Non-cash equity compensation expense	Non-cash equity compensation expense	186		116		532		346		Non-cash equity compensation expense		229		164
Negative (positive) component of interest income represented by Catch-up Premium Amortization Adjustment	Negative (positive) component of interest income represented by Catch-up Premium Amortization Adjustment	(319)		1,508		4,440		2,911		Negative (positive) component of interest income represented by Catch-up Premium Amortization Adjustment		87		1,112
Debt issuance costs related to Other secured borrowings, at fair value	Debt issuance costs related to Other secured borrowings, at fair value	—		—		2,075		1,671		Debt issuance costs related to Other secured borrowings, at fair value		1,665		—
Non-recurring expenses(2)		143		16		143		1,333

(Earnings) losses from investments in unconsolidated entities~~(3)~~(2)	(Earnings) losses from investments in unconsolidated entities~~(3)~~(2)	(10,895)		(1,823)		(8,489)		(3,490)		(Earnings) losses from investments in unconsolidated entities~~(3)~~(2)		(4,178)		6,633
Total Core Earnings	Total Core Earnings	21,054		16,753		64,386		45,850		Total Core Earnings		21,798		23,257
Dividends on preferred stock	Dividends on preferred stock	1,940		—		5,822		—		Dividends on preferred stock		1,941		1,941
Core Earnings attributable to non-controlling interests	Core Earnings attributable to non-controlling interests	1,148		1,316		3,683		3,444		Core Earnings attributable to non-controlling interests		1,045		1,524
Core Earnings Attributable to Common Stockholders	Core Earnings Attributable to Common Stockholders	$	17,966	$	15,437	$	54,881	$	42,406	Core Earnings Attributable to Common Stockholders		$	18,812	$	19,792
Core Earnings Attributable to Common Stockholders, per share	Core Earnings Attributable to Common Stockholders, per share	$	0.41	$	0.47	$	1.26	$	1.38	Core Earnings Attributable to Common Stockholders, per share		$	0.43	$	0.46

(1)Includes realized and unrealized gains (losses) on foreign currency and unrealized gain (loss) on other secured borrowings, at fair value, included in Other, net, on the Condensed Consolidated Statement of Operations.

(2)~~For 2020, non-recurring expenses consisted of expensed deferred offering costs; for 2019, non-recurring expenses consisted primarily of professional fees related to the REIT Conversion.~~

~~(3)~~Adjustment represents, for certain investments in unconsolidated entities, the net realized and unrealized gains and losses of the underlying investments of such entities.

~~Table of Contents~~

Results of Operations for the Three-Month Periods Ended ~~September 30,~~March 31, 2021 and 2020 ~~and 2019~~

Net Income (Loss) Attributable to Common Stockholders

For the three-month period ended ~~September 30, 2020~~March 31, 2021 we had net income (loss) attributable to common stockholders of ~~$46.2~~$37.9 million compared to ~~$17.3~~$(129.4) million for the three-month period ended ~~September 30, 2019.~~March 31, 2020. The period-over-period ~~increase~~reversal in our results of operations was primarily due to ~~an increase in other income (loss),~~ net ~~interest income,~~realized and unrealized gains on securities and loans and earnings ~~(losses)~~ from investments in unconsolidated entities in the current period, as compared to losses in the prior period which were primarily the result of the market and economic disruptions caused by the COVID-19 pandemic. Such gains in the current period were partially offset by an increase in ~~total expenses,~~ income tax expense ~~and dividends on preferred stock.~~for the three-month period ended March 31, 2021.

Interest Income

Interest income was ~~$43.1~~$40.1 million for the three-month period ended ~~September 30, 2020,~~March 31, 2021, as compared to ~~$40.0~~$52.1 million for the three-month period ended ~~September 30, 2019.~~March 31, 2020. Interest income for both periods included coupon payments received and accrued on our holdings, the net accretion and amortization of purchase discounts and premiums on those holdings, and interest on our cash balances, including those balances held by our counterparties as collateral.

For the three-month period ended ~~September 30, 2020,~~March 31, 2021, interest income from our credit portfolio was ~~$36.4~~$33.2 million, as compared to ~~$29.6~~$39.1 million for the three-month period ended ~~September 30, 2019.~~March 31, 2020. This period-over-period ~~increase~~decrease was primarily

Table of Contents

due to lower average asset yields, partially offset by a the larger size of the credit portfolio for the three-month period ended ~~September 30, 2020, partially offset by lower average asset yields on this portfolio.~~March 31, 2021.

For the three-month period ended ~~September 30, 2020,~~March 31, 2021, interest income from our Agency RMBS was ~~$6.7~~$6.8 million, as compared to ~~$9.7~~$12.1 million for the three-month period ended ~~September 30, 2019.~~March 31, 2020. This period-over-period decrease was ~~primarily~~ due to the smaller size of the Agency portfolio, ~~partially offset by higher~~as well as lower average asset yields, for the three-month period ended ~~September 30, 2020.~~March 31, 2021.

The following table details our interest income, average holdings of yield-bearing assets, and weighted average yield based on amortized cost for the three-month periods ended ~~September 30, 2020~~March 31, 2021 and ~~2019:~~2020:

Credit(1)
Agency(1)
Total(1)
(In thousands) Interest Income Average Holdings Yield Interest Income Average Holdings Yield Interest Income Average Holdings Yield
Three-month
period ended September 30, 2020 $ 36,354 $ 1,974,414 7.37 % $ 6,663 $ 835,533 3.19 % $ 43,017 $ 2,809,947 6.12 %
Three-month
period ended September 30, 2019 $ 29,623 $ 1,429,975 8.29 % $ 9,736 $ 1,394,913 2.79 % $ 39,359 $ 2,824,888 5.57 %


	Credit(1)						Agency(1)						Total(1)
(In thousands)	Interest Income		Average Holdings		Yield		Interest Income		Average Holdings		Yield		Interest Income		Average Holdings		Yield
Three-month period ended March 31, 2021	$	33,209	$	1,954,914	6.80	%	$	6,752	$	1,202,132	2.25	%	$	39,961	$	3,157,046	5.06	%
Three-month period ended March 31, 2020	$	39,145	$	1,853,988	8.45	%	$	12,068	$	1,831,340	2.64	%	$	51,213	$	3,685,328	5.56	%

(1)Amounts exclude interest income on cash and cash equivalents (including when posted as margin) and long positions in U.S. Treasury securities. Also excludes long holdings of corporate securities that represent components of certain relative value trading strategies.

Some of the variability in our interest income and portfolio yields is due to the Catch-up Premium Amortization Adjustment. For the three-month periods ended ~~September 30,~~March 31, 2021 and 2020 ~~we had a positive Catch-up Premium Amortization Adjustment of approximately $0.3 million, which increased our interest income, while for the three-month periods ended September 30, 2019~~ we had a negative Catch-up Premium Amortization Adjustment of ~~approximately $(1.5)~~$(0.1) million and $(1.1) million, respectively, which decreased our interest income. Excluding the Catch-up Premium Amortization Adjustment, the weighted average yield of our Agency portfolio and our total portfolio was ~~3.04%~~2.28%% and ~~6.08%~~5.07%, respectively, for the three-month period ended ~~September 30, 2020.~~March 31, 2021. Excluding the Catch-up Premium Amortization Adjustment, the weighted average yield of our Agency portfolio and our total portfolio was ~~3.23%~~2.88% and ~~5.79%~~5.68%, respectively, for the three-month period ended ~~September 30, 2019.~~March 31, 2020.

Interest Expense

Interest expense primarily includes interest on funds borrowed under repos and Total other secured borrowings, interest on our Senior Notes, coupon interest on securities sold short, the related net accretion and amortization of purchase discounts and premiums on those short holdings, and interest on our counterparties' cash collateral held by us. Our total interest expense decreased to ~~$12.9~~$11.3 million for the three-month period ended ~~September 30, 2020,~~March 31, 2021, as compared to ~~$20.0~~$22.1 million for the three-month period ended ~~September 30, 2019.~~March 31, 2020. The ~~period-over-period decrease~~decline in interest expense was ~~primarily due to~~the result of lower average borrowings period over period combined with a significant decrease in borrowing rates on both our Agency and credit assets.

~~Table of Contents~~

The table below summarizes the components of interest expense for the three-month periods ended ~~September 30, 2020~~March 31, 2021 and ~~2019.~~2020.


		Three-Month Period Ended				Three-Month Period Ended
(In thousands)	(In thousands)	September 30, 2020		September 30, 2019	(In thousands)	March 31, 2021		March 31, 2020
Repos and Total other secured borrowings	Repos and Total other secured borrowings	$	11,585	18,493	Repos and Total other secured borrowings	$	9,700	$	20,406
Senior Notes ~~(1)~~	Senior Notes ~~(1)~~	1,248		1,248	Senior Notes ~~(1)~~	1,248		1,248
Securities sold short ~~(2)~~(1)	Securities sold short ~~(2)~~(1)	20		131	Securities sold short ~~(2)~~(1)	88		415
Other ~~(3)~~(2)	Other ~~(3)~~(2)	84		82	Other ~~(3)~~(2)	306		21
Total	Total	$	12,937	19,954	Total	$	11,342	$	22,090

(1)~~Amount includes the related amortization of debt issuance costs. Includes interest expense on the Senior Notes.~~

~~(2)~~Amount includes the related net accretion and amortization of purchase discounts and premiums.

~~(3)~~(2)Primarily includes interest expense on our counterparties' cash collateral held by us.

Table of Contents

The following table summarizes our aggregate secured borrowings, which, other than Other secured borrowings, at fair value, carry interest rates that are based on, or correlated with, LIBOR, including repos and Total other secured borrowings, for the three-month periods ended ~~September 30, 2020~~March 31, 2021 and ~~2019.~~2020.


		Three-Month Period Ended													Three-Month Period Ended
		September 30, 2020						September 30, 2019							March 31, 2021						March 31, 2020
Collateral for Secured Borrowing	Collateral for Secured Borrowing	Average Borrowings		Interest Expense		Average Cost of Funds		Average Borrowings		Interest Expense		Average Cost of Funds		Collateral for Secured Borrowing	Average Borrowings		Interest Expense		Average Cost of Funds		Average Borrowings		Interest Expense		Average Cost of Funds
(In thousands)	(In thousands)													(In thousands)
Credit(1)	Credit(1)	$	1,356,028	$	10,817	3.17	%	$	1,028,341	$	10,142	3.91	%	Credit(1)	$	1,411,154	$	8,995	2.59	%	$	1,428,921	$	12,234	3.44	%
Agency RMBS	Agency RMBS	876,995		768		0.35	%	1,320,588		8,351		2.51	%	Agency RMBS	1,182,899		705		0.24	%	1,747,434		8,168		1.88	%
Subtotal(1)	Subtotal(1)	2,233,023		11,585		2.06	%	2,348,929		18,493		3.12	%	Subtotal(1)	2,594,053		9,700		1.52	%	3,176,355		20,402		2.58	%
U.S. Treasury Securities	U.S. Treasury Securities	25		—		(0.02)	%	15		—		0.98	%	U.S. Treasury Securities	—		—		—	%	1,481		4		1.00	%
Total	Total	$	2,233,048	$	11,585	2.06	%	$	2,348,944	$	18,493	3.12	%	Total	$	2,594,053	$	9,700	1.52	%	$	3,177,836	$	20,406	2.58	%
Average One-Month LIBOR	Average One-Month LIBOR					0.16	%					2.18	%	Average One-Month LIBOR					0.12	%					1.40	%
Average Six-Month LIBOR	Average Six-Month LIBOR					0.31	%					2.11	%	Average Six-Month LIBOR					0.22	%					1.49	%

(1)Excludes U.S. Treasury Securities.

Among other instruments, we use interest rate swaps to hedge against the risk of rising interest rates. If we were to include as a component of our cost of funds the amortization of upfront payments and the actual and accrued periodic payments on our interest rate swaps used to hedge our assets, our total average cost of funds would increase to ~~2.24%~~1.65% for the three-month period ended ~~September 30, 2020~~March 31, 2021 and decrease to ~~3.05%~~2.57% for the three-month period ended ~~September 30, 2019.~~March 31, 2020. Excluding the Catch-up Premium Amortization Adjustment, our net interest margin, defined as the yield on our portfolio of yield-bearing targeted assets less our cost of funds (including amortization of upfront payments and actual and accrued periodic payments on interest rate swaps as described above), was ~~3.84%~~3.42% and ~~2.74%~~3.11% for the three-month periods ended ~~September 30,~~March 31, 2021 and 2020, ~~and 2019,~~ respectively. These metrics do not include costs associated with other instruments that we use to hedge interest rate risk, such as TBAs and futures.

Base Management Fees

For the three-month period ended ~~September 30, 2020,~~March 31, 2021, the gross base management fee, which is based on total equity at the end of each quarter, was ~~$3.2~~$3.5 million, and our Manager credited us with rebates on our base management fee of $0.2 million, resulting in a net base management fee of ~~$3.0~~$3.3 million. For the three-month period ended ~~September 30, 2019,~~March 31, 2020, the gross base management fee was ~~$2.4~~$2.9 million, and our Manager credited us with rebates on our base management fee of $0.5 million, resulting in a net base management fee of ~~$1.9~~$2.4 million. For each period, the base management fee rebates related to those of our CLO investments for which Ellington or one of its affiliates earned CLO management fees. The period-over-period increase in the net base management fee was ~~primarily~~ due to our larger capital base at ~~September 30, 2020, as well as a decrease in rebates on our base management fee.~~March 31, 2021.

Incentive Fees

In addition to the base management fee, our Manager is also entitled to a quarterly incentive fee if our performance (as measured by adjusted net income, as defined in the management agreement) over the relevant rolling four quarter calculation

~~Table of Contents~~

period exceeds a defined return hurdle for the period. No incentive fee was incurred for the three-month periods ended ~~September 30,~~March 31, 2021 or 2020, ~~or 2019,~~ since on a rolling four quarter basis, our income did not exceed the prescribed hurdle amount. Because our operating results can vary materially from one period to another, incentive fee expense can be highly variable.

Other Investment Related Expenses

Other investment related expenses consist of servicing fees on our mortgage and consumer loans, as well as various other expenses and fees directly related to our financial assets and certain financial liabilities carried at fair value. For the three-month periods ended ~~September 30,~~March 31, 2021 and 2020 ~~and 2019~~ other investment related expenses were ~~$3.6~~$4.9 million and ~~$3.3~~$4.0 million, respectively. The increase in other investment related expenses was primarily due to the incurrence of debt issuance costs related to our non-QM loan securitization during the three-month period ended March 31, 2021, as well as an increase in various other expenses related to our residential mortgage loan portfolio, partially offset by a decrease in servicing ~~expense~~expenses on our consumer loan portfolios.

Table of Contents

~~Other Operating Expenses~~

Other operating expenses consist of professional fees, compensation expense related to our dedicated or partially dedicated personnel, and various other operating expenses necessary to run our business. Other operating expenses exclude management and incentive fees, interest expense, and other investment related expenses. Other operating expenses were $3.9 million for the three-month period ended September 30, 2020, as compared to $2.6 million for the three-month period ended September 30, 2019. The increase in other operating expenses for the three-month period ended September 30, 2020 was primarily due to increases in professional fees, compensation expense, and fund administration expense.

~~Income Tax Expense (Benefit)~~

Income tax expense was $2.5 million for the three-month period ended September 30, 2020, as compared to $2 thousand for the three-month period ended September 30, 2019. The increase in income tax expense for the three-month period ended September 30, 2020 was primarily due to an increase in deferred tax liabilities related to unrealized gains on investments held in a domestic TRS.

~~Earnings (Losses) from Investments in Unconsolidated Entities~~

We have elected the fair value option for our equity investments in unconsolidated entities. Earnings (losses) from investments in unconsolidated entities was $11.4 million for the three-month period ended September 30, 2020, as compared to $2.8 million for the three-month period ended September 30, 2019. The increase in Earnings (losses) from investments in unconsolidated entities was primarily due to unrealized gains on our investments in mortgage originators.

~~Other Income (Loss)~~

Other income (loss) consists of net realized and unrealized gains (losses) on securities and loans, financial derivatives, and real estate owned. Other, net, another component of Other income (loss), includes rental income and income related to loan origination, as well as realized gains (losses) on foreign currency transactions and unrealized gains (losses) on foreign currency remeasurement and Other Secured Borrowings, at fair value. For the three-month period ended September 30, 2020, other income (loss) was $21.1 million, consisting primarily of net realized and unrealized gains of $25.7 million on our securities and loans, partially offset by net realized and unrealized losses on our financial derivatives of $(1.9) million, and Other, net of $(2.7) million. Net realized and unrealized gains of $25.7 million on our securities and loans primarily resulted from net realized and unrealized gains on our non-QM loans, non-Agency RMBS, CMBS, CLOs, and asset-backed securities backed by consumer loans, partially offset by net realized and unrealized losses on consumer loans. These gains were primarily due to a tightening in credit yield spreads as liquidity continued to improve in these markets. Net realized and unrealized losses of $(1.9) million on our financial derivatives was primarily related to net realized and unrealized losses on CDS on corporate bond indices, forwards, CDS on corporate bonds, and total return swaps, partially offset by net realized and unrealized gains on TBAs and interest rate swaps. Other, net of $(2.7) million primarily comprised net unrealized losses on Other Secured Borrowings, at fair value, partially offset by other income related to our loan portfolios.

For the three-month period ended September 30, 2019, other income was $3.7 million, consisting primarily of net realized and unrealized gains of $9.9 million on our securities and loans, net realized and unrealized gains of $1.1 million on our real estate owned, and gains included in Other, net of $0.5 million, partially offset by net realized and unrealized losses of $(7.9) million on our financial derivatives. Net realized and unrealized gains of $9.9 million on our securities and loans primarily resulted from net realized and unrealized gains on Agency RMBS, residential mortgage loans, non-Agency RMBS, CMBS, and small balance commercial loans and REO, partially offset by net realized and unrealized losses on CLOs, consumer loans, and corporate equity. Net realized and unrealized losses of $(7.9) million on our financial derivatives was primarily related to net realized and unrealized losses on interest rate swaps, TBAs, and futures.

~~Table of Contents~~

~~Results of Operations for the Nine-Month Periods Ended September 30, 2020 and 2019~~

~~Net Income (Loss) Attributable to Common Stockholders~~

For the nine-month period ended September 30, 2020 we had net income (loss) attributable to common stockholders of $(45.9) million compared to $45.3 million for the nine-month period ended September 30, 2019. The period-over-period reversal in our results of operations was primarily due to net realized and unrealized losses on securities and loans, partially offset by an increase in net interest income for the nine-month period ended September 30, 2020.

~~Interest Income~~

Interest income was $134.5 million for the nine-month period ended September 30, 2020, as compared to $114.5 million for the nine-month period ended September 30, 2019. Interest income for both periods included coupon payments received and accrued on our holdings, the net accretion and amortization of purchase discounts and premiums on those holdings, and interest on our cash balances, including those balances held by our counterparties as collateral.

For the nine-month period ended September 30, 2020, interest income from our credit portfolio was $111.4 million, as compared to $86.0 million for the nine-month period ended September 30, 2019. This period-over-period increase was primarily due to the larger size of the credit portfolio for the nine-month period ended September 30, 2020, partially offset by lower average asset yields on this portfolio.

For the nine-month period ended September 30, 2020, interest income from our Agency RMBS was $22.1 million, as compared to $26.8 million for the nine-month period ended September 30, 2019. This period-over-period decrease was primarily due to lower average asset yields for the nine-month period ended September 30, 2020.

The following table details our interest income, average holdings of yield-bearing assets, and weighted average yield based on amortized cost for the nine-month periods ended September 30, 2020 and 2019:

Credit(1)
Agency(1)
Total(1)
(In thousands) Interest Income Average Holdings Yield Interest Income Average Holdings Yield Interest Income Average Holdings Yield
Nine-month
period ended September 30, 2020 $ 111,377 $ 1,941,332 7.65 % $ 22,116 $ 1,196,610 2.46 % $ 133,493 $ 3,137,942 5.67 %
Nine-month
period ended September 30, 2019 $ 86,029 $ 1,380,891 8.31 % $ 26,798 $ 1,210,975 2.95 % $ 112,827 $ 2,591,866 5.80 %

~~(1)~~Amounts exclude interest income on cash and cash equivalents (including when posted as margin) and long positions in U.S. Treasury securities. Also excludes long holdings of corporate securities that represent components of certain relative value trading strategies.

Some of the variability in our interest income and portfolio yields is due to the Catch-up Premium Amortization Adjustment. For the nine-month periods ended September 30, 2020 and 2019, we had a negative Catch-up Premium Amortization Adjustment of approximately $(4.4) million and $(2.9) million, respectively, which decreased our interest income. Excluding the Catch-up Premium Amortization Adjustment, the weighted average yield of our Agency portfolio and our total portfolio was 2.96% and 5.86%, respectively, for the nine-month period ended September 30, 2020. Excluding the Catch-up Premium Amortization Adjustment, the weighted average yield of our Agency portfolio and our total portfolio was 3.27% and 5.95%, respectively for the nine-month period ended September 30, 2019.

~~Interest Expense~~

Interest expense primarily includes interest on funds borrowed under repos and Total other secured borrowings, interest on our Senior Notes, coupon interest on securities sold short, the related net accretion and amortization of purchase discounts and premiums on those short holdings, and interest on our counterparties' cash collateral held by us. Our total interest expense decreased to $49.7 million for the nine-month period ended September 30, 2020, as compared to $57.3 million for the nine-month period ended September 30, 2019. Although average borrowings increased period over period, interest expense declined as a result of a significant decrease in borrowing rates on our both our Agency and credit assets.

~~100~~

~~Table of Contents~~

~~The table below summarizes the components of interest expense for the nine-month periods ended September 30, 2020 and 2019.~~

Nine-Month Period Ended
(In thousands) September 30, 2020 September 30, 2019
Repos and Total other secured borrowings $ 45,377 52,921
Senior Notes (1)
3,745 3,720
Securities sold short (2)
450 533
Other (3)
141 101
Total $ 49,713 57,275

~~(1)~~Amount includes the related amortization of debt issuance costs. For the nine-month period ended September 30, 2020, amount includes interest expense on the Senior Notes. For the nine-month period ended September 30, 2019, amount includes interest expense on the Senior Notes and the Old Senior Notes.

~~(2)Amount includes the related net accretion and amortization of purchase discounts and premiums.~~

~~(3)Primarily includes interest expense on our counterparties' cash collateral held by us.~~

The following table summarizes our aggregate secured borrowings, which, other than Other secured borrowings, at fair value, carry interest rates that are based on, or correlated with, LIBOR, including repos and Total other secured borrowings, for the nine-month periods ended September 30, 2020 and 2019.

Nine-Month Period Ended
September 30, 2020 September 30, 2019
Collateral for Secured Borrowing Average
Borrowings Interest Expense Average
Cost of
Funds Average
Borrowings Interest Expense Average
Cost of
Funds
(In thousands)
Credit(1)
$ 1,389,000 $ 34,132 3.28 % $ 998,151 $ 30,647 4.11 %
Agency RMBS 1,176,191 11,241 1.28 % 1,130,467 22,208 2.63 %
Subtotal(1)
2,565,191 45,373 2.36 % 2,128,618 52,855 3.32 %
U.S. Treasury Securities 513 4 0.96 % 3,664 66 2.41 %
Total $ 2,565,704 $ 45,377 2.36 % $ 2,132,282 $ 52,921 3.32 %
Average One-Month LIBOR 0.65 % 2.37 %
Average Six-Month LIBOR 0.84 % 2.45 %

~~(1)Excludes U.S. Treasury Securities.~~

Among other instruments, we use interest rate swaps to hedge against the risk of rising interest rates. If we were to include as a component of our cost of funds the amortization of upfront payments and the actual and accrued periodic payments on our interest rate swaps used to hedge our assets, our total average cost of funds would increase to 2.45% for the nine-month period ended September 30, 2020 and decrease to 3.24% for the nine-month period ended September 30, 2019. Excluding the Catch-up Premium Amortization Adjustment, our net interest margin, defined as the yield on our portfolio of yield-bearing targeted assets less our cost of funds (including amortization of upfront payments and actual and accrued periodic payments on interest rate swaps as described above), was 3.41% and 2.71% for the nine-month periods ended September 30, 2020 and 2019, respectively. These metrics do not include costs associated with other instruments that we use to hedge interest rate risk, such as TBAs and futures.

~~Base Management Fees~~

For the nine-month period ended September 30, 2020, the gross base management fee, which is based on total equity at the end of each quarter, was $9.2 million, and our Manager credited us with rebates on our base management fee of $0.9 million, resulting in a net base management fee of $8.3 million. For the nine-month period ended September 30, 2019, the gross base management fee was $6.8 million, and our Manager credited us with rebates on our base management fee of $1.5 million, resulting in a net base management fee of $5.3 million. For each period, the base management fee rebates related to those of our CLO investments for which Ellington or one of its affiliates earned CLO management fees. The period-over-period increase in the net base management fee was primarily due to our larger capital base at September 30, 2020.

~~Incentive Fees~~

~~101~~

~~Table of Contents~~

period exceeds a defined return hurdle for the period. No incentive fee was incurred for the nine-month periods ended September 30, 2020 or 2019, since on a rolling four quarter basis, our income did not exceed the prescribed hurdle amount. Because our operating results can vary materially from one period to another, incentive fee expense can be highly variable.

~~Other Investment Related Expenses~~

Other investment related expenses consist of servicing fees on our mortgage and consumer loans, as well as various other expenses and fees directly related to our financial assets and certain financial liabilities carried at fair value. For the nine-month periods ended September 30, 2020 and 2019 other investment related expenses were $12.8 million and $11.9 million, respectively. The increase in other investment related expenses was primarily due to period-over-period increases in debt issuance costs related to our non-QM loan securitizations and servicing expenses on our consumer loan portfolios, partially offset by a decrease in various other expenses related to our residential and commercial mortgage loan and REO portfolios.

Other Operating Expenses

Other operating expenses consist of professional fees, compensation expense related to our dedicated or partially dedicated personnel, and various other operating expenses necessary to run our business. Other operating expenses exclude management and incentive fees, interest expense, and other investment related expenses. Other operating expenses were ~~$11.5~~$4.2 million for the ~~nine-month~~three-month period ended ~~September 30, 2020~~March 31, 2021 as compared to ~~$9.7~~$3.8 million for the ~~nine-month~~three-month period ended ~~September 30, 2019.~~March 31, 2020. The increase in other operating expenses for the ~~nine-month period~~year ended ~~September 30, 2020~~March 31, 2021 was primarily due to an increase in ~~fund administration expenses, the recognition of Delaware corporate franchise tax, and~~ compensation expense.

~~Income Tax Expense (Benefit)~~

Income tax expense was $3.5 million for the nine-month period ended September 30, 2020, as compared to $0.4 million for the nine-month period ended September 30, 2019. The increase in income tax expense for the nine-month period ended September 30, 2020 was primarily due to an increase in deferred tax liabilities related to unrealized gains on investments held in a domestic TRS.

~~Earnings (Losses) from Investments in Unconsolidated Entities~~

We have elected the fair value option for our equity investments in unconsolidated entities. Earnings (losses) from investments in unconsolidated entities was $10.6 million for the nine-month period ended September 30, 2020, as compared to $6.9 million for the nine-month period ended September 30, 2019. The increase in Earnings (losses) from investments in unconsolidated entities was primarily due to unrealized gains on our investments in mortgage originators.

Other Income (Loss)

Other income (loss) consists of net realized and unrealized gains (losses) on securities and loans, financial derivatives, and real estate owned. Other, net, another component of Other income (loss), includes rental income and income related to loan ~~origination,~~originations, as well as realized gains (losses) on foreign currency transactions and unrealized gains (losses) on foreign currency remeasurement and Other Secured Borrowings, at fair value. For the ~~nine-month~~three-month period ended ~~September 30, 2020,~~March 31, 2021, other income (loss) was ~~$(97.4)~~$20.2 million, consisting primarily of net realized and unrealized gains on our financial derivatives of $16.5 million and net realized and unrealized gains of $2.5 million on our securities and loans. Net realized and unrealized gains of $16.5 million on our financial derivatives were primarily related to net realized and unrealized gains on interest rate swaps, TBAs, futures, and forwards, as long-term interest rates increased during the quarter, partially offset by net realized and unrealized losses on CDS on corporate bond indices and total return swaps. Net realized and unrealized gains of $2.5 million on our securities and loans primarily resulted from net realized and unrealized gains on CMBS, CLOs, non-QM loans, and U.S. Treasury securities, partially offset by net realized and unrealized losses on Agency RMBS. These net realized and unrealized gains were driven by tighter yield spreads in the credit portfolio.

For the three-month period ended March 31, 2020, other income (loss) was $(142.2) million, consisting primarily of net unrealized losses of ~~$(67.8)~~$(121.5) million on our securities and loans, and net realized and unrealized losses on our financial derivatives of ~~$(27.8)~~$(22.4) million. ~~Net~~The net realized and unrealized losses were driven by market volatility related to the spread of ~~$(67.8)~~COVID-19. Net unrealized losses of $(121.5) million on our securities and loans primarily resulted from net unrealized losses on CLOs, non-Agency RMBS, CMBS, non-QM loans, and consumer loans and ABS backed by consumer loans, partially offset by net unrealized gains on Agency ~~RMBS and non-QM loans.~~RMBS. These ~~unrealized~~ losses were primarily due to the market and economic disruptions caused by the COVID-19 pandemic. Net realized and unrealized losses of ~~$(27.8)~~$(22.4) million on our financial derivatives was primarily related to net realized and unrealized losses on interest rate swaps, TBAs, futures, and total return swaps, partially offset by net realized and unrealized gains on CDS on asset-backed indices, CDS on corporate bond indices, and CDS on corporate bonds.

~~For~~Income Tax Expense (Benefit)

Income tax expense (benefit) was $2.0 million for the ~~nine-month~~three-month period ended ~~September 30, 2019, other income~~March 31, 2021, as compared to $(0.5) million for the three-month period ended March 31, 2020. Income tax expense for the three-month period ended March 31, 2021 was ~~$12.0 million, consisting~~ primarily ~~of net realized and unrealized gains of $47.9 million on our securities and loans, gains included~~due to an increase in Other, net of $4.3 million, and net realized and unrealized gains of $0.7 million on our real estate owned, partially offset by net realized and unrealized losses of $(41.0) million on our financial derivatives. Net realized and unrealized gains of $47.9 million on our securities and loans primarily resulted fromdeferred tax liabilities related to related to net realized and unrealized gains on ~~Agency RMBS, residential mortgage loans, and non-Agency RMBS and CMBS, partially offset by net realized and~~investments held in a domestic TRS, whereas the income tax benefit for the three-month period ended March 31, 2020 was related to a decrease in deferred tax liabilities related to unrealized losses on ~~CLOs, consumer loans, U.S. Treasury securities, and corporate debt and equity. Net realized and~~investments held in a domestic TRS.

Earnings (Losses) from Investments in Unconsolidated Entities

We have elected the fair value option for our equity investments in unconsolidated entities. Earnings (losses) from investments in unconsolidated entities was $6.6 million for the three-month period ended March 31, 2021, as compared to $(6.5) million for the three-month period ended March 31, 2020. The Earnings (losses) from investments in unconsolidated entities for the three-month period ended March 31, 2021 was primarily due to unrealized ~~losses of $(41.0) million~~gains on our ~~financial derivatives was primarily related~~investments in mortgage loan originators and equity interest in a consumer loan securitization as compared to ~~net realized and~~ unrealized losses on ~~interest rate swaps, TBAs, futures, CDS on corporate bond indices, and CDS on asset-backed indices, partially offset by net realized and unrealized gains on forwards.~~our investments in mortgage loan originators for the three-month period ended March 31, 2020.

~~102~~

~~Table of Contents~~

Liquidity and Capital Resources

Liquidity refers to our ability to meet our cash needs, including repaying our borrowings, funding and maintaining positions in our targeted assets, making distributions in the form of dividends, and other general business needs. Our short-term (one year or less) and long-term liquidity requirements include acquisition costs for assets we acquire, payment of our base management fee and incentive fee, compliance with margin requirements under our repos, reverse repos, and financial derivative contracts, repayment of repo borrowings and other secured borrowings to the extent we are unable or unwilling to extend such borrowings, payment of our general operating expenses, payment of interest payments on our Senior Notes, and payment of our dividends. Our capital resources primarily include cash on hand, cash flow from our investments (including principal and interest payments received on our investments and proceeds from the sale of investments), borrowings under

Table of Contents

repos and other secured borrowings, and proceeds from equity and debt offerings. We expect that these sources of funds will be sufficient to meet our short-term and long-term liquidity needs.

The following summarizes our borrowings under repos by remaining maturity:


(In thousands)	(In thousands)	September 30, 2020				December 31, 2019				(In thousands)	March 31, 2021				December 31, 2020
Remaining Days to Maturity	Remaining Days to Maturity	Outstanding Borrowings		% of Total		Outstanding Borrowings		% of Total		Remaining Days to Maturity	Outstanding Borrowings		% of Total		Outstanding Borrowings		% of Total
30 Days or Less	30 Days or Less	$	282,208	19.6	%	$	528,545	21.6	%	30 Days or Less	$	238,164	12.5	%	$	303,351	20.3	%
31 - 60 Days	31 - 60 Days	516,641		35.9	%	848,878		34.7	%	31 - 60 Days	696,666		36.5	%	469,695		31.4	%
61 - 90 Days	61 - 90 Days	220,473		15.3	%	733,575		30.0	%	61 - 90 Days	286,746		15.0	%	327,012		21.8	%
91 - 120 Days	91 - 120 Days	160,054		11.1	%	10,270		0.4	%	91 - 120 Days	85,916		4.5	%	89,931		6.0	%
121 - 150 Days	121 - 150 Days	6,015		0.4	%	7,460		0.3	%	121 - 150 Days	152,660		8.0	%	69,104		4.6	%
151 - 180 Days	151 - 180 Days	30,987		2.1	%	34,580		1.4	%	151 - 180 Days	85,686		4.5	%	70,920		4.7	%
181 - 360 Days	181 - 360 Days	175,365		12.2	%	186,661		7.7	%	181 - 360 Days	282,578		14.8	%	72,670		4.9	%
> 360 Days	> 360 Days	48,241		3.4	%	95,331		3.9	%	> 360 Days	81,095		4.2	%	94,248		6.3	%
		$	1,439,984	100.0	%	$	2,445,300	100.0	%		$	1,909,511	100.0	%	$	1,496,931	100.0	%

Repos involving underlying investments that were sold prior to ~~September 30, 2020~~March 31, 2021 for settlement following ~~September 30, 2020,~~March 31, 2021, are shown using their ~~original~~contractual maturity dates even though such repos may be expected to be terminated early upon settlement of the sale of the underlying investment.

The amounts borrowed under our repo agreements are generally subject to the application of "haircuts." A haircut is the percentage discount that a repo lender applies to the market value of an asset serving as collateral for a repo borrowing, for the purpose of determining whether such repo borrowing is adequately collateralized. As of ~~September 30, 2020,~~March 31, 2021, the weighted average contractual haircut applicable to the assets that serve as collateral for our outstanding repo borrowings (excluding repo borrowings related to U.S. Treasury securities) was ~~34.1%~~33.0% with respect to credit assets, ~~6.4%~~5.7% with respect to Agency RMBS assets, and ~~19.9%~~14.7% overall. As of December 31, ~~2019~~2020 these respective weighted average contractual haircuts were ~~29.3%~~33.0%, ~~5.0%~~6.0%, and ~~12.3%~~19.1%. The increase in the weighted average contractual haircuts for both our credit assets and our Agency RMBS was primarily due to volatile market conditions and market-wide liquidity stresses resulting from the COVID-19 pandemic. Although this increase in financing haircuts has not yet been shown to be temporary, market haircut levels as of the end of the third quarter were noticeably lower than those observed in early April 2020. Additionally, a significant portion of the increasedecrease in the weighted average contractual haircut on our overall portfolio is due to the ~~lower~~higher share of our ~~overall portfolio represented by~~outstanding borrowings on Agency ~~RMBS.~~assets at March 31, 2021 as compared to December 31, 2020.

We expect to continue to borrow funds in the form of repos as well as other similar types of financings. The terms of our repo borrowings are predominantly governed by master repurchase agreements, which generally conform to the terms in the standard master repurchase agreement as published by the Securities Industry and Financial Markets Association as to repayment and margin requirements. In addition, each lender may require that we include supplemental terms and conditions to the standard master repurchase agreement. Typical supplemental terms and conditions include the addition of or changes to provisions relating to margin calls, net asset value requirements, cross default provisions, certain key person events, changes in corporate structure, and requirements that all controversies related to the repurchase agreement be litigated in a particular jurisdiction. These provisions may differ for each of our repo lenders.

As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, we had ~~$1.4~~$1.9 billion and ~~$2.4~~$1.5 billion, respectively, of borrowings outstanding under our repos. As of ~~September 30, 2020,~~March 31, 2021, the remaining terms on our repos ranged from 1 day to ~~608~~672 days, with a weighted average remaining term of 98118 days. Our repo borrowings were with a total of 24 counterparties as of ~~September 30,~~March 31, 2021. As of March 31, 2021, our repos had a weighted average borrowing rate of 0.80%. As of March 31, 2021, our repos had interest rates ranging from 0.15% to 5.00%. As of December 31, 2020, the remaining terms on our repos ranged from 4 days to 516 days, with a weighted average remaining term of 94 days. Our repo borrowings were with a total of 24 counterparties as of December 31, 2020. As of ~~September 30,~~December 31, 2020, our repos had a weighted average borrowing rate of ~~1.37%~~1.20%. As of ~~September 30,~~December 31, 2020, our repos had interest rates ranging from ~~0.22%~~0.20% to ~~5.24%. As of December 31, 2019, the remaining terms on our repos ranged from~~

~~103~~

~~Table of Contents~~

2 days to 882 days, with a weighted average remaining term of 91 days. Our repo borrowings were with a total of 28 counterparties as of December 31, 2019. As of December 31, 2019, our repos had a weighted average borrowing rate of 2.37%. As of December 31, 2019, our repos had interest rates ranging from 0.15% to 5.20%5.00%. Investments transferred as collateral under repos had an aggregate fair value of ~~$1.8~~$2.2 billion and ~~$2.8~~$1.8 billion as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, respectively.

The interest rates of our repos have historically moved in close relationship to short-term LIBOR rates, and in some cases are explicitly indexed to short-term LIBOR rates and reset accordingly. It is expected that amounts due upon maturity of our repos will be funded primarily through the roll/re-initiation of repos and, if we are unable or unwilling to roll/re-initiate our repos, through free cash and proceeds from the sale of securities.

~~During March~~We have continued to extend and early April, while we were able to roll our repos in an orderly manner, haircuts and borrowing rates were generally higher, and maturities generally shorter. During the remainder of the second quarter, however, we made substantial progress extending and improvingimprove our sources of financing and leverage. In ~~June, in~~ addition to ~~completing our non-QM securitization, we also obtained term~~adding a new loan financing ~~for numerous loan assets that we had previously held unfinanced,~~facility and ~~we extended~~extending the terms of ~~several of our credit facilities. By~~other financing facilities, we completed a non-QM loan securitization during the end of the second quarter, the market for standard repo financing of securities had largely returned to pre-March levels. During the third quarter, we also added a new financing facility for our residential loan strategies.quarter.

Table of Contents

The following table details total outstanding borrowings, average outstanding borrowings, and the maximum outstanding borrowings at any month end for each quarter under repos for the past twelve quarters:


Quarter Ended	Quarter Ended	Borrowings Outstanding at Quarter End		Average Borrowings Outstanding		Maximum Borrowings Outstanding at Any Month End		Quarter Ended	Borrowings Outstanding at Quarter End		Average Borrowings Outstanding		Maximum Borrowings Outstanding at Any Month End
		(In thousands)							(In thousands)
March 31, 2021								March 31, 2021	$	1,909,511	$	1,736,912	$	1,909,511
December 31, 2020								December 31, 2020	1,496,931		1,408,935		1,496,931
September 30, 2020	September 30, 2020	$	1,439,984	$	1,368,191	$	1,551,147	September 30, 2020	1,439,984		1,368,191		1,551,147
June 30, 2020(1)	June 30, 2020(1)	1,294,549		1,520,985		1,542,577		June 30, 2020(1)	1,294,549		1,520,985		1,542,577
March 31, 2020(2)	March 31, 2020(2)	2,034,225		2,440,982		2,485,496		March 31, 2020(2)	2,034,225		2,440,982		2,485,496
December 31, 2019(3)	December 31, 2019(3)	2,445,300		2,119,394		2,445,300		December 31, 2019(3)	2,445,300		2,119,394		2,445,300
September 30, 2019	September 30, 2019	2,056,422		1,796,310		2,056,422		September 30, 2019	2,056,422		1,796,310		2,056,422
June 30, 2019	June 30, 2019	1,715,506		1,769,909		1,962,866		June 30, 2019	1,715,506		1,769,909		1,962,866
March 31, 2019	March 31, 2019	1,550,016		1,471,592		1,550,016		March 31, 2019	1,550,016		1,471,592		1,550,016
December 31, 2018	December 31, 2018	1,498,849		1,509,819		1,595,118		December 31, 2018	1,498,849		1,509,819		1,595,118
September 30, 2018	September 30, 2018	1,636,039		1,534,490		1,672,077		September 30, 2018	1,636,039		1,534,490		1,672,077
June 30, 2018	June 30, 2018	1,421,506		1,398,813		1,471,052		June 30, 2018	1,421,506		1,398,813		1,471,052
March 31, 2018		1,330,943		1,269,297		1,330,943
December 31, 2017(4)		1,209,315		1,050,018		1,209,315

(1)During this quarter, we continued to lower leverage and improve our liquidity given the uncertainty as a result of the COVID-19 pandemic.

(2)In March 2020, in response to significant volatility and heightened risks in the financial markets as a result of the spread of COVID-19, we significantly reduced our outstanding borrowings to lower leverage and increase our liquidity.

(3)At the end of 2019 we increased the size of both our Credit and Agency portfolios which we subsequently financed through repos.

~~(4)At the end of 2017 we increased the size of our Credit portfolio by purchasing certain more liquid, lower-risk securities which we subsequently financed through repos.~~

In addition to our borrowings under repos, we have entered into various other types of transactions to finance certain of our investments, including non-QM loans and REO, and consumer loans and ABS backed by consumer loans; ~~these~~such transactions are accounted for as collateralized borrowings. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, we had outstanding borrowings related to such transactions in the amount of ~~$838.2~~$975.8 million and ~~$744.7~~$806.0 million, respectively, which is reflected under the captions "Other secured borrowings" and "Other secured borrowings, at fair value" on the Condensed Consolidated Balance Sheet. As of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, the fair value of non-QM loans, ~~and REO,~~ consumer loans and ABS backed by consumer loans, and small balance commercial mortgage loans collateralizing our Total other secured borrowings was ~~$971.2 million~~$1.072 billion and ~~$843.4~~$906.4 million, respectively. See Note 11 in the notes to our condensed consolidated financial statements for further information on our other secured borrowings.

As of both ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, we had $86.0 million outstanding of Senior Notes, maturing in September 2022 and bearing interest at a rate of 5.50%, subject to adjustment based on changes, if any, in the ratings of the

~~104~~

~~Table of Contents~~

Senior Notes. ~~These Senior Notes were issued on February 13, 2019 in connection with the Note Exchange.~~ See Note 11 in the notes to our condensed consolidated financial statements for further detail on the Senior Notes.

As of ~~September 30,~~March 31, 2021, we had an aggregate amount at risk under our repos with 24 counterparties of approximately $316.5 million, and as of December 31, 2020, we had an aggregate amount at risk under our repos with 24 counterparties of approximately ~~$370.9 million, and as of December 31, 2019, we had an aggregate amount at risk under our repos with 28 counterparties of approximately $348.4~~$363.1 million. Amounts at risk represent the excess, if any, for each counterparty of the fair value of collateral held by such counterparty over the amounts outstanding under repos. If the amounts outstanding under repos with a particular counterparty are greater than the collateral held by the counterparty, there is no amount at risk for the particular counterparty. Amount at risk as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019~~2020 does not include approximately ~~$4.5~~$4.7 million and ~~$5.1~~$4.2 million, respectively, of net accrued interest receivable, which is defined as accrued interest on securities held as collateral less interest payable on cash borrowed.

Our derivatives are predominantly subject to bilateral collateral arrangements or clearing in accordance with the Dodd-Frank Act. We may be required to deliver or receive cash or securities as collateral upon entering into derivative transactions. Changes in the relative value of derivative transactions may require us or the counterparty to post or receive additional collateral. Entering into derivative contracts involves market risk in excess of amounts recorded on our balance sheet. In the case of cleared derivatives, the clearinghouse becomes our counterparty and the future commission merchant acts as an intermediary between us and the clearinghouse with respect to all facets of the related transaction, including the posting and receipt of required collateral.

As of ~~September 30, 2020,~~March 31, 2021, we had an aggregate amount at risk under our derivative contracts, excluding TBAs, with ten counterparties of approximately ~~$11.8~~$19.0 million. We also had ~~$6.0~~$12.6 million of initial margin for cleared over-the-counter, or "OTC," derivatives posted to central clearinghouses as of that date. As of December 31, ~~2019,~~2020, we had an aggregate amount at

Table of Contents

risk under our derivatives contracts, excluding TBAs, with ~~ten~~eight counterparties of approximately ~~$26.4~~$11.2 million. We also had ~~$14.2~~$7.2 million of initial margin for cleared OTC derivatives posted to central clearinghouses as of that date. Amounts at risk under our derivatives contracts represent the excess, if any, for each counterparty of the fair value of our derivative contracts plus our collateral held directly by the counterparty less the counterparty's collateral held by us. If a particular counterparty's collateral held by us is greater than the aggregate fair value of the financial derivatives plus our collateral held directly by the counterparty, there is no amount at risk for the particular counterparty.

We purchase and sell TBAs and Agency pass-through certificates on a when-issued or delayed delivery basis. The delayed delivery for these securities means that these transactions are more prone to market fluctuations between the trade date and the ultimate settlement date, and therefore are more vulnerable, especially in the absence of margining arrangements with respect to these transactions, to increasing amounts at risk with the applicable counterparties. As of September 30, 2020, in connection with our forward settling TBA and Agency pass-through certificates, we had an aggregate amount at risk with four counterparties of approximately $3.8 million. As of DecemberMarch 31, ~~2019,~~2021, in connection with our forward settling TBA and Agency pass-through certificates, we had an aggregate amount at risk with nine counterparties of approximately ~~$4.2~~$6.0 million. As of December 31, 2020, in connection with our forward settling TBA and Agency pass-through certificates, we had an aggregate amount at risk with six counterparties of approximately $4.1 million. Amounts at risk in connection with our forward settling TBA and Agency pass-through certificates represent the excess, if any, for each counterparty of the net fair value of the forward settling transactions plus our collateral held directly by the counterparty less the counterparty's collateral held by us. If a particular counterparty's collateral held by us is greater than the aggregate fair value of the forward settling transactions plus our collateral held directly by the counterparty, there is no amount at risk for the particular counterparty.

We held cash and cash equivalents of approximately ~~$126.8~~$149.4 million and ~~$72.3~~$111.6 million as of ~~September 30, 2020~~March 31, 2021 and December 31, ~~2019,~~2020, respectively.

On June 13, 2018, our Board of Directors approved the adoption of a share repurchase program under which we are authorized to repurchase up to 1.55 million shares of common stock. The program, which is open-ended in duration, allows us to make repurchases from time to time on the open market or in negotiated transactions, including under 10b5-1 plans. Repurchases are at our discretion, subject to applicable law, share availability, price and our financial performance, among other considerations. In addition to making discretionary repurchases, we from time to time use 10b5-1 plans to increase the number of trading days available to implement these repurchases.

~~During the nine-month period ended September 30, 2020, we repurchased 290,050 shares at an average price per share of $10.54 and a total cost of $3.1 million.~~ From inception of the current repurchase plan through ~~November 6, 2020,~~May 7, 2021, we repurchased 701,965 shares at an average price per share of $13.36 and a total cost of $9.4 million, and have authorization to repurchase an additional 848,035 common shares.

On April 3, 2019, we commenced an "at-the-market" offering program, or "ATM program," by entering into equity distribution agreements with third party sales agents under which we are authorized to offer and sell shares of common stock from time to time with a maximum aggregate gross offering price of up to $150 million. Through January 21, 2020 we We did not

~~105~~

~~Table of Contents~~

~~issue~~ purchase any shares ~~of common stock under~~during the ~~ATM program. Effective January 21, 2020, we terminated the ATM program.~~

On January 24, 2020, we completed a follow-on offering of 5,290,000 shares of our common stock, of which 690,000 shares were issued pursuant to the exercise of the underwriters' option. The issuance and sale of such common shares generated net proceeds, after underwriters' discount and offering costs, of $95.3 million.three-month period ended March 31, 2021.

We may declare dividends based on, among other things, our earnings, our financial condition, the REIT qualification requirements of the Internal Revenue Code of 1986, as amended, our working capital needs and new opportunities. The declaration of dividends to our stockholders and the amount of such dividends are at the discretion of our Board of Directors.

The following table sets forth the dividend distributions authorized by the Board of Directors payable to common ~~shareholders~~stockholders and holders of Convertible Non-controlling Interest Units (as defined in Note 2 of the ~~notes to~~ condensed consolidated financial statements) for the periods indicated below:

~~Nine-Month~~Three-Month Period Ended ~~September 30,~~March 31, 2021

Declaration Date

Dividend Per Share

Dividend Amount

Record Date

Payment Date

(In thousands)

January 8, 2021

0.10

4,444

January 29, 2021

February 25, 2021

February 7, 2021

0.10

4,444

February 26, 2021

March 25, 2021

March 6, 2021

0.10

4,446

March 31, 2021

April 26, 2021

Three-Month Period Ended March 31, 2020

Declaration Date Dividend Per Share Dividend Amount Record Date Payment Date
(In thousands)
January 8, 2020 $ 0.15 $ 6,699 January 31, 2020 February 25, 2020
February 7, 2020 0.15 6,699 February 28, 2020 March 25, 2020
March 6, 2020 0.15 6,658 March 31, 2020 April 27, 2020
April 7, 2020 0.08 3,551 April 30, 2020 May 26, 2020
May 7, 2020 0.08 3,551 May 29, 2020 June 25, 2020
June 5, 2020 0.09 3,995 June 30, 2020 July 27, 2020
July 8, 2020 0.09 3,995 July 31, 2020 August 25, 2020
August 7, 2020 0.09 3,995 August 31, 2020 September 25, 2020
September 8, 2020 0.09 3,997 September 30, 2020 October 26, 2020

Declaration Date

Dividend Per Share

Dividend Amount

Record Date

Payment Date

(In thousands)

January 8, 2020

0.15

6,699

January 31, 2020

February 25, 2020

February 7, 2020

0.15

6,699

February 28, 2020

March 25, 2020

March 6, 2020

0.15

6,658

March 31, 2020

April 27, 2020

~~Nine-Month Period Ended September 30, 2019~~

Declaration Date Dividend Per Share Dividend Amount Record Date Payment Date
(In thousands)
February 14, 2019 $ 0.41 $ 12,496 March 1, 2019 March 15, 2019
March 11, 2019 0.14 4,267 March 29, 2019 April 25, 2019
April 5, 2019 0.14 4,267 April 30, 2019 May 28, 2019
May 7, 2019 0.14 4,267 May 31, 2109 June 25, 2019
June 7, 2019 0.14 4,267 June 28, 2019 July 25, 2019
July 8, 2019 0.14 4,831 July 31, 2019 August 26, 2019
August 7, 2019 0.14 4,831 August 30, 2019 September 25, 2019
September 9, 2019 0.14 4,833 September 30, 2019 October 25, 2019
90

Table of Contents

On ~~October 7, 2020,~~April 4, 2021, the Board of Directors approved a dividend in the amount of ~~$0.09~~$0.14 per share of common stock payable on ~~November~~May 25, ~~2020~~2021 to stockholders of record as of ~~October~~April 30, ~~2020.~~2021. On ~~November 2, 2020,~~May 6, 2021, the Board of Directors approved a dividend in the amount of ~~$0.10~~$0.15 per share of common stock payable on ~~December 28, 2020~~June 25, 2021 to stockholders of record as of ~~November 30, 2020.~~May 25, 2021.

The following table sets forth the dividend distributions authorized by the Board of Directors payable to holders of our Series A Preferred ~~Stock for the periods indicated below:~~Stock:

Declaration Date

Dividend Per Share

Dividend Amount

Record Date

Payment Date

Declaration Date

Dividend Per Share

Dividend Amount

Record Date

Payment Date

(In thousands)

December 13, 2019

0.459380

2,113

December 31, 2019

January 30, 2020

April 7, 2020

0.421875

1,941

April 17, 2020

April 30, 2020

April 7, 2020

0.421875

1,941

April 17, 2020

April 30, 2020

July 8, 2020

0.421875

1,941

July 20, 2020

July 30, 2020

July 8, 2020

0.421875

1,941

July 20, 2020

July 30, 2020

October 7, 2020

0.421875

1,941

October 19, 2020

October 30, 2020

January 8, 2021

0.421875

1,941

January 19, 2021

February 1, 2021

On ~~October 7, 2020,~~April 4, 2021, the Board of Directors approved a dividend in the amount of $0.421875 per share of Series A

~~106~~

~~Table of Contents~~

Preferred Stock payable on ~~October~~April 30, ~~2020~~2021 to stockholders of record as of ~~October~~April 19, ~~2020.~~2021.

For the ~~nine-month~~three-month period ended ~~September 30, 2020,~~March 31, 2021, our operating activities provided net cash in the amount of ~~$82.5~~$9.2 million and our investing activities ~~provided~~used net cash in the amount of ~~$713.5~~$590.3 million. Our repo activity used to finance many of our investments (including repayments of amounts borrowed under our repos) ~~used~~provided net cash of ~~$975.6~~$415.0 million. We received ~~$251.3~~$231.8 million in proceeds from the issuance of Total other secured borrowings and we used ~~$59.9~~$8.0 million for principal payments on Other secured borrowings. Thus our operating and investing activities, when combined with our repo financings and Other secured borrowings (net of repayments), provided net cash of ~~$11.7~~$57.7 million for the ~~nine-month~~three-month period ended ~~September 30,~~March 31, 2021. We received contributions from non-controlling interests which provided cash of $1.2 million and we used $15.3 million to pay dividends and $5.9 million for distributions to non-controlling interests (our joint venture partners). As a result there was an increase in our cash holdings of $37.7 million, from $111.8 million as of December 31, 2020 to $149.5 million as of March 31, 2021.

For the three-month period ended March 31, 2020, our operating activities provided net cash in the amount of $28.9 million and our investing activities provided net cash in the amount of $428.5 million. Our repo activity used to finance many of our investments (including repayments of amounts borrowed under our repos) used net cash of $484.0 million. We received $31.9 million in proceeds from the issuance of Other secured borrowings and we used $10.7 million for principal payments on Other secured borrowings. Thus our operating and investing activities, when combined with our repo financings and Other secured borrowings (net of repayments), used net cash of $5.5 million for the three-month period ended March 31, 2020. We received proceeds from the issuance of common stock, net of offering costs paid, of $95.3 million and contributions from non-controlling interests provided cash of ~~$9.1~~$3.5 million. We used ~~$50.6~~$21.0 million to pay dividends, ~~$8.0~~$4.8 million for distributions to non-controlling interests (our joint venture partners), and ~~$3.1~~$3.0 million to repurchase common stock. As a result there was an increase in our cash holdings of ~~$54.5~~$64.4 million, from $72.5 million as of December 31, 2019 to ~~$127.0~~$136.9 million as of ~~September 30,~~March 31, 2020.

For the nine-month period ended September 30, 2019, our operating activities provided net cash in the amount of $56.1 million and our investing activities used net cash in the amount of $713.3 million. Our repo activity used to finance many of our investments (including repayments, in conjunction with the sales of investments, of amounts borrowed under our repos) provided net cash of $569.3 million. We received $99.5 million in proceeds from the issuance of Total other secured borrowings, we used $51.4 million for principal payments on Other secured borrowings, and we used $1.0 million for Debt issuance costs, which were related to Other secured borrowings, at fair value. Thus our operating and investing activities, when combined with our repo financings, Other secured borrowings (net of repayments), used net cash of $40.8 million for the nine-month period ended September 30, 2019. We received proceeds from the issuance of common stock, net of offering costs paid, of $69.6 million and contributions from non-controlling interests provided cash of $16.9 million. We used $39.2 million to pay dividends, $17.3 million for distributions to non-controlling interests (our joint venture partners), and $0.8 million to repurchase common stock. As a result there was a decrease in our cash holdings of $11.7 million, from $45.1 million as of December 31, 2018 to $33.4 million as of September 30, 2019.

Based on our current portfolio, amount of free cash on hand, debt-to-equity ratio, and current and anticipated availability of credit, we believe that our capital resources will be sufficient to enable us to meet anticipated short-term and long-term liquidity requirements. However, the unexpected inability to finance our Agency RMBS portfolio would create a serious short-term strain on our liquidity and would require us to liquidate much of that portfolio, which in turn would require us to restructure our portfolio to maintain our exclusion from registration as an investment company under the Investment Company Act and to ~~qualify and~~ maintain our qualification as a REIT. Steep declines in the values of our credit assets financed using repos, or in the values of our derivative contracts, would result in margin calls that would significantly reduce our free cash position. Furthermore, a substantial increase in prepayment rates on our assets financed by repos could cause a temporary liquidity shortfall, because we are generally required to post margin on such assets in proportion to the amount of the announced principal paydowns before the actual receipt of the cash from such principal paydowns. If our cash resources are at any time insufficient to satisfy our liquidity requirements, we may have to sell assets or issue additional debt or equity securities.

In March 2020, as a result of significant declines in asset prices and general price volatility, we received margin calls under our financing arrangements and under our derivative contracts that were higher than typical historical levels. During the second and third quarters, prices for most credit assets stabilized and market volatility subsided, and as a result, our margin calls reverted to more typical levels. We satisfied all margin calls during these periods.

Although we may from time to time enter into financing arrangements that limit our leverage, our investment guidelines do not limit the amount of leverage that we may use, and we believe that the appropriate leverage for the particular assets we hold depends on the credit quality and risk of those assets, as well as the general availability and terms of stable and reliable financing for those assets.

Table of Contents

Contractual Obligations and Commitments

We are a party to a management agreement with our Manager. Pursuant to that agreement, our Manager is entitled to receive a base management fee, an incentive fee, reimbursement of certain expenses and, in certain circumstances, a termination fee. Such fees and expenses do not have fixed and determinable payments. For a description of the management agreement provisions, see Note 13 ~~of the notes~~ to our condensed consolidated financial statements.

We have numerous contractual obligations and commitments related to our outstanding borrowings (see Note 11 of the notes to our condensed consolidated financial statements) and related to our financial derivatives (see Note 8 of the notes to our condensed consolidated financial statements).

~~107~~

~~Table of Contents~~

See Note 21 of the notes to our condensed consolidated financial statements ~~as of September 30, 2020~~ for further detail on our other contractual obligations and commitments.

Off-Balance Sheet Arrangements

As of ~~September 30, 2020,~~March 31, 2021, we did not have any material relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. Further, we have not guaranteed any obligations of unconsolidated entities nor do we have any commitment to provide funding to any such entities that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or resources that would be material to an investor in our securities. As such, we are not materially exposed to any market, credit, liquidity, or financing risk that could arise if we had engaged in such relationships.

At ~~September 30, 2020~~March 31, 2021 we have not entered into any repurchase agreements for which delivery of the borrowed funds is not scheduled until after period end.

Inflation

Virtually all of our assets and liabilities are interest rate sensitive in nature. As a result, interest rates and other factors influence our performance far more so than does inflation. Changes in interest rates do not necessarily correlate with inflation rates or changes in inflation rates. Our activities and balance sheet are measured with reference to historical cost and/or fair market value without considering inflation.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

The primary components of our market risk at ~~September 30, 2020~~March 31, 2021 are related to credit risk, prepayment risk, and interest rate risk. We seek to actively manage these and other risks and to acquire and hold assets that we believe justify bearing those risks, and to maintain capital levels consistent with those risks.

Credit Risk

We are subject to credit risk in connection with many of our assets, especially non-Agency RMBS, CMBS, residential and commercial mortgage loans, corporate debt investments including CLOs and investments in securitization warehouses, and consumer loans.

Credit losses on real estate loans can occur for many reasons, including, but not limited to, poor origination practices, fraud, faulty appraisals, documentation errors, poor underwriting, legal errors, poor servicing practices, weak economic conditions, decline in the value of homes, businesses or commercial properties, special hazards, earthquakes and other natural events, such as the COVID-19 pandemic, or an outbreak of another highly infectious or contagious disease, over-leveraging of the borrower on a property, reduction in market rents and occupancies and poor property management services, changes in legal protections for lenders, reduction in personal income, job loss, and personal events such as divorce or health problems. Property values are subject to volatility and may be affected adversely by a number of factors, including, but not limited to, national, regional, and local economic conditions (which may be adversely affected by industry slowdowns and other factors), local real estate conditions (such as an oversupply of housing), changes or continued weakness in specific industry segments, construction quality, age and design, demographic factors, and retroactive changes to building or similar codes.

The ability of borrowers to repay consumer loans may be adversely affected by numerous borrower-specific factors, including unemployment, divorce, major medical expenses or personal bankruptcy. General factors, including an economic downturn, high energy costs or acts of God or terrorism, pandemics such as ~~novel coronavirus (COVID-19)~~the COVID-19 pandemic or another highly infectious or contagious disease, may also affect the financial stability of borrowers and impair their ability or willingness to repay their loans. Whenever any of our consumer loans defaults, we are at risk of loss to the extent of any deficiency between

Table of Contents

the liquidation value of the collateral, if any, securing the loan, and the principal and accrued interest of the loan. Many of our consumer loans are unsecured, or are secured by collateral (such as an automobile) that depreciates rapidly; as a result, these loans may be at greater risk of loss than residential real estate loans.

Our corporate investments, especially our lower-rated or unrated CLO investments, corporate equity, and our investments in loan originators, have significant risk of loss, and our efforts to protect these investments may involve substantial costs and may not be successful. The risk of loss with respect to these investments has been, and will likely continue to be, exacerbated by the COVID-19 pandemic. We also will be subject to significant uncertainty as to when and in what manner and for what value the corporate debt in which we directly or indirectly invest will eventually be satisfied (e.g., through liquidation of the obligor's assets, an exchange offer or plan of reorganization involving the debt securities or a payment of some amount in

~~108~~

~~Table of Contents~~

satisfaction of the obligation). In addition, these investments could involve loans to companies that are more likely to experience bankruptcy or similar financial distress, such as companies that are thinly capitalized, employ a high degree of financial leverage, are in highly competitive or risky businesses, are in a start-up phase, or are experiencing losses.

Similarly, we are exposed to the risk of potential credit losses on the other assets in our credit portfolio.

For many of our investments, the two primary components of credit risk are default risk and severity risk.

Default Risk

Default risk is the risk that a borrower fails to make scheduled principal and interest payments on a mortgage loan or other debt obligation. We may attempt to mitigate our default risk by, among other things, opportunistically entering into credit default swaps and total return swaps. These instruments can reference various MBS indices, corporate bond indices, or corporate entities. We often rely on third-party servicers to mitigate our default risk, but such third-party servicers may have little or no economic incentive to mitigate loan default rates.

Severity Risk

Severity risk is the risk of loss upon a borrower default on a mortgage loan or other secured or unsecured debt obligation. Severity risk includes the risk of loss of value of the property or other asset, if any, securing the mortgage loan or debt obligation, as well as the risk of loss associated with taking over the property or other asset, if any, including foreclosure costs. We often rely on third-party servicers to mitigate our severity risk, but such third-party servicers may have little or no economic incentive to mitigate loan loss severities. In the case of mortgage loans, such mitigation efforts may include loan modification programs and prompt foreclosure and property liquidation following a default. Many of our consumer loans are unsecured, or are secured by collateral (such as an automobile) that depreciates rapidly; as a result, these loans may be at greater risk of loss than residential real estate loans. Pursuing any remaining deficiency following a default on a consumer loan is often difficult or impractical, especially when the borrower has a low credit score, making further substantial collection efforts unwarranted. In addition, repossessing personal property securing a consumer loan can present additional challenges, including locating and taking physical possession of the collateral. We rely on servicers who service these consumer loans, to, among other things, collect principal and interest payments on the loans and perform loss mitigation services, and these servicers may not perform in a manner that promotes our interests. In the case of corporate debt, if a company declares bankruptcy, the bankruptcy process has a number of significant inherent risks. Many events in a bankruptcy proceeding are the product of contested matters and adversarial proceedings and are beyond the control of the creditors. A bankruptcy filing by a company whose debt we have purchased may adversely and permanently affect such company. If the proceeding results in liquidation, the liquidation value of the company may have deteriorated significantly from what we believed to be the case at the time of our initial investment. The duration of a bankruptcy proceeding is also difficult to predict, and our return on investment can be adversely affected by delays until a plan of reorganization or liquidation ultimately becomes effective. A bankruptcy court may also re-characterize our debt investment as equity, and subordinate all or a portion of our claim to that of other creditors. This could occur even if our investment had initially been structured as senior debt.

Prepayment Risk

Prepayment risk is the risk of change, whether an increase or a decrease, in the rate at which principal is returned in respect of fixed-income assets in our portfolio, including both through voluntary prepayments and through liquidations due to defaults and foreclosures. Most significantly, our portfolio is exposed to the risk of changes in prepayment rates of mortgage loans, including the mortgage loans underlying our RMBS, and changes in prepayment rates of certain of our consumer loan holdings. This rate of prepayment is affected by a variety of factors, including the prevailing level of interest rates as well as economic, demographic, tax, social, legal, and other factors. Changes in prepayment rates will have varying effects on the different types of securities in our portfolio, and we attempt to take these effects into account in making asset management decisions. Additionally, increases in prepayment rates may cause us to experience losses on our interest only securities and inverse interest only securities, as those securities are extremely sensitive to prepayment rates. Prepayment rates, besides being subject to interest rates and borrower behavior, are also substantially affected by government policy and regulation. For

Table of Contents

example, the government sponsored HARP program, which was designed to encourage mortgage refinancings, was a steady contributor to Agency RMBS prepayment speeds from its inception in 2009 until its expiration at the end of 2018. Mortgage rates ~~have~~ declined significantly during 2020, and remain very low by historical standards. As a result, prepayments continue to represent a meaningful risk, especially with respect to our Agency RMBS.

Interest Rate Risk

Interest rates are highly sensitive to many factors, including governmental monetary and tax policies, domestic and international economic and political considerations, and other factors beyond our control. We are subject to interest rate risk in connection with most of our assets and liabilities. For some securities in our portfolio, the coupon interest rates on, and

~~109~~

~~Table of Contents~~

therefore also the values of, such securities are highly sensitive to interest rate movements, such as inverse floating rate RMBS, which benefit from falling interest rates. Our repurchase agreements generally carry interest rates that are determined by reference to LIBOR or similar short-term benchmark rates for those same periods. Whenever one of our fixed-rate repo borrowings matures, it will generally be replaced with a new fixed-rate repo borrowing based on market interest rates prevailing at such time. Subject to ~~qualifying and~~ maintaining our qualification as a REIT and our exclusion from registration under the Investment Company Act, we opportunistically hedge our interest rate risk by entering into interest rate swaps, TBAs, U.S. Treasury securities, Eurodollar futures, U.S. Treasury futures, and other instruments. In general, such hedging instruments are used to mitigate the interest rate risk arising from the mismatch between the duration of our financed assets and the duration of the liabilities used to finance such assets. The majority of this mismatch currently relates to our Agency RMBS.

The following sensitivity analysis table shows the estimated impact on the value of our portfolio segregated by certain identified categories as of ~~September 30, 2020,~~March 31, 2021, assuming a static portfolio and immediate and parallel shifts in interest rates from current levels as indicated below.


(In thousands)	(In thousands)	Estimated Change for a Decrease in Interest Rates by								Estimated Change for an Increase in Interest Rates by								(In thousands)	Estimated Change for a Decrease in Interest Rates by								Estimated Change for an Increase in Interest Rates by
		50 Basis Points				100 Basis Points				50 Basis Points				100 Basis Points					50 Basis Points				100 Basis Points				50 Basis Points				100 Basis Points
Category of Instruments	Category of Instruments	Market Value		% of Total Equity		Market Value		% of Total Equity		Market Value		% of Total Equity		Market Value		% of Total Equity		Category of Instruments	Market Value		% of Total Equity		Market Value		% of Total Equity		Market Value		% of Total Equity		Market Value		% of Total Equity
Agency RMBS	Agency RMBS	$	6,505	0.75	%	$	10,800	1.24	%	$	(8,715)	(1.00)	%	$	(19,640)	(2.25)	%	Agency RMBS	$	13,645	1.45	%	$	22,951	2.43	%	$	(17,984)	(1.91)	%	$	(40,306)	(4.27)	%
Non-Agency RMBS, CMBS, ABS and Loans	Non-Agency RMBS, CMBS, ABS and Loans	5,713		0.66	%	12,152		1.39	%	(4,986)		(0.57)	%	(9,245)		(1.06)	%	Non-Agency RMBS, CMBS, ABS and Loans	5,322		0.56	%	11,158		1.18	%	(4,808)		(0.51)	%	(9,102)		(0.96)	%
U.S. Treasury Securities, and Interest Rate Swaps, Options, and Futures	U.S. Treasury Securities, and Interest Rate Swaps, Options, and Futures	(8,352)		(0.96)	%	(17,002)		(1.95)	%	8,051		0.92	%	15,802		1.81	%	U.S. Treasury Securities, and Interest Rate Swaps, Options, and Futures	(17,784)		(1.89)	%	(36,126)		(3.83)	%	17,224		1.83	%	33,889		3.59	%
Mortgage-Related Derivatives	Mortgage-Related Derivatives	—		—	%	—		—	%	1		—	%	2		—	%	Mortgage-Related Derivatives	1		—	%	2		—	%	—		—	%	1		—	%
Corporate Securities and Derivatives on Corporate Securities	Corporate Securities and Derivatives on Corporate Securities	(4)		—	%	(7)		—	%	6		—	%	13		—	%	Corporate Securities and Derivatives on Corporate Securities	9		—	%	17		—	%	(9)		—	%	(19)		—	%
Repurchase Agreements, Reverse Repurchase Agreements, and Senior Notes	Repurchase Agreements, Reverse Repurchase Agreements, and Senior Notes	(916)		(0.11)	%	(739)		(0.08)	%	1,915		0.22	%	4,480		0.52	%	Repurchase Agreements, Reverse Repurchase Agreements, and Senior Notes	(1,192)		(0.12)	%	(995)		(0.10)	%	2,798		0.30	%	6,126		0.65	%
Total	Total	$	2,946	0.34	%	$	5,204	0.60	%	$	(3,728)	(0.43)	%	$	(8,588)	(0.98)	%	Total	$	1	—	%	$	(2,993)	(0.32)	%	$	(2,779)	(0.29)	%	$	(9,411)	(0.99)	%

The preceding analysis does not show sensitivity to changes in interest rates for instruments for which we believe that the effect of a change in interest rates is not material to the value of the overall portfolio and/or cannot be accurately estimated. In particular, this analysis excludes certain of our holdings of corporate securities and derivatives on corporate securities, and reflects only sensitivity to U.S. interest rates.

Our analysis of interest rate risk is derived from Ellington's proprietary models as well as third-party information and analytics. Many assumptions have been made in connection with the calculations set forth in the table above and, as such, there can be no assurance that assumed events will occur or that other events will not occur that would affect the outcomes. For example, for each hypothetical immediate shift in interest rates, assumptions have been made as to the response of mortgage prepayment rates, the shape of the yield curve, and market volatilities of interest rates; each of the foregoing factors can significantly and adversely affect the fair value of our interest rate-sensitive instruments.

The above analysis utilizes assumptions and estimates based on management's judgment and experience, and relies on financial models, which are inherently imperfect; in fact, different models can produce different results for the same securities. While the table above reflects the estimated impacts of immediate parallel interest rate increases and decreases on specific categories of instruments in our portfolio, we actively trade many of the instruments in our portfolio, and therefore our current

Table of Contents

or future portfolios may have risks that differ significantly from those of our ~~September 30, 2020~~March 31, 2021 portfolio estimated above. Moreover, the impact of changing interest rates on fair value can change significantly when interest rates change by a greater amount than the hypothetical shifts assumed above. Furthermore, our portfolio is subject to many risks other than interest rate risks, and these additional risks may or may not be correlated with changes in interest rates. For all of the foregoing reasons and others, the table above is for illustrative purposes only and actual changes in interest rates would likely cause changes in the actual fair value of our portfolio that would differ from those presented above, and such differences might be significant and adverse. See "—Special Note Regarding Forward-Looking Statements."

~~110~~

~~Table of Contents~~

Item 4. Controls and Procedures

Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management as appropriate to allow timely decisions regarding required disclosures. An evaluation was performed under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of ~~September 30, 2020.~~March 31, 2021. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of ~~September 30, 2020.~~March 31, 2021.

Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting that occurred during the quarter ended ~~September 30, 2020~~March 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

~~111~~95

~~Table of Contents~~

PART IIII—OTHER INFORMATION

Item 1. Legal Proceedings

Neither we nor Ellington nor its affiliates (including our Manager) are currently subject to any legal proceedings that we or our Manager consider material. Nevertheless, we and Ellington and its affiliates operate in highly regulated markets that currently are under regulatory scrutiny, and over the years, Ellington and its affiliates have received, and we expect in the future that we and they may receive, inquiries and requests for documents and information from various federal, state and foreign regulators.

We and Ellington cannot provide any assurance that, whether the result of regulatory inquiries or otherwise, neither we nor Ellington nor its affiliates will become subject to investigations, enforcement actions, fines, penalties or the assertion of private litigation claims or that, if any such events were to occur, they would not materially adversely affect us. For a discussion of these and other related risks, see "Part I, Item 1A. Risk Factors—We, Ellington, or its affiliates may be subject to regulatory inquiries and proceedings, or other legal proceedings" of our Annual Report on Form 10-K for the year ended December 31, ~~2019.~~2020.

Item 1A. Risk Factors

For information regarding factors that could affect our results of operations, financial condition, and liquidity, see the risk factors discussed under "Risk Factors" in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December ~~31, 2019 and in Part II, Item 1A of our Quarterly Report on Form 10-Q, as amended, for the three-month period ended March~~ 31, 2020. There have been no material changes from these previously disclosed risk factors. See also "Special Note Regarding Forward-Looking Statements," included in Part I, Item 2 of this Quarterly Report on Form 10-Q.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered Sales of Equity Securities

~~On September 10, 2020,~~Pursuant to our 2017 Plan, on March 3, 2021, we granted ~~5,710 limited liability company interests ("~~17,231 OP LTIP ~~Units")~~Units to ~~Thomas Robards, 5,710~~certain Ellington personnel. The OP LTIP ~~units~~Units are subject to ~~Ronald I. Simon, Ph.D., 5,710~~forfeiture restrictions that will lapse with respect to 3,697 of the OP LTIP ~~units to Edward Resendez,~~Units on December 31, 2021 and ~~5,710~~13,534 of the OP LTIP ~~units to Lisa Mumford, as compensation for serving as directors. The~~Units on December 31, 2022. Once vested, the OP LTIP Units may be converted ~~upon lapse of the applicable vesting restrictions,~~ at the election of the holder, or at any time at our election, into ~~limited liability company interests of the Operating Partnership designated as common units ("Common Units")~~OP Units on a one-for-one basis. Subject to certain conditions, the ~~Common~~OP Units are redeemable by the holder for an equivalent number of shares of our common ~~shares~~stock or, at our election, for the cash value of such shares of our common ~~shares, at our election. These grants were made pursuant to our 2017 Equity Incentive Plan and such~~stock. Such grants were exempt from the registration requirements of the Securities Act based on the exemption provided in Section 4(a)(2) of the Securities Act.

On September 11, 2020, we issued 3,638 common shares in exchange for OP LTIP Units held by one of our directors. This issuance was exempt from the registration requirements of the Securities Act based on the exemption provided by Section 4(a)(2) of the Securities Act.

~~112~~96

~~Table of Contents~~

Item 6. Exhibits


Exhibit						Description
31.1						Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes – Oxley Act of 2002

31.2						Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes – Oxley Act of 2002

32.1*						Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes – Oxley Act of 2002

32.2*						Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes – Oxley Act of 2002

101.INS						Inline XBRL Instance Document

101.SCH						Inline XBRL Taxonomy Extension Schema

101.CAL						Inline XBRL Taxonomy Extension Calculation Linkbase

101.DEF						Inline XBRL Taxonomy Extension Definition Linkbase

101.LAB						Inline XBRL Taxonomy Extension Label Linkbase

101.PRE						Inline XBRL Taxonomy Extension Presentation Linkbase

104						Cover Page Interactive Data File (embedded within the Inline XBRL document)

* Furnished herewith. These certifications are not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

~~113~~97

~~Table of Contents~~

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ELLINGTON FINANCIAL INC.

Date:

~~November 9, 2020~~May 10, 2021

By:

/s/ LAURENCE PENN

Laurence Penn
Chief Executive Officer
(Principal Executive Officer)

ELLINGTON FINANCIAL INC.

Date:

~~November 9, 2020~~May 10, 2021

By:

/s/ JR HERLIHY

JR Herlihy
Chief Financial Officer
(Principal Financial and Accounting Officer)

~~114~~98


(In thousands)	Beginning Balance as of June 30, 2019		Accreted Discounts / (Amortized Premiums)		Net Realized Gain/ (Loss)		Change in Net Unrealized Gain/(Loss)		Purchases/ Payments(1)		Sales/ Issuances(2)		Transfers Into Level 3		Transfers Out of Level 3		Ending Balance as of September 30, 2019
Assets:
Securities, at fair value:
Agency RMBS	$	11,034	$	(1,164)	$	(621)	$	696	$	13,254	$	0	$	737	$	(437)	$	23,499
Non-Agency RMBS	96,790		(121)		7,836		(6,457)		6,483		(21,457)		5,808		(7,400)		81,482
CMBS	6,278		25		374		(302)		6,815		(1,474)		652		0		12,368
CLOs	17,222		(184)		1,158		184		0		(1,139)		15,287		(4,520)		28,008
Asset-backed securities backed by consumer loans	25,019		(611)		(100)		(320)		18,638		(3,310)		0		0		39,316
Corporate debt securities	4,081		0		(583)		142		6,425		(6,883)		0		0		3,182
Corporate equity securities	1,791		0		(768)		(61)		1,316		0		0		0		2,278
Loans, at fair value:
Residential mortgage loans	663,880		(2,241)		(400)		3,559		191,512		(58,582)		0		0		797,728
Commercial mortgage loans	260,034		(52)		(1)		507		32,426		(32,288)		0		0		260,626
Consumer loans	162,609		(6,474)		(1,055)		28		33,101		(36,510)		0		0		151,699
Corporate loans	5,000		0		0		0		10,790		0		0		0		15,790
Investment in unconsolidated entities, at fair value	69,676		0		(139)		2,935		9,643		(11,680)		0		0		70,435
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	1,090		0		16		(12)		10		(26)		0		0		1,078
Total return swaps	87		0		(15)		148		0		15		0		0		235
Total assets, at fair value	$	1,324,591	$	(10,822)	$	5,702	$	1,047	$	330,413	$	(173,334)	$	22,484	$	(12,357)	$	1,487,724
Liabilities:
Financial derivatives–liabilities, at fair value:
Total return swaps	$	0	$	0	$	48	$	(214)	$	0	$	(48)	$	0	$	0	$	(214)
Other secured borrowings, at fair value	$	(475,816)	$	0	$	0	$	(72)	$	37,259	$	0	$	0	$	0	$	(438,629)
Total liabilities, at fair value	$	(475,816)	$	0	$	48	$	(286)	$	37,259	$	(48)	$	0	$	0	$	(438,843)


(In thousands)	Beginning Balance as of January 1, 2019		Accreted Discounts / (Amortized Premiums)		Net Realized Gain/ (Loss)		Change in Net Unrealized Gain/(Loss)		Purchases/ Payments(1)		Sales/ Issuances(2)		Transfers Into Level 3		Transfers Out of Level 3		Ending Balance as of September 30, 2019
Assets:
Securities, at fair value:
Agency RMBS	$	7,293	$	(2,228)	$	(1,228)	$	1,430	$	14,854	$	(463)	$	4,708	$	(867)	$	23,499
Non-Agency RMBS	91,291		104		7,187		(4,482)		10,239		(27,514)		14,633		(9,976)		81,482
CMBS	803		(16)		76		(73)		7,937		(221)		3,862		0		12,368
CLOs	14,915		(670)		(536)		1,889		816		(1,125)		15,287		(2,568)		28,008
Asset-backed securities backed by consumer loans	22,800		(1,580)		(765)		537		28,189		(9,865)		0		0		39,316
Corporate debt securities	6,318		22		(928)		65		9,257		(11,552)		0		0		3,182
Corporate equity securities	1,534		0		(910)		337		1,317		0		0		0		2,278
Loans, at fair value:
Residential mortgage loans	496,829		(4,515)		1,554		7,717		452,958		(156,815)		0		0		797,728
Commercial mortgage loans	195,301		1,087		1,412		(1,844)		128,839		(64,169)		0		0		260,626
Consumer loans	183,961		(22,432)		(4,565)		2,726		103,983		(111,974)		0		0		151,699
Corporate loan	0		0		0		0		15,790		0		0		0		15,790
Investment in unconsolidated entities, at fair value	72,298		276		1,545		5,125		40,097		(48,906)		0		0		70,435
Financial derivatives–assets, at fair value:
Credit default swaps on asset-backed securities	1,472		0		419		(394)		18		(437)		0		0		1,078
Total return swaps	0		0		1		235		0		(1)		0		0		235
Total assets, at fair value	$	1,094,815	$	(29,952)	$	3,262	$	13,268	$	814,294	$	(433,042)	$	38,490	$	(13,411)	$	1,487,724
Liabilities:
Financial derivatives–liabilities, at fair value:
Total return swaps	$	0	$	0	$	48	$	(214)	$	0	$	(48)	$	0	$	0	$	(214)
Other secured borrowings, at fair value	(297,948)		0		0		(32)		78,887		(219,536)		0		0		(438,629)
Total liabilities, at fair value	$	(297,948)	$	0	$	48	$	(246)	$	78,887	$	(219,584)	$	0	$	0	$	(438,843)


(In thousands)	September 30, 2020 (1)		December 31, 2019 (1)
Assets
Cash and cash equivalents	$	1,152	$	6,016
Restricted cash	175		175
Securities, at fair value	46,857		47,923
Loans, at fair value	1,423,035		1,393,916
Investments in unconsolidated entities, at fair value	6,289		5,641
Real estate owned	24,794		30,584
Investment related receivables	43,542		28,668
Other assets	2,250		6,191
Total Assets	$	1,548,094	$	1,519,114
Liabilities
Repurchase agreements	$	260,310	$	302,791
Investment related payables	0		3,275
Other secured borrowings	142,674		150,334
Other secured borrowings, at fair value	695,516		594,396
Interest payable	402		1,247
Accrued expenses and other liabilities	1,301		2,279
Total Liabilities	1,100,203		1,054,322
Total Stockholders' Equity	422,217		440,394
Non-controlling interests	25,674		24,400
Total Equity	447,891		464,794
Total Liabilities and Equity	$	1,548,094	$	1,519,116